<SEC-DOCUMENT>0001104659-26-077798.txt : 20260625
<SEC-HEADER>0001104659-26-077798.hdr.sgml : 20260625
<ACCEPTANCE-DATETIME>20260625164323
ACCESSION NUMBER:		0001104659-26-077798
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		19
CONFORMED PERIOD OF REPORT:	20260813
FILED AS OF DATE:		20260625
DATE AS OF CHANGE:		20260625

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cytosorbents Corp
		CENTRAL INDEX KEY:			0001175151
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				980373793
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36792
		FILM NUMBER:		261122569

	BUSINESS ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		973-329-8885

	MAIL ADDRESS:	
		STREET 1:		305 COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MedaSorb Technologies CORP
		DATE OF NAME CHANGE:	20060807

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GILDER ENTERPRISES INC
		DATE OF NAME CHANGE:	20020611
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm263197d5_def14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Thu Jun 25 18:21:18 UTC 2026 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:ctso="http://cytosorbents.com/20251231" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Washington,
D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="-sec-ix-hidden: hidden-fact-0">SCHEDULE 14A</span> INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proxy Statement Pursuant to Section&#160;14(a)&#160;of
the Securities Exchange Act of 1934 (Amendment No.)</b></p><div>

</div><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">Filed by the Registrant
</span><span>&#9746;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">Filed by a Party
other than the Registrant </span><span>&#9744;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left"><span style=" font-size: 10pt"><span>&#9744;</span></span></td><td style="text-align: justify">Preliminary Proxy Statement</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left"><span style=" font-size: 10pt">&#9744;</span></td><td style="text-align: justify">Confidential, for Use of the Commission Only (as permitted by
Rule&#160;14a-6(e)(2))</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left"><span>&#9746;</span></td><td style="text-align: justify">Definitive Proxy Statement</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left"><span style="font-size: 10pt"><span>&#9744;</span></span></td><td style="text-align: justify">Definitive Additional Materials</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.5in; text-align: left"><span style="font-size: 10pt"><span>&#9744;</span></span></td><td style="text-align: justify">Soliciting Material under &#167;240.14a-12</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-107"><span style="font-size: 14pt"><b>CYTOSORBENTS
CORPORATION</b></span></ix:nonNumeric>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Name of Registrant as Specified in its Charter)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(Name of Person(s)&#160;Filing Proxy Statement,
if other than the Registrant)</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check the appropriate box):</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style=" font-size: 10pt">&#9746;</span></td><td style="text-align: justify">No fee required.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style=" font-size: 10pt">&#9744;</span></td><td style="text-align: justify">Fee paid previously with preliminary materials.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style=" font-size: 10pt">&#9744;</span></td><td style="text-align: justify">Fee computed on table in exhibit required by Item&#160;25(b)&#160;per
Exchange Act Rules&#160;14a-6(i)(1)&#160;and 0-11.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CytoSorbents Corporation</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>305 College Road East</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Princeton, NJ 08540</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOTICE IS HEREBY GIVEN that
the Annual Meeting of the holders of shares of common stock, each having a par value of $0.001 per share (&#8220;<b>Common Stock</b>&#8221;),
of CytoSorbents Corporation (&#8220;<b>CytoSorbents</b>&#8221; or the &#8220;<b>Company</b>&#8221;) will be held virtually on Thursday,
August&#160;13, 2026 at 10:00&#160;a.m.&#160;Eastern Time (the &#8220;<b>Annual Meeting</b>&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Virtual Annual Meeting</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Board
of Directors (the &#8220;<b>Board</b>&#8221;) has determined to hold a virtual Annual Meeting in order to facilitate stockholder attendance
and participation by enabling stockholders to participate from any location and at no cost. We believe this is the right choice for the
Company at this time, as it enables engagement with our stockholders, regardless of size, resources, or physical location. We are committed
to ensuring that our stockholders will be afforded the same rights and opportunities to participate as they would at an in-person meeting.
You will be able to attend the virtual Annual Meeting and vote your shares electronically during the Annual Meeting by visiting <i>www.virtualshareholdermeeting.com/CTSO2026</i>.
To participate in the virtual Annual Meeting, you will need the 16-digit control number included on your &#8220;Notice of Internet Availability
of Proxy Materials&#8221; (the &#8220;<b>Notice</b>&#8221;) proxy card or voting instruction form. The Annual Meeting webcast will begin
promptly at 10:00&#160;a.m.&#160;Eastern Time. We encourage you to access the Annual Meeting prior to the start time. Online check-in
will begin at approximately 9:45&#160;a.m.&#160;Eastern Time, and you should allow ample time for the check-in procedures. We will have
technicians ready to assist you with any technical difficulties you may have accessing the virtual Annual Meeting. A phone number where
you can obtain technical assistance will be made available on the day of the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Items of Business</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At the Annual Meeting, you will be asked to consider
and take action with respect to the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">1.</td><td style="text-align: justify">To elect five directors, who shall each serve for a term of one-year, or until their respective successors
are elected, except in the case of the death, resignation or removal of any director;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">2.</td><td style="text-align: justify">To approve, on a non-binding, advisory basis, the compensation of the Company&#8217;s named executive
officers, disclosed pursuant to Item&#160;402 of Regulation S-K;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">3.</td><td style="text-align: justify">To ratify the appointment of WithumSmith+Brown, PC as the Company&#8217;s independent registered public
accounting firm to audit the Company&#8217;s financial statements for the fiscal year ending December&#160;31, 2026;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">4.</td><td style="text-align: justify">To approve an amendment to the Company&#8217;s Certificate of Incorporation to effect a reverse stock
split of the Company&#8217;s Common Stock, subject to our Board&#8217;s discretion, at a ratio of not less than 1-for-5 and not greater
than 1-for-20, with the exact ratio to be set within that range at the discretion of our Board, without further approval or authorization
of our stockholders, prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company&#8217;s
stockholders at the Annual Meeting (the &#8220;<b>Reverse Stock Split Proposal</b>&#8221;);</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">5.</td><td style="text-align: justify">To approve an adjournment of the Annual Meeting to a later date or time, if necessary, to permit further
solicitation and vote of proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals presented
for a vote at the Annual Meeting (the &#8220;<b>Adjournment Proposal</b>&#8221;); and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">6.</td><td style="text-align: justify">To conduct such other business as may properly come before the Annual Meeting or any adjournments or postponements
thereof.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing items of business
are fully described in the Proxy Statement accompanying this Notice. Only holders of Common Stock of record at the close of business on
June 15, 2026 are entitled to notice of, and to vote at, the Annual Meeting or any adjournments or postponements thereof.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board recommends that
you vote as follows on the matters to be presented at the Annual Meeting:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">1.</td><td style="text-align: justify"><b>FOR</b> the election of the five nominees to the Board, each for a one-year term, or until their respective
successors are elected, except in the case of the death, resignation or removal of any director.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">2.</td><td style="text-align: justify"><b>FOR</b> the vote to approve the compensation of the Company&#8217;s named executive officers, disclosed
pursuant to Item&#160;402 of Regulation S-K, on a non-binding, advisory basis.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">3.</td><td style="text-align: justify"><b>FOR</b> the ratification of the appointment of WithumSmith+Brown, PC as our independent registered
public accounting firm for the fiscal year ending December&#160;31, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">4.</td><td style="text-align: justify"><b>FOR</b> the approval of an amendment to the Company&#8217;s Certificate of Incorporation to effect
a reverse stock split of the Company&#8217;s Common Stock, subject to our Board&#8217;s discretion, at a ratio of not less than 1-for-5
and not greater than 1-for-20, with the exact ratio to be set within that range at the discretion of our Board, without further approval
or authorization of our stockholders, prior to the one-year anniversary of the date on which the reverse stock split is approved by the
Company&#8217;s stockholders at the Annual Meeting.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">5.</td><td style="text-align: justify"><b>FOR </b>the approval of an adjournment of the Annual Meeting to a later date or time, if necessary,
to permit further solicitation and vote of proxies if there are insufficient votes at the time of the Annual Meeting to approve any of
the proposals presented for a vote at the Annual Meeting.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Consistent with prior years,
we are providing access to our proxy materials, including our annual report on Form&#160;10-K for the year ended December&#160;31, 2025
(the &#8220;<b>Annual Report</b>&#8221;), via the Internet instead of mailing printed copies to each stockholder of record, which allows
for more efficient and timely distribution of our proxy materials. This reduces the amount of paper necessary to produce these materials,
as well as the costs associated with mailing these materials to all stockholders. Accordingly, on or around June 25, 2026, we began mailing the
Notice to all stockholders of record as of June 15, 2026, and posted our proxy materials on the website referenced in the Notice (<i>www.proxyvote.com</i>).
As more fully described in the Notice, all stockholders may choose to access our proxy materials on the website referred to in the Notice
or may request to receive a printed set of our proxy materials. In addition, the Notice and website provide information regarding how
you may request to receive proxy materials in printed form by mail or electronically by email on an ongoing basis. Your choice for ongoing
delivery will remain in effect unless you change it.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>IMPORTANT NOTICE REGARDING THE AVAILABILITY
OF PROXY MATERIALS FOR THE 2026 ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON AUGUST 13, 2026.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OUR PROXY STATEMENT AND ANNUAL REPORT FOR THE
FISCAL YEAR ENDED DECEMBER 31, 2025 ARE AVAILABLE FREE OF CHARGE AT WWW.PROXYVOTE.COM.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>YOUR VOTE IS VERY IMPORTANT, REGARDLESS OF THE
NUMBER OF SHARES YOU OWN. WHETHER OR NOT YOU EXPECT TO ATTEND VIRTUALLY, PLEASE PROMPTLY VOTE YOUR PROXY BY ACCESSING THE INTERNET SITE
AND FOLLOWING THE INSTRUCTIONS ON THE PROXY CARD OR BY REQUESTING A PRINTED COPY OF THE PROXY MATERIALS AND MARKING, DATING, SIGNING AND
RETURNING THE PROXY CARD.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table border="0" cellpadding="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
<tr style="vertical-align: top">
  <td style="border-bottom: Black 1pt solid; width: 50%"><span style="font-size: 10pt">/s/ Phillip P. Chan</span></td>
  <td style="width: 50%">&#160;</td></tr>
</table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Phillip
P. Chan, MD, PhD<br/>
Chief Executive Officer</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Princeton, New Jersey<br/>
Dated: June 25, 2026</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 3 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="margin: 0pt">&#160;</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Table
of Contents</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Page</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table border="0" cellpadding="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v14"><span style="text-transform: uppercase">QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v14"><span style="text-transform: uppercase">1</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v15"><span style="text-transform: uppercase">VOTING RIGHTS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v15"><span style="text-transform: uppercase">8</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v24"><span style="text-transform: uppercase">Proposals to Be Voted Upon by Stockholders</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v24"><span style="text-transform: uppercase">9</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v16"><span style="text-transform: uppercase">PROPOSAL NO.&#160;1 - ELECTION OF DIRECTORS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v16"><span style="text-transform: uppercase">9</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v17"><span style="text-transform: uppercase">PROPOSAL NO.&#160;2 - NON-BINDING, ADVISORY VOTE ON EXECUTIVE COMPENSATION</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v17"><span style="text-transform: uppercase">12</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v18"><span style="text-transform: uppercase">PROPOSAL NO.&#160;3 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v18"><span style="text-transform: uppercase">13</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v19"><span style="text-transform: uppercase">PROPOSAL NO.&#160;4 - REVERSE STOCK SPLIT PROPOSAL</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v19"><span style="text-transform: uppercase">14</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v20"><span style="text-transform: uppercase">PROPOSAL NO.&#160;5 - ADJOURNMENT PROPOSAL</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v20"><span style="text-transform: uppercase">22</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v21"><span style="text-transform: uppercase">STOCK OWNERSHIP OF PRINCIPAL STOCKHOLDERS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v21"><span style="text-transform: uppercase">23</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v22"><span style="text-transform: uppercase">STOCK OWNERSHIP OF DIRECTORS, NOMINEES FOR DIRECTOR AND EXECUTIVE OFFICERS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v22"><span style="text-transform: uppercase">23</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v23"><span style="text-transform: uppercase">BOARD OF DIRECTORS AND CORPORATE GOVERNANCE MATTERS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v23"><span style="text-transform: uppercase">24</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v1"><span style="text-transform: uppercase">DIRECTOR COMPENSATION</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v1"><span style="text-transform: uppercase">29</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v2"><span style="text-transform: uppercase">EXECUTIVE OFFICERS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v2"><span style="text-transform: uppercase">30</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v4"><span style="text-transform: uppercase">COMPENSATION DISCUSSION AND ANALYSIS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v4"><span style="text-transform: uppercase">31</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v5"><span style="text-transform: uppercase">COMPENSATION COMMITTEE REPORT</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v5"><span style="text-transform: uppercase">37</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v6"><span style="text-transform: uppercase">EXECUTIVE COMPENSATION</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v6"><span style="text-transform: uppercase">37</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v25"><span style="text-transform: uppercase">Summary Compensation Table</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v25"><span style="text-transform: uppercase">37</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v26"><span style="text-transform: uppercase">Pay vs. Performance</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v26"><span style="text-transform: uppercase">39</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v28"><span style="text-transform: uppercase">Employment Agreements</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v28"><span style="text-transform: uppercase">41</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v29"><span style="text-transform: uppercase">Outstanding Equity Awards at Fiscal Year-End</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v29"><span style="text-transform: uppercase">43</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v7"><span style="text-transform: uppercase">AUDIT COMMITTEE REPORT</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v7"><span style="text-transform: uppercase">44</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v8"><span style="text-transform: uppercase">AUDIT AND OTHER FEES</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v8"><span style="text-transform: uppercase">45</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v9"><span style="text-transform: uppercase">CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v9"><span style="text-transform: uppercase">45</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v10"><span style="text-transform: uppercase">STOCKHOLDER PROPOSALS AND NOMINATION OF DIRECTOR CANDIDATES</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v10"><span style="text-transform: uppercase">46</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v11"><span style="text-transform: uppercase">HOUSEHOLDING OF ANNUAL MEETING MATERIALS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v11"><span style="text-transform: uppercase">46</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v12"><span style="text-transform: uppercase">OTHER MATTERS</span></a></td>
  <td style="text-align: right; width: 10%"><a href="#v12"><span style="text-transform: uppercase">47</span></a></td></tr>

<tr style="vertical-align: top; ">
  <td>&#160;</td>
  <td style="text-align: right">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(204,238,255)">
  <td><a href="#v13"><span style="text-transform: uppercase">APPENDIX A FORM&#160;OF CERTIFICATE OF AMENDMENT NO. 1 TO THE SECOND AMENDED AND RESTATED CERTIFICATE
OF INCORPORATION TO EFFECT THE REVERSE STOCK SPLIT PROPOSAL</span></a></td>
  <td style="text-align: right; vertical-align: bottom; width: 10%"><a href="#v13"><span style="text-transform: uppercase">A-1</span></a></td></tr>
</table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">-<!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->-</p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CytoSorbents Corporation</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>305 College Road East</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Princeton, New Jersey 08540</b></p><div>

</div><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROXY STATEMENT</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2026 ANNUAL MEETING OF STOCKHOLDERS</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TO BE HELD ON AUGUST 13, 2026</b></p><div>

</div><p style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This proxy statement (the
 &#8220;<b>Proxy Statement</b>&#8221;) is furnished in connection with the solicitation of proxies by the Board of Directors (the &#8220;<b>Board</b>&#8221;)
of CytoSorbents Corporation (&#8220;<b>CytoSorbents</b>&#8221; or the &#8220;<b>Company</b>&#8221;) to be used at the Company&#8217;s
2026 annual meeting of stockholders of CytoSorbents, to be held on August&#160;13, 2026, and at any adjournment or postponement thereof
(the &#8220;<b>Annual Meeting</b>&#8221;). The Annual meeting will be held via virtual webcast which will begin promptly at 10:00&#160;a.m.&#160;Eastern
Time. You will be able to attend the virtual Annual Meeting and vote your shares electronically during the Annual Meeting by visiting
<i>www.virtualshareholdermeeting.com/CTSO2026</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Consistent with prior years,
we are providing access to our Notice, Proxy Statement, Proxy Card, and annual report on Form&#160;10-K for the year ended December&#160;31,
2025 (the &#8220;<b>Annual Report</b>&#8221;), together referred to here as the &#8220;<b>Proxy Materials</b>&#8221;, via the Internet
instead of mailing printed copies to each stockholder of record, which allows for more efficient and timely distribution of our proxy
materials. This reduces the amount of paper necessary to produce these materials, as well as the costs associated with mailing these materials
to all stockholders. Accordingly, on or about June 25, 2026, we began mailing the Proxy Materials to all stockholders of record, holding shares
of our common stock, par value $0.001 per share (&#8220;<b>Common Stock</b>&#8221;), as of June 15, 2026 (the &#8220;<b>Record Date</b>&#8221;),
and posted the Proxy Materials on the website referenced therein (<i>www.proxyvote.com</i>). As more fully described in the Notice, all
stockholders may choose to access our Proxy Materials on the website referred to therein or may request to receive a printed set of our
Proxy Materials. In addition, the Notice and website provide information regarding how you may request to receive the Proxy Materials
in printed form by mail or electronically by email on an ongoing basis. Your choice for ongoing delivery will remain in effect unless
you change it.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A single Notice or single
copy of Proxy Materials may be sent to two or more stockholders sharing the same address. See the disclosures under &#8220;Householding
of Annual Meeting Materials&#8221; below for more information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v14"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration:underline">QUESTIONS AND ANSWERS ABOUT THE ANNUAL MEETING</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Why are you holding a virtual meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has determined to
hold a virtual annual meeting in order to facilitate stockholder attendance and participation by enabling stockholders to participate
from any location and at no cost. We believe this is the right choice for the Company at this time, as it enables engagement with our
stockholders, regardless of size, resources, or physical location. We are committed to ensuring that our stockholders will be afforded
the same rights and opportunities to participate as they would at an in-person meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Why am I being provided with these materials?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are providing these Proxy
Materials to you in connection with the solicitation by our Board of proxies to be voted at our Annual Meeting to be held on August&#160;13,
2026, and at any postponements or adjournments thereof. The Proxy Materials are being made available via the Internet or, upon your request,
will be provided in printed form.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What proposals will be voted on at the meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The proposals to be voted
on at the meeting are as follows:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">1.</td><td style="text-align: justify">To elect five directors, who shall each serve for a term of one year, or until their respective successors
are elected, except in the case of the death, resignation or removal of any director;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">2.</td><td style="text-align: justify">To approve, on a non-binding, advisory basis, the compensation of the Company&#8217;s named executive
officers, disclosed pursuant to Item&#160;402 of Regulation S-K;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">3.</td><td style="text-align: justify">To ratify the appointment of WithumSmith+Brown, PC as the Company&#8217;s independent registered public
accounting firm to audit the Company&#8217;s financial statements for the fiscal year ending December&#160;31, 2026;</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">4.</td><td style="text-align: justify">To approve an amendment to the Company&#8217;s Certificate of Incorporation to effect a reverse stock
split of the Company&#8217;s Common Stock, subject to our Board&#8217;s discretion, at a ratio of not less than 1-for-5 and not greater
than 1-for-20, with the exact ratio to be set within that range at the discretion of our Board, without further approval or authorization
of our stockholders, prior to the one-year anniversary of the date on which the reverse stock split is approved by the Company&#8217;s
stockholders at the Annual Meeting (the &#8220;<b>Reverse Stock Split Proposal</b>&#8221;);</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">5.</td><td style="text-align: justify">To approve an adjournment of the Annual Meeting to a later date or time, if necessary, to permit further
solicitation and vote of proxies if there are insufficient votes at the time of the Annual Meeting to approve any of the proposals presented
for a vote at the Annual Meeting (the &#8220;<b>Adjournment Proposal</b>&#8221;); and</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">6.</td><td style="text-align: justify">To conduct such other business as may properly come before the Annual Meeting or any adjournments or postponements
thereof.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How does the Board recommend I vote on the proposals presented at
the Annual Meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board recommends that you vote as follows
on the matters to be presented at the Annual Meeting:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">1.</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the election of the five nominees to the Board, each for a one-year term, or
until their respective successors are elected, except in the case of the death, resignation or removal of any director.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">2.</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the vote to approve the compensation of the Company&#8217;s named executive officers,
disclosed pursuant to Item&#160;402 of Regulation S-K, on a non-binding, advisory basis.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">3.</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the ratification of the appointment of WithumSmith+Brown, PC as our independent
registered public accounting firm for the fiscal year ending December&#160;31, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">4.</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the approval of an amendment to the Company&#8217;s Certificate of Incorporation
to effect a reverse stock split of the Company&#8217;s Common Stock, subject to our Board&#8217;s discretion, at a ratio of not less than
1-for-5 and not greater than 1-for-20, with the exact ratio to be set within that range at the discretion of our Board, without further
approval or authorization of our stockholders, prior to the one-year anniversary of the date on which the reverse stock split is approved
by the Company&#8217;s stockholders at the Annual Meeting.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">5.</td><td style="text-align: justify">&#8220;<b>FOR</b>&#8221; the approval of an adjournment of the Annual Meeting to a later date or time,
if necessary, to permit further solicitation and vote of proxies if there are insufficient votes at the time of the Annual Meeting to
approve any of the proposals presented for a vote at the Annual Meeting.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What if another matter is properly brought before the Annual Meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not expect that any
other items of business will be presented for consideration at the Annual Meeting other than those described in this Proxy Statement.
However, by completing, signing, dating and returning a Proxy Card (if you received a printed copy of the proxy materials) or submitting
your proxy or voting instructions over the Internet or by telephone, you will give to the persons named as proxies on the Proxy Card discretionary
voting authority with respect to any matter that may properly come before the Annual Meeting, and of which we did not have notice at least
by March 9, 2025 (<i>i.e.</i>, at least 45&#160;days before the date on which the Company first sent its proxy materials for the prior
year&#8217;s annual meeting of shareholders) and such persons named as proxies intend to vote on any such other matter in accordance with
the instructions of the Board (to the extent permitted by Rule&#160;14a-4(c)&#160;of the Securities Exchange Act of 1934, as amended (the
 &#8220;<b>Exchange Act</b>&#8221;). However, if the date of the 2026 Annual Meeting of Stockholders is changed by more than 30 days from
the date of the previous year&#8217;s meeting, then the deadline is a reasonable time before we begin to print and send our proxy statement
for the 2026 Annual Meeting of Stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 6 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How do I attend the Annual Meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You can access the Annual
Meeting at <i>www.virtualshareholdermeeting.com/CTSO2026</i>. You must enter the 16-digit control number found on your Notice, proxy card
or voting instruction form. The Annual Meeting webcast will begin promptly at 10:00&#160;a.m.&#160;Eastern Time. We encourage you to access
the Annual Meeting prior to the start time. Online check-in will begin at approximately 9:45&#160;a.m.&#160;Eastern Time, and you should
allow ample time for the check-in procedures.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What is a Notice of Internet Availability of Proxy Materials?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with rules&#160;adopted
by the Securities and Exchange Commission (the &#8220;<b>SEC</b>&#8221;), instead of mailing a printed copy of our Proxy Materials to
each stockholder of record, we are permitted to furnish our Proxy Materials, including the Notice of Annual Meeting of Stockholders, this
Proxy Statement, and our Annual Report, which includes a copy of our Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31,
2025, by providing access to such documents over the Internet. Unless requested, stockholders will not receive printed copies of the Proxy
Materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We began mailing a Notice
of Internet Availability of Proxy Materials on or around June 25, 2026, to holders of record of shares of our Common Stock at the close of business
on the Record Date. At the same time, we provided those stockholders with access to our online Proxy Materials and filed our Proxy Materials
with the SEC. The Notice of Internet Availability of Proxy Materials contains information on how to access the Notice of Annual Meeting
of Stockholders, the Proxy Statement, the form of proxy card (the &#8220;<b>Proxy Card</b>&#8221;), and the Annual Report, over the Internet,
as well as instructions on how to request a paper copy of the Proxy Materials. Registered stockholders who prefer to receive a paper copy
of the Proxy Materials must follow the instructions provided in the Notice of Internet Availability of Proxy Materials for requesting
such materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Notice of Internet Availability
of Proxy Materials only identifies the matters to be voted on at the Annual Meeting. You cannot vote by marking the Notice of Internet
Availability of Proxy Materials and returning it. The Notice of Internet Availability of Proxy Materials provides instructions on how
to cast your vote. If you wish to request a paper copy of the Proxy Materials for the Annual Meeting, you may (1)&#160;visit www.ProxyVote.com,
(2)&#160;call 1+ (800)&#160;579-1639, or (3)&#160;send an email to sendmaterial@proxyvote.com. If sending an email, please include your
16-digit control number (indicated on the Notice of Internet Availability of Proxy Materials) in the subject line.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Please make the request as
instructed above on or before July&#160;30, 2026, to facilitate timely delivery of the physical copy of the Proxy Materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A notice that directs beneficial
owners of our Common Stock to the website where they can access our Proxy Materials is to be forwarded to each beneficial stockholder
by the brokerage firm, bank, dealer or other similar organization that is considered the registered owner with respect to the shares of
the beneficial stockholder. Such brokerage firm, bank, dealer or other similar organization is to also provide each beneficial owner of
our shares with instructions on how the beneficial stockholder may request a paper or e-mail copy of our proxy materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What if I need technical assistance during the Annual Meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will have technicians ready
to assist you with any technical difficulties you may have accessing the virtual Annual Meeting. A phone number where you can obtain technical
assistance will be made available on the day of the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Who may vote at the meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of Common Stock of
record at the close of business on June 15, 2026, are entitled to notice of, and to vote at, the Annual Meeting or any adjournments or postponements
thereof.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 7 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What is the quorum requirement for the meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A majority of the shares of
capital stock of the Company entitled to vote at the meeting, as of the Record Date, must be present in person or represented by proxy
at the Annual Meeting in order for us to hold the meeting and conduct business. This is called a quorum.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are present in person,
including virtually, or by proxy at the Annual Meeting, but abstain from voting on any or all proposals, your shares are still counted
as present and entitled to vote. The proposals listed in this Proxy Statement identify the votes needed to approve or ratify the proposed
actions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How many votes do I have?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You have one vote for each
share of our Common Stock that you owned as of the Record Date for each matter presented at the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What is the difference between holding shares as a stockholder of
record and as a beneficial owner?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Stockholder of Record: Shares Registered in Your Name</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If, as of the Record Date,
your shares were registered directly in your name with the transfer agent for our Common Stock, Equiniti Trust Company, LLC (&#8220;<b>EQ</b>&#8221;),
then you are a stockholder of record. As a stockholder of record, you may vote at the Annual Meeting or vote by proxy. Whether or not
you plan to attend the virtual Annual Meeting, we urge you to fill out and return the proxy card or vote by proxy over the telephone or
on the Internet as instructed below to ensure your vote is counted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Beneficial Owner: Shares Registered in the Name of a Broker, Bank
or Other Agent</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If, as of the Record Date,
your shares were held in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner
of shares held in &#8220;street name&#8221; and these proxy materials are being forwarded to you by that organization. The organization
holding your account is considered the stockholder of record for purposes of voting at the Annual Meeting. As a beneficial owner, you
have the right to direct your broker or other agent on how to vote the shares in your account. You are also invited to attend the virtual
Annual Meeting. However, since you are not the stockholder of record, you may not vote your shares during the Annual Meeting unless you
request and obtain a valid proxy card from your broker or other agent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How do I give voting instructions if I am a beneficial owner?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a beneficial owner
of shares of Common Stock as of the Record Date, that is, you own your shares through a bank or broker, you should receive from your bank
or broker a voting instruction form that outlines the methods by which you can vote your shares. A number of banks and brokers have arranged
for beneficial owners to vote their shares via the Internet or telephone and will provide voting instructions on the voting instruction
form. If your bank or broker uses Broadridge Financial Solutions, you may vote your shares via the Internet at <i>www.proxyvote.com</i>
or by phone by calling the telephone number shown on the voting instruction form received from your broker or bank. If you do not give
instructions to your bank or broker, it may vote your shares with respect to &#8220;routine&#8221; matters but will not be permitted to
vote your shares with respect to &#8220;non-routine&#8221; matters. When a bank or broker has not received instructions from the beneficial
owners or persons entitled to vote and the bank or broker cannot vote on a particular matter because it is not a routine matter, then
there is a &#8220;broker non-vote&#8221; on such non-routine matter. It is therefore important that you provide instructions to your bank
or broker if your shares are beneficially held by a bank or broker so that your votes with respect to election of directors, advisory
vote to approve executive compensation, and any other matters treated as non-routine, are counted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 8 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What are the votes required to adopt the proposals at the Annual
Meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom; ">
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; width: 20%; text-align: center">Proposal</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; width: 19%; text-align: center; padding-left: 5.4pt">Vote Required</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; width: 19%; text-align: center; padding-left: 5.4pt">Voting Choices</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 19%; text-align: center; padding-left: 5.4pt">Effect of <br/>
Abstentions</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; width: 1%; padding-bottom: 1pt; vertical-align: bottom">&#160;</td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; font: bold 10pt Times New Roman, Times, Serif; width: 19%; text-align: center; padding-left: 5.4pt">Effect of <br/>Broker <br/>Non-Vote</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Election of the director nominees named in the Proxy Statement (&#8220;<b>Proposal 1</b>&#8221;)</span></td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">The majority of the votes cast by Stockholders present at the Annual Meeting in person or represented by proxy, meaning the number of shares voted &#8220;FOR&#8221; a nominee must exceed 50% of the votes cast for such nominee.</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">&#8220;FOR&#8221;, &#8220;AGAINST&#8221;, or &#8220;ABSTAIN&#8221;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 5.4pt">No Effect</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">No Effect</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-binding, advisory vote to approve the compensation of the Company&#8217;s named executive officers (&#8220;<b>Proposal 2</b>&#8221;)</span></td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">The vote of the holders of a majority in voting power of the shares present in person or represented by proxy and entitled to vote on such proposal. </td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">&#8220;FOR&#8221;, &#8220;AGAINST&#8221;, or &#8220;ABSTAIN&#8221;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 5.4pt">Vote Against</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">No Effect</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ratification the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for the year ending December&#160;31, 2026 (&#8220;<b>Proposal 3</b>&#8221;)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p></td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">The vote of the holders of a majority in voting power of the shares present in person or represented by proxy and entitled to vote on such proposal.</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">&#8220;FOR&#8221;, &#8220;AGAINST&#8221;, or &#8220;ABSTAIN&#8221;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 5.4pt">Vote Against</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Not Applicable</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval of Reverse Stock Split Proposal&#160;&#160;(&#8220;<b>Proposal 4</b>&#8221;)</span></td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">The vote of the holders of a majority in voting power of the shares present in person or represented by proxy and entitled to vote on such proposal. </td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">&#8220;FOR&#8221;, &#8220;AGAINST&#8221;, or &#8220;ABSTAIN&#8221;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 5.4pt">Vote Against</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Not Applicable</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval of the Adjournment Proposal (&#8220;<b>Proposal 5</b>&#8221;)</span></td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">The vote of the holders of a majority of the shares of stock present or represented at the Annual Meeting and entitled to vote on such proposal.</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">&#8220;FOR&#8221;, &#8220;AGAINST&#8221;, or &#8220;ABSTAIN&#8221;</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; padding-left: 5.4pt">No Effect</td><td style="text-align: left; font: 10pt Times New Roman, Times, Serif; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; font: 10pt Times New Roman, Times, Serif; text-align: left; padding-left: 5.4pt">Not Applicable</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only stockholders as of the
close of business on the Record Date are entitled to notice of and to vote at the Annual Meeting. As of the Record Date, there were 62,842,748 shares of Common Stock issued and outstanding and no other outstanding classes of voting securities. Each holder of our Common Stock
is entitled to one vote per share on each matter presented at the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A majority of the votes cast
by stockholders is required with respect to the election of directors at the Annual Meeting. As such, this means that for Proposal 1,
the number of shares voted FOR a director&#8217;s election must exceed fifty percent (50%) of the number of votes cast with respect to
that director&#8217;s election. Cumulative voting for the election of directors is not permitted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a
majority in voting power of the shares present, in person or represented by proxy and entitled to vote on a matter is required to approve
Proposal 2, the non-binding, advisory vote on the compensation of the Company&#8217;s named executive officers, Proposal 3, the ratification
of the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December&#160;31,
2026, and Proposal 4, the approval of an amendment to the Company&#8217;s Certificate of Incorporation to effect a reverse stock split.
As such, this means that for Proposals 2, 3, and 4, such proposals must receive more FOR votes than AGAINST votes plus ABSTENTIONS in
order to be approved.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 9 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a
majority of the shares of stock present or represented at the Annual Meeting and entitled to vote on the matter is required to approve
Proposal 5, the approval of an adjournment of the Annual Meeting, as necessary. As such, this means that for Proposal 5, such proposal
must receive more FOR votes than AGAINST in order to be approved. Abstentions will not be counted as votes cast &#8220;for&#8221; or
 &#8220;against&#8221; this proposal, and therefore, will have no impact on the outcome of the voting.&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What are the effects of abstentions and broker-non votes?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A &#8220;broker non-vote&#8221;
occurs when a stockholder holds shares of Common Stock in &#8220;street name&#8221; through a broker or similar organization, and the
stockholder does not provide the broker or other organization with instructions within the required timeframe before the Annual Meeting
as to how to vote the shares on &#8220;non-routine&#8221; matters. See &#8220;<i>How do I give voting instructions if I am a beneficial
owner?</i>&#8221; above for additional information.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under relevant Nasdaq rules,
we believe that Proposal 1, the election of directors, is considered a &#8220;non-routine&#8221; matter on which brokers cannot exercise
discretionary voting unless the broker receives instructions on how to vote from the beneficial owner of the Company&#8217;s Common Stock.
Abstentions and broker non-votes shall not be deemed votes cast either &#8220;for&#8221; or &#8220;against&#8221; a director&#8217;s election
and, as such, for this proposal, broker non-votes and abstentions will have &#8220;NO EFFECT&#8221; on the outcome of the vote for the
election of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under relevant Nasdaq rules,
we believe that Proposal 2, the non-binding, advisory vote on the compensation of the Company&#8217;s named executive officers, is considered
a &#8220;non-routine&#8221; matter on which brokers cannot exercise discretionary voting unless the broker receives instructions on how
to vote from the beneficial owner of the Company&#8217;s Common Stock. For this proposal, broker non-votes will have &#8220;NO EFFECT&#8221;
on the outcome of the vote for this proposal. Abstentions will have the same effect as a vote &#8220;AGAINST&#8221; this proposal.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under relevant Nasdaq rules,
we believe that Proposal 3, the ratification of the appointment of our independent auditors named in this Proxy Statement, is considered
a &#8220;routine&#8221; matter on which brokers are permitted to vote in their discretion even if the beneficial owner of the Company&#8217;s
Common Stock does not provide voting instructions with respect to such proposal. Accordingly, we do not expect there to be any broker
non-votes for this proposal, and as such, broker non-votes will have no effect on the outcome of this proposal. Abstentions will have
the same effect as a vote &#8220;AGAINST&#8221; this proposal.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under relevant Nasdaq rules,
we believe that Proposal 4, the approval of an amendment to the Company&#8217;s Certificate of Incorporation to effect a reverse stock
split, is considered a &#8220;routine&#8221; matter on which brokers are permitted to vote in their discretion even if the beneficial
owner of the Company&#8217;s Common Stock does not provide voting instructions with respect to such proposal. Accordingly, we do not expect
there to be any broker non-votes for this proposal, and as such, broker non-votes will have no effect on the outcome of this proposal.
Abstentions will have the same effect as a vote &#8220;AGAINST&#8221; this proposal.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under relevant Nasdaq rules,
we believe that Proposal 5, the approval of an adjournment of the Annual Meeting, as necessary, is considered a &#8220;routine&#8221;
matter on which brokers are permitted to vote in their discretion even if the beneficial owner of the Company&#8217;s Common Stock does
not provide voting instructions with respect to such proposal. Accordingly, we do not expect there to be any broker non-votes for this
proposal, and as such, broker non-votes will have no effect on the outcome of this proposal. Abstentions will not be counted as votes
cast &#8220;for&#8221; or &#8220;against&#8221; this proposal, and therefore, will have no impact on the outcome of the voting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How may I vote my shares personally at the meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If your shares are registered
directly in your name with our transfer agent, EQ, you are considered, with respect to those shares, the stockholder of record. As the
stockholder of record, you have the right to vote during the meeting at <i>www.virtualshareholdermeeting.com/CTSO2026</i> using your unique
16-digit control number that was included in your Notice, proxy card or voting instruction form. If your shares are held in a brokerage
account or by another nominee or trustee, you are considered the beneficial owner of shares held in street name. As the beneficial owner,
you are also invited to attend the meeting via the Internet. Because a beneficial owner is not the stockholder of record, you may not
vote these shares at the meeting unless you obtain a &#8220;legal proxy&#8221; from your broker, nominee, or trustee that holds your shares,
giving you the right to vote the shares at the meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 10 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How can I vote my shares without attending the Annual Meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Whether you hold shares directly
as a registered stockholder of record or beneficially in street name, you may vote without attending the Annual Meeting. If your shares
are held by a broker, trustee or other nominee, they should send your instructions that you must follow in order to have your shares voted.
If you hold shares in your own name, you may vote by proxy in any one of the following ways:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Via the Internet by accessing the Proxy Materials
on the secure website www.proxyvote.com and following the voting instructions on that website;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Via telephone by calling toll free 1-800-690-6903
and following the recorded instructions; or</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8226;</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Via mail, by marking, signing and dating the
enclosed proxy card and returning it to Vote Processing, c/o&#160;Broadridge, 51 Mercedes Way, Edgewood, NY 11717.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Internet and telephone
voting procedures are designed to authenticate stockholders&#8217; identities by use of a 16-digit control number to allow stockholders
to vote their shares and to confirm that stockholders&#8217; instructions have been properly recorded. Voting via the Internet or telephone
must be completed by 11:59&#160;p.m.&#160;Eastern Time on August&#160;12, 2026. Of course, you can always attend the Annual Meeting virtually
and vote your shares. If you submit or return a proxy card without giving specific voting instructions, your shares will be voted as recommended
by the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>What is a proxy?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">A proxy is your designation of another person to
vote shares of Common Stock you own. If you designate someone as your proxy in a written document, that document is also called a proxy,
a form of proxy, or a proxy card. When you designate a proxy, you also may direct the proxy how to vote your shares. Dr.&#160;Phillip
P. Chan and Vincent J. Capponi have been designated on behalf of the Board as the proxies to cast the vote of the Company&#8217;s stockholders
at the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>How can I change my vote?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You can revoke your proxy
or voting instructions at any time before it is exercised at the Annual Meeting by:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">delivering to any of the persons named as proxies
on the proxy card, or addressed to and received by the Secretary, an instrument revoking the proxy;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">voting via the Internet or telephone during the
Annual Meeting;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">executing and delivering a later dated proxy;
or</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">voting virtually at the Annual Meeting.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Attendance at the Annual Meeting
will not, by itself, revoke a proxy. If you are a beneficial owner and hold your shares in street name, you will need to contact your
bank, broker, or other nominee to determine how to revoke your voting instructions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Who will count the vote?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Broadridge Financial Solutions,&#160;Inc.
(&#8220;<b>Broadridge</b>&#8221;) has been engaged as our independent agent to tabulate stockholder votes as the Inspector of Election
(the &#8220;<b>Inspector</b>&#8221;). If you are a stockholder of record, your executed proxy card is returned directly to Broadridge
for tabulation. As noted above, if you hold your shares through a broker, if instructed properly then your broker will return a proxy
card to Broadridge on your behalf.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Where can I find the voting results of the meeting?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We expect to announce the
preliminary voting results at the Annual Meeting. We will publish the finalized results in a Current Report on Form&#160;8-K filed with
the SEC within four (4)&#160;business days of the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 11 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Who will pay for the solicitation of proxies?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The costs and expenses of
the Board&#8217;s soliciting of proxies, including the mailing the Notice of Internet Availability of Proxy Materials (or, if applicable,
paper copies of this Proxy Statement, the Notice of Annual Meeting of Stockholders, the proxy card, and the Annual Report), as well as
the cost of forwarding such material to the beneficial owners of stock, except for some costs associated with individual stockholders&#8217;
use of the Internet or telephone, and postage, and any additional information furnished to stockholders will be borne by the Company.
Solicitation of proxies may be in person, by telephone, facsimile, electronic mail, or personal solicitation by our directors, officers,
or staff members. Other than the persons described in this Proxy Statement, no general class of employee of the Company will be employed
to solicit stockholders in connection with this proxy solicitation. However, in the course of their regular duties, our employees, officers,
and directors may be asked to perform clerical or ministerial tasks in furtherance of this solicitation. None of these individuals will
receive any additional or special compensation for doing this, but they may be reimbursed for reasonable out-of-pocket expenses. We may
reimburse brokers and others holding stock in their names or in the names of nominees for their reasonable out-of-pocket expenses in sending
proxy materials to principals and beneficial owners.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, we have also
engaged D.F. King&#160;&amp; Co.,&#160;Inc., or D.F. King, as our proxy solicitor and D.F. King may solicit the return of proxies, either
by mail, telephone, telecopy, e-mail or through personal contact. We have agreed to pay D.F. King a base fee of approximately $7,500 plus
additional fees for requested services, to reimburse costs and expenses, and to indemnify D.F. King in connection with its performance
of services.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you have any questions
or need assistance voting your shares, please contact our proxy solicitor, D.F. King, at:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>D.F. King&#160;&amp; Co.,&#160;Inc.</b>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">28 Liberty Street, 53rd Floor&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">New York, New York 10005&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Banks and Brokers call: (646) 677-2515&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">All others call toll free (U.S. only): (800) 347-4826&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Email: CTSO@dfking.com</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Who is soliciting this proxy?</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Solicitation of proxies is
made on behalf of the Board. Proxies will be solicited on behalf of the Board by the Company&#8217;s directors, director nominees, and
certain executive officers and other employees of the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v15"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>VOTING RIGHTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders of record may
vote their shares via the Internet, telephone or mail by following the instructions included in the Proxy Materials. If you vote by Internet,
you may access the voting platform by going to <i>www.proxyvote.com. </i>Once you access that website, in order to vote your shares, you
will be required to provide the login control number contained on your proxy card. After providing this information, you will be prompted
to complete an electronic proxy card. Your votes will be indicated on your computer screen and you will be prompted to submit or revise
your electronic proxy card as desired.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the law of the
State of Delaware, under which CytoSorbents is incorporated, permits electronic voting, provided that each proxy submitted by a stockholder
via the Internet or telephone contains or is submitted with information from which it can be determined that such proxy was authorized
by the stockholder. Submitting a proxy via the Internet or telephone will not affect your right to vote should you decide to attend the
virtual Annual Meeting. If you vote your shares via the Internet or telephone, you are responsible for any Internet access or telephone
charges that you may incur.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a beneficial owner
of shares of Common Stock as of the Record Date, that is, you own your shares through a bank or broker, you should receive from your bank
or broker a voting instruction form that outlines the methods by which you can vote your shares. A number of banks and brokers have arranged
for beneficial owners to vote their shares via the Internet or telephone and will provide voting instructions on the voting instruction
form. If your bank or broker uses Broadridge Financial Solutions, you may vote your shares via the Internet at <i>www.proxyvote.com</i>
or by phone by calling the telephone number shown on the voting instruction form received from your broker or bank. If you do not give
instructions to your bank or broker, it may vote your shares with respect to &#8220;routine&#8221; matters but will not be permitted to
vote your shares with respect to &#8220;non-routine&#8221; matters. See &#8220;<i>How do I give voting instructions if I am a beneficial
owner?</i>&#8221; above for additional information. <b>We strongly encourage you to submit your voting instructions and exercise your
right to vote as a stockholder.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you request a printed copy
of the Proxy Materials by mail, mark, date, sign, and return the enclosed proxy card to Broadridge Representatives of Broadridge Financial
Solutions,&#160;Inc., and our inspectors of election will tabulate and certify the votes. A postage prepaid envelope addressed to Broadridge
Financial Solutions,&#160;Inc. will be provided with requested printed Proxy Materials.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 12 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><div><a id="v24"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Proposals to Be Voted Upon by Stockholders</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following describes each
of the  five proposals to be voted upon by stockholders at our Annual Meeting:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v16"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO.&#160;1 - ELECTION OF DIRECTORS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Second Amended and Restated
Bylaws of the Company (the &#8220;<b>Bylaws</b>&#8221;) provide that our Board shall consist of not less than three members. Each director
serves for a one-year term, or until their respective successors are elected, except in the case of the death, resignation or removal
of any director, with each director being elected at each annual meeting of stockholders. Five directors are currently serving on the
Board. The directorships expiring at the Annual Meeting are currently filled by Phillip P. Chan, Edward R. Jones, Michael G. Bator, Alan
D. Sobel and Jiny Kim. Following the recommendation of our Nominating and Corporate Governance Committee, our Board has nominated each
of Phillip P. Chan, Edward R. Jones, Michael G. Bator, Alan D. Sobel and Jiny Kim for election at the Annual Meeting. If each of the directors
is reelected, the total number of directors comprising our Board will remain at five directors effective immediately following the Annual
Meeting. If elected, each director&#8217;s term will expire in 2027. Our Board is authorized to increase or decrease the total number
of directors within the limitations prescribed by our Bylaws.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The nominees for election
at this Annual Meeting have informed us that they are willing to serve for the term to which they are nominated, if elected. If any nominee
should become unavailable for election or is unable to serve as a director, the shares represented by proxies voted in favor of that nominee
will be voted for any substitute nominee that may be named by the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Set forth in the table and
paragraphs below is certain information about the nominees for election as directors, including each nominee&#8217;s age and length of
service as a director of the Company, principal occupation and business experience for at least the past five years and the names of other
publicly held companies on whose boards the director serves or has served in the past five years. There are no family relationships among
any of our directors, nominees for director and executive officers, and there are no arrangements or understandings between a director
and any other person pursuant to which such person was selected as a director or nominee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Age</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="text-align: left; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Director Since</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Position(s)&#160;with CytoSorbents</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 35%; font: 10pt Times New Roman, Times, Serif; text-align: left">Phillip P. Chan, MD, PhD</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: left">55</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: left">2008</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 39%; font: 10pt Times New Roman, Times, Serif; text-align: left">Director and Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Michael G. Bator</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">62</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2015</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Director and Chairman of the Board</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Edward R. Jones, MD, MBA</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">77</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2007</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Director</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Alan D. Sobel, CPA</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">65</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2014</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jiny Kim, MBA</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">49</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2022</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Director</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Director Experience, Qualifications, Attributes and Skills</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the backgrounds
and qualifications of our directors and director nominees, considered as a group, provide a broad mix of experience, knowledge and abilities
that will allow the Board to fulfill its responsibilities. Our Nominating and Corporate Governance Committee does not have a specific
policy with regard to the consideration of diversity in identifying director nominees. However, our Nominating and Corporate Governance
Committee values diversity on our Board and considers the diversity of the professional experience, education and skills, as well as diversity
of origin, in identifying director nominees. Our Board is composed of a diverse group of leaders in their respective fields. Many of the
current directors have leadership experience at major domestic and international companies with operations inside and outside the United
States, as well as experience serving on other companies&#8217; boards, which provides an understanding of different business processes,
challenges and strategies facing boards and other companies. Collectively, our directors have experience as chief executive officers,
presidents, or general partners of medical-device companies, physician or other professional organizations, and investment companies which
brings unique perspectives to the Board. Furthermore, our directors also have other experience that makes them valuable members, such
as prior experience with financing transactions or mergers and acquisitions that provides insight into issues faced by companies.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 13 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following biographies
highlights the specific experience, qualification, attributes, and skills of our individual Board members that have led our Nominating
and Corporate Governance Committee to conclude that these individuals should serve on our Board:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Phillip
P. Chan, MD, PhD.</i></b></span> has served as a director of CytoSorbents since July&#160;2008, and has served as our Chief Executive
Officer since January&#160;2009. Dr.&#160;Chan served as our President from January&#160;2009 to April&#160;2020. Prior to joining CytoSorbents,
Dr.&#160;Chan led healthcare and life science investments for the NJTC Venture Fund from 2003 to 2008, most recently as a Partner. Dr.&#160;Chan
was a co-founder and Vice Chairman of the Board of Directors of Medality Medical,&#160;Inc., fka Andrew Technologies, a medical device
company that received U.S.&#160;Food and Drug Administration (FDA)&#160;510(k)&#160;clearance of its HydraSolve<sup>&#174;</sup> lipoplasty
system and completed a human clinical study using the system to remove visceral mesenteric fat as a potential surgical treatment of Type
2 diabetes. He is an Internal Medicine physician with a strong background in clinical medicine and research. Dr.&#160;Chan received his
MD and PhD from the Yale University School of Medicine, completed his Internal Medicine residency at the Beth Israel Deaconess Medical
Center at Harvard Medical School and received his Board certification. He also holds a BS in cell and molecular biology from Cornell
University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dr.&#160;Chan is qualified
to serve on our Board based on his extensive experience as an executive in the medical device industry and his position as our Chief Executive
Officer and former President of the Company. As a member of the executive team, Dr.&#160;Chan serves a vital function in the link between
management and the Board, enabling the Board to perform its oversight function with the benefits of management&#8217;s perspective on
the business.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Michael
G. Bator, MBA</i></b></span> has served as a director of CytoSorbents since July&#160;2015, and as Chairman of the Board since June&#160;2023.
Mr.&#160;Bator is a founder and partner of Quartz Advisory Group, LLC, a capital markets investment bank since November&#160;2018. From
April&#160;2015 to December&#160;2016, Mr.&#160;Bator was the Chief Financial Officer of Trek Therapeutics, a development stage pharmaceutical
company. Mr.&#160;Bator has served as an advisor to IBF Venture Capital Fund, LLC since June&#160;2015. From January&#160;2001 until February&#160;2015,
Mr.&#160;Bator held several positions with Jennison Associates, a United States mutual and pension fund management company, where he was
most recently Managing Director, Healthcare Research. Prior to that time, he worked in management consulting with Cambridge Pharma Consultancy,
Lexington Strategy, and The Boston Consulting Group. Mr.&#160;Bator received his MBA in Finance from Wharton Business School at the University
of Pennsylvania, and his BA from Princeton University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr.&#160;Bator is qualified
to serve on our Board based on his extensive experience serving in various executive level roles in the pharmaceuticals industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Edward
R. Jones, MD, MBA</i></b></span> has served as a director of the Company since April&#160;2007. Dr.&#160;Jones retired from the clinical
practice of nephrology in January&#160;2020. Dr.&#160;Jones has been an attending physician at Albert Einstein Medical Center and Chestnut
Hill Hospital as well as Clinical Professor of Medicine at Temple University Hospital since 1985. Dr.&#160;Jones has published or contributed
to the publishing of 30 chapters, articles, and abstracts on the subject of treating kidney-related illnesses. He has been a member of
the Renal Physicians Association, the Philadelphia County Medical Society for 17 years, and is a former board member of the National Kidney
Foundation of the Delaware Valley. From March&#160;2009 to March&#160;2011, Dr.&#160;Jones served as President of, and Counselor at, the
Renal Physicians Association. Dr.&#160;Jones is the former Chairman of Kidney Care Partners, and he served as former President of Delaware
Valley Nephrology and Hypertension Associates. He retired from that practice on June&#160;30, 2018. Dr.&#160;Jones graduated from the
Medical University of South Carolina and completed his Internal Medicine residency at Temple University Hospital (TUH). He later served
as Chief Medical Resident at Temple University Hospital. He was a fellow in the Renal and Electrolyte Section&#160;of the University of
Pennsylvania after which he joined the faculty of Temple where he ran the renal physiology laboratory while teaching and providing patient
care. Dr.&#160;Jones received his MBA in healthcare management from St. Joseph&#8217;s University in Philadelphia.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Dr.&#160;Jones is qualified
to serve on our Board based on his medical credentials and various contributions to the medical field, as well as his experience in the
medical device and pharmaceutical industries.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Alan
D. Sobel, CPA</i></b></span> has served as a director of CytoSorbents since November&#160;2014. Mr.&#160;Sobel is a Principal in the New
Jersey Offices of CLA (CliftonLarsonAllen, LLP), serving in various positions since February&#160;2023. Previously, since 1996, Mr.&#160;Sobel
has served as the Managing Member of Sobel&#160;&amp; Co., LLC, a full-service accounting, auditing, taxation, and business consulting
firm. He has provided corporate advisory and consulting services, including mergers and acquisitions, for clients in the real estate,
manufacturing, pharmaceutical, and distribution businesses, among others. Mr.&#160;Sobel is a Certified Public Accountant and has served
in various leadership roles including President of the New Jersey Society of Certified Public Accountants and Chairman of the Audit Committee
of the New Jersey Society of Certified Public Accountants. Mr.&#160;Sobel received his BS in accounting from Bentley College and his MS
in taxation from Fairleigh Dickenson University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 14 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr.&#160;Sobel is qualified
to serve on our Board based on his extensive financial and accounting experience as well as his experience consulting and advising in
the medical device and pharmaceutical industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Jiny
Kim, MBA</i></b></span> has served as a director of CytoSorbents since April&#160;2022. Ms.&#160;Kim has served as Senior Vice President
at Solta Medical at Bausch Health since September&#160;2023. Previously, Ms.&#160;Kim served as the Vice President at Zimmer Biomet, where
she served as the general manager of the Smart Implants portfolio and was responsible for leading the end-to-end program and product management
for Zimmer Biomet&#8217;s Smart Implants technology in the orthopedic field from June&#160;2021 to August&#160;2023. Prior to this, Ms.&#160;Kim
served as Vice President, Global Strategic Marketing and Chief of Staff for the General Manager, Neuromodulation and Depression at LivaNova
from February&#160;2020 to May&#160;2021. Prior to this, Ms.&#160;Kim served in increasing roles of responsibility at Ethicon, Johnson&#160;&amp;
Johnson Medical Devices in U.S. Sales and Marketing, Business Development (Licensing and Acquisition), and Strategic Global Marketing
from 2011 to 2020. Ms.&#160;Kim received her MBA at the MIT Sloan School of Management, and she received a dual degree from the University
of Pennsylvania with a B.S. in Economics from The Wharton School and a B.A. in Political Science from The College of Arts and Sciences.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ms.&#160;Kim is qualified
to serve on our Board based on her extensive experience serving in executive level roles in the medical device industry.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Vote Required</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each nominee for director
will be elected to the Board by a majority of the votes cast by stockholders entitled to vote in the election of directors. This means
that the votes cast &#8220;<b>FOR</b>&#8221; such nominee&#8217;s election must exceed fifty percent (50%) of the number of votes cast
with respect to that director&#8217;s election. Cumulative voting for the election of directors is not permitted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board unanimously recommends
that stockholders vote &#8220;<b>FOR</b>&#8221; the election of the five nominees to the Board each for a one-year term, or until their
respective successors are elected, except in the case of the death, resignation or removal of any director.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 15 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v17"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO.&#160;2 - NON-BINDING, ADVISORY
VOTE ON EXECUTIVE COMPENSATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As required under Section&#160;14A
of the Exchange Act, and the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the Board is submitting a &#8220;Say-on-Pay&#8221;
proposal for stockholder consideration. While the vote on executive compensation is non-binding and solely advisory in nature, the Board
and the Compensation Committee value the opinion of our stockholders and will review and consider the outcome of the voting results. We
currently intend to hold future advisory votes on executive compensation once every year, and the next &#8220;Say-on-Pay&#8221; vote is
expected to occur at the annual meeting of our stockholders in 2027. The next frequency vote is expected to occur at the annual meeting
of our stockholders in 2027.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our executive officers are
compensated based upon performance, and in a manner consistent with our strategy, competitive practice, sound corporate governance principles,
and our Company&#8217;s and our stockholders&#8217; interests. We believe our compensation program is strongly aligned with the long-term
interests of our Company and our stockholders. Compensation of our executive officers is designed to enable us to attract and retain talented
and experienced senior executives to lead our Company successfully in a competitive environment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The compensation of our named
executive officers is described more fully in the &#8220;Compensation Discussion and Analysis&#8221; and &#8220;Executive Compensation&#8221;
sections of this Proxy Statement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are asking stockholders
to vote on the following resolution:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#8220;<b>RESOLVED</b>, that
the stockholders of CytoSorbents Corporation approve, on a non-binding, advisory basis, the compensation paid to its named executive officers,
disclosed pursuant to Item&#160;402 of Regulation S-K in the Company&#8217;s definitive proxy statement for the 2026 Annual Meeting of
Stockholders.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As indicated above, the stockholder
vote on this resolution will not be binding on our Company, the Board or the Compensation Committee and will not be construed as overruling
or determining any decision by us, by the Board or by the Compensation Committee. The vote will not be construed to create or imply any
change to our fiduciary duties or those of the Board or the Compensation Committee, or to create or imply any additional fiduciary duties
for our Company or the Board or the Compensation Committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Furthermore, because this
non-binding, advisory resolution primarily relates to the compensation of our named executive officers that has already been paid or contractually
committed, there is generally no opportunity for us to revisit these decisions. However, our Board, including our Compensation Committee,
values the opinions of our stockholders and, to the extent there is any significant vote against the executive officer compensation as
disclosed in this Proxy Statement, we consider our stockholders&#8217; concerns and evaluate what actions, if any, may be appropriate
to address those concerns.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Vote Required</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a
majority in voting power of the shares present, in person or represented by proxy and entitled to vote on the matter is required to approve,
on a non-binding, advisory basis, the compensation of the Company&#8217;s named executive officers, disclosed pursuant to Item&#160;402
of Regulation S-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board unanimously recommends
stockholders vote, on a non-binding, advisory basis, &#8220;<b>FOR</b>&#8221; the approval of the compensation of our named executive
officers, disclosed pursuant to Item&#160;402 of Regulation S-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 16 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v18"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO.&#160;3 - RATIFICATION OF APPOINTMENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has appointed
WithumSmith+Brown, PC as the independent registered public accounting firm to audit the Company&#8217;s financial statements for the fiscal
year ending December&#160;31, 2026, and has recommended to the Board that such appointment be submitted to our stockholders for ratification.
WithumSmith+Brown, PC has served as our independent registered public accounting firm since 2005. Representatives from WithumSmith+Brown,
PC are expected to be present at the Annual Meeting and will have an opportunity to make a statement if they so desire and to respond
to appropriate questions from those attending the meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although stockholder ratification
of the appointment of our independent registered public accounting firm is not required by our Bylaws or otherwise, we are submitting
the selection of WithumSmith+Brown, PC to the stockholders for ratification as a matter of good corporate practice. If the stockholders
fail to ratify the selection, then our Audit Committee will reconsider whether or not to retain that firm.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Vote Required</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a
majority in voting power of the shares present, in person or represented by proxy and entitled to vote on the matter is required to approve
the ratification of the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year
ending December&#160;31, 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board unanimously recommends
that stockholders vote &#8220;<b>FOR</b>&#8221; the ratification of the appointment of WithumSmith+Brown, PC as our independent registered
public accounting firm for the fiscal year ending December&#160;31, 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 17 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v19"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO.&#160;4 - REVERSE STOCK SPLIT PROPOSAL</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Background and Purpose of Proposed Amendment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Certificate of Incorporation,
as amended, currently authorizes the Company to issue a total of 105,000,000 shares, of which 100,000,000 shares shall constitute Common
Stock and 5,000,000 shares shall constitute Preferred Stock, having a par value of $0.001 per share.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On June&#160;9, 2026, subject
to stockholder approval, the Board approved an amendment to our Second Amended and Restated Certificate of Incorporation to, at the discretion
of the Board, effect the Reverse Stock Split of the Common Stock at a ratio of not less than 1-for-5 and not greater than 1-for-20, with
the exact ratio within such range to be determined by the Board at its discretion (the &#8220;<b>Reverse Stock Split</b>&#8221;). The
Reverse Stock Split may be effected at any time prior to the one-year anniversary date of the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The primary goal of the
Reverse Stock Split is to increase the per share market price of our Common Stock, which would, among other considerations, allow
the Company to meet the minimum per share bid price requirements for continued listing on The Nasdaq Stock Market LLC
(&#8220;<b>Nasdaq</b>&#8221;). The Board of Directors believes that the Reverse Stock Split would, among other things, (a)&#160;be
an effective tool to enable the Company to maintain the listing of its Common Stock on Nasdaq, (b)&#160;better enable the Company to
raise funds to finance its planned and continuing operations, and (c)&#160;facilitate higher levels of institutional stock
ownership, where investment policies generally prohibit investments in lower-priced securities. We believe that a range of Reverse
Stock Split ratios provides us with the most flexibility to achieve the desired results of the Reverse Stock Split. The Reverse
Stock Split is not intended as, and will not have the effect of, a &#8220;going private transaction&#8221; covered by
Rule&#160;13e-3 promulgated under the Exchange Act. The Reverse Stock Split is not intended to modify the rights of existing
stockholders in any material respect.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>The reverse stock split
would reduce the number of outstanding shares while proportionately increasing the per-share value of those shares, subject to market
conditions and other factors. As a result, the reverse stock split would not, by itself, affect the dollar value of the shares owned by
the shareholder, the shareholders&#8217; proportionate ownership interests, or the Company&#8217;s market capitalization, except for the
effect of rounding up fractional shares.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Reverse Stock Split
Proposal is approved by our stockholders and the Reverse Stock Split is effected, every 5 shares of our issued and outstanding Common
Stock, or up to every 20 shares of our outstanding Common Stock would be combined and reclassified into one share of Common Stock. The
Reverse Stock Split may be effected at any time prior to the one year anniversary date of the Special meeting. The actual timing for implementation
of the Reverse Stock Split would be determined by the Board based upon its evaluation as to when such action would be most advantageous
to the Company and its stockholders. Notwithstanding approval of the Reverse Stock Split Proposal by our stockholders, the Board will
have the sole authority to elect whether or not and when to amend our Certificate of Incorporation to effect the Reverse Stock Split.
If the Reverse Stock Split Proposal is approved by our stockholders, the Board will make a determination as to whether effecting the Reverse
Stock Split is in the best interests of the Company and our stockholders in light of, among other things, the Company&#8217;s ability
to increase the trading price of our Common Stock to meet the minimum stock price standards of Nasdaq without effecting the Reverse Stock
Split, the per share price of the Common Stock immediately prior to the Reverse Stock Split and the expected stability of the per share
price of the Common Stock following the Reverse Stock Split. If the Board determines that it is in the best interests of the Company and
its stockholders to effect the Reverse Stock Split, it will hold a Board meeting to determine the ratio of the Reverse Stock Split. For
additional information concerning the factors the Board will consider in deciding whether to effect the Reverse Stock Split, see &#8220;&#8212;<i>Determination
of the Reverse Stock Split Ratio</i>&#8221; and &#8220;&#8212;<i>Board Discretion to Effect the Reverse Stock Split</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The text of the proposed amendment
to the Company&#8217;s Certificate of Incorporation to effect the Reverse Stock Split is included as <span style="text-decoration:underline">Appendix A</span> to this proxy statement.
If the Reverse Stock Split Proposal is approved by the Company&#8217;s stockholders, the Company will have the authority to file the Reverse
Stock Split Amendment with the Secretary of State of the State of Delaware, which will become effective upon its filing; <i>provided,
however, </i>that the Reverse Stock Split Amendment is subject to revision to included such changes as may be required by the office of
the Secretary of State of the State of Delaware and as the Board deems necessary and advisable. The Board has determined that the amendment
is advisable and in the best interests of the Company and its stockholders and has submitted the amendment for consideration by our stockholders
at the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 18 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reasons for the Reverse Stock Split Amendment</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are submitting this proposal
to our stockholders for approval in order to increase the trading price of our Common Stock, which would, among other considerations, allow the Company to meet the minimum per share bid price requirement
for continued listing on Nasdaq. We believe increasing the trading price of our Common Stock may also assist in our capital-raising efforts
by making our Common Stock more attractive to a broader range of investors. The Board has not authorized the Company to take any action
with respect to the shares that would become available for issuance after the implementation of the Reverse Stock Split, and the Company
currently does not have any definitive agreements with respect to the issuance of such additional shares of Common Stock; however, the
Company expects that it may need to raise additional capital or otherwise issue shares of Common Stock in the future to fund its ongoing
operations, working capital needs and other corporate purposes. Although the Company has not determined the timing, amount, structure
or terms of any such issuance, the additional authorized shares that become available following the Reverse Stock Split could be used
for one or more financing transactions or other issuances if and when approved by the Board. Accordingly, we believe that the Reverse
Stock Split is in our stockholders&#8217; best interests.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that the Reverse
Stock Split, if necessary, is a potential effective means to meet the criteria to satisfy the minimum per share bid price requirement
for continued listing on the Nasdaq. Nasdaq requires, among other criteria, that the Company maintain a continued closing bid price of
at least $1.00 per share. On the Record Date, the last reported sale price of our Common Stock on Nasdaq was $0.43 per share. We have in
the past, and may in the future, be unable to comply with certain of the listing standards that we are required to meet to maintain the
listing of our Common Stock on Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October&#160;2, 2025, the
Company received written notice from the Listing Qualifications Department (the &#8220;<b>Staff</b>&#8221;) of the Nasdaq Stock Market
LLC that the Company was not in compliance with Nasdaq Listing Rule&#160;5550(a)(2)&#160;because the Company&#8217;s Common Stock had
fallen below $1.00 per share for 30 consecutive business days the (&#8220;<b>Minimum Bid Price Requirement</b>&#8221;). On April&#160;1,
2026, the Company received a letter (the &#8220;<b>Extension Notice</b>&#8221;) from the Staff of the Nasdaq Stock Market LLC advising
that the Company had been granted a 180-day extension, or until September&#160;28, 2026, to regain compliance with the Minimum Bid Price
Requirement, in accordance with Nasdaq Listing Rule&#160;5810(c)(3)(A). If at any time prior to September&#160;28, 2026, the bid price
of the Company&#8217;s Common Stock closes at $1.00 per share or more for a minimum of 10 consecutive trading days, the Company will regain
compliance with the Minimum Bid Price Requirement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board believes that effecting
the Reverse Stock Split, if the Company does not regain compliance with the Minimum Bid Price Requirement, may be necessary to maintain
the listing of our Common Stock on Nasdaq, which the Board considers important to the Company and its stockholders. If enacted, the Board intends the Reverse Stock
Split  to increase the per share trading price of our Common Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Potential Consequences if the Reverse Stock
Split Proposal is Not Approved</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Reverse Stock Split
Proposal is not approved by our stockholders, our Board will not have the authority to effect the Reverse Stock Split Amendment to, among
other things, facilitate the continued listing of our Common Stock on Nasdaq by increasing the per share trading price of our Common Stock, which would, among other considerations, allow the Company
to  achieve a share price high enough to satisfy the $1.00 per share Minimum Bid Price Requirement. Any inability of our Board to
effect the Reverse Stock Split could result in our delisting from Nasdaq, which may impact the visibility and liquidity of our Common
Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 19 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Treatment of Fractional Shares in the Reverse
Stock Split</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company will not issue
fractional certificates for post-reverse stock split shares in connection with the Reverse Stock Split. In lieu of issuing fractional
shares, stockholders of record who otherwise would be entitled to receive fractional shares will be entitled to rounding up of the fractional
share to the nearest whole number. For example, if as a result of a reverse stock split a record stockholder would otherwise be entitled
to hold 15.3 shares of our Common Stock after giving effect to the Reverse Stock Split, such stockholder would instead hold 16 shares
of our Common Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Determination of the Reverse Stock Split Ratio</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board believes that stockholder
approval of a range of potential Reverse Stock Split ratios is in the best interests of our Company and stockholders because it is not
possible to predict market conditions at the time the Reverse Stock Split would be implemented. We believe that a range of Reverse Stock
Split ratios provides us with the most flexibility to achieve the desired results of the Reverse Stock Split. The Reverse Stock Split
ratio to be selected by our Board will be not less than 1-for-5 and not greater than 1-for-20.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The selection of the specific
Reverse Stock Split ratio will be based on several factors, including, among other things:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">our ability to maintain the listing of our Common
Stock on the Nasdaq;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the per share price of our Common Stock immediately
prior to the Reverse Stock Split;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the expected stability of the per share price
of our Common Stock following the Reverse Stock Split;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the likelihood that the Reverse Stock Split will
result in increased marketability and liquidity of our Common Stock;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">prevailing market conditions;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">general economic conditions in our industry;
and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">our market capitalization before, and anticipated
market capitalization after, the Reverse Stock Split.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We believe that granting our
Board the authority to set the ratio for the Reverse Stock Split is essential because it allows us to take these factors into consideration
and to react to changing market conditions. If the Board chooses to implement the Reverse Stock Split, the Company will make a public
announcement regarding the determination of the Reverse Stock Split ratio.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain Risks and Potential Disadvantages Associated
with a Reverse Stock Split</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><i>We cannot assure
you that the proposed Reverse Stock Split will result in a sustained increase in the per share price of our Common Stock and, if applicable,
have the desired effect of maintaining compliance with Nasdaq Rules</i></span>. However, the effect of the Reverse Stock Split upon the
market price of our Common Stock cannot be predicted with any certainty, and the history of similar reverse stock splits for companies
in like circumstances is varied, particularly since some investors may view a reverse stock split negatively. In particular, we cannot
assure you that the price of a share of our Common Stock after the Reverse Stock Split will remain increased in proportion to the reduction
in the number of shares of our Common Stock outstanding immediately prior to the Reverse Stock Split. In addition, although we believe
the Reverse Stock Split may enhance the desirability of our Common Stock to certain potential investors, we cannot assure you that, if
implemented, our Common Stock will be more attractive to institutional and other long-term investors. Even if we implement the Reverse
Stock Split, the market price of our Common Stock may decrease due to factors unrelated to the Reverse Stock Split. In any case, the market
price of our Common Stock may also be based on other factors which may be unrelated to the number of shares outstanding, including our
future performance. If the Reverse Stock Split is consummated and the trading price of our Common Stock declines, the percentage decline
as an absolute number and as a percentage of our overall market capitalization may be greater than would occur in the absence of the Reverse
Stock Split. Additionally, we may be delisted due to a failure to meet continued listing requirements, including Nasdaq requirements related
to the minimum number of shares that must be in the public float, the minimum market value of the public float and the minimum number
of &#8220;round lot&#8221; holders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><i>The proposed
Reverse Stock Split may decrease the liquidity of our Common Stock and result in higher transaction costs</i></span>. The liquidity of
our Common Stock may be negatively impacted by a Reverse Stock Split due to the reduced number of shares that would be outstanding after
the Reverse Stock Split, particularly if the post-split trading price is not sustained at the proportionately adjusted level once market
forces take effect. In addition, if a Reverse Stock Split is implemented, it will increase the number of our stockholders who own &#8220;odd
lots&#8221; of fewer than 100 shares of Common Stock. Brokerage commission and other costs of transactions in odd lots are generally higher
than the costs of transactions of more than 100 shares of Common Stock. Accordingly, a Reverse Stock Split may not achieve the desired
results of increasing marketability and liquidity of our Common Stock described above.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 20 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt"><i>The effective
increase in the authorized number of shares of our Common Stock as a result of the Reverse Stock Split could have anti-takeover implications</i></span>.
The implementation of a Reverse Stock Split will result in an effective increase in the authorized number of shares of our Common Stock
available for issuance, which could, under certain circumstances, have anti-takeover implications. The additional shares of Common Stock
that would become available for issuance if this Proposal 4 is approved and a Reverse Stock Split is implemented could be used by us to
oppose a hostile takeover attempt or to delay or prevent changes in control or our management. For example, without further stockholder
approval, the Board could adopt a &#8220;poison pill&#8221; which would, under certain circumstances related to an acquisition of our
securities that is not approved by the Board, give certain holders the right to acquire additional shares of our Common Stock at a low
price. The Board also could strategically sell shares of Common Stock in a private transaction to purchasers who would oppose a takeover
or favor the current Board. Although this Proposal 4 has been prompted by business and financial considerations and not by the threat
of any hostile takeover attempt (nor is the Board currently aware of any such attempts directed at us), stockholders should be aware that
approval of this Proposal 4 could facilitate future efforts by us to deter or prevent changes in control, including transactions in which
the stockholders might otherwise receive a premium for their shares over then current market prices.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Discretion to Effect the Reverse Stock
Split</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Reverse Stock
Split Proposal is approved by our stockholders, the Board will have the discretion to implement the Reverse Stock Split or to not
effect the Reverse Stock Split at all. The Board currently intends to effect the Reverse Stock Split, if necessary,  which would,
among other considerations, allow the Company to comply with the Minimum Bid Price Requirement. If the trading price of our Common
Stock increases without effecting the Reverse Stock Split, the Reverse Stock Split may not be necessary. Following the Reverse Stock
Split, if implemented, there can be no assurance that the market price of our Common Stock will be sustained at the proportionately
adjusted level once market forces take effect or that the market price of the post-split Common Stock can be maintained above $1.00.
There also can be no assurance that our Common Stock will not be delisted from Nasdaq for other reasons.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If our stockholders approve
the Reverse Stock Split Proposal at the Annual Meeting, the Reverse Stock Split will be effected, if at all, only upon a determination
by the Board that the Reverse Stock Split is in the best interests of the Company and its stockholders at that time. No further action
on the part of the stockholders will be required to either effect or abandon the Reverse Stock Split. If our Board does not implement
the Reverse Stock Split prior to the one-year anniversary date of the Annual Meeting, the authority granted in this proposal to implement
the Reverse Stock Split will terminate and the Reverse Stock Split Amendment will be abandoned.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The market price of our Common
Stock is dependent upon our performance and other factors, some of which are unrelated to the number of shares outstanding. If the Reverse
Stock Split is effected and the market price of our Common Stock declines, the percentage decline as an absolute number and as a percentage
of our overall market capitalization may be greater than would occur in the absence of the Reverse Stock Split. Furthermore, the reduced
number of shares that will be outstanding after the Reverse Stock Split may reduce the trading volume and otherwise adversely affect the
liquidity of our Common Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not proposed the Reverse
Stock Split in response to any effort which we are aware to accumulate our shares of Common Stock or obtain control of the Company, nor
is it a plan by management to recommend a series of similar actions to our Board or our stockholders. Notwithstanding the decrease in
the number of outstanding shares of Common Stock following the Reverse Stock Split, our Board does not intend for this transaction to
be the first step in a &#8220;going private transaction&#8221; within the meaning of Rule&#160;13e-3 of the Exchange Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 21 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effectiveness of the Reverse Stock Split</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Reverse Stock Split, if
approved by our stockholders, will become effective upon the filing with the Secretary of State of the State of Delaware of a certificate
of amendment to our Certificate of Incorporation in substantially the form of the Reverse Stock Split Amendment attached to this proxy
statement as <span style="text-decoration:underline">Appendix A</span>. The exact timing of the filing of the Reverse Stock Split Amendment will be determined by the Board based
upon its evaluation of when such action will be most advantageous to the Company and our stockholders. The Board reserves the right, notwithstanding
stockholder approval and without further action by our stockholders, to elect not to proceed with the Reverse Stock Split if, at any time
prior to filing such Reverse Stock Split Amendment, the Board, in its sole discretion, determines that it is no longer in the best interests
of the Company and our stockholders. The Board currently intends to effect the Reverse Stock Split, if necessary, to comply with the Minimum
Bid Price Requirement. If our Board does not implement the Reverse Stock Split prior to the one-year anniversary date of the Special Meeting,
the authority granted in this proposal to implement the Reverse Stock Split will terminate and the Reverse Stock Split Amendment to effect
the Reverse Stock Split will be abandoned.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effects of the Reverse Stock Split on Issues
and Outstanding Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Reverse Stock Split
is effected, it will reduce the total number of issued and outstanding shares of Common Stock, including any shares held by the Company
as treasury shares, by a Reverse Stock Split ratio of not less than 1-for-5 and not greater than 1-for-20. Accordingly, each of our stockholders
will own fewer shares of Common Stock as a result of the Reverse Stock Split. However, the Reverse Stock Split will affect all stockholders
uniformly and will not affect any stockholder&#8217;s percentage ownership interest in the Company, expect to the extent that the Reverse
Stock Split would result in an adjustment to a stockholder&#8217;s ownership of Common Stock due to the effect of rounding up fractional
shares in the Reverse Stock Split, as described in more detail herein. Therefore, voting rights and other rights and preferences of the
holders of Common Stock will not be effected by the Reverse Stock Split (except for the effect of rounding up fractional shares). Common
Stock issued pursuant to the Reverse Stock Split will remain fully paid and nonassessable, and the par value per share of Common Stock
will remain $0.001.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the Record Date, approximately
62,842,748 shares of our Common Stock were outstanding and 0 shares of our Preferred Stock were outstanding. For purposes of illustration, if
the Reverse Stock Split is effected at a ratio of 1-for-20, the number of issued and outstanding shares of Common Stock after the Reverse
Stock Split would be approximately 3,142,138 shares. Nasdaq requirements state that a listed company must have at least 500,000 shares in the
public float. The Company would meet this requirement if the Reverse Stock Split is effected at a ratio of 1-for-20.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effects of the Reverse Stock Split on Outstanding
Equity Awards and Warrants to Purchase Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Reverse Stock Split
is effected, the terms of equity awards granted under our CytoSorbents Corporation 2006 Long-Term Incentive Plan and Amended and Restated
CytoSorbents Corporation 2014 Long-Term Incentive Plan (collectively the &#8220;<b>Equity Plans</b>&#8221;), including the per share exercise
price of options and the number of shares issuable under such options, will be proportionally adjusted to maintain their economic value,
subject to adjustments for any fractional shares as described herein. In addition, the total number of shares of Common Stock that may
be the subject of future grants under the Equity Plan, as well as any plan limits on the size of such grants will be adjusted and proportionately
decreased as a result of the Reverse Stock Split. The number and exercise prices of outstanding warrants that we have issued will be correspondingly
adjusted.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effects of the Reverse Stock Split on Voting
Rights</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Proportionate voting rights
and other rights of the holders of Common Stock would not be affected by the Reverse Stock Split (except for the effect of rounding up
fractional shares). For example, a holder of 1% of the voting power of the outstanding Common Stock immediately prior to the effective
time of the Reverse Stock Split would continue to hold 1% of the voting power of the outstanding Common Stock after the Reverse Stock
Split (except for the effect of rounding up fractional shares).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effects of the Reverse Stock Split on Regulatory
Matters</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are subject to the periodic
reporting and other requirements of the Exchange Act. The Reverse Stock Split will not affect our obligation to publicly file financial
and other information with the SEC. After the effective time of any Reverse Stock Split that our Board elects to implement, our Common
Stock would have a new committee on uniform securities identification procedures, or CUSIP number, a number used to identify our Common
Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 22 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is currently
registered under Section&#160;12(b)&#160;of the Exchange Act, and we are subject to the periodic reporting and other requirements of the
Exchange Act. The implementation of any proposed Reverse Stock Split will not affect the registration of our Common Stock under the Exchange
Act. Our Common Stock would continue to be listed on Nasdaq under the symbol &#8220;CTSO&#8221; immediately following the Reverse Stock
Split, although it is likely that Nasdaq would add the letter &#8220;D&#8221; to the end of the trading symbol for a period of twelve
trading days after the effective date of the Reverse Stock Split to indicate that the Reverse Stock Split had occurred.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effects of the Reverse Stock Split on Authorized
Share Capital</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The total number of shares
of capital stock that we are authorized to issue will not be affected by the Reverse Stock Split and will remain at 105,000,000 shares,
consisting of 100,000,000 shares of Common Stock and 5,000,000 shares of Preferred Stock if the Board elects to proceed with a Reverse
Stock Split. The Reverse Stock Split will not change the proportionate equity interests of the Company&#8217;s stockholders, nor will
it alter the relative voting rights or dividend rights of such stockholders, except for minor adjustments due to the treatment of fractional
shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effects of the Reverse Stock Split on the Number
of Shares of Common Stock Available for Future Issuance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">By reducing the number of
shares outstanding without reducing the number of shares of available but unissued Common Stock, the Reverse Stock Split will increase
the number of authorized but unissued shares of Common Stock. The Board has no current intention to use all of the authorized but unissued
shares made available as a result of the Reverse Stock Split. However, the Board believes that maintaining these authorized but unissued
shares is appropriate to provide the Company with flexibility to support its future operations and to pursue potential financing or capital-raising
transactions, including in the near term, if and when the Board determines that such transactions are advisable and in the best interest
of the Company and its stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although the Reverse Stock
Split would not have any dilutive effect on our stockholders, the Reverse Stock Split without a reduction in the number of shares authorized
for issuance would reduce the proportion of shares owned by our stockholders relative to the number of shares authorized for issuance,
giving the Board an effective increase in the authorized shares available for issuance, in its discretion. The Board from time to time
may deem it to be in the best interests of the Company to enter into transactions and other ventures that may include the issuance of
shares of our Common Stock. If the Board authorizes the issuance of additional shares subsequent to the Reverse Stock Split, the dilution
to the ownership interest of our existing stockholders may be greater than would occur had the Reverse Stock Split not been effected.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Mechanics of the Reverse Stock Split</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Reverse Stock Split
is approved and effected, beginning on the effective date of the Reverse Stock Split, each certificate representing pre-split shares will,
until surrendered and exchanged as described below, for all corporate purposes, be deemed to represent, respectively, only the number
of post-split shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Exchange of Stock Certificates</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Shortly after the Reverse
Stock Split becomes effective, stockholders will be notified and offered the opportunity at their own expense to surrender any current
certificates they may hold to our stock transfer agent in exchange for the issuance of new certificates reflecting the Reverse Stock Split
in accordance with the procedures to be set forth in a letter of transmittal to be sent by our stock transfer agent. In connection with
the Reverse Stock Split, the CUSIP number for the Common Stock will change from its current CUSIP number. This new CUSIP number will appear
on any new stock certificates issued representing post-split shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>STOCKHOLDERS SHOULD NOT DESTROY ANY STOCK CERTIFICATE(S)&#160;AND
SHOULD NOT SUBMIT ANY STOCK CERTIFICATE(S)&#160;UNLESS AND UNTIL REQUESTED TO DO SO FOLLOWING THE ANNOUNCEMENT OF THE COMPLETION OF THE
REVERSE STOCK SPLIT.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 23 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Effect on Registered &#8220;Book-Entry&#8221;
Holders of Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of Common Stock may
hold some or all of their Common Stock electronically in book-entry form (&#8220;street name&#8221;) under the direct registration system
for securities. These stockholders will not have stock certificates evidencing their ownership. They are, however, provided with a statement
reflecting the number of shares of Common Stock registered in their accounts. If you hold registered Common Stock in book-entry form,
you do not need to take any action to receive your post-split shares, if applicable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Appraisal Rights</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under the Delaware General
Corporation Law, our stockholders are not entitled to appraisal or dissenter&#8217;s rights with respect to the Reverse Stock Split, and
we will not independently provide our stockholders with any such rights.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Regulatory Approvals</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Reverse Stock Split will
not be consummated, if at all, until after approval of our stockholders is obtained. We are not obligated to obtain any governmental approvals
or comply with any state or federal regulations in order to effect the Reverse Stock Split other than the filing of the Reverse Stock
Split Amendment with the Secretary of State of the State of Delaware.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Accounting Treatment of the Reverse Stock Split</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Reverse Stock Split
is effected, the par value per share of our Common Stock will remain unchanged at $0.001. Accordingly, on the effective date of the Reverse
Stock Split, the stated capital on our consolidated balance sheets attributable to our Common Stock will be reduced in proportion to the
size of the Reverse Stock Split ratio, and the additional paid-in-capital account will be increased by the amount by which the stated
capital is reduced. Our stockholders&#8217; equity, in the aggregate, will remain unchanged. Per share net income or loss will be increased
because there will be fewer shares of Common Stock outstanding. Any Common Stock held in treasury will be reduced in proportion to the
Reverse Stock Split ratio. The Company does not anticipate that any other accounting consequences, including changes to the amount of
stock-based compensation expense to be recognized in any period, will arise as a result of the Reverse Stock Split.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain U.S. Federal Income Tax Consequences
of the Reverse Stock Split</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following discussion is
a summary of certain material U.S. federal income tax considerations of the Reverse Stock Split applicable to U.S. holders (as defined
below). This discussion does not purport to be a complete analysis of all potential tax consequences that may be relevant to a U.S. holder.
The effects of U.S. federal tax laws other than U.S. federal income tax laws, such as estate and gift tax laws, and any applicable state,
local or non-U.S. tax laws are not discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;),
Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the IRS, in
each case in effect as of the date hereof. These authorities may change or be subject to differing interpretations. Any such change or
differing interpretation may be applied retroactively in a manner that could adversely affect a U.S. holder. We have not sought and do
not intend to seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not
take a position contrary to that discussed below regarding the tax consequences of the Reverse Stock Split.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This discussion is limited
to U.S. holders that hold Common Stock as a &#8220;capital asset&#8221; within the meaning of Section&#160;1221 of the Code (generally,
property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to a U.S. holder&#8217;s
particular circumstances, including the impact of the alternative minimum tax, the rules&#160;related to &#8220;qualified small business
stock&#8221; within the meaning of Section&#160;1202 of the Code or the Medicare contribution tax on net investment income. In addition,
it does not address consequences relevant to U.S. holders subject to special rules, including, without limitation:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">U.S. expatriates and former citizens or long-term
residents of the United States;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">U.S. holders whose functional currency is not
the U.S. dollar;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Persons holding Common Stock as part of a hedge,
straddle or other risk reduction strategy or as part of a conversion transaction or other integrated investment;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 24 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">banks, insurance companies, and other financial
institutions;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">real estate investment trusts or regulated investment
companies;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">brokers, dealers or traders in securities;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">corporations that accumulate earnings to avoid
U.S. federal income tax;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">S corporations, partnerships or other entities
or arrangements treated as partnerships for U.S. federal income tax purposes (and investors therein);</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">tax-exempt organizations or governmental organizations;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">persons deemed to sell Common Stock under the
constructive sale provisions of the Code;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0.25in"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">persons who hold or received Common Stock pursuant
to the exercise of any employee stock option or otherwise as compensation; and tax-qualified retirement plans.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an entity treated as a
partnership for U.S. federal income tax purposes holds Common Stock, the tax treatment of a partner in the partnership will generally
depend on the status of the partner, the activities of the partnership and certain determinations made at the partner level. Accordingly,
partnerships holding Common Stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income
tax consequences to them.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">THIS DISCUSSION IS FOR INFORMATION
PURPOSES ONLY AND IS NOT TAX ADVICE. HOLDERS SHOULD CONSULT THEIR TAX ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME
TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT ARISING UNDER THE U.S. FEDERAL ESTATE
OR GIFT TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL OR NON-U.S. TAXING JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Reverse Stock Split should
constitute a &#8220;recapitalization&#8221; for U.S. federal income tax purposes. As a result, a U.S. holder of Common Stock generally
should not recognize gain or loss upon the Reverse Stock Split. A U.S. holder&#8217;s aggregate tax basis in the shares of Common Stock
received pursuant to the Reverse Stock Split should equal the aggregate tax basis of the shares of the Common Stock surrendered, and such
U.S. holder&#8217;s holding period in the shares Common Stock received should include the holding period in the shares of Common Stock
surrendered. Treasury Regulations provide detailed rules&#160;for allocating the tax basis and holding period of the shares of Common
Stock surrendered to the shares of Common Stock received in a recapitalization pursuant to the Reverse Stock Split. U.S. holders of shares
of Common Stock acquired on different dates and at different prices should consult their tax advisors regarding the allocation of the
tax basis and holding period of such shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As noted above, we will not
issue fractional shares in connection with the Reverse Stock Split. Instead, stockholders who otherwise would be entitled to receive fractional
shares will be automatically entitled to receive an additional fraction of a share of Common Stock to round up to the next whole post-split
share. The U.S. federal income tax treatment of the receipt of such a fractional share in a Reverse Stock Split is not clear. It is possible
that the receipt of such an additional fraction of a share of Common Stock may be treated as a distribution taxable as a dividend or as
an amount received in exchange for Common Stock. We intend to treat the issuance of such an additional fraction of a share of Common Stock
in the Reverse Stock Split as a non-recognition event, but there can be no assurance that the Internal Revenue Service or a court would
not successfully assert otherwise.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Vote Required</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a
majority in voting power of the shares present, in person or represented by proxy and entitled to vote on the matter is required for the
approval of the Reverse Stock Split Proposal.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board unanimously recommends
that stockholders vote &#8220;<b>FOR</b>&#8221; the proposal to amend our Second Amended and Restated Certificate of Incorporation to
effect the Reverse Stock Split.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 25 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v20"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL NO.&#160;5 - ADJOURNMENT PROPOSAL</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>General</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company is asking its
stockholders to approve, if necessary, a proposal to adjourn the Annual Meeting to a later date and time to solicit additional proxies
in favor of one or more proposals submitted to a vote by the stockholders at the Annual Meeting. Any adjournment of the Annual Meeting
for the purpose of soliciting additional proxies will allow stockholders who have already sent in their proxies to revoke them at any
time prior to the voting of the proxies at the adjourned meeting by following the proxy revocation procedures described in this proxy
statement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Vote Required</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote of a
majority of the shares of stock present or represented at the Annual Meeting and entitled to vote on the matter is required for the approval
of the Adjournment Proposal.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Recommendation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board unanimously recommends
that stockholders vote &#8220;<b>FOR</b>&#8221; the adjournment of the Annual Meeting to a later date or time, if necessary, to permit
further solicitation and vote of proxies if there are not sufficient votes at the time of the Annual Meeting to approve any of the proposals
presented for a vote at the Annual Meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 26 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v21"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>STOCK OWNERSHIP OF PRINCIPAL STOCKHOLDERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based on information publicly
filed or otherwise provided to us, the stockholders named in the following table are each beneficial owners of 5% or more of our Common
Stock. Unless otherwise indicated, the information is as of June&#160;1, 2026. For purposes of this table, and as used elsewhere in this
Proxy Statement, the term &#8220;beneficial owner&#8221; means any person who, directly or indirectly, has or shares the power to vote,
or to direct the voting of, shares of our Common Stock, the power to dispose, or to direct the disposition of, a security or has the right
to acquire shares within sixty (60)&#160;days. Except as otherwise indicated, we believe that the owners listed below exercise sole voting
and dispositive power over their shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Name and Address of Beneficial Owner</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Number of Shares <br/> Beneficially Owned</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Percentage <br/> Beneficially Owned</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -0.125in; padding-left: 0.125in; width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: left">ROKK LLC <br/>P.O.&#160;Box 894 <br/>Nogales, Arizona 85628</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: right">4,582,591</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">(1)</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: right">5.7</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Avenir Corporation <br/>277 South Washington Street, Suite&#160;350 <br/>Alexandria, VA 22314</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,230,099</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">(2)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td style="text-align: justify">Includes 3,450,055 shares held by ROKK LLC, formerly the Robert F. Shipley Family Trust and 566,268 shares
held by Mary Shipley Ley, and 566,268 shares held by Reed Robert Shipley over all of which Mary Shipley Ley or Reed Robert Shipley holds
voting power.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td style="text-align: justify">This information is based in part on a Schedule&#160;13G/A filed by Avenir Corporation with the SEC on
February&#160;13, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v22"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>STOCK OWNERSHIP OF DIRECTORS, NOMINEES FOR DIRECTOR
AND EXECUTIVE OFFICERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table and notes
thereto set forth information with respect to the beneficial ownership of shares of our Common Stock as of June&#160;1, 2026 (except as
otherwise indicated below) by each of our directors and director nominees, each named executive officer and by our directors and executive
officers as a group, based upon information furnished to us by such persons. In accordance with SEC rules, each listed person&#8217;s
beneficial ownership includes (i)&#160;all shares the stockholder actually owns beneficially or of record, (ii)&#160;all shares over which
the stockholder has or shares voting or investment power, and (iii)&#160;all shares the stockholder has the right to acquire within 60&#160;days.
Unless otherwise indicated, all shares are or will be owned directly, and the indicated person has or will have sole voting and/or investment
power. Unless otherwise indicated, the address of each person listed in the table is 305 College Road East Princeton, New Jersey 08540.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Name of Beneficial Owner<sup>(1)</sup></b></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of <br/>
Shares</td><td style="vertical-align: super; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><sup>&#160;</sup></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Percentage of<br/>
 Common Stock<sup>(1)</sup></b></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 64%; font: 10pt Times New Roman, Times, Serif; text-align: left">Michael G. Bator, MBA</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: right">318,555</td><td style="vertical-align: super; width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(2)</sup></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 15%; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vincent J. Capponi, MS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,179,029</td><td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(3)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.9</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Phillip P. Chan, MD, PhD</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,100,126</td><td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(4)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Efthymios Deliargyris, MD</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">618,257</td><td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(5)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Edward R. Jones, MD, MBA</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">187,090</td><td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(6)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jiny Kim, MBA</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">105,875</td><td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(7)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Peter J. Mariani</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">170,613</td><td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(8)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Alan D. Sobel, CPA</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">251,276</td><td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(9)</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">All current directors, director nominees and executive officers as a group (8 persons)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,930,821</td><td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>&#160;</sup></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.8</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">*&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Less
than 1%</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td style="text-align: justify">Applicable percentage of ownership is based on 62,842,748 shares of our Common Stock outstanding as of
June&#160;1, 2026. Beneficial ownership is determined in accordance with the rules&#160;of the SEC and means voting or investment power
with respect to securities. Shares of our Common Stock issuable upon the exercise of stock options and warrants exercisable currently
or within sixty (60)&#160;days of June&#160;1, 2026, are deemed outstanding and to be beneficially owned by the person holding such option
for purposes of computing such person&#8217;s percentage ownership but are not deemed outstanding for the purpose of computing the percentage
ownership of any other person.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 27 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td style="text-align: justify">Includes 81,973 shares of Common Stock, 13,157 warrants, and 223,425 shares of Common Stock issuable pursuant
to stock options currently exercisable within 60&#160;days of June&#160;1, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(3)</td><td style="text-align: justify">Includes 429,668 shares of Common Stock, 6,578 warrants, and 742,783 shares of Common Stock issuable pursuant
to stock options currently exercisable within 60&#160;days of June&#160;1, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(4)</td><td style="text-align: justify">Includes 1,113,363 shares of Common Stock, 26,315 warrants, and 960,448 shares of Common Stock issuable
pursuant to stock options currently exercisable within 60&#160;days of June&#160;1, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(5)</td><td style="text-align: justify">Includes 197,525 shares of Common Stock, 7,894 warrants, and 412,838 shares of Common Stock issuable pursuant
to stock options currently exercisable within 60&#160;days of June&#160;1, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(6)</td><td style="text-align: justify">Includes 19,534 shares of Common Stock, 2,631 warrants, and 164,925 shares of Common Stock issuable pursuant
to stock options currently exercisable within 60&#160;days of June&#160;1, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(7)</td><td style="text-align: justify">Includes 8,519 shares of Common Stock, 2,631 shares of warrants, and 94,725 shares of Common Stock issuable
pursuant to stock options currently exercisable within 60&#160;days of June&#160;1, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(8)</td><td style="text-align: justify">Includes 116,613 shares of Common Stock, and 54,000 shares of Common Stock issuable pursuant to stock
options currently exercisable within 60&#160;days of June&#160;1, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(9)</td><td style="text-align: justify">Includes 78,457 shares of Common Stock. 7,894 warrants, and 164,925 shares of Common Stock issuable pursuant
to stock options currently exercisable within 60&#160;days of June&#160;1, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v23"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>BOARD OF DIRECTORS AND CORPORATE GOVERNANCE
MATTERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Independence of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board has determined
that each of Messrs., Bator and Sobel, Ms.&#160;Kim, and Dr.&#160;Jones are independent as that term is defined under the applicable
independence listing standards of the Nasdaq Stock Market (&#8220;<b>Nasdaq</b>&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Meetings</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board held nine meetings
during the year ended December&#160;31, 2025. During such year, no incumbent director attended fewer than 75% of the aggregate of all
meetings of the Board held during the period in which he or she served as a director and the total number of meetings held by the committee
on which he or she served during the period. It is the policy of our Board that each director attends our annual meetings of stockholders.
All incumbent directors who were directors at the time virtually attended the Company&#8217;s 2025 Annual Meeting of Stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Board Leadership Structure and Role in Risk Oversight</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board evaluates its leadership
structure and role in risk oversight on an ongoing basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board believes that its
current leadership structure with Dr.&#160;Chan serving as the Chief Executive Officer and Mr.&#160;Bator serving as our independent non-executive
Chairman, is appropriate for the Company at this time as it promotes balance between the Board&#8217;s independent authority to oversee
our business and the Chief Executive Officer and his management team who manage the business on a day-to-day basis. Both Dr.&#160;Chan
and our independent, non-executive Chairman are actively engaged on significant matters affecting us, including in consultation with the
full Board, such as succession planning, risk management, operating initiatives, and long-term strategy. The Chief Executive Officer has
overall responsibility for all aspects of our operation, while our independent, non-executive Chairman has a greater focus on governance
of the Company, including oversight of the Board. We believe this balance of shared leadership between the two positions is a strength
for the Company. Our independent, non-executive Chairman calls and chairs regular and special meetings of the Board and all executive
sessions of the independent directors, chairs and presides at annual or special meetings of stockholders, provides meaningful input into
the agenda of Board meetings, authorizes the retention of outside advisors, consultants and legal counsel who report directly to the Board,
consults frequently with committee chairs and has the right to and often does attend Board committee meetings.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 28 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board, acting primarily
through the Audit Committee, is also responsible for oversight of our risk management practices, while management is responsible for the
day-to-day risk management processes. This division of responsibilities is the most effective approach for addressing the risks facing
the Company, and the Company&#8217;s board leadership structure supports this approach. Through our Chief Executive Officer, and other
members of management, the Board receives periodic reports regarding the risks facing the Company. In addition, the Audit Committee assists
the Board in its oversight role by receiving periodic reports regarding our risk and control environment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
also reviews the Company&#8217;s compensation practices to confirm that our practices are consistent with the goal of retaining and hiring
qualified leadership and to ensure that such practices and policies do not encourage unnecessary and excessive risk taking by the Company&#8217;s
executive officers and employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Committees of the Board</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Board currently has three
standing committees: an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. These committees,
their principal functions and their respective memberships are described below.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Audit Committee</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
current members of the Audit Committee are Mr.&#160;Sobel, who serves as Chairman, Mr.&#160;Bator and Dr.&#160;Jones, each of whom served
on such committee during the fiscal&#160;year ended December&#160;31, 2025. Each of the members of the Audit Committee is independent
as defined by the applicable Nasdaq listing standards and SEC rules&#160;applicable to audit committee members. The Board has determined
that Mr.&#160;Sobel qualifies as an &#8220;audit committee financial expert,&#8221; as such term is defined by Item&#160;407(d)(5)&#160;of
Regulation S-K as promulgated by the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">The
Audit Committee oversees our financial reporting process and system of internal control over financial reporting, and selects and oversees
the performance of, and approves in advance the services provided by, our independent auditors. The Audit Committee provides an open avenue
of communication among our independent auditors, financial and senior management and the Board. The Audit Committee meets regularly with
our independent auditors without management present, and from time to time with management in separate private sessions, to discuss any
matters that the Committee or these individuals believe should be discussed privately with the Audit Committee, including any significant
issues or disagreements that may arise concerning our accounting practices or financial statements. In addition, the Audit Committee assists
the Board in its oversight role by receiving periodic reports regarding our risk and control environment.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; ">In
2025, the Audit Committee held seven meetings, at which all members attended. A copy of the Audit Committee&#8217;s charter is posted
on our website at www.cytosorbents.com. Our website is not a part of this Proxy Statement, and all references to our website address in
this Proxy Statement are intended to be inactive textual references only.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Review and Approval of Related Person Transactions</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span>Our
Board has adopted written policies and procedures for the review, approval or ratification of transactions involving CytoSorbents and
any executive officer, director, director nominee, 5% stockholder and certain of their immediate family members (each of whom we refer
to as a &#8220;related person&#8221;). The policies and procedures cover any transaction involving $120,000 or more with a related person
(a &#8220;related person transaction&#8221;) in which the related person has a material interest, and which does not fall under an explicitly
stated exception set forth in the applicable disclosure rules&#160;of the SEC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 29 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><!-- Field: Split-Segment; Name: 1 --><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any proposed related person
transaction must be reported to the Chairman of our Audit Committee. The policy calls for the transaction to be reviewed and, if deemed
appropriate, approved by the Audit Committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt; ">A
related person transaction will be considered approved or ratified if it is authorized by the Audit Committee or Chairman after full disclosure
of the related person&#8217;s interest in the transaction. The transaction may be approved or ratified only if the Audit Committee determines
that the transaction is not inconsistent with the Company&#8217;s best interests. In considering related person transactions, the Audit
Committee will consider any information considered material to investors and the following factors</span>:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the related person&#8217;s interest in the transaction;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the approximate dollar value of the transaction;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">whether the transaction was undertaken in the
ordinary course of our business;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">whether the terms of the transaction are no less
favorable to us than terms that we could have reached with an unrelated third party; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the purpose and potential benefit to us of the
transaction.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The policy provides that related
party transactions involving the compensation of our executive officers will be reviewed and approved by the Compensation Committee or
our Board, in accordance with the Compensation Committee&#8217;s charter. There were no such related party transactions in 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Nominating and Corporate Governance Committee</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The current members of the
Nominating and Corporate Governance Committee are Mr.&#160;Sobel, who serves as Chairman, Dr.&#160;Jones, and Ms.&#160;Kim, each of whom
served on such committee during the fiscal year ended December&#160;31, 2025. Each of the members of the Nominating and Corporate Governance
Committee is independent as defined by the applicable Nasdaq listing standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Corporate
Governance Committee assists the Board in fulfilling its responsibilities regarding the oversight of the composition of the Board and
other corporate governance matters. Among its other duties, the Nominating and Corporate Governance Committee evaluates nominees and reviews
the qualifications of individuals eligible to stand for election and reelection as directors and makes recommendations to the Board on
this matter; oversees compliance with our Code of Business Conduct and Ethics; reviews and approves related party transactions; recommends
and advises the Board on certain other corporate governance matters; and oversees the Board&#8217;s performance evaluation process.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During 2025, the Nominating
and Corporate Governance Committee held one meeting, at which all members attended. A copy of the Nominating and Corporate Governance
Committee&#8217;s charter is posted on our website at <i>www.cytosorbents.com</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Evaluation and Indemnification of Director Nominees</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Corporate
Governance Committee considers a number of factors in identifying and evaluating director nominees. While all nominees should have the
highest personal integrity, meet any required regulatory qualifications and have a record of exceptional ability and judgment, the Board
relies on the judgment of members of the Nominating and Corporate Governance Committee, with input from our Chief Executive Officer, to
assess the qualifications of potential Board nominees with a view to the contributions that they would make to the Board and to CytoSorbents.
Because our Board believes that its members should ideally reflect a mix of experience and other qualifications, there is no rigid formula.
The Nominating and Corporate Governance Committee charter includes a policy whereby diversity, including diversity of gender, origin and
background, is a key consideration when identifying candidates for membership on the Board. In evaluating potential candidates, the Nominating
and Corporate Governance Committee will consider, among other items, the degree to which a potential candidate fulfills a current Board
need, such as the need for an audit committee financial expert, as well as the candidate&#8217;s ability and commitment to understand
CytoSorbents and its industry and the candidate&#8217;s ability to devote the time necessary to fulfill the role of director (including,
without limitation, regularly attending and participating in meetings of the Board and its Committees). In considering potential candidates,
the Nominating and Corporate Governance Committee will consider the overall competency of the Board in the following areas:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">industry knowledge;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 30 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">accounting and finance;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">business judgment;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">management;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">leadership;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">business strategy;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">diversity of gender, origin, and background;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">crisis management; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">corporate governance.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Nominating
and Corporate Governance Committee may consider other factors, as appropriate in a particular case, including, without limitation, the
candidate&#8217;s:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">sound business and personal judgment;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">senior management experience and demonstrated
leadership ability;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">accountability and integrity;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">financial literacy;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">industry or business knowledge, including science,
technology, and marketing acumen;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">the extent, nature and quality of relationships
and standing in the research and local communities;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">in connection with nominees to be designated
as &#8220;independent&#8221; directors, &#8220;independence&#8221; under regulatory definitions, as well as in the judgment of the Nominating
and Corporate Governance Committee;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">independence of thought and ideas; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">other board appointments and service.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Corporate
Governance Committee considers recommendations for nominations from a variety of sources, including members of the Board, business contacts,
community leaders and members of management. As described below, the Nominating and Corporate Governance Committee will also consider
stockholder recommendations for Board nominees. The Nominating and Corporate Governance Committee&#8217;s process for identifying and
evaluating candidates is the same with respect to candidates recommended by members of the Board, management, stockholders or others.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Stockholder Director Nominee Recommendations</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Corporate
Governance Committee will consider director nominees recommended by stockholders. There are no differences in the manner in which the
Nominating and Corporate Governance Committee evaluates nominees for director based on whether the nominee is recommended by a stockholder
or by the Nominating and Corporate Governance Committee. Stockholders who wish their proposed nominee to be considered by the Nominating
and Corporate Governance Committee for nomination at our next annual stockholders&#8217; meeting should follow the procedures set forth
in our Bylaws as described in &#8220;Stockholder Proposals and Nomination of Director Candidates&#8221; in this Proxy Statement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Committee</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The current members of the
Compensation Committee are Mr.&#160;Bator, who serves as Chairman, and Ms.&#160;Kim, each of whom served on such committee during the
fiscal year ended December&#160;31, 2025. Each of the current members of the Compensation Committee is independent as defined by the applicable
Nasdaq listing standards.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Decisions regarding the compensation
of our executive officers are made by the Compensation Committee. The Compensation Committee&#8217;s principal responsibilities include
reviewing the Company&#8217;s overall compensation philosophy and the adequacy and market competitiveness of our compensation plans and
programs, evaluating the Company&#8217;s compensation policies and practices to determine whether such policies and practices encourage
unnecessary and excessive risk taking by the Company&#8217;s executive officers and employees, evaluating the performance of and reviewing
and approving compensation for our executive officers, evaluating and recommending director compensation, and reviewing and discussing
with management the compensation disclosures included in this Proxy Statement. The Compensation Committee also administers our equity-based
and other incentive plans, including assuming responsibility for granting, or delegating as appropriate the authority for granting, and
making decisions with respect to, awards under our equity compensation and other incentive plans. On an annual basis the Compensation
Committee approves a pool of stock options to be awarded to non-executive employees and delegates the authority for granting these awards
to the Chief Executive Officer. The roles of management is discussed below under &#8220;Significant Corporate Governance Standards&#8221;
and &#8220;Compensation-Setting Process.&#8221; The Compensation Committee held one meeting during 2025 at which all members attended.
A copy of the Compensation Committee&#8217;s charter is posted on our website at <i>www.cytosorbents.com</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 31 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Committee Interlocks and Insider Participation</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation Committee
currently consists of Mr.&#160;Michael Bator, who serves as Chairman, and Ms.&#160;Jiny Kim, each of whom served as members of the Compensation
Committee during 2025. Neither of these individuals is or has been an executive of the Company, or had any relationship requiring disclosure
by the Company under the SEC&#8217;s rules&#160;requiring disclosure of certain relationships and related party transactions. None of
our executive officers served as a director or a member of a compensation committee, or other committee serving an equivalent function,
of any other entity, the executive officers of which served as a director of the Company or a member of the Compensation Committee during
2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stockholder Communications to the Board of Directors</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders may send communications
to our Board in writing, addressed to the full Board or a specific committee of the Board, to Effie Perdikis, Executive Assistant, c/o,
CytoSorbents Corporation, 305 College Road East, Princeton, New Jersey 08540, telephone (732)&#160;398-5396. Such correspondence will
be logged and forwarded to the Board.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Code of Ethics</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have adopted a Code of
Business Conduct and Ethics that applies to our employees (including our principal executive officer, chief financial officer and other
members of our finance and administration department) and our directors. Our Code of Business Conduct and Ethics is posted on our website
at <i>www.cytosorbents.com. </i>In addition, we intend to post on our website all disclosures that are required by law or Nasdaq listing
standards concerning any amendments to, or waivers from, any provision of our Code of Business Conduct and Ethics.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Hedging and Pledging</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our executive officers
and members of the Board are prohibited from entering into hedging or pledging transactions in respect of our Common Stock or other securities
issued by us.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation Recovery Policy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have not implemented a
policy regarding retroactive adjustments to any cash or equity-based incentive compensation paid to our named executive officers and other
employees where the payments were predicated upon the achievement of financial results that were subsequently the subject of a financial
restatement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Insider Trading Policy</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" id="ixv-6885">The Company&#8217;s Insider
Trading Policy applies to all</ix:nonNumeric> employees, directors, and officers of the Company and its subsidiaries. Under the Insider Trading Policy,
transactions in puts, calls, or other derivative securities involving the Company&#8217;s equity securities, as well as hedging transactions
involving the Company&#8217;s equity securities, such as collars and forward sale contracts, are prohibited. The Company believes that
the Insider Trading Policy is reasonably designed to promote compliance with insider trading laws, rules&#160;and regulations, and any
listing standards applicable to the Company. A copy of the Company&#8217;s Insider Trading Policy is filed with our Annual Report on Form&#160;10-Q
as Exhibit&#160;19.1.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 32 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Policies and Practices Related to the Grant of Certain Equity Awards
Close In Time to the Release of Material Nonpublic Information</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" escape="true" name="ecd:AwardTmgMnpiDiscTextBlock" id="ixv-3243"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:AwardTmgPredtrmndFlag" id="ixv-6886">From time to time, the Company
grants stock options, stock appreciation rights, or similar option-like instruments to employees, including our named executive officers.</ix:nonNumeric>
Historically, <ix:nonNumeric contextRef="c0" continuedAt="_AwardTmgMethodTextBlock-c0_alt_0_cont_1" escape="true" name="ecd:AwardTmgMethodTextBlock" id="ixv-6887">we have granted such equity in connection with annual compensation and performance reviews, as well as for new hires, promotions,
or other non-routine grants where the timing of such grants is tied to the event giving rise to the award.</ix:nonNumeric> The Company does not have
any formal policy that requires us to grant, or avoid granting, stock options at particular times and no specific practice on the timing
of awards of such options in relation to the disclosure of material nonpublic information by the Company. However, <ix:nonNumeric contextRef="c0" escape="true" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" id="ixv-6888">the Company&#8217;s
practice is to <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ecd:AwardTmgMnpiCnsdrdFlag" id="ixv-6889">consider</ix:nonNumeric> such information, with participation of the Board and Compensation Committee, to ensure grants are unlikely to
occur close to the release of material nonpublic information.</ix:nonNumeric> In all cases, <ix:continuation id="_AwardTmgMethodTextBlock-c0_alt_0_cont_1">the timing of grants of stock options occurs independent
of the release of any material nonpublic information</ix:continuation>, and <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="ecd:MnpiDiscTimedForCompValFlag" id="ixv-6891">we do not time the disclosure of material nonpublic information for the purpose
of affecting the value of executive compensation.</ix:nonNumeric>&#160;</p></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v1"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DIRECTOR COMPENSATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table shows
for the fiscal year ended December&#160;31, 2025, certain information with respect to the compensation of all non-employee directors of
the Company.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fees Earned or<br/>
 Paid in Cash ($)</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Stock Awards ($)</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option Awards<br/>
 ($)(1)</td>
    <td style="vertical-align: super; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><sup>&#160;</sup></td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total<br/>
 ($)</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48%; text-align: left">Michael G. Bator, MBA(2)&#8239;&#8239;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">116,855</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">30,673</td>
    <td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><sup>(2)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">147,528</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Edward R. Jones, MD, MBA(3)</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">65,042</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,337</td>
    <td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(3)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">80,379</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Alan D. Sobel, CPA(4)</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">91,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,337</td>
    <td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(4)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">106,837</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Jiny Kim, MBA(5)</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">65,042</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">15,337</td>
    <td style="vertical-align: super; font: 10pt Times New Roman, Times, Serif; text-align: left"><sup>(5)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">80,379</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span>The value of option awards granted to directors is based upon the
grant date fair value of awards calculated in accordance with ASC Topic 718. ASC 718 requires companies to calculate the grant date &#8220;fair
value&#8221; of their stock-based awards using a variety of assumptions. This calculation is performed for accounting purposes and reported
in the compensation tables, even though recipients may never realize any value from their awards. ASC 718 also requires companies to recognize
the compensation cost of their stock-based awards in their statements of operations over the period that the recipient of the award is
required to render service in exchange for the award.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td style="text-align: justify">In connection with his service as a director in 2025, we issued Mr.&#160;Bator options to purchase 44,000
shares of our Common Stock at an exercise price of $1.00 per share, which were granted on August&#160;8, 2025, and expire on August&#160;8,
2035. These options shall vest in four equal quarterly installments over a period of one year following the date of grant.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(3)</td><td style="text-align: justify">In connection with his service as a director in 2025 we issued Dr.&#160;Jones options to purchase 22,000
shares of our Common Stock at an exercise price of $1.00 per share, which were granted on August&#160;8, 2025, and expire on August&#160;8,
2035. These options shall vest in four equal quarterly installments over a period of one year following the date of grant.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(4)</td><td style="text-align: justify">In connection with his service as a director in 2025 we issued Mr.&#160;Sobel options to purchase 22,000
shares of our Common Stock at an exercise price of $1.00 per share, which were granted on August&#160;8, 2025, and expire on August&#160;8,
2035. These options shall vest in four equal quarterly installments over a period of one year following the date of grant.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(5)</td><td style="text-align: justify">In connection with her service as a director in 2025 we issued Ms.&#160;Kim options to purchase 22,000
shares of our Common Stock at an exercise price of $1.00 per share, which were granted on August&#160;8, 2025, and expire on August&#160;8,
2035. These options shall vest in four equal quarterly installments over a period of one year following the date of grant.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span>Pursuant
to the fee schedule, the Chairman of the Board is entitled to an annual retainer of $77,168 and each non-employee Board member is entitled
to an annual retainer of $38,584. The Chairs of each committee are entitled to an additional annual fee of $26,458 and non-chair committee
members are entitled to an additional annual fee of $13,299 for each committee upon which they serve. In addition, each of our directors
is eligible to receive reimbursement for actual out-of-pocket expenses incurred by them in connection with their attendance at meetings
of the Board and Board committees and an annual equity grant.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 33 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In 2025, the Compensation
Committee elected to defer undertaking an analysis of Board and executive management compensation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><div><a id="v2"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXECUTIVE OFFICERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below is information about
our current executive officers Phillip P. Chan, Vincent J. Capponi, Efthymios N. Deliargyris, and Peter J. Mariani. Our Board appoints
our executive officers annually, and executive officers serve until they resign or the Board terminates their contract or position. There
are no family relationships among any of our directors, nominee for director and executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Name</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Age</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Position</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 34%; text-align: left">Phillip P. Chan, MD, PhD</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: left">55</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: left">Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vincent J. Capponi, MS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">68</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">President and Chief Operating Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Peter J. Mariani</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">62</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Financial Officer</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Efthymios N. Deliargyris, MD</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">57</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Medical Officer</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Phillip
P. Chan, MD, Ph.D. </i></b></span>For Dr.&#160;Chan&#8217;s background, please see the section entitled &#8220;<i>Director Experience,
Qualifications, Attributes and Skills</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Vincent
J. Capponi</i></b></span>, <b>MS.&#160;</b>Mr.&#160;Capponi joined the Company as Vice President of Operations in 2002, became our Chief
Operating Officer in July&#160;2005 and became President and Chief Operating Officer in April&#160;2020 as well as Co-Managing Director
CytoSorbents MEA FZCO and Director and CytoSorbents India Private Limited. He has more than 30&#160;years of management experience in
medical device, pharmaceutical and imaging equipment at companies including Upjohn, Sims Deltec and Sabratek. Prior to joining CytoSorbents
in 2002, Mr.&#160;Capponi held several senior management positions at Sabratek and its diagnostics division GDS and was interim president
of GDS diagnostics in 2001. From 1998 to 2000, Mr.&#160;Capponi was Senior Vice President and Chief Operating Officer for Sabratek and
Vice President Operations from 1996 to 1998. He received his MS in Chemistry and his BS in Chemistry and Microbiology from Bowling Green
State University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Peter
J. Mariani, CPA (inactive)</i></b></span>. Mr.&#160;Mariani has served as our Chief Financial Officer since August&#160;2024. Prior to
joining CytoSorbents, Mr.&#160;Mariani served as Executive Vice President and Chief Financial Officer of Axogen,&#160;Inc (NASDAQ: AXGN),
a medical technology company focused on peripheral nerve repair and regeneration from March&#160;2021 to December&#160;2023, and previously
as its Chief Financial Officer from March&#160;2016 to March&#160;2021. At Axogen, Mr.&#160;Mariani was responsible for all finance and
accounting functions, investor relations, information technology and security, and Global Quality. Prior to this, Mr.&#160;Mariani was
the Chief Financial Officer of Lensar,&#160;Inc., from July&#160;2014 to January&#160;2016, which at the time was privately-held and a
global leader in next generation femtosecond laser technology for refractive cataract surgery. Prior to this, he served as Chief Financial
Officer at Hansen Medical,&#160;Inc., from June&#160;2011 to June&#160;2014, a publicly-traded company that designed and manufactured
robotic solutions for intravascular procedures. Earlier in his career Mr.&#160;Mariani served in senior financial roles of increasing
importance from November&#160;1994 to December&#160;2006 including Vice President and Corporate controller for Guidant Corporation, a
$3.8&#160;billion, publicly traded leader in the development and sale of medical devices for the treatment of cardiovascular disease.
His experience at Guidant included Vice President of Finance and Administration, Guidant Japan from June&#160;1998 to June&#160;2002.
He started his career at Ernst and Young, LLP, where he served a diverse client base as a Certified Public Accountant. Mr.&#160;Mariani
earned a Bachelor of Science in accounting from Indiana University.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-size: 10pt"><b><i>Efthymios
N. Deliargyris, MD</i></b></span><i>. </i>Dr.&#160;Deliargyris joined the Company as Chief Medical Officer on May&#160;1, 2020. Dr.&#160;Deliargyris
is a triple board-certified physician (internal medicine, cardiology and interventional cardiology) with a distinguished career in clinical
medicine and academia and significant biotech experience in global leadership roles. Prior to joining CytoSorbents, Dr.&#160;Deliargyris
served as the Chief Medical Officer of PLx Pharma Inc. (NASDAQ: PLXP) from August&#160;2018 to April&#160;2020. Prior to this, Dr.&#160;Deliargyris
was the founder and managing director of the Science and Strategy Consulting Group providing expert advice and solutions on scientific,
regulatory, strategic and commercialization challenges to companies engaging in the cardiovascular arena. From 2012 until 2017, Dr.&#160;Deliargyris
served as Global Medical Lead of the Cardiovascular franchise at The Medicines Company where he led global medical strategy, global medical
affairs and late stage R&amp;D. Prior to this, Dr.&#160;Deliargyris served as Chief, Cardiology and Interventional Cardiology at Athens
Medical Center in Athens, Greece from 2004 until 2010 and as Assistant Professor of Cardiology and Director of the Intravascular Laboratory
(IVUS)&#160;at Wake Forest University in Winston-Salem, NC from 2001 to 2004. Dr.&#160;Deliargyris received his Doctor of Medicine degree
from the Kapodistrian University of Athens School of Medicine and completed his residency training in internal medicine at Tufts University
School of Medicine and his fellowships in cardiology and interventional cardiology at the University of North Carolina at Chapel Hill.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 34 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><div><a id="v3"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DELINQUENT SECTION&#160;16(a)&#160;REPORTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#160;16(a)&#160;of
the Exchange Act, and the rules&#160;promulgated thereunder require our officers and directors and persons owning more than 10% of our
outstanding Common Stock to file reports of ownership and changes in ownership with the SEC and to furnish us with copies of all these
filings. We believe, based solely upon a review of reports and amendments thereto filed on EDGAR during and with respect to our fiscal
year ended December&#160;31, 2025, that all of our directors and executive officers complied with the reporting requirements of Section&#160;16(a)&#160;of
the Exchange Act during fiscal 2025, except for a late Form&#160;4 filed on behalf of Mr.&#160;Michael G. Bator on March&#160;4, 2025,
with respect to one transaction that was not reported on a timely basis.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v4"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COMPENSATION DISCUSSION AND ANALYSIS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Compensation Discussion
and Analysis explains how our executive compensation program is designed and operates with respect to our named executive officers by
describing the objectives of our executive compensation program, what the compensation program is designed to reward, and each compensation
component that we provide. In addition, we explain how and why our Compensation Committee arrived at specific compensation policies and
decisions involving our named executive officers for the fiscal year ended December&#160;31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our named executive officers
for the fiscal year ended December&#160;31, 2025, are Phillip P. Chan, Vincent J. Capponi, Peter J. Mariani, and Efthymios N. Deliargyris.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Compensation Discussion
and Analysis contains forward-looking statements that are based on our current plans, considerations, expectations, and determinations
regarding future compensation programs. The actual compensation programs that we adopt in the future may differ materially from currently
planned programs as summarized in this discussion.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Significant Executive Compensation Actions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation Committee,
which consists of two independent directors, sets the compensation of our named executive officers. The Compensation Committee has taken
the following actions with respect to the compensation of our named executive officers:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In 2024, the Committee authorized and approved
a voluntary salary reduction program for certain of the Company&#8217;s named executive officers, which was in effect from April&#160;1,
2024 through December&#160;31, 2024.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In 2024, the Committee approved cash bonuses
linked to the Company&#8217;s 2023 performance and then deferred the payment of these bonuses pending the raise of additional capital.
This payment was subsequently approved in January&#160;2025 following the execution of a Rights Offering which raised $7.8&#160;million
of gross proceeds.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In 2025, the Committee approved cash bonuses
linked to the Company&#8217;s 2024 performance and deferred the payment of these bonuses pending the Compensations Committee&#8217;s determination
of sufficient liquidity.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In 2025, the Committee approved an additional
annual grant of incentive compensation in the form of restricted stock units and stock options, to further align the incentives of the
executives and stockholders, retain key executives and reward performance.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In 2026, the Committee approved cash bonuses
linked to the Company&#8217;s 2025 performance and deferred the payment of these bonuses pending the Compensations Committee&#8217;s determination
of sufficient liquidity; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In 2023, the Committee approved a long-term incentive
compensation program in the form of stock options, which would have vested based upon achievement of certain long-term milestones if achieved
before December&#160;31, 2025. In January&#160;of 2026 the Committee determined that these specific long-term milestones were not achieved,
and the stock options for each of the executives were forfeited as of December&#160;31, 2025.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 35 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Significant Corporate Governance Standards</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have endeavored to maintain
high standards in our executive compensation practices. We conduct an annual review of our compensation programs for executive officers
and other employees to assess the Company&#8217;s ability to attract and retain the best talent and whether such policies and practices
encourage unnecessary and excessive risk taking by the Company&#8217;s executive officers and employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Compensation Philosophy and Objectives</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are the leader in the treatment
of life-threatening conditions in the intensive care unit and cardiac surgery through blood purification. CytoSorbents&#8217; proprietary
blood purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from
blood and other bodily fluids by pore capture and surface adsorption. Our lead product, CytoSorb<sup>&#174;</sup>, is approved in the European
Union and distributed in over 70 countries worldwide, with more than 300,000 devices used cumulatively to date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the U.S.&#160;and Canada,
CytoSorbents is developing the DrugSorb&#8482;-ATR antithrombotic removal system, an investigational device based on an equivalent polymer
technology to CytoSorb, to reduce the severity of perioperative bleeding in high-risk surgery due to blood thinning drugs. It has received
two U.S. Food and Drug Administration (&#8220;FDA&#8221;) Breakthrough Device Designations: one for the removal of ticagrelor and another
for the removal of the direct oral anticoagulants (DOAC) apixaban and rivaroxaban in a cardiopulmonary bypass circuit during urgent cardiothoracic
procedures. The Company is actively pursuing regulatory approval of DrugSorb-ATR with the FDA and will pursue regulatory approval with
Health Canada with better visibility from the FDA. DrugSorb-ATR is not yet granted or approved in either the United States or Canada.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While we have limited direct
competitors, we compete for capital with other early-stage microcap and small-cap companies in the life sciences space. To effectively
operate in this dynamic market, we need a highly talented and seasoned team of executives and business professionals.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We compete with pharmaceutical
and medical device companies in seeking to attract and retain a skilled management team. To meet this challenge, we have adopted a compensation
philosophy designed to offer our named executive officers&#8217; compensation and benefits that are market competitive and that meet our
goals of attracting, retaining, and motivating highly skilled individuals to help us achieve our financial and strategic objectives.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Our executive compensation program is designed
to achieve the following principal objectives:</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">attract and retain talented and experienced individuals;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">offer total compensation opportunities that take
into consideration the practices of other comparably positioned life sciences companies;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">directly and substantially link total compensation
to measurable corporate and individual performance;</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">create and sustain a sense of urgency surrounding
strategy execution and the achievement of key business objectives; and</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span>&#9679;</span></span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif">strengthen the alignment of the interests of
our named executive officers and stockholders through equity-based, long-term incentives and reward our named executive officers for creating
long-term stockholder value.</span></td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Compensation-Setting Process</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Role of the Compensation Committee</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation Committee
is responsible for overseeing our executive compensation philosophy and our executive compensation program, determining, and approving
the compensation for our named executive officers, negotiating executive employment contracts, and helping to establish appropriate compensation
for Board members and other key employees. Our Compensation Committee regularly reports to our Board on its deliberations, but is ultimately
responsible for compensation decisions, as described in the Compensation Committee&#8217;s charter.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Compensation Committee
reviews, on at least an annual basis, our executive compensation program, including our incentive compensation plans, to determine whether
they are appropriate, properly coordinated, and achieve their intended purposes, and recommends to our Board any modifications or new
plans or programs. It also reviews the compensation of our named executive officers and makes decisions about the various components that
comprise their compensation packages.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 36 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Role of Management</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In carrying out its responsibilities,
our Compensation Committee works with members of our management team, including our Chief Executive Officer, Chief Operating Officer,
Chief Financial Officer, and Chief Medical Officer. Typically, our management team assists our Compensation Committee by providing information
about our corporate, financial, and individual performance, competitive market data and management&#8217;s perspective and recommendations
on compensation matters.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Typically, our Chief Executive
Officer makes recommendations to our Compensation Committee regarding the compensation of our executive officers, including our named
executive officers (except with respect to his own compensation), and, at the request of the Compensation Committee, attends Compensation
Committee meetings (except with respect to discussions involving his own compensation).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Competitive Data</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To assess the competitiveness
of our executive compensation program and compensation levels, our Compensation Committee examines the competitive compensation data for
senior executives of other similar life science companies on the Nasdaq.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Compensation Program Design</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In designing our compensation
program, we were cognizant of our need to motivate our named executive officers to meet our short-term goals and long-term strategic objectives.
Thus, we emphasized the use of equity in the form of options to purchase shares of our Common Stock and restricted stock units to incentivize
our named executive officers to focus on the growth of our overall enterprise value and, correspondingly, to create sustainable long-term
value for our stockholders. We believe that stock options and restricted stock units offer our named executive officers a valuable long-term
incentive that aligns their interests with the interests of our stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The equity compensation awarded
to our named executive officers is discussed below under &#8220;<i>&#8212;Executive Compensation Program Components&#8212;Equity Compensation</i>.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We also offer cash compensation
to our named executive officers in the form of base salaries at levels that we believe help us provide competitive compensation packages.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March&#160;29, 2024, the
Board of the Company authorized and approved a voluntary salary reduction program for certain of the Company&#8217;s employees, including
the Company&#8217;s named executive officers, as part of the Company&#8217;s cost-cutting measures implemented in the best interests of
the Company and its stockholders (the &#8220;Reduction Program&#8221;). Executive officers Phillip P. Chan, MD, PhD (Chief Executive Officer),
Vincent J. Capponi, MS (President and Chief Operating Officer), Kathleen P. Bloch, MBA, CPA (Former Chief Financial Officer) and Efthymios
N. Deliargyris, MD (Chief Medical Officer) chose to participate. In connection with the Reduction Program, the Board authorized, approved
and adopted a form payment reduction agreement, which was executed by each of the named executive officers and the Company. The salary
reduction agreements serve as amendments to the existing employment agreements between the named executive officers and the Company. Pursuant
to the salary reduction agreements, the CEO agreed to reduce his base salary by 35% and each of the other named executive officers agreed
to reduce his or her base salary by 15%. The reduced base salary was effective for the period of April&#160;1, 2024 through December&#160;31,
2024, resulting in the Adjusted Base Salary amounts as set forth in the table below. As consideration for the voluntary participation
in the Reduction Program, on March&#160;29, 2024, the Company&#8217;s Board also approved grants of nonqualified stock options to each
participant under the Company&#8217;s 2014 Long-Term Incentive Plan, as amended, and the form of Nonqualified Stock Option Agreement.
The nonqualified stock options granted to each participant, as set forth in the table below, is equal in value to the amount by which
such participant&#8217;s base salary was reduced as determined using the market closing price for a share of Company Common Stock on March&#160;28,
2024, which amount was $0.95. The nonqualified stock options vested on January&#160;31, 2025, and have an exercise price equal to the
fair market value of a share of Company Common Stock on the date of grant as set forth in the 2014 Long-Term Incentive Plan. As of January&#160;1,
2025, each of the named executive officer&#8217;s base salary was restored to the base salary in effect prior to the reduction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 37 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We do not provide significant
perquisites or other personal benefits to our executive officers. Our executive officers participate in broad-based company-sponsored
health and benefit programs on substantially the same basis as our other salaried employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Compensation Program Components</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following describes each
component of our executive compensation program, the rationale for each component and how compensation amounts, and awards were determined
for 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Base Salary</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Base salary represents the
fixed portion of our named executive officers&#8217; compensation, which we view as an important element to attract, retain, and motivate
highly talented executives. Base salaries represent a significant portion of the total compensation opportunity for our named executive
officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In April&#160;of 2025, our
Compensation Committee conducted a review of each named executive officer&#8217;s base salary with input from our Chief Executive Officer.
Following the review, the Committee noted that after three years of no base salary increases, the voluntary salary reduction program of
2024, and the successful Rights Offering completed in each of January&#160;and April&#160;of 2025, the Committee would approve increases
to executive base salaries and make those adjustments retroactive to January&#160;1, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The salaries of our named
executive officers are set forth in the following table:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; text-align: left; font: bold 10pt Times New Roman, Times, Serif">Named Executive Officer</td><td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025 Base Salary</td><td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024 Adjusted <br/>
Base Salary</td><td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center; border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p><p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><b>2024 Base Salary</b></p></td><td style="text-align: center; font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">% Base Increase from<br/>
 2024 to 2025</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: left">Phillip P. Chan, MD, PhD</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">502,165</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">359,352</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 17%; text-align: right">482,851</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right">+4%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vincent J. Capponi, MS</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">460,040</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">377,523</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">424,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">+8.5%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Efthymios N. Deliargyris, MD</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">432,586</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">363,336</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">408,100</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">+6%</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter J. Mariani, CPA<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">442,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">152,019</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">(1)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">425,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">+4%</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td style="text-align: justify">Mr.&#160;Mariani was appointed Chief Financial Officer of the Company effective as of August&#160;14,
2024. 2024 Adjusted Base Salary reflects the pro-rated salary received based on his employment period.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 38 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Annual Cash Bonuses</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Cash bonuses are solely discretionary
based upon the approval of the Board. In determining whether to award cash bonuses, the Compensation Committee considers the operational
performance of the Company relative to its pre-approved operating plan and specified performance milestones including revenue growth,
gross margin targets, cash management, clinical and regulatory milestones, business development achievements, as well as individual performance
indicators. In 2025, the Compensation Committee approved cash bonuses linked to the Company&#8217;s 2024 performance totaling $665,435
for all NEO&#8217;s and then deferred the payment of these bonuses pending the Compensation Committee&#8217;s determination of sufficient
liquidity. In February&#160;2026, the Compensation Committee approved cash bonuses linked to the Company&#8217;s 2025 performance totaling
$328,825 for all NEO&#8217;s and deferred the payment of these bonuses pending the Compensation Committee&#8217;s determination of sufficient
liquidity.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Equity Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We use equity awards to motivate
and reward our named executive officers, to encourage long-term corporate performance based on the value of our Common Stock and to align
the interests of our named executive officers with those of our stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In order to better align the
interests of our named executive officers with our stockholders and to retain key talent, in 2025, the Compensation Committee awarded
the named executive officers (i)&#160;restricted stock units that vest in equal parts at the first and second year anniversaries of the
date of grant, subject to the named executive officer&#8217;s continued service as of the applicable vesting date, and (ii)&#160;incentive
stock options that vest as to one-half of the award on the first year anniversary of the date of grant, one-fourth of the award on the
second year anniversary of the date of grant, and one-fourth of the award on the third year anniversary of the date of grant, subject
to the reporting person&#8217;s continued service as of the applicable vesting date.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Retirement and Other Benefits</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our named executive officers
are eligible to participate in our tax-qualified Section&#160;401(k)&#160;retirement savings plan on the same basis as our other employees
who satisfy the plan&#8217;s eligibility requirements, including requirements relating to age and length of service. Under this plan,
participants may elect to reduce their current compensation by up to the statutory limit, $23,000 in fiscal 2025 plus an additional $7,500
for participants 50&#160;years or older and have us contribute the amount of this reduction to the Section&#160;401(k)&#160;plan. During
2025, we matched 100% of 401(k)&#160;of elective deferral contributions of the first 3% of the gross pay, plus 50% of elective deferral
contributions which are over 3% of gross pay but are not over 5% of annual gross pay. We intend for the 401(k)&#160;plan to qualify under
Section&#160;401 of the Internal Revenue Code so that contributions by employees or by us to the 401(k)&#160;plan, and income earned on
plan contributions, are not taxable to employees until withdrawn from the 401(k)&#160;plan.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Additional benefits received
by our named executive officers include medical, dental, vision, short-term disability, long term disability, life and accidental death
and dismemberment insurance, and Health Savings Account contributions. These benefits are provided on substantially the same basis as
to all of our full-time employees.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Historically, we have not
provided perquisites or other personal benefits to our named executive officers. Currently, we do not view perquisites or other personal
benefits as a component of our executive compensation program. Our future practices with respect to perquisites or other personal benefits
will be approved and subject to periodic review by our Compensation Committee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Employment Agreements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;30, 2019, we
entered into an amended and restated employment agreements with Dr.&#160;Phillip P. Chan, Chief Executive Officer, and Vincent J. Capponi,
President and Chief Operating Officer. On April&#160;9, 2020, we entered into an employment agreement with Efthymios N. Deliargyris, Chief
Medical Officer, which agreement became effective May&#160;18, 2020. With the exception of his own agreement, each of these agreements
was negotiated on our behalf by our CEO, with the oversight and approval of our Compensation Committee. Our CEO&#8217;s employment agreement
was negotiated directly with our Compensation Committee. We believe that these employment agreements were necessary to retain these individuals
and induce them to lead us in achieving our goals as a publicly traded company. The term of the employment agreements with Dr.&#160;Chan,
Mr.&#160;Capponi, and Dr.&#160;Deliargyris concluded on December&#160;31, 2021, and each employment agreement automatically renews for
an additional one-year term, unless the Company or the executive officer provides written notice of non-renewal to the other party at
least sixty (60)&#160;days prior to commencement of a Renewal Term (as defined in such employment agreement).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 39 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;14, 2024, we
entered into an employment agreement with Mr.&#160;Mariani in connection with his appointment as the Company&#8217;s Chief Financial Officer.
The initial term commenced on the effective date and ended on December&#160;31, 2025, and the employment agreement automatically renews
for an additional one-year term, unless the Company or the executive officer provides written notice of non-renewal to the other party
at least sixty (60)&#160;days prior to commencement of a Renewal Term (as defined in such employment agreement).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For a summary of the material
terms and conditions of these employment agreements, see the section entitled &#8220;Executive Compensation- Employment Agreements.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Post-Employment Compensation Arrangements</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The employment agreements
provide each of our named executive officers with certain protection in the event of his or her termination of employment under specified
circumstances, including following a change of control of our Company. We believe that these protections serve our executive retention
objectives by helping our named executive officers maintain continued focus and dedication to their responsibilities to maximize stockholder
value, including in the event that there is a potential transaction that could involve a change in control of our Company. The terms of
these agreements were determined after review by our Compensation Committee of our retention goals for each named executive officer and
an analysis of competitive market data.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For a summary of the material
terms and conditions of these severance and change in control arrangements, see the sections entitled &#8220;Compensation of Named Executive
Officers - Employment Agreements&#8221; and &#8220;Executive Compensation - Potential Payments upon Termination or Change of Control.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Tax and Accounting Considerations</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Deductibility of Executive Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, Section&#160;162(m)&#160;of
the Internal Revenue Code disallows a tax deduction to any publicly-held corporation for any remuneration in excess of $1.0&#160;million
paid in any taxable year to its chief executive officer and each of its three next most highly-compensated named executive officers (other
than its chief financial officer). Remuneration in excess of $1.0&#160;million may be deducted if, among other things, it qualifies as
 &#8220;performance-based compensation&#8221; within the meaning of the Internal Revenue Code. Additionally, under a Section&#160;162(m)&#160;exception
for private companies that subsequently become publicly held, any compensation paid pursuant to a compensation plan in existence before
the effective date of the public offering of securities will not be subject to the $1.0&#160;million limitation until the earliest of:
(i)&#160;the expiration of the compensation plan, (ii)&#160;a material modification of the compensation plan (as determined under Section&#160;162(m)),
(iii)&#160;the issuance of all the employer stock and other compensation allocated under the compensation plan, or (iv)&#160;the first
meeting of stockholders at which directors are elected after the close of the third calendar year following the year in which the public
offering of securities occurred.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2017 tax reform legislation
removed the &#8220;performance-based compensation&#8221; exception from Section&#160;162(m), effective for taxable years beginning after
December&#160;31, 2017, such that compensation paid to our covered executive officers in excess of $1&#160;million will not be deductible
unless it qualifies for transition relief applicable to certain arrangements in place as of November&#160;2, 2017.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Despite the Compensation Committee&#8217;s
efforts to structure certain variable compensation in a manner intended to be exempt from Section&#160;162(m)&#160;and therefore not subject
to its deduction limits, because of ambiguities and uncertainties as to the application and interpretation of Section&#160;162(m)&#160;and
the regulations issued thereunder, including the uncertain scope of the transition relief under the legislation repealing Section&#160;162(m)&#8217;s
exemption from the deduction limit, no assurance can be given that compensation intended to satisfy the requirements for exemption from
Section&#160;162(m)&#160;in fact will. Further, the Compensation Committee reserves the right to modify compensation that was initially
intended to be exempt from Section&#160;162(m)&#160;if it determines that such modifications are consistent with our business needs. In
addition, our Compensation Committee may, in its judgment, authorize compensation payments that do not comply with the exemptions in Section&#160;162(m)&#160;when
it believes that such payments are appropriate to attract and retain executive talent.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 40 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Taxation of &#8220;Parachute&#8221; Payments and Deferred Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Sections&#160;280G and 4999
of the Internal Revenue Code provide that named executive officers and directors who hold significant equity interests and certain other
service providers may be subject to an excise tax if they receive payments or benefits in connection with a change of control of our Company
that exceed certain prescribed limits, and that we (or a successor) may forfeit a deduction on the amounts subject to this additional
tax. Section&#160;409A of the Internal Revenue Code imposes significant additional taxes in the event that an employee, including a named
executive officer, director, or service provider receives &#8220;nonqualified deferred compensation&#8221; that does not satisfy the conditions
of Section&#160;409A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We did not provide any named
executive officer with a &#8220;gross-up&#8221; or other reimbursement payment for any tax liability that he or she might owe as a result
of the application of Sections&#160;280G, 4999 or 409A of the Internal Revenue Code during the fiscal year ended December&#160;31, 2025.
We have not agreed and are not otherwise obligated to provide any named executive officer with a &#8220;gross-up&#8221; or other reimbursement
under Section&#160;409A.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Accounting for Stock-Based Compensation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We follow the FASB ASC Topic
718 for our stock-based compensation awards. ASC 718 requires companies to calculate the grant date &#8220;fair value&#8221; of their
stock-based awards using a variety of assumptions. This calculation is performed for accounting purposes and reported in the compensation
tables that accompany this Compensation Discussion and Analysis, even though recipients may never realize any value from their awards.
ASC 718 also requires companies to recognize the compensation cost of their stock-based awards in their statements of operations over
the period that the recipient of the award is required to render service in exchange for the award.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v5"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COMPENSATION COMMITTEE REPORT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
has reviewed and discussed with management the Compensation Discussion and Analysis required by SEC regulations. Based on its review and
discussions, the Compensation Committee recommended to the Board that the Compensation Discussion and Analysis be included in this Proxy
Statement and, through incorporation by reference, in CytoSorbents Corporation&#8217;s Annual Report on Form&#160;10-K for the fiscal
year ended December&#160;31, 2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Submitted by:<br/>
The Compensation Committee of the Board of Directors</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Michael G. Bator, Chairman<br/>
Jiny Kim</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v6"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXECUTIVE COMPENSATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v25"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Summary Compensation Table</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table shows
for the fiscal years ended December&#160;31, 2025 and 2024, compensation awarded to or paid to, or earned by, our named executive officers.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Named Executive Officer</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Salary ($)</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Bonus<sup>(11)</sup>
    <br/>
($)</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Stock <br/>
Awards<sup>(1)</sup>&#160;<br/>
($)</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; vertical-align: super; padding-bottom: 1pt"><sup>&#160;</sup></td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option<br/>

    Awards<sup>(2)</sup>&#160;<br/>
($)</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; vertical-align: super; padding-bottom: 1pt"><sup>&#160;</sup></td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">All Other<br/>
 Compensation</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; vertical-align: super; padding-bottom: 1pt"><sup>&#160;</sup></td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total ($)</td>
    <td style="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: left">Phillip P. Chan, MD, PhD</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">2025</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">502,165</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">87,804</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">105,600</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; width: 1%; text-align: left"><sup>(3)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">100,862</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; width: 1%; text-align: left"><sup>(4)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">12,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; width: 1%; text-align: left"><sup>(5)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">808,431</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Executive Officer</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2024</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">359,352</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">266,775</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">91,680</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(6)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">169,888</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(7)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(5)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">899,695</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Peter J. Mariani(7)</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2025</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">442,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">79,821</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">71,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(3)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">66,551</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(4)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>&#160;</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">659,872</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Financial Officer</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2024</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">152,019</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">66,340</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">169,138</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(8)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">197,268</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(9)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>&#160;</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">584,765</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vincent J. Capponi, MS</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2025</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">460,040</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">83,079</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">89,100</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(3)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">82,153</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(4)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>&#160;</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">714,372</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">President and Chief Operating Officer</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2024</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">377,523</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">169,335</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">77,355</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(6)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">227,824</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(7)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>&#160;</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">852,037</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Efthymios N. Deliargyris, MD</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2025</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">432,586</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">78,121</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">70,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(3)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">70,248</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(4)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(10)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">663,455</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Chief Medical Officer</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2024</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">363,336</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">162,985</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">58,255</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(6)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">216,366</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(7)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">12,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: super; text-align: left"><sup>(10)</sup></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">813,442</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 41 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td style="text-align: justify">Prior to 2019, Dr.&#160;Chan and Mr.&#160;Capponi received grants of restricted stock units which will
vest upon a &#8220;Change in Control&#8221; of the Company, as defined in the Company&#8217;s 2014 Long-Term Incentive Plan. The value
of these grants has been calculated in accordance with ASC Topic 718. Because a &#8220;Change of Control&#8221; is not contemplated or
probable at this time, there is no amount associated with these awards.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td style="text-align: justify">The value of option awards granted to our named executive officers is based upon the grant date fair value
of awards calculated in accordance with ASC Topic 718. ASC 718 requires companies to calculate the grant date &#8220;fair value&#8221;
of their stock-based awards using a variety of assumptions. This calculation is performed for accounting purposes and reported in the
compensation tables that accompany this Compensation Discussion and Analysis, even though recipients may never realize any value from
their awards. ASC 718 also requires companies to recognize the compensation cost of their stock-based awards in their statements of operations
over the period that the recipient of the award is required to render service in exchange for the award.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(3)</td><td style="text-align: justify">On August&#160;8, 2025, Dr.&#160;Chan, Mr.&#160;Mariani, Mr.&#160;Capponi, and Dr.&#160;Deliargyris received
restricted stock units which vest in equal parts on the first and second anniversaries of the date of grant. The amount shown represents
the fair market value of the vested and unvested restricted stock units awarded on August&#160;8, 2025.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(4)</td><td style="text-align: justify">On August&#160;8, 2025, Dr.&#160;Chan, Mr.&#160;Mariani, Mr.&#160;Capponi, and Dr.&#160;Deliargyris received
stock options granting them the right to purchase shares of Common Stock at a purchase price of $1.00 per share. These options vest one-half
on the first anniversary of the date of grant, one-fourth on the second year anniversary of the date of grant, and one-fourth on the third
year anniversary of the date of grant.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(5)</td><td style="text-align: justify">In addition to his base salary, Dr.&#160;Chan is entitled to a $12,000 annual car allowance.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(6)</td><td style="text-align: justify">On April&#160;2, 2024, Dr.&#160;Chan, Mr.&#160;Mariani, Mr.&#160;Capponi, and Dr.&#160;Deliargyris received
restricted stock units which vest in equal parts at the first and second year anniversaries of the date of grant. The amount shown represents
the fair market value of the vested and unvested restricted stock units awarded on April&#160;2, 2024.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(7)</td><td style="text-align: justify">On March&#160;29, 2024, Dr.&#160;Chan, the reporting person received nonqualified stock options at an
exercise price of $0.95 which vested January&#160;31, 2025, related to their participation in the 2024 voluntary salary reduction program.
On April&#160;2, 2024, the reporting person received incentive stock options at an exercise price of $0.9550 which vest as to one-half
of the award on the first year anniversary of the date of grant, one-fourth of the award on the second year anniversary of the date of
grant, and one-fourth of the award on the third year anniversary of the date of grant, subject to the reporting person&#8217;s continued
service as of the applicable vesting date. On October&#160;4, 2024, Mr.&#160;Capponi and Dr.&#160;Deliargyris each received stock options
at an exercise price of $1.19, which will vest only if the Company obtains U.S. Food and Drug Administration clearance, Health Canada
clearance, or approval of DrugSorb-ATR before June&#160;30, 2026.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(8)</td><td style="text-align: justify">Upon the appointment of Chief Financial Officer, Mr.&#160;Mariani received 65,000 restricted stock units,
which vest as to one-half of the award on each of the first and second anniversaries of the date of grant. Additionally, Mr.&#160;Mariani
also received 110,000 restricted stock units which vest upon the earlier of (i)&#160;a &#8220;Change In Control&#8221; of CytoSorbents
Corporation (the &#8220;Company&#8221;), as defined in Mr.&#160;Mariani&#8217;s employment agreement (the &#8220;Mariani Employment Agreement&#8221;),
or (ii)&#160;the fourth anniversary from the date of grant, subject to the reporting person&#8217;s continued service as of the applicable
vesting date.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(9)</td><td style="text-align: justify">Upon the appointment of Chief Financial Officer, Mr.&#160;Mariani received 80,000 stock options which
vest in accordance with the following schedule: (i)&#160;41,000 upon the six-month anniversary of the date of grant, and (ii)&#160;13,000
on the one-year, two-year and three-year anniversaries of the date of grant. Additionally, Mr.&#160;Mariani also received 215,000 stock
options which vest only upon the achievement of certain milestones pursuant to the terms of the Employment Agreement.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(10)</td><td style="text-align: justify">In addition to his base salary, Dr.&#160;Deliargyris receives a $12,000 annual car allowance.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(11)</td><td style="text-align: justify">The bonuses for 2024 and 2025 have been earned and accrued. The Company has deferred payment of the bonuses
until a future determination, by the Compensation Committee, of sufficient liquidity, and that such payment may occur either in a lump
sum or over a period of time, not to exceed twelve months.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 42 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v26"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Pay vs. Performance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with rules&#160;adopted
by the Securities and Exchange Commission pursuant to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we provide
the following disclosure, as it applies to smaller reporting companies, regarding executive compensation for our principal executive officer
(&#8220;<b>PEO</b>&#8221;) and Non-PEO named executive officers (&#8220;<b>NEOs</b>&#8221;) and Company performance for the fiscal years
listed below. The Compensation Committee did not consider the pay versus performance disclosure below in making its pay decisions for
any of the years shown.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As required by Item&#160;402(v)&#160;of
Regulation S-K, as adopted by the SEC, we are providing the following information regarding the relationship between executive compensation
and our financial performance for each of the last three completed fiscal years. In determining the &#8220;compensation actually paid&#8221;
to our NEOs, we are required to make various adjustments to amounts that have been previously reported in the Summary Compensation Table
in previous years, as the SEC&#8217;s valuation methods for this section differ from those required in the Summary Compensation Table.
The table below summarizes compensation values both previously reported in our Summary Compensation Table, as well as the adjusted values
required in this section for the 2025, 2024 and 2023 fiscal years. Note that for our NEOs other than our PEO, compensation is reported
as an average.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><ix:nonNumeric contextRef="c0" continuedAt="_PvpTableTextBlock-c0_cont_1" escape="true" name="ecd:PvpTableTextBlock" id="ixv-4570"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Summary<br/> Compensation <br/>
Table Total for<br/> PEO($)(1)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Compensation<br/> Actually Paid to<br/> PEO($)(2)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Average<br/> Summary<br/> Compensation<br/> Table Total for<br/> Non-PEO Named<br/> Executive<br/> Officers($)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Average<br/> Compensation<br/> Actually Paid to<br/> Non-PEO Named<br/> Executive<br/> Officers($)(3)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Value of Initial<br/> Fixed $100<br/> Investment Based<br/> On Total<br/> Shareholder<br/> Return($)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Net <br/>
Income/(Loss) ($)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center">2025</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-6892">808,431</ix:nonFraction></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-6893">723,164</ix:nonFraction></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-6894">679,233</ix:nonFraction></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-6895">564,719</ix:nonFraction></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-6896">11.73</ix:nonFraction></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c0" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-6897">8,197,439</ix:nonFraction></td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-6898">899,695</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-6899">953,144</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-6900">895,556</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-6901">770,636</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c1" decimals="2" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-6902">16.70</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c1" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-6903">20,718,957</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoTotalCompAmt" scale="0" unitRef="usd" id="ixv-6904">1,333,401</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:PeoActuallyPaidCompAmt" scale="0" unitRef="usd" id="ixv-6905">729,761</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgTotalCompAmt" scale="0" unitRef="usd" id="ixv-6906">994,690</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" scale="0" unitRef="usd" id="ixv-6907">734,380</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c2" decimals="2" format="ixt:num-dot-decimal" name="ecd:TotalShareholderRtnAmt" scale="0" unitRef="usd" id="ixv-6908">20.37</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c2" decimals="0" format="ixt:num-dot-decimal" name="us-gaap:NetIncomeLoss" scale="0" sign="-" unitRef="usd" id="ixv-6909">29,246,760</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" escape="true" name="ecd:NamedExecutiveOfficersFnTextBlock" id="ixv-4697"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td style="text-align: justify">For years 2025, 2024 and 2023,&#160;<ix:nonNumeric contextRef="c0" name="ecd:PeoName" id="ixv-6910">Dr.&#160;Phillip P. Chan</ix:nonNumeric>&#160;has been our Principal Executive Officer.
The averages for year 2025 for our Non-PEO Named Executive Officers consist of our President and Chief Operating Officer (Vincent J. Capponi),
our Chief Financial Officer (Peter J. Mariani), and our Chief Medical Officer (Efthymios, N. Deliargyris). The averages for 2024 for our
Non-PEO Named Executive Officers consists of Vincent J. Capponi, our Chief Financial Officer (Kathleen P. Bloch from January&#160;1, 2024
to August&#160;13, 2024 and Peter J. Mariani from August&#160;14, 2024 to December&#160;31, 2024), and Efthymios, N. Deliargyris. The
averages for 2023 for our Non-PEO Named Executive Officers consists of Vincent J. Capponi, Kathleen P. Bloch, and Efthymios, N. Deliargyris.</td></tr></table></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="c0" continuedAt="_AdjToPeoCompFnTextBlock-c0_cont_1" escape="true" name="ecd:AdjToPeoCompFnTextBlock" id="ixv-4704"><ix:nonNumeric contextRef="c0" continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_cont_1" escape="true" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="ixv-4705"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td style="text-align: justify">Adjustment to Compensation Actually Paid to PEO include deduction of &#8220;stock awards&#8221; and &#8220;options
awards&#8221; for the year, which include a) add award granted in the year that remain outstanding and unvested at fair value as of end
of the year, b) add award granted in the year that vested in the same year at fair value as of the vesting date, c) add or subtract (if
negative) any award granted before the year and remain outstanding and unvested as of year-end at fair value, d) add or subtract (if negative)
any award granted before the year but vested during the year at fair value as of the vesting date, e) subtract any award vested and forfeited
at fair value as of end of the prior year, f) add unvested award on which dividends or other earnings were paid during the year not otherwise
included in summary total compensation column.</td></tr></table></ix:nonNumeric></ix:nonNumeric>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:continuation continuedAt="_AdjToPeoCompFnTextBlock-c0_cont_2" id="_AdjToPeoCompFnTextBlock-c0_cont_1"><ix:continuation continuedAt="_AdjToNonPeoNeoCompFnTextBlock-c0_cont_2" id="_AdjToNonPeoNeoCompFnTextBlock-c0_cont_1"><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;">
<tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(3)</td><td style="text-align: justify">Adjustment to Average Compensation Actually Paid to Non-PEO Named Executive Officers.</td></tr>
</table></ix:continuation></ix:continuation></ix:nonNumeric><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 43 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><ix:continuation id="_PvpTableTextBlock-c0_cont_1"><ix:continuation id="_AdjToPeoCompFnTextBlock-c0_cont_2"><ix:continuation id="_AdjToNonPeoNeoCompFnTextBlock-c0_cont_2"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Adjustment to Determine Compensation &#8220;Actually Paid&#8221; to PEO</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(<ix:nonFraction contextRef="c3" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6911">105,600</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(<ix:nonFraction contextRef="c4" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6912">91,680</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(<ix:nonFraction contextRef="c5" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6913">307,110</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Option Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c6" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6914">100,862</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c7" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6915">169,888</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c8" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6916">374,514</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c9" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6917">27,428</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c10" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6918">144,361</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c11" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6919">188,015</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-2">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c15" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6920">32,639</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c16" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6921">58,377</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c17" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6922">341,105</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c18" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6923">126,406</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c19" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6924">229,032</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c20" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6925">231,073</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-4">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-5">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-6">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-7">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-8">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-9">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Total Adjustments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c27" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6926">85,267</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c28" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6927">53,448</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c29" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6928">603,641</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c30" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6929">76,867</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c31" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6930">122,274</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c32" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6931">180,313</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Option Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c33" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6932">72,984</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c34" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6933">244,350</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c35" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6934">242,195</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c36" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6935">19,724</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c37" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6936">188,731</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c38" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6937">130,704</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-10">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-11">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c41" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6938">20,886</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c42" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6939">53,424</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c43" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6940">106,288</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c44" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6941">164,467</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c45" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6942">69,037</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c46" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6943">159,261</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><ix:nonFraction contextRef="c47" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" unitRef="usd" id="ixv-6944">175,076</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-12">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-13">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-14">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-15">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-16">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-17">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Total Adjustments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c54" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6945">114,514</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c55" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6946">124,920</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<ix:nonFraction contextRef="c56" decimals="0" format="ixt:num-dot-decimal" name="ecd:AdjToCompAmt" scale="0" sign="-" unitRef="usd" id="ixv-6947">260,310</ix:nonFraction></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table></ix:continuation></ix:continuation></ix:continuation><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Pay Versus Performance Graphic Description</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with Item&#160;402(v)&#160;of
Regulation S-K, we are providing the following graphic descriptions of the relationships between (i)&#160;compensation actually paid to
the PEO and the NEOs other than the PEO, and total shareholder return (&#8220;<b>TSR</b>&#8221;); and (ii)&#160;compensation actually
paid to the PEO and the NEOs other than the PEO, and net income (loss).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><ix:nonNumeric contextRef="c0" escape="true" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="ixv-5038"><img alt="" src="tm263197d5_def14aimg01.jpg" style="height: 461px; width: 650px"/></ix:nonNumeric>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 44 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" escape="true" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="ixv-5058"><img alt="" src="tm263197d5_def14aimg02.jpg" style="height: 434px; width: 650px"/></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><div><a id="v28"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Employment Agreements</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Dr.&#160;Phillip P. Chan</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;30, 2019, we
entered into an amended and restated executive employment agreement with Dr.&#160;Chan relating to his employment as our Chief Executive
Officer. Pursuant to his employment agreement, Dr.&#160;Chan receives an annual car allowance in the amount of $12,000 per year. Dr.&#160;Chan&#8217;s
employment agreement also provides for terms of benefits afforded to Dr.&#160;Chan, including the ability to participate in various group
insurance plans, reimbursement for reasonable business expenses, liability insurance, vacation time and bonuses. Dr.&#160;Chan&#8217;s
amended and restated employment agreement had an initial term of three years and became effective as of January&#160;1, 2019. Accordingly,
Dr.&#160;Chan&#8217;s employment agreement expired on December&#160;31, 2021, and automatically renewed for one year to December&#160;31,
2022. Thereafter, Dr.&#160;Chan&#8217;s employment shall automatically renew for additional terms of one year, unless the Company or Dr.&#160;Chan
provides written notice of non-renewal to the other party at least sixty (60) days prior to commencement of a renewal term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Dr.&#160;Chan&#8217;s
employment agreement provides for benefits if his employment is terminated under certain circumstances, as more fully described under
 &#8220;Executive Compensation - Potential Payments upon Termination or Change of Control.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Vincent J. Capponi, MS</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July&#160;30, 2019, we
entered into an amended and restated executive employment agreement with Mr.&#160;Capponi relating to his employment as our Chief Operating
Officer. Mr.&#160;Capponi&#8217;s employment agreement provides for terms of benefits afforded to Mr.&#160;Capponi, including the ability
to participate in various group insurance plans, reimbursement for reasonable business expenses, liability insurance, vacation time and
bonuses. Mr.&#160;Capponi&#8217;s amended and restated employment agreement had an initial term of three years and became effective as
of January&#160;1, 2019. Accordingly, Mr.&#160;Capponi&#8217;s employment agreement expired on December&#160;31, 2021, and automatically
renewed for one year to December&#160;31, 2022. Thereafter, Mr.&#160;Capponi&#8217;s employment shall automatically renew for additional
terms of one year, unless the Company or Mr.&#160;Capponi provides written notice of non-renewal to the other party at least sixty (60)
days prior to commencement of a renewal term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 45 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Mr.&#160;Capponi&#8217;s
employment agreement also provides for benefits if his employment is terminated under certain circumstances, as more fully described under
 &#8220;Executive Compensation - Potential Payments upon Termination or Change of Control.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Efthymios, N. Deliargyris, MD</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On April&#160;12, 2020, we
entered into an executive employment agreement with Dr.&#160;Deliargyris relating to his employment as our Chief Medical Officer. Under
the terms of his employment agreement, Dr.&#160;Deliargyris receives an annual car allowance in the amount of $12,500 per year. Dr.&#160;Deliargyris&#8217;
employment agreement also provides for terms of benefits afforded to Dr.&#160;Deliargyris, including the ability to participate in various
group insurance plans, reimbursement for reasonable business expenses, liability insurance, vacation time and bonuses. Dr.&#160;Deliargyris&#8217;
employment agreement term became effective on May&#160;18, 2020, and had an initial term which expired on December&#160;31, 2021, and
automatically renewed for one year to December&#160;31, 2022. Thereafter, Dr.&#160;Deliargyris&#8217; employment shall automatically renew
for additional terms of one year, unless the Company or Dr.&#160;Deliargyris provides written notice of non-renewal to the other party
at least sixty (60) days prior to commencement of a renewal term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Dr.&#160;Deliargyris&#8217;
employment agreement also provides for benefits if his employment is terminated under certain circumstances, as more fully described under
 &#8220;Executive Compensation - Potential Payments upon Termination or Change of Control.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Peter J. Mariani</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On August&#160;14, 2024, Mr.&#160;Mariani
and the Company entered into an executive employment agreement related to his employment as our Chief Financial Officer. Mr.&#160;Mariani&#8217;s
employment agreement provides for customary benefits which include participation in employee benefit plans, paid time off and reimbursement
of certain business-related expenses, including entertainment and travel expenses. Mr.&#160;Mariani&#8217;s employment agreement had an
initial term through December&#160;31, 2025, and automatically renewed for one year to December&#160;31, 2026. Thereafter, Mr.&#160;Mariani&#8217;s
employment shall automatically renew for additional terms of one year, unless the Company or Mr.&#160;Mariani provides written notice
of non-renewal to the other party at least sixty (60) days prior to commencement of a renewal term.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Mr.&#160;Mariani&#8217;s Employment
Agreement also provides for certain termination benefits in the event of termination without &#8220;Cause,&#8221; voluntary termination
of employment for &#8220;Good Reason,&#8221; or in the event of a &#8220;Change of Control&#8221; of the Company, each as defined in the
Mariani Employment Agreement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 46 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v29"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Outstanding Equity Awards at Fiscal Year-End</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes
the equity awards we have made to our named executive officers that have not been exercised and remained outstanding as of December&#160;31,
2025.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt; text-align: center">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option Award</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="9" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Stock Awards</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Name</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/>
 Securities<br/>
 Underlying<br/>
 Unexercised<br/>
 Options (#)<br/>
 Exercisable</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity<br/>
 incentive<br/>
 plan<br/>
 awards:<br/>
 number of<br/>
 securities<br/>
 underlying<br/>
 unexercised<br/>
 unearned <br/>
options (#)</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option<br/>
 Exercise<br/>
 Price ($)</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option<br/>
 Expiration<br/>
 Date</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity<br/>
 incentive<br/>
 plan<br/>
 awards:<br/>
 number of<br/>
 unearned<br/>
 shares, <br/>
units or <br/>
other rights<br/>
 that have <br/>
not vested <br/>
(#)(1)</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Equity<br/>
 incentive <br/>
plan <br/>
awards: <br/>
market or<br/>
 payout<br/>
 value of<br/>
 unearned<br/>
 shares, <br/>
units or <br/>
other rights<br/>
 that have <br/>
not vested<br/>
 ($)(2)</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: left">Phillip P. Chan, MD, PhD</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">77,600</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">4.690</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">6/7/2026</td>
    <td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td>
    <td style="width: 10%; font-size: 10pt; text-align: right">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">95,200</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.600</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2/24/2027</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">70,650</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.900</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3/15/2028</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">80,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.330</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7/22/2029</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">80,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6.030</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2/28/2030</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">96,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.990</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4/12/2031</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">106,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.950</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8/10/2032</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">84,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">28,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.530</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7/7/2033</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">48,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.530</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7/7/2033</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">129,998</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.950</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3/29/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">62,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">62,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.955</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4/2/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">136,400</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8/8/2035</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">369,600</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">236,205</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Vincent J. Capponi, MS</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">73,200</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4.690</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6/7/2026</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">89,250</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.600</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2/24/2027</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">66,210</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.900</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3/15/2028</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">68,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7.330</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7/22/2029</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">68,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6.030</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2/28/2030</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">78,200</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.990</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4/12/2031</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">86,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.950</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8/10/2032</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">42,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.530</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7/7/2033</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">68,250</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">22,750</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.530</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7/7/2033</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">48,923</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#8212;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.950</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3/29/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">50,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.955</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4/2/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">150,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.190</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10/4/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">111,100</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8/8/2025</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Efthymios N. Deliargyris, MD</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">85,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">6.590</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4/9/2030</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">63,250</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8.990</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4/12/2031</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">74,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.950</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8/10/2032</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">58,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,500</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.530</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7/7/2033</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">40,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3.530</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7/7/2033</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">47,088</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.950</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">3/29/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.955</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4/2/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">150,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.190</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">10/4/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">95,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8/8/2035</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">254,334</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">231,444</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Peter J. Mariani</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">54,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">26,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.967</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8/14/2034</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">90,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">8/8/2035</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td>
    <td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: right">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">389,000</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">248,614</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(1)</td><td style="text-align: justify">Amount includes (i)&#160;restricted stock units held by each of the named executive officers that will
vest upon a &#8220;Change in Control&#8221; of the Company, as defined in the Company&#8217;s 2014 Long-Term Incentive Plan and (ii)&#160;the
unvested portion of restricted stock units awarded on April&#160;2, 2024, August&#160;14, 2024, August&#160;8, 2025.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(2)</td><td style="text-align: justify">Based on the $0.639 per share closing price of our Common Stock on December&#160;31, 2025, as reported
by Nasdaq.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Equity Compensation Plan Information<br/>
As of December&#160;31, 2025</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">Plan category</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/>
 securities to be<br/>
 issued upon<br/>
 exercise of<br/>
 outstanding<br/>
 options, warrants<br/>
 and rights</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted-average<br/>
 exercise price of<br/>
 outstanding options,<br/>
 warrants and rights</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of<br/>
 securities<br/>
 remaining<br/>
 available for future <br/>
issuance under<br/>
 equity<br/>
 compensation<br/>
 plans (excluding<br/>
 securities reflected <br/>
in column (a))</td><td style="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: center; font-size: 10pt">&#160;</td><td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="text-align: center; font: bold 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)</b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left">Equity compensation plans approved by security holders</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">10,988,604</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">3.58</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">9,014,966</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Equity compensation plans not approved by security holders</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">653,714</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Warrants</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,780,701</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.33</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif">Total</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16,769,305</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">&#160;</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,668,680</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 47 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v7"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AUDIT COMMITTEE REPORT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee of the
Board oversees CytoSorbents Corporation&#8217;s financial reporting process on behalf of the Board. Management is responsible for CytoSorbents
Corporation&#8217;s disclosure controls and procedures and financial reporting process, including its system of internal control over
financial reporting, and for preparing CytoSorbents Corporation&#8217;s financial statements in accordance with accounting principles
generally accepted in the United States. CytoSorbents Corporation&#8217;s independent registered public accounting firm are responsible
for auditing those financial statements and issuing a report thereon. The Audit Committee&#8217;s responsibility is to monitor and oversee
these processes.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee is directly
responsible for the appointment, compensation, retention and oversight of the independent registered public accounting firm. The Committee
operates under a written charter adopted by the Board, a copy of which is available on CytoSorbents Corporation&#8217;s website at <i>www.cytosorbents.com</i>.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has met
and held discussions with management and the independent registered public accounting firm, both separately and together. Management has
represented to the Audit Committee that CytoSorbents Corporation&#8217;s audited financial statements for 2025 were prepared in accordance
with generally accepted accounting principles, and the Audit Committee has reviewed and discussed the financial statements with management
and the independent auditors. The Audit Committee discussed with the independent registered public accounting firm the matters required
to be discussed by Statement on Auditing Standards No.&#160;61 (Communication with Audit Committees), as amended (AICPA, Professional
Standards, Vol.&#160;1. AU section 380), as adopted by the Public Company Accounting Oversight Board in Rule&#160;3200T.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, the Audit Committee
has discussed with the independent registered public accounting firm their independence from CytoSorbents Corporation and its management,
including the written disclosures and the letter required by the applicable requirements of the Public Company Accounting Oversight Board
regarding the independent auditor&#8217;s communications with the Audit Committee concerning the independent auditor&#8217;s independence.
Finally, the Audit Committee has discussed with CytoSorbents Corporation&#8217;s independent registered public accounting firm the overall
scope and plans for their audits, the results of their examinations, their evaluations and assessment of CytoSorbents Corporation&#8217;s
internal control over financial reporting and the overall quality of CytoSorbents Corporation&#8217;s financial reporting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In its oversight function,
the Audit Committee relies on the representations of management and the independent registered public accounting firm and thus does not
have an independent basis to determine that management has maintained appropriate accounting and financial reporting principles or policies
or appropriate internal control over financial reporting, that CytoSorbents Corporation&#8217;s financial statements are presented in
accordance with accounting principles generally accepted in the United States, that the audit of CytoSorbents Corporation&#8217;s financial
statements has been carried out in accordance with auditing standards generally accepted in the United States, or that the independent
registered public accounting firm are in fact &#8220;independent.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon the Audit Committee&#8217;s
discussions with management and the independent registered public accounting firm as described above and the Audit Committee&#8217;s review
of the representations of management and the report of the independent registered public accounting firm to the Audit Committee, the Audit
Committee recommended to the Board that CytoSorbents Corporation&#8217;s audited financial statements be included in the Company&#8217;s
Annual Report on Form&#160;10-K for the year ended December&#160;31, 2025 for filing with the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Submitted by:</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>The Audit Committee of the Board of Directors</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Alan D. Sobel, CPA, Chairman</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Michael G. Bator</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Edward R. Jones, MD, MBA</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 48 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v8"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>AUDIT AND OTHER FEES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes
the aggregate fees billed for professional services rendered to us by WithumSmith+Brown, PC, our independent registered public accounting
firm, in fiscal years 2025 and 2024. A description of these fees and services follows the table.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="border-collapse: collapse; width: 70%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
  <tr style="vertical-align: bottom">
    <td style="font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 74%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Fees<sup>(1)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">333,049</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">292,058</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Audit Related Fees<sup>(2)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,200</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">67,589</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Fees<sup>(3)</sup></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">37,896</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,696</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">All Other Fees</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">-</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif">Total</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">376,145</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">380,343</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-size: 10pt">(1)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Fees </span><span>for audit services in
2025 and 2024 consisted of fees associated with the annual audit and the reviews of CytoSorbents Corporation&#8217;s quarterly reports
on Form&#160;10-Q along with fees associated with SEC and accounting regulations and compliance consulting</span>.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in"><span style="font-size: 10pt">(2)</span></td><td style="text-align: justify"><span style="font-size: 10pt">Fees for audit-related services in 2025 and 2024 are associated with SEC
registration and other filings and certain attestations in </span>connection with Company financings and agreements.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 0.5in">(3)</td><td style="text-align: justify">Tax fees for 2025 and 2024 were as a result of services associated with the filing of the Company&#8217;s
Federal and State tax returns and other tax services.</td></tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has considered
whether the provision of these services by WithumSmith+Brown, PC is compatible with maintaining the independence of WithumSmith+Brown,
PC. Beginning with 2015, in accordance with the Audit Committee&#8217;s pre-approval policies and procedures described below, all fees
and services have been and will be pre-approved by the Audit Committee. The Audit Committee did not rely on the waiver of pre-approval
procedures permitted with respect to de&#160;minimis non-audit services under the applicable rules&#160;of the SEC for its approval of
any of the services provided by WithumSmith+Brown, PC in 2025 and 2024.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Pre-Approval Policies and Procedures</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has adopted
policies and procedures relating to the pre-approval of all audit and non-audit services to be provided by our independent registered
public accounting firm. Under these policies and procedures, the Audit Committee approves in advance the provision of services and fees
for such services that are specifically identified in the independent registered public accounting firm&#8217;s annual engagement letter
for the audits and reviews, in management&#8217;s annual budget relating to services to be provided by the independent auditors and any
amendments to the annual budget reflecting additional services to be provided by or higher fees of the independent registered public accounting
firm. All other services to be provided by the independent registered public accounting firm are pre-approved by the Audit Committee as
they arise. The Chairman of the Audit Committee has been delegated authority to pre-approve services in accordance with these policies
and procedures. The Chairman is to report any such approval of services to the Audit Committee at its next meeting. The Audit Committee
considers, among other things, whether the provision of such audit or non-audit services is consistent with applicable regulations regarding
maintaining auditor independence, whether the provision of such services would impair the independent registered public accounting firm&#8217;
independence and whether the independent registered public accounting firm are best positioned to provide the most effective and efficient
service.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v9"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN RELATIONSHIPS AND RELATED-PARTY TRANSACTIONS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our directors and officers
complete a Directors and Officers questionnaire in the first calendar quarter of each year, in which they are asked to disclose family
relationships and other related party transactions. Our Audit Committee must review and approve or ratify all related party transactions,
as defined in Item 404 of Regulation S-K promulgated under the Securities Act of 1933, as amended. In examining related party transactions,
our Audit Committee considers whether any of our directors, officers, holders of more than five percent (5%) of our voting stock, or any
immediate family members of the foregoing persons and any other persons whom the Audit Committee determines to be related parties, have
a conflict of interest where an individual may have a private interest which interferes with or appears to interfere with our interests.
In determining whether to approve or ratify a related party transaction, the Audit Committee will take into account, among other factors
it deems appropriate, whether the related party transaction is on terms no less favorable to us than terms generally available to us from
an unaffiliated third-party under the same or similar circumstances, and the extent of the related party&#8217;s interest in the transaction.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 49 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During 2025 and 2024 there
were no, and currently there are no proposed, transactions in which we were or are to be a participant where the amount involved exceeds
$120,000 (or, if less, 1% of the average of the Company&#8217;s total assets at December&#160;31, 2025 and 2024) and in which any related
person had or will have a direct or indirect material interest, which would be required to be disclosed herein pursuant to Item 404(a)&#160;of
Regulation S-K.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">See &#8220;Executive Compensation&#8221;
and &#8220;Director Compensation&#8221; above for a discussion of director compensation, executive compensation and our named executive
officers&#8217; employment agreements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v10"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>STOCKHOLDER PROPOSALS AND NOMINATION OF DIRECTOR
CANDIDATES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholder proposals submitted
to us pursuant to SEC Rule&#160;14a-8 under the Exchange Act for inclusion in our proxy statement for the 2027 Annual Meeting must be
received by the Company on or before February&#160;24, 2027, unless the date of the annual meeting in 2027 is changed by more than 30
calendar days from August&#160;13, 2027, and must satisfy the requirements of the proxy rules&#160;promulgated by the SEC.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to our Bylaws, any
other Stockholder proposals and Stockholder nominations for director nominees to be presented at the Company&#8217;s next annual meeting
of Stockholder must be given in writing, pursuant to the requirements of our Bylaws, to the Company&#8217;s Secretary and received at
the Company&#8217;s principal executive offices not later than May&#160;15, 2027, nor earlier than April&#160;15, 2027; provided, however,
that in the event that the annual meeting is not held within 30 calendar days before or after August&#160;13, 2027, to be timely, notice
by the Stockholder must be received not later than the close of business on the tenth calendar day following the date on which the first
public announcement of the date of the annual meeting was made.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to the notice
requirements under the Company&#8217;s Bylaws, Stockholders who intend to nominate an individual for election to the Board at the Company&#8217;s
2027 annual meeting of stockholders and solicit proxies in support of such nominee must also provide notice that sets forth the information
required by Exchange Act Rule&#160;14a-19 to the Secretary of the Company not later than June&#160;14, 2027.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For a proposal to be presented
at the annual meeting, the proposal must contain specific information required by our Bylaws, a copy of which may be obtained by accessing
the SEC&#8217;s EDGAR filing database at www.sec.gov or by writing to the Company&#8217;s Secretary. If a proposal is not timely and properly
made in accordance with the procedures set forth in our Bylaws, it will be defective and may not be brought before the meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v11"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>HOUSEHOLDING OF ANNUAL MEETING MATERIALS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEC has adopted rules&#160;that
permit companies and intermediaries (e.g., brokers, banks and nominees) to satisfy the delivery requirements for proxy statements and
annual reports with respect to two or more stockholders sharing the same address by delivering a single Notice or set of proxy materials
addressed to those stockholders. This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience
for stockholders and cost savings for companies and intermediaries. Under this process, stockholders of record who have the same address
and last name and have not previously requested electronic delivery of proxy materials will receive a single envelope containing the Notice
for all stockholders having that address. The Notice for each stockholder will include that stockholder&#8217;s unique control number
needed to vote his or her shares.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you would like to receive
a separate Notice, please contact our investor relations department at our offices located at 305 College Road East, Princeton, New Jersey
08540; telephone (732)&#160;329-8885.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For those stockholders who
have the same address and last name and who request to receive a printed copy of the Proxy Materials by mail, we will send only one copy
of such materials to each address unless one or more of those stockholders notifies us, in the same manner described above, that they
wish to receive a printed copy for each stockholder at that address.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you are a beneficial owner,
you can request information about householding from your broker, bank or nominee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 50 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="v12"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OTHER MATTERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board does not know of
any matters to be presented at the virtual Annual Meeting other than those listed in the Notice of Annual Meeting of Stockholders that
accompanies this Proxy Statement. However, if other matters properly come before the Annual Meeting, it is the intention of the persons
named in the accompanying proxy to vote in accordance with their best judgment on such matters insofar as the proxies are not limited
to the contrary.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To the extent that information
contained in this Proxy Statement is within the knowledge of persons other than our management, we have relied on such persons for the
accuracy and completeness thereof.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Proxy Statement and our
Annual Report are available at <i>www.proxyvote.com. </i>Alternatively, upon the receipt of a written request from any stockholder entitled
to vote at the forthcoming Annual Meeting, we will mail, at no charge to the stockholder, a copy of our Annual Report, including the financial
statements and schedules required to be filed with the SEC pursuant to Rule&#160;13a-1 under the Exchange Act, for CytoSorbents Corporation&#8217;s
most recent fiscal year. Requests from beneficial owners of our voting securities must set forth a good faith representation that, as
of the Record Date for the Annual Meeting, the person making the request was the beneficial owner of securities entitled to vote at such
meeting. Written requests for such report should be directed to:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Effie Perdikis, Executive Assistant</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CytoSorbents Corporation</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">305 College Road East</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Princeton, New Jersey 08540</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If you would like us to send
you a copy of the exhibits listed on the exhibit index of the Annual Report, we will do so upon your payment of our reasonable expenses
in furnishing a requested exhibit.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Annual Meeting will be
a virtual meeting and you may attend by going to www.virtualshareholdermeeting.com/CTSO2026 at the time of the meeting, and you will be
able to vote your shares during the meeting. To vote, you will need the 16-digit control number included on your proxy card, voter instruction
card or Notice. Even if you plan to attend the Annual Meeting, we encourage you to submit your proxy or voting instructions in advance
so that your vote will be counted if you later decide not to attend the Annual Meeting. Also, the Notice and the proxy card contain instructions
for record holders who want to vote their shares via the Internet. If you have requested the Proxy Materials to be sent to you by mail,
for your convenience, a return envelope is enclosed requiring no additional postage if mailed in the United States.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">By Order of the Board of Directors,</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table border="0" cellpadding="0" style="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;">
<tr style="vertical-align: top">
  <td style="border-bottom: Black 1pt solid; width: 50%"><span style="font-size: 10pt">/s/ Peter J. Mariani</span></td>
  <td style="padding-bottom: 1pt; width: 50%"/></tr>
</table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Peter
J. Mariani<br/>
<i>Chief Financial Officer and Secretary</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dated: June 25, 2026</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 51; Value: 27 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><div><a id="v13"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>APPENDIX A</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;OF CERTIFICATE OF AMENDMENT NO. 1
TO THE SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO EFFECT THE REVERSE STOCK SPLIT PROPOSAL</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 52; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #231f20"><b>CERTIFICATE OF AMENDMENT</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #231f20"><b>TO THE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #231f20"><b>SECOND AMENDED AND RESTATED
CERTIFICATE OF INCORPORATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; color: #231f20"><b>OF</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CYTOSORBENTS CORPORATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">CytoSorbents
Corporation, a corporation organized and existing by virtue of the General Corporation Law of the State of Delaware (the &#8220;<span style="text-decoration:underline">Corporation</span>&#8221;),
does hereby certify:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">FIRST:
At the Effective Time (as defined below), each share of the Corporation&#8217;s common stock, $0.001 par value per share (the &#8220;<span style="text-decoration:underline">Old
Common Stock</span>&#8221;), either issued or outstanding or held by the Corporation as treasury stock, immediately prior to the Effective
Time, will be automatically reclassified and combined (without any further act) into a smaller number of shares such that each [&#9679;]
([&#9679;]) shares of Old Common Stock issued and outstanding or held by the Corporation as treasury stock immediately prior to the Effective
Time is reclassified into one (1)&#160;share of Common Stock, $0.001 par value per share, of the Corporation (the &#8220;<span style="text-decoration:underline">New Common
Stock</span>&#8221;), without increasing or decreasing the amount of stated capital or paid-in surplus of the Corporation (the &#8220;<span style="text-decoration:underline">Reverse
Stock Split</span>&#8221;). The Board of Directors shall make provision for the issuance of that number of fractions of New Common Stock
such that any fractional share of a holder otherwise resulting from the Reverse Stock Split shall be rounded up to the next whole number
of shares of New Common Stock. Each stock certificate that, immediately prior to the Effective Time, represented shares of the Old Common
Stock shall thereafter, from and after the Effective Time, automatically and without the necessity of presenting the same for exchange,
represent the number of shares of the New Common Stock into which such shares of Old Common Stock shall have been combined, subject to
the treatment of fractional shares as described above.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">SECOND:
The foregoing amendment has been duly adopted in accordance with the provisions of Section&#160;242 of the General Corporation Law of
the State of Delaware.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify; text-indent: 0.25in">THIRD:
This Certificate of Amendment shall be effective as of 5:00 PM Eastern Time on [ &#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;], 2026 (the &#8220;<span style="text-decoration:underline">Effective Time</span>&#8221;).</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[SIGNATURE PAGE FOLLOWS]</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 53; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">IN WITNESS
WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed in its corporate name and on its behalf by its duly
authorized officer this ______ day of _______________, 2026.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><table cellpadding="0" style="font-size: 10pt; border-collapse: collapse; width: 100%; border-spacing: 0px;">
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">CYTOSORBENTS CORPORATION</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt; width: 50%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Name: Dr.&#160;Phillip P. Chan</span></td></tr>
  <tr style="font-size: 10pt; vertical-align: bottom">
    <td style="font-size: 10pt"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Title: Chief Executive Officer</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 54; Options: NewSection; Value: 3 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><p style="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"></p></div><div>
    </div><!-- Field: /Page --><div>
</div><div><div style="text-align: center;"><div style="margin-left: auto; margin-right: auto; text-align: center;"><table border="0" cellpadding="0" style="width:100%;border-collapse:collapse; margin-left: auto; margin-right: auto; border-spacing: 0px;"><tr style="page-break-inside:avoid;"><td style="padding:0in 5.4pt 0in 5.4pt;width:7.7%"/><td style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;" valign="top"><p style="margin:0in 0in .0001pt;text-align:center;"><img alt="GRAPHIC" src="tm263197d5_def14aimg03.jpg"/></p></td><td style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;" valign="middle"><p style="margin:0in 0in .0001pt;"><span style="color:white;font-size:1.0pt; font-family: Arial;">Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date
TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS:
KEEP THIS PORTION FOR YOUR RECORDS
DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED.
T01896-P54969
For Against Abstain
! ! ! For Against Abstain
! ! !
! ! !
! ! !
! ! !
! ! !
! ! !
! ! !
! ! !
CYTOSORBENTS CORPORATION
THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR"
THE FOLLOWING PROPOSALS:
1. To elect the following nominees to serve as directors:
Nominees:
Please sign and return this Proxy Card so that the shares can be represented at the meeting. If signing for a corporation or partnership or as agent, attorney
or fiduciary, indicate the capacity in which you are signing. If you vote by ballot, such vote will supersede this proxy.
1a. Phillip P. Chan, MD, PhD
1b. Michael G. Bator, MBA
1c. Edward R. Jones, MD, MBA
1d. Alan D. Sobel, CPA
1e. Jiny Kim, MBA
2. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers, disclosed pursuant to Item 402 of Regulation
S-K.
3. To ratify the appointment of WithumSmith+Brown, PC as CytoSorbents Corporation's independent auditors to audit CytoSorbents Corporation's financial
statements for the fiscal year ending December 31, 2026.
4. To approve an amendment to the Company's Certificate of Incorporation to effect a reverse stock split of the Company's Common Stock, subject to
our Board's discretion, at a ratio of not less than 1-for-5 and not greater than 1-for-20, with the exact ratio to be set within that range at the discretion
of our Board, without further approval or authorization of our stockholders, prior to the one-year anniversary of the date on which the reverse stock
split is approved by the Company's stockholders at the Annual Meeting.
5. To approve an adjournment of the Annual Meeting to a later date or time, if necessary, to permit further solicitation and vote of proxies if there are
insufficient votes at the time of the Annual Meeting to approve any of the proposals presented for a vote at the Annual Meeting.
6. To conduct such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
SCAN TO
CYTOSORBENTS CORPORATION
VIEW MATERIALS &amp; VOTEw 305 COLLEGE ROAD EAST
PRINCETON, NEW JERSEY 08540
ATTN: CORPORATE SECRETARY
YOUR VOTE IS IMPORTANT
VOTE TODAY IN ONE OF THREE WAYS
VOTE BY INTERNET
Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above
Use the Internet to transmit your voting instructions and for electronic delivery of information up until
11:59 p.m. Eastern Time on August 12, 2026. Have your proxy card in hand when you access the website
and follow the instructions to obtain your records and to create an electronic voting instruction form.
During The Meeting - Go to www.virtualshareholdermeeting.com/CTSO2026
You may attend the meeting via the Internet and vote during the meeting. Have the information that
is printed in the box marked by the arrow available and follow the instructions.
VOTE BY PHONE - 1-800-690-6903
Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time
on August 12, 2026. Have your proxy card in hand when you call and then follow the instructions.
VOTE BY MAIL
Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or
return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.
You may vote by Internet 24 hours a day, 7 days a week.
Your Internet vote authorizes the named proxies to vote in the same
 manner as if you marked, signed and returned your proxy car</span></p></td></tr></table></div><div style="page-break-after:always; margin-left: auto; margin-right: auto;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div style="margin-left: auto; margin-right: auto; text-align: center;"><table border="0" cellpadding="0" style="width:100%;border-collapse:collapse; margin-left: auto; margin-right: auto; border-spacing: 0px;"><tr style="page-break-inside:avoid;"><td style="padding:0in 5.4pt 0in 5.4pt;width:7.7%"/><td style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;" valign="top"><p style="margin:0in 0in .0001pt;text-align:center;"><img alt="GRAPHIC" src="tm263197d5_def14aimg04.jpg"/></p></td><td style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;" valign="middle"><p style="margin:0in 0in .0001pt;"><span style="color:white;font-size:1.0pt; font-family: Arial;">T01897-P54969
PLEASE RETURN THIS CARD PROMPTLY IN THE ENCLOSED, POSTAGE-PAID ENVELOPE OR OTHERWISE
TO CYTOSORBENTS CORPORATION, C/O BROADRIDGE, 51 MERCEDES WAY, EDGEWOOD, NY 11717,
SO THAT THE SHARES CAN BE REPRESENTED AT THE MEETING.
Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Proxy Statement for the 2026 Annual Meeting of Stockholders and Annual Report on Form 10-K for the
year ended December 31, 2025 are available at: www.proxyvote.com.
DETACH HERE
CytoSorbents Corporation
COMMON STOCK
 PROXY CARD
This Proxy is Solicited on Behalf of the Board of Directors for the Annual Meeting of Stockholders on August 13, 2026.
YOUR VOTE IS IMPORTANT! PLEASE SIGN AND DATE ON THE REVERSE SIDE OF THIS CARD.
PROXY
The undersigned, revoking all prior proxies, hereby appoints Dr. Phillip P. Chan and Vincent J. Capponi, and each of them, with full power of substitution,
proxies to appear on behalf of the undersigned and to vote all shares of Common Stock of the undersigned at the Annual Meeting of Stockholders
to be held via live webcast at www.virtualshareholdermeeting.com/CTSO2026, on Thursday, August 13, 2026 at 10:00 a.m., Eastern Time, and at any
adjournments thereof, subject to any directions indicated on the reverse side of this card, upon the matters set forth in the Notice of Annual Meeting
of Stockholders and Proxy Statement dated June 25, 2026, a copy of which has been received by the undersigned. The proxies are further authorized to
vote, in their discretion, upon such other business as may properly come before the meeting or any adjournments or postponements thereof.
If this Proxy is properly executed and returned, and not revoked, the shares it represents will be voted at the meeting in accordance with the choices specified
on this proxy card. If no choice is specified, the shares will be voted by the proxies FOR the election of the nominees listed in Proposal 1 to serve as directors on
the Board of Directors, FOR Proposal 2 to approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers, disclosed
pursuant to Item 402 of Regulation S-K, FOR Proposal 3 to ratify the appointment of WithumSmith+Brown, PC as CytoSorbents Corporation's independent
auditors to audit CytoSorbents Corporation's financial statements for the fiscal year ending December 31, 2026, FOR Proposal 4 to approve an amendment to
the Company's Certificate of Incorporation to effect a reverse stock split, FOR Proposal 5 to approve an adjournment of the Annual Meeting, if necessary, and
at their discretion on any matter that may properly come before the meeting or any adjournments or postponements thereof.
CONTINUED AND TO BE SIGNED ON REVERSE SIDE
SEE REVERSE SIDE SEE REVERSE SIDE</span></p></td></tr></table></div><div style="page-break-after:avoid; margin-left: auto; margin-right: auto;"><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div></div></div><div>


</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
<ix:nonFraction contextRef="c12" id="hidden-fact-1" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c13" id="hidden-fact-2" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c14" id="hidden-fact-3" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c21" id="hidden-fact-4" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c22" id="hidden-fact-5" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c23" id="hidden-fact-6" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c24" id="hidden-fact-7" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c25" id="hidden-fact-8" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c26" id="hidden-fact-9" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c39" id="hidden-fact-10" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c40" id="hidden-fact-11" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c48" id="hidden-fact-12" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c49" id="hidden-fact-13" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c50" id="hidden-fact-14" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c51" id="hidden-fact-15" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c52" id="hidden-fact-16" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonFraction contextRef="c53" id="hidden-fact-17" name="ecd:AdjToCompAmt" unitRef="usd" xsi:nil="true"></ix:nonFraction>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-6968">0001175151</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-6969">false</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="ctso-20251231.xsd" xlink:type="simple"/></ix:references>
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c1">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c2">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c3">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c4">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c5">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c6">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c7">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c8">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c9">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c10">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c11">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c12">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c13">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c14">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c15">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c16">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c17">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c18">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c19">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c20">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c21">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c22">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c23">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c24">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c25">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c26">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c27">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c28">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c29">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c30">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c31">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c32">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c33">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c34">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c35">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c36">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c37">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c38">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c39">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c40">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c41">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c42">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c43">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c44">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c45">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c46">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c47">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c48">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c49">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c50">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c51">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c52">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c53">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c54">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-01-01</xbrli:startDate>
    <xbrli:endDate>2025-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c55">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2024-01-01</xbrli:startDate>
    <xbrli:endDate>2024-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:context xmlns="" id="c56">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001175151</xbrli:identifier>
    <xbrli:segment>
      <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
      <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
    </xbrli:segment>
  </xbrli:entity>
<!-- [WMV7][A+hjqvVazatW51P4h4X531bcfBTll0lfArflh1+kA9ndsxPpNu7N5AvKJE20b6QhSInm6ZMnFEOYVHQmN6yY+WL7xgi9awbWdWJoFlcdgmn0ognzMlUUl++w4WyMlrqbj0mmkdZK6YmkxkMnkpXZ6eCUIX/bPtuiYdijo9Sqcv8r0pnWvTWrJAi78LUA2BIfiTdVhWosP+4orBlQegfkZ5UTU2qBOvc/X+V04WvAAYoDw/IN+VvCUXnXqcvLe8jt48GTZfA6MnhbNGUJM0/txq+GBjArOfD21FTlDgOGbNqCSxJ2AMJh31p1JxOprDlSD2ETE4KGtA==] CSR-->
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-12-31</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>
</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>ctso-20251231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Thu Jun 25 18:21:17 UTC 2026 -->
<xs:schema xmlns:ctso="http://cytosorbents.com/20251231" elementFormDefault="qualified" targetNamespace="http://cytosorbents.com/20251231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dtr="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20251231_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20251231_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="ctso-20251231_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2025" schemaLocation="https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:element name="EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember"/>
  <xs:element name="EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember"/>
  <xs:element name="EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember"/>
  <xs:element name="EquityAwardsAdjustmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsMember"/>
  <xs:element name="EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember"/>
  <xs:element name="NetAdjustmentsForEquityAwardsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_NetAdjustmentsForEquityAwardsMember"/>
  <xs:element name="NetAdjustmentsForPensionMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_NetAdjustmentsForPensionMember"/>
  <xs:element name="OptionAwardsValueInCompensationTableForTheApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember"/>
  <xs:element name="PensionAdjustmentsMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_PensionAdjustmentsMember"/>
  <xs:element name="PensionAdjustmentsPriorServiceCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_PensionAdjustmentsPriorServiceCostMember"/>
  <xs:element name="PensionAdjustmentsServiceCostMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_PensionAdjustmentsServiceCostMember"/>
  <xs:element name="PensionValueInCompensationTableForTheApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_PensionValueInCompensationTableForTheApplicableYearMember"/>
<!-- [WMV7][9DgKYRqWKcmKh95G+WYmW88dYRakhlfviNt85cC4IolYvvPgn1gorc6mre2syMpTqrgDeEk7RPcxLL+OczYWx+pkXMrEjF50EWMO3cCs5ceoCVNbjBi2OMbbnJxmCQL843t8PRF4lSJPxM0zyGPu42yg3DNdX5yg9D3YbjeVUsP6vdvKM3olOmkhYuiwiuieHMVFIsI6agKx4xmTmz46fxVVbZeYRfBASZkn3YnXKSHv2REt9j0e5eEnE25dolofnonwpPQnaUMt+EHhDK3GadQ10jWP49f4vz9LUrRlpEVtnNt66wPCTIpdDLpKm7yelMP4lLwK] CSR-->
  <xs:element name="StockAwardsValueInCompensationTableForTheApplicableYearMember" type="dtr:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>ctso-20251231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Thu Jun 25 18:21:17 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <loc xlink:type="locator" xlink:label="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="ctso-20251231.xsd#ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_EqtyAwrdsAdjsMember" xlink:to="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="ctso-20251231.xsd#ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_EqtyAwrdsAdjsMember" xlink:to="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember" order="2" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <loc xlink:type="locator" xlink:label="ctso_NetAdjustmentsForEquityAwardsMember" xlink:href="ctso-20251231.xsd#ctso_NetAdjustmentsForEquityAwardsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ecd_AllAdjToCompMember" xlink:to="ctso_NetAdjustmentsForEquityAwardsMember" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsMember"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ctso_NetAdjustmentsForEquityAwardsMember" xlink:to="ctso_EquityAwardsAdjustmentsMember" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember"/>
<!-- [WMV7][O0FFrTJn/0MT1g5NIVD5vuBNSW/wPsQiJhOs3ch49hFj5ksCMYSlG/2hHPX7GS0fwPmWurSAJOxvgLwv0pONAoZXTWXOxXDB2dWg6+P5JIRVZQq6QVTv75WsWAVV0o5DykmiNFEejUMj5RpXRrrFY6nNfxBkb/w1aynJ3/m02g9gzYzbFNfXGkOtgVs/lTf8UDVSSVXHwa4GSViAN22MsNZIZPyoEMO3KqwgBURowwEoNDRzGdhJ5y2G8RwDCalKKh0COxeVyoPf6wj6+YU+Qjt1U6LOPXe5HtBibYk/tekTAcAZwVB7jF2HYRVSCrsEAc+TAbzkhHU=] CSR-->
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="ctso_EquityAwardsAdjustmentsMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember" order="1" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ctso-20251231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Thu Jun 25 18:21:17 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl" xml:lang="en-US">Adjustments For Equity Awards Failed To Meet Performance Conditions [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:to="ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on adjustments for equity awards that failed to meet performance conditions.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember" xlink:to="ctso_EquityAwardsAdjustmentsAdjustmentsForEquityAwardsFailedToMeetPerformanceConditionsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Current Year Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of current  year awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfCurrentAwardsVestedDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of prior year awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfPriorYearAwardsVestedDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Awards Vested During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value (as of vesting date) of awards vested during current year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfVestingDateOfVestedAwardsDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl" xml:lang="en-US">Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueAsOfYearEndOfOutstandingAndUnvestedAwardsGrantedInPriorYearsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember_lbl" xml:lang="en-US">Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are forfeited during applicable fiscal year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl" xml:lang="en-US">Dividends Or Other Earnings Paid On Equity Awards Not Otherwise Reflected In Fair Value [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:to="ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on dividends or other earnings paid on equity awards not otherwise reflected in fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember" xlink:to="ctso_EquityAwardsAdjustmentsDividendsOrOtherEarningsPaidOnEquityAwardsNotOtherwiseReflectedInFairValueMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsMember_lbl" xml:lang="en-US">Total Equity Awards Adjustments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsMember" xlink:to="ctso_EquityAwardsAdjustmentsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsMember_lbl0" xml:lang="en-US">This member presents the total equity awards adjustments, which may be comprised of adjustments for (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal to the change in value as of the vesting date (from the end of the prior fiscal year); (iv) adjustments for equity awards that failed to meet performance conditions; and (v) dividends or other earnings paid on equity awards not otherwise reflected in fair value.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsMember" xlink:to="ctso_EquityAwardsAdjustmentsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl" xml:lang="en-US">Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl0" xml:lang="en-US">This member presents the equity awards adjustments on the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember" xlink:to="ctso_EquityAwardsAdjustmentsYearEndFairValueOfAwardsGrantedInCurrentYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_NetAdjustmentsForEquityAwardsMember" xlink:href="ctso-20251231.xsd#ctso_NetAdjustmentsForEquityAwardsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_NetAdjustmentsForEquityAwardsMember_lbl" xml:lang="en-US">Total Net Adjustments For Equity Awards [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_NetAdjustmentsForEquityAwardsMember" xlink:to="ctso_NetAdjustmentsForEquityAwardsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_NetAdjustmentsForEquityAwardsMember_lbl0" xml:lang="en-US">This member presents the net compensation adjustment for equity awards, which is comprised of equity awards value from summary compensation table, net of total equity awards adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_NetAdjustmentsForEquityAwardsMember" xlink:to="ctso_NetAdjustmentsForEquityAwardsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_NetAdjustmentsForPensionMember" xlink:href="ctso-20251231.xsd#ctso_NetAdjustmentsForPensionMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_NetAdjustmentsForPensionMember_lbl" xml:lang="en-US">Total Net Adjustments For Pension [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_NetAdjustmentsForPensionMember" xlink:to="ctso_NetAdjustmentsForPensionMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_NetAdjustmentsForPensionMember_lbl0" xml:lang="en-US">This member presents the net compensation adjustment for pension, which is comprised of pension value from summary compensation table, net of total pension adjustments.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_NetAdjustmentsForPensionMember" xlink:to="ctso_NetAdjustmentsForPensionMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="ctso-20251231.xsd#ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember_lbl" xml:lang="en-US">Option Awards Value In Compensation Table For The Applicable Year Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember_lbl0" xml:lang="en-US">This member stands for option awards.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_PensionAdjustmentsMember" xlink:href="ctso-20251231.xsd#ctso_PensionAdjustmentsMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_PensionAdjustmentsMember_lbl" xml:lang="en-US">Total Pension Adjustments [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionAdjustmentsMember" xlink:to="ctso_PensionAdjustmentsMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_PensionAdjustmentsMember_lbl0" xml:lang="en-US">This member presents the total pension adjustments, which may be comprised of adjustments for service cost and prior service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionAdjustmentsMember" xlink:to="ctso_PensionAdjustmentsMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_PensionAdjustmentsPriorServiceCostMember" xlink:href="ctso-20251231.xsd#ctso_PensionAdjustmentsPriorServiceCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ctso_PensionAdjustmentsPriorServiceCostMember_lbl" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionAdjustmentsPriorServiceCostMember" xlink:to="ctso_PensionAdjustmentsPriorServiceCostMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_PensionAdjustmentsPriorServiceCostMember_lbl0" xml:lang="en-US">This member presents the total pension adjustments, prior service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionAdjustmentsPriorServiceCostMember" xlink:to="ctso_PensionAdjustmentsPriorServiceCostMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_PensionAdjustmentsServiceCostMember" xlink:href="ctso-20251231.xsd#ctso_PensionAdjustmentsServiceCostMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ctso_PensionAdjustmentsServiceCostMember_lbl" xml:lang="en-US">Pension Adjustments Service Cost [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionAdjustmentsServiceCostMember" xlink:to="ctso_PensionAdjustmentsServiceCostMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_PensionAdjustmentsServiceCostMember_lbl0" xml:lang="en-US">This member presents the pension adjustments, service cost.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionAdjustmentsServiceCostMember" xlink:to="ctso_PensionAdjustmentsServiceCostMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_PensionValueInCompensationTableForTheApplicableYearMember" xlink:href="ctso-20251231.xsd#ctso_PensionValueInCompensationTableForTheApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_PensionValueInCompensationTableForTheApplicableYearMember_lbl" xml:lang="en-US">Pension Adjustments Pension Value In Summary Compensation Table [Member]</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionValueInCompensationTableForTheApplicableYearMember" xlink:to="ctso_PensionValueInCompensationTableForTheApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_PensionValueInCompensationTableForTheApplicableYearMember_lbl0" xml:lang="en-US">This member presents the adjustment (deduction) for pension value from summary compensation table.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionValueInCompensationTableForTheApplicableYearMember" xlink:to="ctso_PensionValueInCompensationTableForTheApplicableYearMember_lbl0"/>
    <loc xlink:type="locator" xlink:label="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="ctso-20251231.xsd#ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember_lbl" xml:lang="en-US">Stock Awards Value In Compensation Table For The Applicable Year Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember_lbl0" xml:lang="en-US">This member stands for Stock awards.</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember" xlink:to="ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_PensionAdjustmentsPriorServiceCostMember_lbl1" xml:lang="en-US">Pension Adjustments Prior Service Cost Member</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionAdjustmentsPriorServiceCostMember" xlink:to="ctso_PensionAdjustmentsPriorServiceCostMember_lbl1"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ctso_PensionAdjustmentsServiceCostMember_lbl1" xml:lang="en-US">Pension Adjustments Service Cost Member</label>
<!-- [WMV7][bb4/tCP70jgXypklXa4rMzFuUQPgFwfAG+aab2eUmt9oEBgC4U/rlck9jwSI75kwj6Cc4Gp6y4XR7gXRROGiXBnX6H1xo+UsJB0tEz0R5O0eRKiPuz96Rg8i/SS0Hfj2X9Cdz+tDVdZ678gB2SbDyvGI6yhsX9f+WiSdUGt8j/8BTkqerN7YZq3225P2mQkFOpFHAaSTI/9nG6fx/SxjmyEuk7ZRq4YrGsAlDCPfM9vd9PoDM4mH7uFQcifjq++l4SOdxBJWFdO0SznjeDcXUxf+g+vZD+5A81KExtEKmpnT6RoT+sJEyY9fa3ZFJo+iMEQcXhev] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ctso_PensionAdjustmentsServiceCostMember" xlink:to="ctso_PensionAdjustmentsServiceCostMember_lbl1"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ctso-20251231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Broadridge Transform (tm) - http://www.broadridge.com -->
<!-- Created: Thu Jun 25 18:21:17 UTC 2026 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure"/>
  <presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd#ecd_AllAdjToCompMember"/>
    <loc xlink:type="locator" xlink:label="StockAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="ctso-20251231.xsd#ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="StockAwardsValueInCompensationTableForTheApplicableYearMember" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="OptionAwardsValueInCompensationTableForTheApplicableYearMember" xlink:href="ctso-20251231.xsd#ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="OptionAwardsValueInCompensationTableForTheApplicableYearMember" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="NetAdjustmentsForEquityAwardsMember" xlink:href="ctso-20251231.xsd#ctso_NetAdjustmentsForEquityAwardsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="NetAdjustmentsForEquityAwardsMember" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityAwardsAdjustmentsMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsMember"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="EquityAwardsAdjustmentsMember" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <loc xlink:type="locator" xlink:label="EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember" xlink:href="ctso-20251231.xsd#ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember"/>
<!-- [WMV7][+hwQe1opk1ENtgWVMUJqeIerdwttRR6O/SANm3TJWgGXf2auTQxumEYL6NBOZWylq0riRtJZUKm0rWokH3BYY7kTymKaNN9L5mpiIiTqY9T0drxP284wJLoBy/RO0Q4SwuYDXBgzQWNnbOHoeB30oGIw6tITHIjISC7h7AezvC1aHGU8k9l28Gm2k82lMx1bMX6REDQsu1tFWeEyAtCHwe/foHOnkOrQ23jY8paIPOAFVfo91BKL/t55MBXlCgNp8vqg6Yvd5iMppiZ0IEXpZzB4AYjgh1XD3/+wiotc70wgezMo1bwHZyABPdIYxg2dqSEnG4sVhA==] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ecd_AllAdjToCompMember" xlink:to="EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm263197d5_def14aimg01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm263197d5_def14aimg01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (B P(# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^HOM"9(
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MV_PJ6B@"+ST_NR?]^V_PH\]/[LG_ '[;_"I:* (O/3^[)_W[;_"CST_NR?\
M?MO\*EHH B\]/[LG_?MO\*//3^[)_P!^V_PJ6B@"+ST_NR?]^V_PH\]/[LG_
M '[;_"I:* (O/3^[)_W[;_"CST_NR?\ ?MO\*EHH B\]/[LG_?MO\*//3^[)
M_P!^V_PJ6B@"+ST_NR?]^V_PH\]/[LG_ '[;_"I:* (O/3^[)_W[;_"CST_N
MR?\ ?MO\*EHH B\]/[LG_?MO\*//3^[)_P!^V_PJ6B@"+ST_NR?]^V_PH\]/
M[LG_ '[;_"I:* (O/3^[)_W[;_"CST_NR?\ ?MO\*EHH B\]/[LG_?MO\*//
M3^[)_P!^V_PJ6B@"+ST_NR?]^V_PH\]/[LG_ '[;_"I:* (O/3^[)_W[;_"C
MST_NR?\ ?MO\*EHH B\]/[LG_?MO\*//3^[)_P!^V_PJ6B@"+ST_NR?]^V_P
MH\]/[LG_ '[;_"I:* (O/3^[)_W[;_"CST_NR?\ ?MO\*EHH B\]/[LG_?MO
M\*//3^[)_P!^V_PJ6B@"+ST_NR?]^V_PH\]/[LG_ '[;_"I:* (O/3^[)_W[
M;_"CST_NR?\ ?MO\*EHH B\]/[LG_?MO\*//3^[)_P!^V_PJ6B@"+ST_NR?]
M^V_PH\]/[LG_ '[;_"I:* (O/3^[)_W[;_"CST_NR?\ ?MO\*EHH B\]/[LG
M_?MO\*//3^[)_P!^V_PJ6B@"+ST_NR?]^V_PH\]/[LG_ '[;_"I:* (O/3^[
M)_W[;_"CST_NR?\ ?MO\*EHH B\]/[LG_?MO\*//3^[)_P!^V_PJ6B@"+ST_
MNR?]^V_PI4F1WV#<&QG#*1Q^-25 ?^/]?^N1_F* )Z*** "HH/\ 5G_??_T(
MU+44'^K/^^__ *$: ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **YG7]2OI==L/#^F3_ &::Y1IY[D*&,<2_W0>,DC&>U1W]CKVCS6MU
MIFH7>I0^:JW-I<A&+(3RRL ,$>E '545CZGXDM--NQ9K!=WMX5WFWLXO,=5_
MO'D #ZFGP>(+&YT>ZU*(R%+5':>(KB6,J,E2IZ-Q0!JT5S7_  G&EJ;=Y8;V
M&TGP%O)+<B$,1D*6]>V0"/>K-KXJL;G58]/:WO;=Y@3;R7,!C2?')V$\].>0
M* -RBL*[\5VEK?7EDEG?W5U:L@>*V@\PD,H8,.>!@XYQSTS5FW\0:=<:(^KB
M8QVL8/F>8I#1D'!4CKNSQB@#4HK#L/%%K>7L5I+9W]C+-GR/MD'EB7 R0IR>
M<<X.#4=UXNM+;4[[3DLM0NKNS\O?';0;RP==V1ST'&<XY(QF@#H**QH_%.E2
M>'VUKSF6T7Y6#+\ZOG&PK_>SVHTWQ);:C>?8WM+VRN2GF)%>0[#(O<KR1_6@
M#9HKG9_&5A#+*5M-0FM87*37D5N3#&1UR<Y('<@&J?B'Q5<:;K.DP6EG>7%O
M.2SM!"KB=2I($9SR1U/3B@#KJ*PTU&&7Q1:P%]0BN);#SQ;OM$07</O#KO!X
M]*BNO&%C;7$R+::A<6\#%9[NWMR\,9'7+9YQWP#B@#H:*QM2\3Z;I=O87,KO
M);WSJD4L0##D9!/.<?3)]J;IGB>TU+4GT]K6]L[H)YBQWD/EF1,XRO/- &W1
M4-W=0V5G-=3MLAA0R.WH ,FN/\&:QJ<M\]MK$SM)?6XO[56_@0LP*C\-I_&@
M#MJ*Q=2\36FG7ALH[:\OKM5#O!90^8T:GH6Y &?K63XC\8>1X2DU+2$G:4MY
M>_R@1;N&&X2@_=/./J10!V%%8"^*H([/3YKJPO[=KVZ2T1)HE5@[=&(W?=]_
MTJ]=ZS;V>M:?I4B2F>^$AB90-HV+N.XYST] : -&BL*_\56MC=30)8ZA>>1_
MKY+2#>D1QG#'(YQS@9JIX@U:02>&YM/NB+>]OHU9DZ21L,X^E '445R?]LW-
MKXRUI)6GFL[2P2=;>, G/4[1QS^-:LOB/3X?#0UXL[69B$@"@%CG@+C.-V3C
M&>M &O167K-W+'X5U"\A$EO,MC)*@8 /&VPD9]P:YI+?4SX)BUR'Q!?)>"S%
MT1,R/$Q"[B"I7H>G6@#N:*P'\4P066GLUK=7-Y=VZSBUM(M[A2 23R !DXY-
M-N/$-A?>&=1O4EO8$MU9)UC79<0L.HPW :@#H:*P[GQ#8Z7I=A)(;JXENHU^
MSP(F^>;Y0<X'?'4]*S=*UZ;4_'<MNOVJ&V731(UI<)L:.3S ,D>N"/;!H ZZ
MBL^YUBWM=:LM+E2437BNT3X&P[1D@G.<X]JANO$=A9:G/8SLZ-;VOVN:7 V(
MF<8)SG)],4 :U%8-AXKL[Z[AMWM+^T-P,V[W4&Q9N,_*<GMSSBMZ@ HKG?%.
MK7EI)IVF::RQWNI3&-)F7=Y2#!9L=R :KZEI>N:98_;-*U>]OKN(@M;7.QDG
M&>0, ;?7@]J .JHK-&M0C5[72Y(9DN;BW-P.!M4#J"<YS^%/AU>WGUNZTI4E
M$]M&DCL0-I#=,'.<_A0!?HKEAX]TUK*.]2RU)[4_ZR9+;*0\X^<YQ^6:LMXQ
MTY;VWA,%[]GN)!%%>F B!F/0!CUSZXQ[T =!16:FMVS^(Y-#"2_:DMOM)<@;
M-N0,9SG//I5+4=<2;2/$2V?FQ7.FP2 N0!\_EE@5Y^G6@#?HK"L];BLO"&F:
MCJ$LCO+;0_=7<\LC(#@ =23FELO%%M>336S6=_;7D<1F6VN(=LDB#NG)!YXZ
MT ;E%<;X7\576KP:@E[:7R^7+-MG$*JJ(N,(3G[X_P FKVB>(;%K71K59+^3
M[?%(UO/=[2S;#R'(/WO3CI0!TE%9LNN6D.LOIKB021VINI9<#RXTSCYCG@\9
MZ=*HVWC'3[BYA0V]]#;W#A+>[FMRL,Q/0*W7GMD#- '0456OK1KVV,*W5Q;$
MD'S+=@&'XD&N-T.WOK_Q+KMC-KNJ>3I\D0BQ(F6#!B=WR\].V* .[HKB-/N;
MO7M;UJWN==N+&6UNF@MK: HAV#HY!!+9H\07VO:5\/;F:[N!'J4,JH+B(@;U
MW@!L#@$@\B@#MZ*XSQ!;W_AVQCU"TUZ]FE2>-?LUTR.)PS %0 H.><\>AKLZ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *@/_ !_K_P!<C_,5
M/4!_X_U_ZY'^8H GHHHH *B@_P!6?]]__0C4M10?ZL_[[_\ H1H EHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#C]<D&D>/--UF[_=Z?):
MM:/.?NQODL-WIGI5[5O%UG:&V@TUX-1OKF54CMX90>#U8D9P *WIH(KF)HIX
MDEC;AD=0P/U!JO::3IMA(7L]/M+9SP6AA5"?R% '-65S!I_Q(UT7L\<!NH('
MMS*P4.JKAL$^]4+-UN;7QW?6Y#VDRNL4B_=<K$P8CUY(YKM[S3K'4%5;VSM[
ME5^Z)HE?'TR*>MI;):?9%MXA;;2GDA $VGJ-O3'M0!QOB3_D0]&_ZZ6?]*N^
M*/\ D:?"O_7U)_Z!722V5K-;I!+;0R0H04C:,%5QTP.@QVITMK;SRQ2S0122
M0DM$[H"4)[J3T_"@#F=.U2PL_&'B."ZNX8)6D@=1*X7<HA7.">N*P;K?>>#]
M;O;.5EM)-9-R)4&=T2LFYP.X#*6_"NKAT"&;6-8GU&SMKB"YEB>$2HK_ '8E
M4\$<<BMJ.W@BMQ;QPQI"!M$:J H'ICIB@#C1;P3:CI!NO%\E\6N%FMH%BC/F
M, >?D&0,$\GCFKFA?\C]XM_[<_\ T4:W;71],LIC-::=:6\IZO% J-^8%6([
M6WBN)KB."))IMOFR*@#28&!N/4X'3- ' 6,6E/X>\3P:M*UO9-KLZ"6-3^Z;
M*;3P#MYQR>*TM,U*_P!.\2VNC2ZK'K%M<P/*LNT>;#M'&2O!!]3WKJEL+-8I
MHEM(!'.Y>9!&,2,>I8=R?4TRTTO3]/9FLK"UMBWWC#"J9^N!0!P%UK5WK?@N
M^U2[UZ&R2:&9$T^&-,G (",6RQ)QVQP:NNZPV/@*YF8)"BH'D<X4$P<9/O@U
MUW]B:3YLDO\ 9=EYDH(D?[.F7!Z@G'.:FET^RGLULYK.WDM4 "PO$I10.@"D
M8XH YV5A)\3+9HW!#:.Q5AR/]9P:J>#]3L-'\&?9M4N88+BR>9+N.1AN#;V/
M3J<@C'K77I96D<R3):PK+''Y2.L8#*G]T'L/;I4,^CZ7=7/VFXTVSEG_ .>L
MD"LWYD9H X(0R0Z%X$252K?;HV /4 Y(_0BMW5@/^%E>'CCDV]P"?^ UT\UI
M;7#1--;Q2&%@\1= =C>JYZ'W%#VMO)<QW+V\33Q B.5D!9 >H!ZC- ',^/II
MYM)M]$L]OVK59Q I8D!5'+$X[= ?8FL35D\0Z+>Z/K>I)I2VMA(+=OL;29\I
M\*<[AC [>]>@R6EM-<17$MO$\T.?*D9 63/!VGJ,^U+<VUO>0-!=013POC='
M*@93SGD'B@#D]*N[;3O'?B.._GC@EN!!+"TK!=Z!"."?0\4SQ?J=OK/P[U:X
MLM[PJP0.5P'VR+DKZCKS[5U-UI6G7J(EW86LZQC""6%6"CVR.*F%K;BU^RB"
M+[/MV>5L&S;Z8Z8H XWQ==V\ECX:O4GB:VBU6W:257!50 223VI=2U"SO?B3
MX:2UN8IVB6Y\SRV#!28S@$COQTKJETG34LFLUT^T6U8[F@$*A"?4KC%$&DZ;
M;-"T&GVD30EC$8X54QEA@[<#C(X..M '(-KESJUMJUQ-KD6DV]K/);+;HB,[
M;>,L7R<DGH!6:DBQ>%/ TTKA(TOX]SL<!?O=37H+Z3ILEV;M]/M&N3UF,*ES
M_P "QFG-IMBUD+)K*V-H!@0&)?+'_ <8H YFRFBC^*&H!Y$4W%A$T.3_ *P
M]O6L.WM6-Y'X+;Y1!JANL=C:X,@'_?1 ^M>AG3[)IH9FM+<RP#;"YC&Z,>BG
M''X5B:3I-_)XIO->U*&&W=[=;:"&.3S"J@Y))P!R: +_ (F_Y%36/^O&?_T
MUS/A_P &VNH^&],EOM3U6XMY((Y&LWN?W'0$#:!G ^M=Q+%'/$\4J+)&ZE71
MQD,#P01W%$,,5O"D,,:1Q( J(B@*H'0 #H* .6OM6NI/$LNAV]_!I-O;6RS&
M9D5G?/&%W?* !WP:YFUD67PQXV=+PWBE\BX( \SY>O  _*O1[K2]/OI$>\L;
M:X=/NM-"KE?ID<4O]FV/ESQ_8K;9<?ZY?*7$G;YACG\: .+,T5AXC\)WEY(L
M5JVFF%)'X59-HX)[9!JY8WEM>_%.Z>UGCF5-*",T;9 ;S <9_$5U4]A9W-JM
MK/:02VZX BDC#(,=.#Q3;?3;"SD62VLK:!U3RPT42J0F<[<@=,\X]: ,?QB/
MLVF6^K*FY]-N8[@XZE,[7'_?)/Y5C:>=.U/3/$?B#52WV"^D,(=59L6\?R*P
M !/7)/'&*[B:&*XA>&:-)(G!5T=058'L0>M-AM;>WMA;0P11VX!41(@"@'M@
M<4 <59WUUH.I:/9VVMQZQI]^_E(C[3+$H'#!EZCUS786^I65U>W-G!<(]S;;
M?.C'5,\BF6NCZ993&:TTZT@E/5XH%1C^(%6([:"*>6>."-)9<>9(J ,^.F3W
MQ0!RWB\-9ZUX>UIT8V=C/(MPX&?+60!0Q]ABKNK^+]-L-,^T6=S;WUS)@6]M
M#,&:9B0  !D_I6^Z)(C)(JLC##*PR"*IV^B:5:3B>VTRRAF'22.W56_,"@#G
MKZ<6WCO1;N^,=LLMA*A+N HDR"5R?K2:'>6]]\0-:GM9EFA-K"HD0Y5B"0<'
MOSD9%=1=V%GJ$:QWMI!<HIR%FC#@'UP12P6-I;/OM[6")]@3='&%.T=!QV'I
M0!R&F_\ )()O^P=<_P GJ?Q+_P B;IG_ %WM/_0EKJ%L[5+,V:6T*VI4H81&
M A4]1MZ8.32RVEM-"L,MO%)$A!5&0%01TP/;M0!R$D\.G_%>6:\FC@BFTG"/
M(X4$B09&3_NG\JJ6UQ%>Z=X[GMG\R*5'*,!PP\C@CV]^]=M=Z;8:@4-[96UR
M4^[YT2OM^F1Q4D=I;1&0QV\2&7 DVH!OP,#/K@#'TH XQ/$$EEX4\+P6,]NC
M7D<-LUS+\RP$(,\9'S9[&H;-R?B591MK1U.1+24.VQ%$9X^7Y!C^M=G_ &1I
MOV,V?]GVGV4MN\GR5V9]=N,9IT&F6%L\;P6-M$T2E8VCB52@/4# X% ')>$Y
MXETCQ#:M*@N%OKHF(L-P''..N*S8(6B^&V@ZQ$,RZ5(+G:/XDWD.OY'/X5W_
M /9MB+M[L65M]ID4J\WE+O8'L3C)%/2RM([/[&EM"MKM*>0(P$VGJ-O3% '"
MR>?K_A?Q5JED"3>.8K?;_'#$ ./K\_'O44,5K>:#IANO%\K6L[0K%;"",G>"
M-J *N[@@"O0;>V@LX%@MH(X(4^['$@51WX XJO'HVEPW7VJ+3;-+C.?-6!0^
M?7.,T 7:X[PM_P COXO_ .NMO_Z"]=C4,5I;03S3PV\4<TY!ED1 &DQTW$=<
M9[T <A//X3\427::S;P6E]:2-"XN)1%*H'1@P(R/2N>U"ZN;GX7ZPLL\ES:P
MWHBL[F3[TL(D4 Y[]^?\*])NM'TR^E$MWIMG<2#^.6!7/YD5++86<]G]CFM(
M)+; 'DO&"G'3Y3Q0!Q7B'PMIGAZVM]>TN!HI=/G25U>1I0\>X!AAB<$ YR,5
MW@(90RD$$9!'>F3017,+PSQ)+$XPR2*&5AZ$'K3D18T5$4*B@!548 'H* '4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4!_P"/]?\ KD?YBIZ@
M/_'^O_7(_P Q0!/1110 5%!_JS_OO_Z$:EJ*#_5G_??_ -"- $M%%% !1110
M 445$MS ]P]ND\;3H SQAP64'H2.HH EHJM=ZA96 4WEY;VP;[IFE5,_3)I)
M]3T^UACFN+ZVABE_U;R2JJO]"3S0!:HJK<:E86:QM=7MM LG*&655#?3)YJR
M64(7+ *!DDGC% "T55M]2L;R.22VO;:=(_OM%*K!/J0>*6WU&RNX7FMKRWFB
MC^^\<JLJ]^2#Q0!9HJ"UO;2^C,EI=0W" X+0R!P#Z9%3T %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1152'5=.N3*(
M+^UE,0)D"3*VP#J3@\4 6Z*J6FJ:=?NR6=_:W+*,E89E<@>O!IUUJ%E8LBW=
MY;VYD^X)953=],GF@"S156XU*QM)8XKF]MH9)/N))*JEOH">:M4 %%%% !11
M10 5 ?\ C_7_ *Y'^8J>H#_Q_K_UR/\ ,4 3T444 %10?ZL_[[_^A&I:B@_U
M9_WW_P#0C0!+1110 4444 %<UI\5A9>,KFWLQ!$OV",;$(R6\R3.?4^O>NEJ
MDFC:7%>F]CTVS2Z+%S.L"A]QZG=C.3D_G0!EZEJNE07EO=6Q@NM2N8FAMBLH
M*[,Y8DYP%!')Z\8&>E9>CVL&B:U:6]U=0M FD[(YF8"-F\UC)MSQW7\!6_'X
M9T1+:&"33+2<0J55IX%=N26/)'<DGTY-6FTC36M8[5M/M#;1'='"85V(>N0,
M8'6@#D=$EM;:ZLVOV2.)M$7RC+P-F]BP&?\ 9*<5<NY&/PX%F)!]M72HWDA#
M?/LV@,<=<<$5TUS86=ZB)=6D$ZH=R"6,,%/J,]*:-/@&IOJ!!:=H1#DXP$SG
M'3N?7TH Y#Q1+!=6VIM8/'+"NE#S#"01L\P$#C_9#TSQ&ZW3ZI+8.LEHMA:^
M<8B"NT3DD<>D>_\  ^]=I;6-G9(Z6EK! KG<RQ1A0Q]3CK2VUC:6<316MK!!
M&Y+,D484$GJ2!0!A:9)'/XVU26U='@^QVZN\9RI?+D<COMQ725#:VEM90^3:
M6\4$62=D2!!D]3@5-0 QS(#\B(1[L1_2F[I_^><?_?P_X5+10!%NG_YYQ_\
M?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YY
MQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%N
MG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+1
M0!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_
MX5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?
M_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_
M^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X
M4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\
M?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YY
MQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%N
MG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+1
M0!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_
MX5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?
M_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_
M^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X
M4;I_^><?_?P_X5+10!%NG_YYQ_\ ?P_X4;I_^><?_?P_X5+10!%NG_YYQ_\
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M7=@<_C3I=.L9Q )K.WD%OS"'B4^7_NY''0=* .-BD@M]$U./4'1)VT> ;92
MS#RF& #U^;/XFNVM0XM(1)GS!&N[/KCFF3V-G=3137%K!-+$<QO)&&*'V)Z5
M8H **** "BBB@ J _P#'^O\ UR/\Q4]0'_C_ %_ZY'^8H GHHHH *B@_U9_W
MW_\ 0C4M10?ZL_[[_P#H1H EHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH *@/_'^O_7(_S%3U ?\ C_7_ *Y'^8H
MGHHHH *B@_U9_P!]_P#T(U+44'^K/^^__H1H EHHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1110 4444 %0'_C_ %_ZY'^8J>H#_P ?Z_\ 7(_S% $]%%% !44'^K/^^_\
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M444 1R01RMN<$G&.&(_E3/L</]UO^^V_QJ>B@"#['#_=;_OMO\:/L</]UO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^S0!/14'VH?\\IO^_9H^U#_GE-_W[- $]%0?:A_SRF_[]FC[4/\ GE-_W[-
M$]%0?:A_SRF_[]FC[4/^>4W_ '[- $]%0?:A_P \IO\ OV:/M0_YY3?]^S0!
M/14'VH?\\IO^_9H^U#_GE-_W[- $]%0?:A_SRF_[]FC[4/\ GE-_W[- $]%0
M?:A_SRF_[]FC[4/^>4W_ '[- $]%0?:A_P \IO\ OV:/M0_YY3?]^S0!/6#X
MRL;2\\)ZJUS;0S-#9S21&1 Q1@A((ST/%:_VH?\ /*;_ +]FLKQ1<AO"6LCR
MIAFQG&2A_P">;4XJ[29%3X7Z'S1@48(Z4M%>G+"4F[Q5GY:'S=Q,D=:,BEI,
M"H]GB(?#+F7G_F@T.B\"?\CQI'_7<?R-?2-?+6BP7T^LVL6F2M'>L^(75BI#
M?45Z(GC/QSX4^37=,:[MQ_RUD3;Q[2+Q^8)KBQ-:7,O:1M^)Z6$JJG%W6G<]
MAHKD-&^)7AW6"D8G>VN&'^JG7;SZ ]#73B[4@$13$'_IF:R4D]4>G&<9*\7<
ML45!]J'_ #RF_P"_9H^U#_GE-_W[-,HGHJ#[4/\ GE-_W[-'VH?\\IO^_9H
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M.BOB/K%;^9_>?HOU6A_(ON1N?\)AKW_/_P#^04_^)H_X3#7O^?\ _P#(*?\
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M_P"N1_F*GJ _\?Z_]<C_ #% $]%%% !44'^K/^^__H1J6HH/]6?]]_\ T(T
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M]%_Y .G?]>T?_H(KU\K^.7I^IX>=?PX>K_(O4445[I\T%%%% !1110 4444
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M"LB[64@D$$=B""/PJQ6=H1L#HEJ=,E:6S*GRY&SEN3DG/.<YSGO6C0 5 ?\
MC_7_ *Y'^8J>H#_Q_K_UR/\ ,4 3T444 %10?ZL_[[_^A&I:B@_U9_WW_P#0
MC0!+1110!@^(="NM8,;07WEJ@(>UE#&&7G^(*RG]2/:J7AFWOM$NI].GT988
M;B=I4N+1@8%&T<$<,/N]QWK:UR^GT[3&GMQ!YADCC#3G$:;F"[FQS@9S5>PE
MUAKQ!=W^DRP<[DMXG5SQQ@ER.OM0!LT444 9=[JD\6J1:=96BW%RT)G<R2^6
MB(#@9(5CDGH,=C5;^W;R6:"TM]+_ -.>W-Q-!//Y?E*&V@;@IR20<?3M4.KZ
M4TNOQW\FE)J=LUMY#PG82C!BRL Y"G[S#U%4M,TS5-&N+>^%@UPSVCP/;Q3+
MF#]ZTD:AG(R 'V_\!'6@#0'B2:Z-LNG:?Y\DMG]L=9)O+\M2<!<A3EB01Z<'
MFM"76+>+P^=8(8P?9Q<*.Y!7('U.0*P[/3M5T66UGBLOM;'3EMY5CD1=DJL6
M'WB,KEB,CG@<4Z:TGET7_A%5C'F1:7'B<."OF+A0I'4 D=3UYQTH MS>(YM/
MM[M]3L!!)!;"Y6.*;S-X)QMSM&&!P.XY'-$OB1[&"\.HV:P7%O"DRQ13>9Y@
M<E5 )4<[AM/'<<U1U33-3U^WOG>R-G*;$0Q)+*C;I-X<\J3\N549.#R>!2:E
MH^H:XM_=/:M:3&VAB@BED0[W23S3DJ2 "0H'?J<4 ;6G:M+=:A<Z?=VJVUW
MB2E4E\Q61LX(.!T((/'YUJ5A:7:7DOB"]U:ZM6M5DMXH(XG=6;Y2Q8G:2.K8
M'/;M6[0 44QXE<Y)?\'(_D:;Y"?WI/\ OXW^- $M%1>0G]Z3_OXW^-'D)_>D
M_P"_C?XT 2UD^*?^10UK_KPG_P#1;5H^0G]Z3_OXW^-97BB!!X2UD@R<6,_6
M1C_RS;WJH_$B)_"_1GS/1117N'S04444 =9\,_\ DH6E_P#;7_T4]?0U?/'P
MU4-\0-+!S@^;T./^63U]!>0G]Z3_ +^-_C7F8OXUZ'LX#^&_4\3HHHKX _4
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MC?XT 2T5%Y"?WI/^_C?XT>0G]Z3_ +^-_C0!+13$B5#D%_Q<G^9I] !1110
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MZ^%Q'\:7JS])PO\  AZ+\@HHHK$Z KV/1?\ D Z=_P!>T?\ Z"*\<KV/1?\
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M9=[Q1Z.TJ*< <-Y9!X Y!YH Z71A&-)MQ"MVL>#@7F[S>I^]NY_/M5ZJ&BW
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M17KY7\<O3]3P\Z_AP]7^1>HHHKW3YH**** "BBB@ HHHH *R?%/_ "*&M?\
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MU_U_S_\ HQJR:]R/PH^9G\3]6%%%%42%?65?)M?65<&,^R>IE_VOD>5>,/\
MD:KW_@'_ * M8=;GC#_D:KW_ (!_Z M8=?!8C^-+U9^FX7^!#T7Y!1116)T!
M7KGAK_D6[#_KE_6O(Z]<\-?\BW8?]<OZUZN5_P 27I^IXN<_PH^OZ&K1117O
MGS 4444 %%%% !6%:^%X+>[O)Y;^^NEO05N(;AD*2#;MY 4'@<=:W:* ,:S\
M.6]GYS+>7TDCP&WCDDERT$?HA &.QR<G@<T7OARWODB62[O4*P"WE9)<-<1_
MW9#CGOR,'D\\ULT4 8U[X:L[QP1-=6\9B6"6&"3:DT8SA6&.F"1Q@X.*V0
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MB/XTO5GZ;A?X$/1?D%%%%8G0%>L>&YE7P[8@A\B/M&Q_I7D]>N>&O^1;L/\
MKE_6O5RO^)+T_4\7.?X4?7]#0\]/[LG_ '[;_"CST_NR?]^V_P *EHKWSY@B
M\]/[LG_?MO\ "CST_NR?]^V_PJ6B@!B2JYP _P"*$?S%/HHH **** "BBB@
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MQI'_ %W'\C7TC7FXOXD>Q@/@?J>5>,/^1JO?^ ?^@+6'6YXP_P"1JO?^ ?\
MH"UAU\+B/XTO5GZ3A?X$/1?D%%%%8G0%>QZ+_P @'3O^O:/_ -!%>.5['HO_
M " =._Z]H_\ T$5Z^5_'+T_4\/.OX</5_D7J***]T^:"BBB@ HHHH **** "
MBBB@#YC\4_\ (WZU_P!?\_\ Z,:LFM;Q3_R-^M?]?\__ *,:LFO<C\*/F9_$
M_5A1115$A7UE7R;7UE7!C/LGJ9?]KY'E7C#_ )&J]_X!_P"@+6'6YXP_Y&J]
M_P" ?^@+6'7P6(_C2]6?IN%_@0]%^04445B= 5ZYX:_Y%NP_ZY?UKR.O7/#7
M_(MV'_7+^M>KE?\ $EZ?J>+G/\*/K^AJT445[Y\P%%%% !1110 4444 %%%%
M !1110 4444 %%%% !4!_P"/]?\ KD?YBIZ@/_'^O_7(_P Q0!/1110 5%!_
MJS_OO_Z$:EJ*#_5G_??_ -"- $M%%% &/=,\_B6UMGNY8(HH3.D<;[?/?=@A
MO4 8X_VJBN7:T\5V2PWTK?;=XFM&;<JJJ$B11_#R #V.ZM+4-,L=5@\F_M8K
MB,'($BYVGU!ZC\*CTW1--TA6%A9Q0%_O,HRS?5CR: +]%%% !1110 4444 %
M%%% !1110 4444 %%%% !63XI_Y%#6O^O"?_ -%M6M63XI_Y%#6O^O"?_P!%
MM51^)$3^%^C/F.BBBO</F@HHHH ZSX9_\E"TO_MK_P"BGKZ&KYY^&?\ R4+2
M_P#MK_Z*>OH:O,Q?QKT/9P'\-^IX=1117P!^H!1110 5['HO_(!T[_KVC_\
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MIW_7M'_Z"*]?*_CEZ?J>'G7\.'J_R)_+N?\ GX7_ +]__7H\NY_Y^%_[]_\
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M?QI>K/TW"_P(>B_(****Q.@*]6\.).?#UB5G51Y? V9_K7E->N>&O^1;L/\
MKE_6O5RO^)+T_4\7.?X4?7]"]Y=S_P _"_\ ?O\ ^O1Y=S_S\+_W[_\ KU/1
M7OGS!!Y=S_S\+_W[_P#KT>7<_P#/PO\ W[_^O4]% $<:2JV9)0XQT"8_K4E%
M% !1110 4444 %%%% !1110 4444 %0'_C_7_KD?YBIZ@/\ Q_K_ -<C_,4
M3T444 %10?ZL_P"^_P#Z$:EJ*#_5G_??_P!"- $M%%% !1110 4444 %%%%
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MY7\<O3]3P\Z_AP]7^1>HHHKW3YH**** "BBB@ HHHH *R?%/_(H:U_UX3_\
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M4Y7[?J>'G+3IPL^K_(T**;YD?]]?SH\R/^^OYU[A\X.HIOF1_P!]?SH\R/\
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M525^WZGBYPTZ4;/K^AK44WS(_P"^OYT>9'_?7\Z]X^:'44WS(_[Z_G1YD?\
M?7\Z '44@=6. P)]C2T %%-DD2&)Y975(T4LSL<!0.I)["H[:ZM[R$36L\4\
M1. \3AE/XB@":BBB@ HHHH **** "BBB@ J _P#'^O\ UR/\Q4]0'_C_ %_Z
MY'^8H GHHHH *B@_U9_WW_\ 0C4M10?ZL_[[_P#H1H EHHHH **** "BBB@
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MH^9')ND5 ^YQF%B6&>V,GMQ#J$OVO39S//\ N;?4[7'EZA).L8)4-^\.#_\
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M"8%F_"O1C:6Y" V\1"#" H/E'MZ4XV\#8W0QG"[!E1]WT^GM0!ROGZ@?$?\
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M8]O:VD=Z=/FWQ33L44;TZ,JY)Z=A2"U;P[=:+:_VG9V[I:7>Z>ZCRC%I86(
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MC.<@CL.U<S_PIKP[_P _NJ?]_8__ (BO1**ATXMW:,I4:<G>2/._^%->'?\
MG]U3_O['_P#$4?\ "FO#O_/[JG_?V/\ ^(KT2BE[*'8GZO2_E/._^%->'?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %0'_C_7_KD?YBIZ@/\
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H4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>tm263197d5_def14aimg02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm263197d5_def14aimg02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (% P<# 2(  A$! Q$!_\0
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MM;1$PQDE 22H]* +-%1?9H/^>,?_ 'R*/LT'_/&/_OD4 2T5%]F@_P">,?\
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M^>,?_?(H^S0?\\8_^^10!+147V:#_GC'_P!\BC[-!_SQC_[Y% $M%1?9H/\
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M%]F@_P">,?\ WR*/LT'_ #QC_P"^10!+147V:#_GC'_WR*/LT'_/&/\ [Y%
M$M%1?9H/^>,?_?(H^S0?\\8_^^10!+147V:#_GC'_P!\BC[-!_SQC_[Y% $M
M%1?9H/\ GC'_ -\BC[-!_P \8_\ OD4 2T5%]F@_YXQ_]\BC[-!_SQC_ .^1
M0!+147V:#_GC'_WR*/LT'_/&/_OD4 2T5%]F@_YXQ_\ ?(H^S0?\\8_^^10!
M+147V:#_ )XQ_P#?(H^S0?\ /&/_ +Y% $M%1?9H/^>,?_?(J.!%2ZG5%"C"
M\ 8]: +-%%% !45M_P >L/\ N#^52U%;?\>L/^X/Y4 2T444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "H(_\ C\G_ -U/ZU/4$?\
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MEE;"K80LS'L!&"37'V%EK'B+0=6NXK'3C!K4CR!KB9Q*JCY8Q@(1\NW(YKT
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MY /X9/YT 8:ZI)>WVOBV.F:=':OY,\T\.^28A?O'YEP/3.:YZP<)X+\$RR,
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MZU<U+0M*U=T?4+""X=!A6=>0/3/I5RWMX;2W2WMHDBAC&$1%P%'L* ):***
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_Z]'EW/_/PO_?O_ .O4]% $'EW/_/PO_?O_ .O1Y=S_ ,_"_P#?O_Z]3T4
M0>7<_P#/PO\ W[_^O1Y=S_S\+_W[_P#KU/10!!Y=S_S\+_W[_P#KT>7<_P#/
MPO\ W[_^O4]% $'EW/\ S\+_ -^__KT>7<_\_"_]^_\ Z]3T4 0>7<_\_"_]
M^_\ Z]'EW/\ S\+_ -^__KU/10!!Y=S_ ,_"_P#?O_Z]'EW/_/PO_?O_ .O4
M]% $'EW/_/PO_?O_ .O1Y=S_ ,_"_P#?O_Z]3T4 0>7<_P#/PO\ W[_^O1Y=
MS_S\+_W[_P#KU/10!!Y=S_S\+_W[_P#KT>7<_P#/PO\ W[_^O4]% $'EW/\
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MO_Z]'EW/_/PO_?O_ .O4]% $'EW/_/PO_?O_ .O1Y=S_ ,_"_P#?O_Z]3T4
M0>7<_P#/PO\ W[_^O1Y=S_S\+_W[_P#KU/10!!Y=S_S\+_W[_P#KT>7<_P#/
MPO\ W[_^O4]% $'EW/\ S\+_ -^__KT>7<_\_"_]^_\ Z]3T4 0>7<_\_"_]
M^_\ Z]'EW/\ S\+_ -^__KU/10!!Y=S_ ,_"_P#?O_Z]'EW/_/PO_?O_ .O4
M]% $'EW/_/PO_?O_ .O1Y=S_ ,_"_P#?O_Z]3T4 0>7<_P#/PO\ W[_^O1Y=
MS_S\+_W[_P#KU/10!!Y=S_S\+_W[_P#KT>7<_P#/PO\ W[_^O4]% #4#! '8
M,W<@8IU%% ',>)[.6ZN[9FTLW42-'Y4]O((YXGW_ ##<6& 1MP0>"#GVAO+#
M5;K2$LM0T\7TJVZ&">*508I]I!+EF&<'!R >_%=;10!QFH:'>W F,FF+-JC"
M,P:E#*$".$4%F!8$$$'[JX(P,5K7LTVH2I+;6CR-IM^,H'3,H\L@[23CCS.A
M(Z&MVB@#CX-(U*TU&+5Q9M([WMQ/):K(F]$D157DD*2-@)Y[GK4]GI^H:=<V
M^I&Q>:5UNA-;Q2IF/S9A(O+$ X (//7I74T4 <?)IUPWAEO":QDW3::9#/D>
M6'+?</<<YP<<@'TJQ=V.I:H]S=M8M;R+#;K'#)(A,C1R^8W*D@#@ 9/Y5U%%
M ''W.D:E<ZC/K"6;))]KMI$M7D3>R1!@W()4$^8V.>PK<T>"Y674+NY@-N]W
M<"18F<,RJ(T09(R,G:3P3U%:E% !1110 4444 %01_\ 'Y/_ +J?UJ>H(_\
MC\G_ -U/ZT 3T444 %16W_'K#_N#^52U%;?\>L/^X/Y4 2T444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %01_\?D_^
MZG]:GJ"/_C\G_P!U/ZT 3T444 %16W_'K#_N#^52U%;?\>L/^X/Y4 2T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUS0!B7>H7]MJ=QHL5[+M-Y:HD[8:18Y Q9<XZ_NS@]MWM6]HLDZS:E9SW#W
MM;D)'))C=L:-' )'7!8C/TIC^&K6:"99KBYDN)IDG:Z)42!TQL(PH48QTQCD
M^M7=.TZ/38I52669YI3-++,06=C@9. !T & !P* +E%%% !1110 5!'_ ,?D
M_P#NI_6IZ@C_ ./R?_=3^M $]%%% !45M_QZP_[@_E4M16W_ !ZP_P"X/Y4
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MOLT'_/&/_OD4?9H/^>,?_?(J6B@"+[-!_P \8_\ OD4?9H/^>,?_ 'R*EHH
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MKQ:OQOU/HZ/\./H@HHHK,U"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** "BBB@ HHHH **** "BBB@ HHHH **** *][86FI6K6U[;17$+=4D4$?\
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M -KK6^,?_(H6G_7^G_HN2O$*[\/1A.%Y(\K%8BI"IRQ>AZS_ ,+L_P"I?_\
M)W_[71_PNS_J7_\ R=_^UUY-171]6I=CF^MUN_Y'K/\ PNS_ *E__P G?_M=
M>A^&=;_X2+P]:ZK]G^S^?O\ W6_?MVN5ZX&>F>E?,=?0WPS_ .2>Z7_VU_\
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M ) ,'_7RO_H+5YQ7Q&8_QWZ(_1LI_P!V7JPHHHKSSU KU7P?_P BK9?\#_\
M0VKRJO5?!_\ R*ME_P #_P#0VKT\L_C/T_R/'SC^ O7]&;E%%%?0GRP4444
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M !1110 4444 >-_&?_D+Z7_UP;_T*O,:].^,_P#R%]+_ .N#?^A5YC7KX?\
MAH\#%?QI!1116YS!7T-\,_\ DGNE_P#;7_T:]?/-?0WPS_Y)[I?_ &U_]&O7
M)B_@7J=^ _B/T.LHHHKS#V0HHHH **** "BBB@ HHHH **** ,/7-.U&\F1K
M62"6W;RUDMKA,KE7SOZ^AP1WP*JC0-1B%A L]M/9V4*HD4N]0[C'SL!UQC@=
M!]>G344 <Y?:!?WGVZ(7D,=MJ)C>X7RR60JJJVPYZ,$ YZ5:GMM0U LY$4+V
M=Z)+0LIQ(H3:=W/?<XR/0'%;-% '-)X;NH)H;Z&ZB^WK=37,FY#Y;^8H4KUR
M  JX/^S[U+!H5[9?9KFWN8'O46<3-)&0LGFN)"0 >,,./:N@HH YM]#GDTMO
M#@*KIO\ 9_EFYV_.9B>N,XQP21[CGTDET*]O5N9;RZ@^TO%#'$8HSM4QOO#'
M)YRV,CT%=!10!S4WANZN99KY[J)-0>YAG0JA,:B($!>N3G<V3_M>U:NEV,]I
M]KFNI4DN+J?S7,:X5?E50H^@4<_6M"B@ KFM<U/5[;5&M;*"0K+;HENRP%U\
MUGPSLW0!%&<'KFNEKFM=BUHZBWV.8QVL\*0B7S@@@._,C$'DL5P%(SCGI0!H
M:#)=-:W$=S<R77E3LD=Q+%Y;2+@'.,#HQ9<XYVUJUFZ+!/!!<+*)Q$9R8%GG
M\UQ'@#ELG.2&(Y/!'TK2H *@C_X_)_\ =3^M3U!'_P ?D_\ NI_6@">BBB@
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MM$1&(\R,&#=#G>!@'/6I_#\%R$T&REM+B&33H9%N&>)E3.-@"L1ALYSQG@4
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M1'Z-E/\ NR]6%%%%>>>H%>J^#_\ D5;+_@?_ *&U>55ZKX/_ .15LO\ @?\
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M?\?]G_UR/\ZXZOD\1CZE.JX)*R/N<+EE*M1C4DW=_P!=CU7_ (3#0?\ G_\
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M7_VU_P#1KUR8OX%ZG?@/XC]!WC__ ) ,'_7RO_H+5YQ7H_C_ /Y ,'_7RO\
MZ"U><5\1F/\ '?HC]&RG_=EZL****\\]0*]5\'_\BK9?\#_]#:O*J]5\'_\
M(JV7_ __ $-J]/+/XS]/\CQ\X_@+U_1FY1117T)\L%%%% !1110 4444 %>>
M?&/_ )%"T_Z_T_\ 1<E>AUYY\8_^10M/^O\ 3_T7)6U#^(CGQ/\ !EZ'B%%%
M%>P?/A1110!]#?#/_DGNE_\ ;7_T:].\?_\ (!@_Z^5_]!:F_#/_ ))[I?\
MVU_]&O3O'_\ R 8/^OE?_06KYO,/X=3Y_F?7Y5_%I?+\CSBBBBOD3[H****
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M_P#)/=+_ .VO_HUZ^>:^AOAG_P D]TO_ +:_^C7KDQ?P+U._ ?Q'Z&7\0O\
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MGF@CFO0]A!=/=10"'#;FW'!?/*@NV!@=N>*?I?A^33VLT>\$UM8HR6R>5M8
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MCZ(^&Q7\>?J_S)Z*@^QP_P!UO^^V_P :/L</]UO^^V_QK<YR>BH/L</]UO\
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M3M)X)ZB@#4HHHH **** "H(_^/R?_=3^M3U!'_Q^3_[J?UH GHHHH *BMO\
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M?^BY*VH?Q$<^)_@R]#Q"BBBO8/GPHHHH ^AOAG_R3W2_^VO_ *->G>/_ /D
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M/ZU/4$?_ !^3_P"ZG]: )Z*** "HK;_CUA_W!_*I:BMO^/6'_<'\J ):***
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MJOX2M  __'\G5"/^6<GJ*\3KV_XQ_P#(H6G_ %_I_P"BY*\0KU<+_#/#QO\
M&^2"BBBNDXPKZ"^&LRK\/]+!#Y'F]$)_Y:O[5\^U]#?#/_DGNE_]M?\ T:]<
MF+^!>IWX#^(_03QY*KZ'  '_ ./E>J$?PMZBO.Z]'\?_ /(!@_Z^5_\ 06KS
MBOB,Q_COT1^C93_NR]6%%%%>>>H%>H^$9E7PO9@A\C?T0G^-O:O+J]5\'_\
M(JV7_ __ $-J]/+/XS]/\CQ\X_@+U_1FOYZ?W9/^_;?X4>>G]V3_ +]M_A4M
M%?0GRQ%YZ?W9/^_;?X4>>G]V3_OVW^%2T4 1>>G]V3_OVW^%'GI_=D_[]M_A
M4M% $7GI_=D_[]M_A1YZ?W9/^_;?X5+10!%YZ?W9/^_;?X5Y]\895?PE: !_
M^/Y.J$?\LY/45Z-7GGQC_P"10M/^O]/_ $7)6U#^(CGQ/\&7H>(4445[!\^%
M%%% 'T%\-9E7X?Z6"'R/-Z(3_P M7]J?X\E5]#@ #_\ 'RO5"/X6]12_#/\
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M<**** "BBB@ HHHH \;^,_\ R%]+_P"N#?\ H5>8UZ=\9_\ D+Z7_P!<&_\
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MO3RS^,_3_(\?./X"]?T9N4445]"?+!1110 4444 %%%% !7GGQC_ .10M/\
MK_3_ -%R5Z'7GGQC_P"10M/^O]/_ $7)6U#^(CGQ/\&7H>(4445[!\^%%%%
M'T-\,_\ DGNE_P#;7_T:].\?_P#(!@_Z^5_]!:F_#/\ Y)[I?_;7_P!&O3O'
M_P#R 8/^OE?_ $%J^;S#^'4^?YGU^5?Q:7R_(\XHHHKY$^Z"BBB@#U7P?_R*
MME_P/_T-JW*P_!__ "*ME_P/_P!#:MROK</_  8^B/AL5_'GZO\ ,****W.<
M**** "BBB@ HHHH \;^,_P#R%]+_ .N#?^A5YC7IWQG_ .0OI?\ UP;_ -"K
MS&O7P_\ #1X&*_C2"BBBMSF"OH;X9_\ )/=+_P"VO_HUZ^>:^AOAG_R3W2_^
MVO\ Z->N3%_ O4[\!_$?H9?Q"_X_[/\ ZY'^=<=78_$+_C_L_P#KD?YUQU?!
MXW_>)'Z9E_\ NT/ZZL****Y#N"O5?!__ "*ME_P/_P!#:O*J]5\'_P#(JV7_
M  /_ -#:O3RS^,_3_(\?./X"]?T9N4445]"?+!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !4$?_'Y/_NI_6IZ@C_X_)_]U/ZT 3T444 %
M16W_ !ZP_P"X/Y5+45M_QZP_[@_E0!+1110 4444 %%%% !1110 4444 %%%
M4+36].O[R6TMKE9)H\D@*0#@X.TD8;!X.,XH OT444 %%%% !1110!YY\8_^
M10M/^O\ 3_T7)7B%>W_&/_D4+3_K_3_T7)7B%>KA?X9X>-_C?)!11172<85]
M#?#/_DGNE_\ ;7_T:]?/-?0WPS_Y)[I?_;7_ -&O7)B_@7J=^ _B/T'>/_\
MD P?]?*_^@M7G%>C^/\ _D P?]?*_P#H+5YQ7Q&8_P =^B/T;*?]V7JPHHHK
MSSU KU7P?_R*ME_P/_T-J\JKU7P?_P BK9?\#_\ 0VKT\L_C/T_R/'SC^ O7
M]&;E%%%?0GRP4444 %%%% !1110 5YY\8_\ D4+3_K_3_P!%R5Z'7GGQC_Y%
M"T_Z_P!/_1<E;4/XB.?$_P &7H>(4445[!\^%%%% 'T-\,_^2>Z7_P!M?_1K
MT[Q__P @&#_KY7_T%J;\,_\ DGNE_P#;7_T:].\?_P#(!@_Z^5_]!:OF\P_A
MU/G^9]?E7\6E\OR/.****^1/N@HHHH ]5\'_ /(JV7_ _P#T-JW*P_!__(JV
M7_ __0VK<KZW#_P8^B/AL5_'GZO\PHHHK<YPHHHH **** "BBB@#QOXS_P#(
M7TO_ *X-_P"A5YC7IWQG_P"0OI?_ %P;_P!"KS&O7P_\-'@8K^-(****W.8*
M^AOAG_R3W2_^VO\ Z->OGFOH;X9_\D]TO_MK_P"C7KDQ?P+U._ ?Q'Z&7\0O
M^/\ L_\ KD?YUQU=C\0O^/\ L_\ KD?YUQU?!XW_ 'B1^F9?_NT/ZZL****Y
M#N"O5?!__(JV7_ __0VKRJO5?!__ "*ME_P/_P!#:O3RS^,_3_(\?./X"]?T
M9N4445]"?+!1110 4444 %%9FJZ_IVBM$M[.5>4_*JJ6(&<%B!T SUK1CD2:
M))8W#QNH964Y!!Z$4 .HHHH **** "BBB@ HHHH **** "BBB@ J"/\ X_)_
M]U/ZU/4$?_'Y/_NI_6@">BBB@ J*V_X]8?\ <'\JEJ*V_P"/6'_<'\J ):**
M* "BBB@ HHHH **** "BBB@".=6>WD1.&92!]<5QWAN5)%T"P0,+K3H9%O(R
MI!B.W;AOJ<$>N,UVM% !43-(TQ1&10%!Y7/7/N/2I:,<Y[T 1;9_^>D?_?L_
MXT;9_P#GI'_W[/\ C4M% $6V?_GI'_W[/^-&V?\ YZ1_]^S_ (U+10!@^)?#
M$7BK3H[&^N7CBCF$P,"@-D COGCYC7+?\*:T7_H(ZA^:?_$UZ/16D:LXJR9E
M.C3F[R5V><?\*:T7_H(ZA^:?_$T?\*:T7_H(ZA^:?_$UZ/15>WJ=R/JU'^5'
MG'_"FM%_Z".H?FG_ ,379:%H@\/Z-;Z7:3EX(-VUI4RQW,6.<$#J3VK5HJ95
M)R5I,N%&$'>*L96L:,-:M$MKF?8BR"0&-,'(!'<GUK%_X5]8_P#/Y<?DO^%=
M?17)/#TJCYIQNSMIXJM3CRPDTCD/^%?6/_/Y<?DO^%'_  KZQ_Y_+C\E_P *
MZ^BH^IT/Y$:?7L3_ #O^OD<A_P *^L?^?RX_)?\ "N@TW36TO3XK."8-''G!
M=,GDD]B/6K]%:4Z%*F[PC9F=7$UJJY9R;1%MG_YZ1_\ ?L_XT;9_^>D?_?L_
MXU+16QSD6V?_ )Z1_P#?L_XT;9_^>D?_ '[/^-2T4 0 SF5DWQ\*#G8>^??V
MIVV?_GI'_P!^S_C4N.<]Z* (ML__ #TC_P"_9_QHVS_\](_^_9_QJ6B@"+;/
M_P ](_\ OV?\:QO$OAB+Q5IT=C?7+QQ1S"8&!0&R 1WSQ\QK>HIIM.Z%**DK
M/8\X_P"%-:+_ -!'4/S3_P")H_X4UHO_ $$=0_-/_B:]'HK7V]3N8?5J/\J/
M./\ A36B_P#01U#\T_\ B:/^%-:+_P!!'4/S3_XFO1Z*/;U.X?5J/\J,K0M$
M'A_1K?2[2<O!!NVM*F6.YBQS@@=2>U&L:,-:M$MKF?8BR"0&-,'(!'<GUK5H
MK":4TU+6YTTY.FTX:6V.0_X5]8_\_EQ^2_X4?\*^L?\ G\N/R7_"NOHKF^IT
M/Y$=?U[$_P [_KY'(?\ "OK'_G\N/R7_  H_X5]8_P#/Y<?DO^%=?11]3H?R
M(/KV)_G?]?(H:;IK:7I\5G!,&CCS@NF3R2>Q'K5K;/\ \](_^_9_QJ6BNF*4
M59;'+*3DW)[LBVS_ //2/_OV?\:-L_\ STC_ ._9_P :EHIDD6V?_GI'_P!^
MS_C309S*R;X^%!SL/?/O[5/1CG/>@"+;/_STC_[]G_&C;/\ \](_^_9_QJ6B
M@"+;/_STC_[]G_&C;/\ \](_^_9_QJ6B@#E?$_@6S\5W,$]]=SQM A11   0
M3GG.:PO^%-:+_P!!'4/S3_XFO1Z*T56<59,QE0IR=W'4\X_X4UHO_01U#\T_
M^)H_X4UHO_01U#\T_P#B:]'HJO;U.Y/U:C_*CSC_ (4UHO\ T$=0_-/_ (FN
MRT+1!X?T:WTNTG+P0;MK2IECN8L<X('4GM6K14RJ3DK29<*,(.\58PM9\-1:
MW-%)<W+HT:E1Y:@?SS6;_P *^L?^?RX_)?\ "NOHKCEAJ,WS2BFSOABZ\(J,
M9M)'(?\ "OK'_G\N/R7_  H_X5]8_P#/Y<?DO^%=?14_4Z'\B*^O8G^=_P!?
M(Y#_ (5]8_\ /Y<?DO\ A70:;IK:7I\5G!,&CCS@NF3R2>Q'K5^BM*="E3=X
M1LS.KB:U5<LY-HBVS_\ /2/_ +]G_&C;/_STC_[]G_&I:*V.<BVS_P#/2/\
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M=)DLH[22V=XHW+IOGD+J3P<.6W8/IG%1W/A31;JX2=[1TDCB$*>3/)$%0=%
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MW=PSAB/5LF@#3!R 1WHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "H(_^/R?_=3^M3U!'_Q^3_[J?UH GHHHH *BMO\ CUA_
MW!_*I:BMO^/6'_<'\J ):*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "H(_P#C\G_W4_K4]01_\?D_^ZG]: )Z***
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M9_\ XJC_ (0_0?\ GP_\C/\ _%5YOU3%_P _XL]?Z]@?^??X(X;_ (3#7O\
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M\\IO^_9H^U#_ )Y3?]^S0!/14'VH?\\IO^_9H^U#_GE-_P!^S0!/14'VH?\
M/*;_ +]FC[4/^>4W_?LT 3T5!]J'_/*;_OV:/M0_YY3?]^S0!/14'VH?\\IO
M^_9H^U#_ )Y3?]^S0!/14'VH?\\IO^_9H^U#_GE-_P!^S0!/14'VH?\ /*;_
M +]FC[4/^>4W_?LT 3T5!]J'_/*;_OV:/M0_YY3?]^S0!/14'VH?\\IO^_9H
M^U#_ )Y3?]^S0!/4$?\ Q^3_ .ZG]:/M0_YY3?\ ?LTD!+W$S['52% W+CUH
M L4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
80 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>tm263197d5_def14aimg03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm263197d5_def14aimg03.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U$# 2(  A$! Q$!_\0
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MU+_!5]RZU5MONY;=R=UKI;W)5I?,V#9[>\J0MR5WXO/N%(2 DGD$IY95@D@
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MAM\L_P"RA!<"BX X3Q^B5ZD!21E.2,U\.[S6QN'%EIM-V<COI?65!#*2T&G
MA7-*G0H9*D$  YYCV.0 L"E0)_>6SPU0C)A7&.Q.*##?6VV4R&E*X]8 +)2@
M A1Y!)XG(![U,++=F;[;&)\8+##X*D=08)&2 ?R'&1^(T&;2E*!2E*!2E*!2
ME*!2E*!6N>TY:9#G4=M<)U?,N<EQT$\BM"RK./?FTVK/VMI/ND8V-*#QB1&(
M$5J-&9;CQVDA#;+2 E"$CL  .P ^P5[4I0*Q'')PNL=MN/'5;5,NJ?D*D*#R
M'0IOIH2WP(4E22Z5**TE)0@!*^9*,NE I2E I2E I2E I2E I2E I2E I2E
MI2E I2E!R/X@/Y^GAM_]WO'^F577%<!_=!-W1L1XDMD-=FU_+0L\2YK\CU^A
MU>:$M?7XJQCJ9]C[5$_GD$_@I/Z?_P#U>C4K^E%*XPO7CHW+T]L[$W0G["NL
MZ.DH;=1+_A*V7$M.$!MU388YI0HD8)'Q'VBJF^>03^"D_I__ /5Z)-7QX /X
MG?/_ .)-U_\ T=="[J:"C[G[=Z@TM)><BHN<1;")#2BE;+F,H<21W!2H)/\
MNKEW[F'JC^&^W^Z&H_+>3^5];S;AY?GSZ75:9<X<L#..6,X&<>U=FT-]?S@L
M+FX.YFWFZ>J]=^:MTC;G24O24-M+JDB1/2VKS$L^V5< V,_\JH=<[K:9&[UF
M;U/>=,1H@T18'&AK"YSX[:EED<BUY5:2I9^/+M7]3D-I;Y<4A/(\C@8R?MKZ
MH5P)O9HG7K.\]QVHTA-DQ=);LJCW8W5IU:ODM+ _VT-]^P6 T<9'U@/C4I\'
MT/7NXFZ$R[;@A]D[:P#I",@N*X3)@4>M*(^*BT&QGO\ 7S7:!;25I64@K2"
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MP6KDBQ,\@XXB L=53:4E0"S'6/47,#Z@/3/%0J.1=5;AV^ 7;F+I(N"&WW#
MB6[F.082ML]01@E:.84G@GBL%0&5XJ<0]R9LS0CFI4V/BWS24,K=>3ADD9>6
M2P%!(2>7H2L8]B>^/&S[H3[\ZTQ"LC"GY$A]F*7I;K;3B&20MWFICNDGCQX!
M>>7?C@X#ZTPYJV3<+8Q,FNJ@KAHE2I#\8)<#@6H%E.6&L!8*2>2 I(3@?6"A
M"[SK+<%V>4P&+LPVZZ0O-I/!A0<6D-MDLJYCB6E%2B$*PH!Q'PW]LWME7;4'
MR3'T]R=,M44.AY\HPDK"U]H^>.4)PH H(6,J2017[(WV9M5P8BW2%"C*=EO,
M_0W+FH--N+:ZO%3:2>3B,!(SV"CD<<$->_JK<#J.L0[;<YB'+HA!N"8[:&VH
MY=22E#3K;2QZ%$*60X!P[*R>TOVRNM^O$6;)O0E)2KI%MN7$\LIMPHRZA"2E
M*BVDD)"E9)*5')&*U>G-W9NH(=N<&FWFGKBXZQ&;#R\=1O@5!SFTA38 +F24
M^[1 Y<DYLJ@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4
MI2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@\)TM%OA2)3@6IMAM3J@VD
MJ40!DX [D]O:JY=\1FB B%Y:;,N3\Z/&D18UO@/2'GQ(0XMM*4(23RX-.*(_
MHA.3C(JS",BJ=M'A<TSIN(19+M>[3<47AR\Q;FR\PM^(M;9:Z+8<:4WT0VI2
M0A2%8!]\]Z#(<\46A4AQQ#MV=BMVQR[JEMVF061&;R'%E7#L4J!04GN%CB1G
MM6%N!J+1$B+I;<J_0+[Y>&F3;XJ$6IQ2P)?!E0=;X%:0HA(2<I'K^.:SE^&?
M2JM/R;0F7=41Y-ADZ?><#S9<6T^\7G7B2V075+).<<>Y]-;P;-6E6VL71+LV
M6NV1WF7TOM,Q8SN6GTO)'%EE#0') !PV"1GODYHKGZ5;]I[5'2N;K#6;3FGV
M Q:+I*@ )MGDB)*XL=?E0VZX@(PM+@<40V4Y)2K&9&TYLKIF%;M>2+]?HL_3
M$Z/!5+GQ"U/8DJ>=D*ZC2HX6 \)+A7Q2$%ONGB$Y%G:D\+>F]4IN<:9>KZFT
M3'ILMNTM.L!B))E-K0\^T2R5\B''"$K4I *U$)]L?$WPHZ3OB5?+UUU#?7'I
M#DJ4Z_<!'7*<5'$9)7Y9#6 AKDA*4<4X6KD%9H-#+TKM5NONMJ1U4VYR]0S[
M5*M%RM: I#49#90E<@CAE#BDJ:2APJPM(3Q! )K1:-O.U&I;VTD:SO\ J#4;
MMVLLPS+BPAM]U00HPFL(80CI8*N7%(.5^I0)%71H+9VS;>SI\V'+G3ILZWPK
M;(DSE-J<<;C(4AM14E"<J(7ZB?? ["H78O")HO3USL%PC3;TJ999S$Z.ZN0U
ME9:90T&G,-#DV0VA1'8\D@@CVH(E+M>UFA&=PM'2[]?!$U!)>;NDM-L:#462
M\%R"P);<4<G"EPE*75N$ I2,$X.MBZBVBN+^H[E'U%?[R]N!;6;>IJ!;&TK#
M#R)!0$I:CI*G$I:>!6]S6D-@$_ VOJ?PY6'5=WNDB5=[RS;;G,3<I5F8=9$5
MR8EH-)?R6BX% )2>(7P*D@E)[YC"_!;HA,Y,J-<KS%6EZ)(2V1#DLAQAAUD'
MI/QW$>L/+6KT_7/(<:"'[C;0[/Z5U0IV_774R)ZV#<I7DV2^U$94MM")$@H8
M4&TI+:TI4OV#CWP[IVNG=$;:L62X.:-<U#9KAH^=+7(U#9+4T9DIU:EH?25*
MCJ1)P"1G@2 E)![9JT=>[&6G7]SD3)%XN]K\];DVFYLVY;*6[C$2LJ#3O-I1
M3W4L<FRA6%J&?;&ST;M%IS0D74#5JB]-V^2GY4R4I#?7475$\.82"4)Y$)"L
MX'Q-!SYI&P[(V>5 U=;)U_M4J):8K[+\J*6WGH#@7$0/6SS6AU3A6H9^LE*A
M@#!UD>#L?+3 D,WW6TBZ6IRV6RWEIN0EY*6$O(9#;*6@TZA?2E!2BA7UG,%.
M15S7'PHZ(N\"W1IJ9DM5NM$.S1)+X86\PU&>ZJ'$*+1XN*/92A@$=@![UJ#X
M+]$,P51(4^[0&G)C-Q=2A$)Y#TELOD/.-NQEMK41(4DDI.0AOXIR0BFC=LMJ
MO(:U=M$K5:(5LBPXMT6Y'XMA5M<"\M99PITJ:^D"??X $YJV(?B3V_GW"5#8
MO16]&=::=/EW D=2,N2E05C!2&FUDJ'8<2#WK*V^V/LNW-RU++A3)<X:@><?
MELRX\-("EJ)5A;3"'"GU$!*UJ"1[ 5 8O@CT)$A1HK=TU$&V8+]O6KSC04^T
MZXI2N:@T#R"%N-!2<$-K4/?"@$PMGB8T!=XUK>CW5\_*K:'(+2X;J')/)_H%
M"$E.2M#G9:?=(()P.]2W0&X=HW,LAO%C\T[;"XI#4F1%<82^!_3;Y@<D_C%1
M'37APTII.]VRXV]^Z'Y,N<FZPX\R7YE++S['1= 6ZE3A2?K]UD\R3G':MYME
MM-;MKE7YR%.ESW[U-\]*7);CLIZG$)]+<=IIM.0,D\>2CW))HB<4I2@4I2@4
MI2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@5B.6J
M$\MU;D..M;JT..*4TDE:D$%"CV[E) P?A@8K+I08";#;$):2FW1$I:0VVV P
MG"$(5R0D=NP2KN!\#W%?D;3]KAQY#$>VQ&&)'+K--L)2EWD5*5R &#DK43GW
M*C]IK84H-(G1&G4*C*%AMH5%&&#Y1O+0SGT]O3W)/:LN/I^UQ'%.,6V(RM3?
M1*FV$I)1A*>&0/JX0@8]L)'V"MA2@TL;16GH;"F&+%;&65 @MMPVTI(/'(P!
M\>"/_E3]@K*_@_:^I'7\FQ.<9 :85T$Y:0 4A*3CTC"E# ^!/VUL*4&F_@7I
M_P"2FK9\A6T6UI?4;AB(V&4*^T(Q@'_=7RG1&G41!%38;8B,'C(#*8;80'?B
MO &.7<]_>MW2@TYT?83+C2C9+<94488?\HWS9&<^A6,I[]^U>JM+V9<61%5:
M8*HTA04\R8R.#I!R"H8P2#W[_&MG2@Q&;3!CO)=:AQVW4J4H+0TD*!5CD<X]
MS@9^W K+I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4
MI2@4I2@4I2@4I2@\)TM%OA2)3@6IMAM3J@VDJ40!DX [D]O:JY=\1FB B%Y:
M;,N3\Z/&D18UO@/2'GQ(0XMM*4(23RX-.*(_HA.3C(JS#C!S[?&N<=&;7;:,
MPR-/ZINVGKFF]JNL*?(>8;DLN.L\$LL)>:*%L=)S"4%"B H=\X-!-'/%%H5(
M<<0[=G8K=L<NZI;=ID%D1F\AQ95P[%*@4%)[A8XD9[5NM0;XZ9TMHNVZHNHN
M<.VW"1Y9AM=N>,@KXK5W:"2H#BVHYQ["J[L^W&UM_P!)3(4?4ST:$_8)MC==
M>N,7JNQ7'RX_+.0?4ISDKDH!/?Z@&*V][V7T5K[:V!I!K43US@6"0)R'+2U;
M5N\N+@2E3*8QCX(<5@=($D YSDT5,-)[Y:/UO>H]HLUP=E7)\+6(QC.(6EI+
M;;@=4%)'%M27FBE1P%<P!WR!IAXG]O57.9;Q=GC-BI"UL>4=Y*!EF)Z?3ZOI
MAQP/@0?8YK7[8KT!:=2KNT"?)AW)>G8$'_PVZVTMV$QU2T[ZL+4HCD5J)Q@)
M.!49N_AUVQ0_9YKU[NSKEVO,=Z!+BR&G I]$B1*" I+1'34IUQ*LY! 0,A0R
M0FT/Q+Z0G*C(;C7[K2;@[;&65V:0E:Y#0474@%/]#B>1]A7A%\5NV\E3:57:
M5%+DYBWI,JWOM N/*=0VH%2,%LJ9='/.!Q.<5')6VNVVL'8Z$:J?B/6C4=QN
MC9D^26')3N52 E$EA:5MHY'"DIRG!//(S6HM^PNS=L<>A1=0J?CK6BXS8C<Z
M*&7R1*;\PZ0@ GB\ZE2DJ!PTCXIR0L>W>([2%ZDRV;8F[W142+YM\P[4^X$-
MY6!DA/N>FOM[]JF.A-;V[<72\+4%I1+3;9J Y'5-C+CK<00"%A*P#Q(.0?C5
M/;:[&;;Z!OT*59=:N7"7)MPM;3<R5;Y#LEL=5/)+G0ZW+*UYZ:PDE/<'!JV;
M/ M.TV@[1:4/R7+;:H[%OCEQ/5?>P VVG"$CDM1P.P'<^P%$2BE:B)JJVONP
MX[\A%ON$L%35OFK2U)4 3G#9.3['VS[5XL:ZT[(FN0T7R!YM$E4,L*D)2LO)
MXY;"2<DCDGL/MH-[2M',USINW27(\K4%JC2&U.)6T]-;0M);0'' 059!2A06
M?L203V-8Z]RM(-,J>7JJR(:0V'E.*N+(2&RLH"R>7U2M*D@^V01[B@DE*T\+
M6-@N4PQ(E\MLJ4%J;+#,MM:PI* M2>(.<A"DJ(^ 4#[&M;&W8T1,:#D?66GW
MVS(3$YMW1A0ZRAE+60KZY'LGW-!*J5%XNZ>BYK?4CZOL,A'-37)JYLJ'-)2%
M)R%>X*T CX%2?M%>PW&TF2 -3V8DQC,'_A!KNP,Y=^M]08/J]NQ[T$BI4+O&
M]&@K"'C.UC962S,:@/)3.;6IF0XKBVVM*22@DY^MC !)P :V\/7>FKA:9]TB
MZBM4FV0%*1,FLS6ELQBD94'%A6$$?')&*#>TJ+)W5T4HN@:PL!+,9,QP"YL>
MAA6.+I]79!Y)PH]CD=^]9-BW!TMJAF6]9M2V>[LQ$!V2Y GM/I9002%+*5'B
M" 3D_8:"04J.6W<G2-Y5;TV_5-EG*N*EHA"-<67#*4CZX;XJ/,I^(3G'QKX_
MX3M'=4-_PLL?4,I4$(^4F<F0GNIG'+ZX^*?<?902:E12)NSH>>Y ;C:RT_(<
MN"RW#2U=&%&2K/'BV OUG/; SWK3:D\0.@-)Z@<LMRU+!CW!B6U#EH6^A"8:
MW&ENH+RE$!"2EM7?/8X!]Z"Q*5I8NMM/3[A(@1;];),Z,P)3T5F8VMUID@$.
M*0#D)(((41@Y%0$^)[0?D%R_,W/@4L.QD*M,E+DUIYT--.QTE +J%+(&4Y]P
M3V(R%L4JL[_XC-"Z:TEI[4TRXR39;ZA;D*0Q ?<)0A!6M2T!') 2D$G([8-2
M-S=71;*Y"'-76)IR.ZAA]MRY,I4RXL$I0L%64J.#A)P3@_902FE1B'NCHRX2
M(4>+JZQ27YJEHBM,W)E:I"D'"P@!65%)!R!G'QK4VC?;0=[G7&/&U3:NG"E,
MPC+7.9$=]]Q'-+;3G/"U8[%([@]L4$]I41USNOI7;R+.7>;S#9EQ(:YZK:F0
MWYM;" 2I:&BH*4!@]_;L:^VMV-$O1;?(3K"P]&X%8B+^4V,2"CZX0>7J*3V(
M&<?&@E=*CKNXNDV'8S;FI[,VY*<0TPA=P:!>6M(6A*!R]14E25 #W"@1[U(J
M!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*
M!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*
M!2E*!2E*!2E*!2E*!2E*!2E*#PFQ1-AOQRXMD/-J;ZC1 4G(QD9!&1^2JWL7
MA\T[IZ1#=C29BC'QE"D,)0X0$<24(:2D$%M!RD DC)R>]63+DIAQ'GU J2TA
M2R![D 9J*,[J60S8<62IZ&Y,AQYK/-LK!2ZEQ6#Q!X\4MJ*B< #XT&M:V1LK
M:&&#-N*X3+C3R(BEM<.HAMMOD3T^1Y(;"2"<>I6 ,C&WTSMO;=*Q;HS#?DJ5
M/YI4^X4=5M*BH\4J"1V!6HCEGN?C7XC=&P2;1'N4-^1.BOS6X"2Q%<*DNKP4
M\DE(*4X4D\B,8(/QK"L^]&E[G$M:WIJX,J>EOC%?CNA22L(QDE ''+B %_5)
M/8T'A==DK#=H*(JY$YI#:F5MEM:,H+3(:;'=!R  3@_%:O@<#.NFU5INMEM]
MM5(F16X*%!EV(I#:PXI:%EW/' 7R1G('])7;OV]I>Y]CMMVFVZ8Y(8DQGPQA
M,9QT*REDA64)(2"7T)'+&2:PHV]>DGV(BU3WV'9++3R(SD)[J_2<>""D(/K/
M-)XC)P0<8[T&JE^'K3,DR '9K33S9;+25-E*?6M2"G*#@IZA ^&  <]\Y2]C
M[(\TIIR9.4RLH4XT"TE+B@EU*B<-_P!(/.9'VG/:MBK>32#<8/N753394$CJ
MQ'T$@A1Y@%&2C"5>OZHP>]>J]TK(U8;?>'1-8@392XJ''8;B2VI'/DI8QZ4?
M1J/(]J#2PMJ'(.NT71J4I-J$Q=R=:<=2XJ1(*7 DE/1!0$]96,.$82GTYR:E
MERT;;Y]M=B-%V"52DSDR(RAU&WPH*#B>84,Y'L01C(Q6*_N-96K,;FA4MZ.F
M6S"6A$)T/-N.*0$\FU)"@/I$G)'L01G(K%>W<TM'CPGW9[[;4UGKQE+@2!UD
M9QZ/H_43[@#N1W QWH,&S;-VJR36Y#%PGD>81*>8PPAMYU#BW$$A+0X@*<5V
M04@]LY[Y]YNT]OFWN9<57*X-^<>2Z_&06NFL!;:PC);*@.38/8@]SW]L>[F[
MNE6D%1GOJQQY);@2%J225 )*0V2%90OTGN.)R.U>2=WM//.PDQG9,I,MU#"
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M]%3%HN349:"XN5(;;"6QR:"3Q#F5!0</<'MP5D=B*"4Q]K--1(BXS$)UII0
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MA(*L<LMJ]R![=ZT\G?*T0($R3,M=TB&,2"P[Y?J.!*W4+* 'CRXEES(!S@9
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M//W-!#+CX)]N;PY)7/3<YRY3R9#ZI+[;A==2"$K5R;.5 *4 3W'(_;4RV\V
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M(_(D?8*S;98K;90L6^!&@!:4(4(S*6P4H2$(& !V2D!(^P "LZE I2E I2E
MI2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
MI2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
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M+$"#)E%M;H9;4YTVQE2L G 'VG%5?:][W;I-:::LL-YA)94_)C7/JH0'5L(
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MOVE I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
MI2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
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MB%X"W4E.>0+>?Q"Y:4%2/;C:UF-.)M]@+;S$8N.F5:Y7%3P;?46T=T\LJ;:
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M$J27FDA#:G/ZR<A)(_W&O71TN]R[NMZ<B?'AO6:&\B)+2"(\@ET.("^"2I6
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M&UK='K"BDY4._OZA[G/LS>X3>M(K,YY2]/M%T*?4B,2^GJ/!)<XX4E7#H$%
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MR/64X6!Q "#QX]7EG/?C]IHJ9WV%<-2Z!?@&(])NZ0F*77T] %X80J0D9&4
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M<;')"N1>.$IR H$ D@ =N61.Z4%(V6Z:^N&HD67Y0?86RVGSOE1!6U%3U6@
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M4I2/M"LD $T$VI5=W#>9FUPYKDC2]^1,@O,,R[?_ +)UF \H)963YC@I"U'
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M ZPS_P"D6G.4H_Y1P*QW=>:99C2)#FHK2W'CL-2GG53F@AIES^+<4>6 A?\
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M>S:^XPC%<TUN TCSKEP2Y%TM>V'42'.7-:7$-!:>7-0(! PHC&*D>B-T-O\
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ME"G,<R  >R:V^IG-$[&ZNTS<),?5LJ=%LQMC(M%EDW%EYI/!(6^8["@'0$
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MX?[2@LNE5I]\WL]^%?0_ZQP_VE/OF]GOPKZ'_6.'^TH++I5:??-[/?A7T/\
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M[@*) *EG)('P ]@!6#"VITY:Y,9^W1YEL6PE* F#<9#"'$)45)2XE+@"PG)
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M%\RPXPEO#05Q",*5E&,'/<51-TW@W3;VPTW,N=T5:TO;:W*Y1IUOOC[[\QY
MC\9+X4RWTW4\CC"G,<E>K[2OZ%4KCK4>OYD'P7WJ_6;6##]P1.BH<NULUF_=
M4L\I#"5I5.4VA;/I4>20D\ HD9S4/T;NE<[O!TG$UKN)=K+M\[=;RS(U-$O"
MVV'76^F8D=-TPA;C/%3A2ZK@7%)*2.V"([UI7!5^W>W*U'M=IC3&F;CJ:XZ@
M7(N=V8N]N8Y3I-JC.K1 <?\ JY0^LMA2OZ2$$X.:QX6^NJ->;SVK5%OOUVM&
MCY%QT\Q)6BYK,6"J1'5U8SD(C@H./(+9<Y H5CL<]A'?M*XB\/FYMWO.L] ,
MVC75YU7>+A/NK6K++*F*G1X$5M;W1=5RSY98*6DI2%#D%>Q]Z:UW)O4746LW
MUZXO4#=6#JQJ%I[13,Q28\NWEQH-XA_5>;<;+BE/$'B1]9.*$=NTKF+8V3JZ
MZ7#=C4-SN$R5;8USO$&"^]J&2\6NDZ>"$PE-])H) [.)<)^'$9J@;?O'J1&U
M")FD=Q+]J5]W0TB?J5UV>N6FT3T]/HJ1(.2RZI1<26@KV&<#%"/Z-TK^?UNW
M)UW$W.U-(EZGO4&RNS-1PHDARZK?CONL0@XS%3'4 (ZD9+B7$J)5Q*<#%9.B
M]T9\S:O0#URW!=BZ=N=T8:U9J*T:P?NK\%)B%;:'WUMI-OZCO9:4DA.,<^]"
M.^*5R6[" WDTXG1&O-2ZGLS^EKA>H38U3(FQ)LN.\RAD$]0I<025)4DDA63G
M-5Y9MT;LG3^GY>F]Q;]J35T[3MVDZSM<J<IT6EUN&XL.%GVA+;D!*$)2$\A\
M#[T([WI7\\]+ZYUP-L=2,WS<9S2TV,;%<$P]0ZF<;\Y%=CJ<<Z-S* XSY@@@
M)"?HU-E.2#FK"W@W"U-J;:+96=HM&I(;]\,E:K8Y?G8<Z0EN"\XE+DI*5*</
M)L+!(PO"<XY9 CLJE<#;5;NWZ_;F14.Z\;O\P:<MDFW1+CJAVV.39BH;BE);
MMR$*1*4IU("TJ4G!'Q-;2)N0#L=%O4#="^S=<2W8*=9LKNBERK%&7(0F8XB#
M[1.GDH"P@822<GWH1W+2N"-;ZRU/<;9J.Q;:;BWN[:7<U#985FU,+HN4L27D
M.^8C(EY)>;!2R2"I6"HC/PJ,ZEWWU]KI>I=51-17O3MKN&F'FH%OCR%LIC/Q
MI$%EY]*1C"^L[)3R^Q(H1_1VE?SUD;P;C7/4EACR-0W>WHTO&N&F;HE#ZVTW
M&XM09CJI"_ZY"6HRP?@5FLO3VN=8ZDV9V\5I/7J9.K;CJ"&A]Z'JY^]=1P0'
MG@Q*#B$>7#BT +9'(#[3BA'?]*_G98]^G-:ZI,W5FX>HM#624_J%R.TW='(S
MK,AI<4,QPWW#BFRMU(:XJ![X%3C2VZFKH>XFT\S7.H)-QN-[@0(SFD[?=E0)
M\*0LN9F2+>D 2&G$A)65$=/![4([;I7'F]6^VI[%OR+O9S?%:#T1)B0;[Y%K
ME;WB_P#\:5(5GZS*'&%)['!Y>U;[Q(Z]U9M_KYF%8KG/<C[AVE%DLO2<4IN#
M= ^A(>;QV1EAY:R1C)8!H1U+2N'=Q-=WC3UUW"8E[@W^V[C6.XQ8>CM,HG+2
MBZ1^#(;7Y;VE]91=ZBU!13@]TXK\W-7?]'QM_IL76FJX\C3<"UNV]M_44HLQ
MER4!3WNH@#).#CTCVH1W'2J-VXM,C<W8V+&LVN3&DKG!U5ZL.I7;_C@X%*:$
MMQ+:E!0'%2<#CR([U6BF-R;;N_KV'9[M<=4#2&G(/EO-W^2QU)9A.X7Y)+:V
MY"G'$)*@M:<'N.5!U[2OYXZFW6NMNT"U+T+N9J'4]UDZ/G3=5ID7);RK1,2V
MV6EX_P#P;O6*VPVGCV_H]LU:^R^F];;H:;U58KCN%J'2UZL5_6A4-,]4Y^.P
MN(GII,I7!3S:ROK)*@,$<<=LT(ZWI7RVDH0E))40 ,GXU]40I2E I2E I2E
MI2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
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M;F[IV)<G&5R>O*>A)<X@,$M!:RDX 7]7)]_;O0617RMQ#0!6I* 2$@J..Y[
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MI*R,#-6!5>;R_P#%M'?G/;_\PU8= KY<<#3:EJ[)2"3^2OJO"=_Q*1_S:O\
M\E!7MLWUM=ZM\>?;].:KFP9* ZS(9L;Q0X@]PI)QW!%;[1^X]NUG<[C;H\.Y
MVZ? ;:>?C72$N,L(<*PA0"O<$MK]OLK6;!?R)Z'_ .B(W^6*\M/_ ,NNL_\
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M*4"E*4"E*4"E*4"E*4"E*4"E*4'&7W5_^:]%_.&)_E/UV4U_%(_(*XU^ZO\
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M!2E*!2E*!2E*!2E*!2E*!2E*#C+[J_\ S7HOYPQ/\I^NRFOXI'Y!7&OW5_\
MFO1?SAB?Y3]=E-?Q2/R"B\?=*4HA2E*!2E*!7&'@(_EG\4GY[/?ZF979]<8>
M C^6?Q2?GL]_J9E%X[/I2E$*4I0*T>H+(_=;OIJ4RMM+=LGKE/!9(*DF*^R
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M:5A/, )PO'(<4X/I&/!K:G3#;,Q"H#LA4QEYB2](F/NNO(=X!P*<4LJ.0TV
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MG,N141T!"2MPK+CZ%)"4@DGCC[,U+JA.Y>V[>XC$1#MP,!$9N0G(:"^1<:*
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MG!>@H4Y&Y*92X6SR)Y^K'3'V9_%BL2X;?P)=_NEHE:DB"7+9N70B^4/4:3/
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MJ:0X\?5]&5J /J*C[=R=[.V9:O+USF1[VA+-RM[T1OIQ@I*0Y%89"P0OU =
M*QVSRQD8R0E&EMS=/:NN4RWP;G#5/8>6VF*)+:G74)2E752D')00L=Z_=4;A
MP=.0[<^Q%DWTSY+D5ANUK942M"'%KRIQQ"0$AI8/JSD8QFM+#VE[QUS;H5N_
M*3]QD*@H<BJ<+L8L%*%H<YHQGD%!6>P'XZCLCPW0OX+6RSM7!JXIB7)^X.(U
M(R_=HSP<#X".B[(]. _]9*NY3DC)[!.XFZFD9=N8F*U';8C;L9J66Y<MMEQM
MMT)+96A1!3D*3C/OD5M(^K[#+1'6Q>[<\B0ZB.RIN6VH.N*1S2A.#W44>H =
MR._M5>6#:=,:,Q*L^I&IEPM\]E:)<N+UTER/%,-:'0'$E1^N<A0*3CWP<X*_
M#D0A2X^HS'DB/U6W$PO2U<>L74S$IZGLD** WGZN!RH++@Z[TU<[L+7#U#:I
M=R.<0V)K:WNPR?0%9[#O[>U:[6VY4'0LJ.S+@3Y@7%?G.NPTME,=ADH#CB^:
MTD@=1/9 4H]\"H?I[1EAM,U=KL6I+9-N]GN";HNVI<;+R"B"(@;= 65)R<**
MR/CC'QJ0?P)MNX4[2^I;S\D7SR5O<;Z33"9,5;SBFE%UI2B<!*FB![GO[C'<
M-O8]=-ZDNCK%MM%QE6UMYQA5Y 91%ZB"0M("G XK"@4Y2@C(/?L365)UYIJ'
M(GL/ZAM;+\ !4MIR8VE4<$@ N JRGNI([_$C[:C.DPWIG45PL</5UCDVV,Z_
M-=LZVP9\1+BBXH*6'L! 6LD%3?8$#)]ZA$S2]FN%PE:AG;DV2Y0KEYF' 7-E
M.*9"UR67DI;4F6E*5M=)*4]$-G/%1[CN%JWK7<.V.6QB#$E:@FW)M3\6-:BT
MHN,I">3O-:T-A YH&2H9*@!FEXW$L.F]/R+O>+C&M3$9*O,-2)#9<9<2WU%-
M$)407 GOQ23]HR.]1EZSN0[UIR+$UM;5:WM]N5$=1<FP\N>PK@I2U,)=0L'D
MT%!04<>K/+.:UMSVIN&J-8ZEDS'O)Q)=F\FAX-)Z3DYUOINR4-APJ #:&D84
M0?K#)]Z";2=S-+1V9BTWZWR78L14YR-&DH=?Z*4=0J#:25$<<'V]B/MKYB;C
M6A-HA7"].MZ61-/^S-7F9&0MY. 0I!0ZM)!!']+/V@5'+=M3=8<Z,\Y?8+C,
M:>_=FFQ;5!7FW65MJY*ZWJ:!<6>& K'%/+MDZF+L3<8(N3D2^VZ&Y<6),1Z*
MU:5>3CL/AODF.UU_HSR;*CE125+4>-!+[UN_I.PWB+ E7VVMEQUUA]]4UI*(
MKB$\N#I*O2HX. >_8UM9&OM,1)#K#^H[2P^TR)+C;DYI*D-$ AP@J[)P0<^V
M"/MJ%M[,RK2Q:/D6]QH[]NF3I25SK<9"7!)2I)2H!U!Y)!^MGOCV -:*%X98
M\*(]!^63)@E*"SYE#ZULNAE#*E! D!D@I0?_ #>0%$9["@L)6[&CA,@1TZFM
M;BIS;[K#C<QM3:DLXZAY X''/?\ (?L-9%TW M,*TP)T):KZ+B]Y>"S:E(>5
M*<PHD(45!'8(425*  2<FH]=-IG)E[F3VI\-QN6_+<>B3H)=:4V_'99*" XG
M."P%9^(41@>]>S.VUUCZ?LC*=1=6^V:6Y*B3Y4=;[02L+265H4Z5K0&W"D$N
M\O2D\OA02 :WM<00&KS(9TY<9IPS;;I+81(4>7$ !#BDJR2/JD^X'OVKP>W/
MT='(#NK+&V2XIH<[BR,K3CDGZWN.2<CX9'VU'-0[6W?4SLQV5?8+2[K!:M]S
M#-M7A3;;JUI+!+Q+:L.*!*N8SA0 Q@Z6Y;.W@3+5;;9/B,6]%FN<"5.D00[G
MS3[2RE* ZDA6.9Y9(]/<=Q06.]KS3,:7,BO:BM34F$@N2F5S6DK82,94L%64
M@<D]S]H^VL"[;L:.LL&7+DZFM0;C1//.(1,;4OHX!"PD')!!&"/?D/M%0N9L
M"Y-MS5I7?6OD:*_*DQ6S )?"WR2L.N=3#B1S7@!*<Y3DGCW]]5;)W+5>H[C<
M).JG?*OMRFX\5;3RPPEZ,60D)ZX:PDDJREM*E9P5?&BIHK<?33#?5EWRV06%
MNAIAV1/92E\E"%^GU_8M/8X/<'&""?V9N+IZ/\IM1[K%N=PMS3CK]MM[Z'I0
M".RAT@K.02!@_$BH9,V8N;\^[7!G4$-N;=XSL29U;:IQH-N,L-JZ:>L"E66,
M@DJ&%8(.,G=Z7VJ:TO*M+C-P+J+?*FR E3.%."1\"KE[I[=\>K'L*(D+FLK.
M8MU=C7*'-7:PKS;3,MKDP1G*5DJ 0>Q^L1C!S[5\#7VF3*FQ?X16GS,%"W);
M/GFN<=*#A9<'+*0DD9)]L]ZC2]K)3L36,,WAN/;[^RMMJ''C+#45:RLK=XJ=
M4"I7,<@C@DE.<9436#?=D$7F!T$W81UB;-G)7Y3D"M]P.)"AS&0DI3GOZ@,>
MF@W]HW<TI=E2BF^VUEEN<8##[DUH(EN!MM9Z1Y>K^-2,#OFM@UN-I-]$Y;>I
M[.XF".4I2)[1# Y<<K]7I]7;O\>U5U(\/LJY7^;=[C?H\M^XO/*FQFHTF-'<
M:<2PDH"6I222.@.ZU*!Y=T]A6MMFP=YO.GK4F[7=JV2[87506(L=;:FBJ8F0
M>LXT^"O/32!P+9&2<DT5;2=P-+KEP8J=26E4F<E*XK(G-%<A*B0DH'+*@2"
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M&4^8RAY*EJ4%\CC"0 ..3C7C8>3>;=)M3VHD+M3DB5,1U8/.47WV%M*+CO4
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MR.LN,K<0%%I124E22?8\5*&1\"1\:0H4>W1&HL1AJ+&:2$-LLH"$(2/8!([
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MAH]0X*%$#..Q.*".2-[KE&-Z:5IR(9-A8?E71/RFH(#3:\?0*+.7%$ G"@@
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MQ07$+ZC:R,],#*"DC)[_ &::/ME\D;9W_3,%5OM,NZ/SGFE1ATVSU7EK2%8
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M6_6]=WG3WKU(5*E2YK<=Q946T-E(1TNGPXMI'$H/N:U=WT5:=.:8TS#^6;G
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M6OBG)7A(PK.?MS4"M6P\Z(S<)#S5H$]T14PT(4M2(3:)[LE;#:BV"$!"T(&
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MC*0AIAA 0AM(]@E([ ?B%>] I2E I2E I2E I2E I2E I2E I2E I2E I2E
MI2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E I2E
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M@LNK*3E!]*PE0R.WOB+P=\XL"%8V+JP9-VNBG$-MQ)$9!*NLXAM/26\ESOP
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M90$.GN %=)7$J]/+!D^(&PPF&YSHD^4F-QEP6G0Q'+P>ZZD+#CKR4!*D,*6
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MV,+L>7!9NK,6V.%2F&$1%*4URMQA%/)3IY) XK&>_8@DYR,;6.VETM=S^7K
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M2F.DZAE'T3?6RE0#*>ZE*!).1V K\7LI>(S4B-;-6+MEM<>;<$",W);;("7
MLJ4B2E84LK0I734A*E-Y*3R50930T/?I;$*;=9(7!FB/;S+O[^9;I:0ZEUKZ
M;Z10$@<5=R,C&/37X=#;8V34K,%V='C7M;R)/D7[ZZ'GW@M;J'%M*=RXKDM9
M!4#G)^ &,:Q[&2]/1;.W#U"AN3 >CK5/3$<2^IMMB,RMH$/8XN"-E06%CU X
MR@$^UYVRO&I-=:AD.RX\"PS'K:_WC!Q]Y4;*P$+#@X#E@'DD]LXQG-!A3[-H
MC4=[TX;=K.U0F[?;7K?9V[;/09*0KBE:T.EPE7%#92,#(RH\LU*KS=]!:N^1
M7)E^M4L%]:8)1=$I#ZRGIK;'%8ZH(7Q*#D'D.W<5&X>P+,*X6MPW%N7#BP(4
M1V'(;D!IQ<4'IN!MN0A'<G)2M*_;L>YK$B>'R0BYQY,S4 G14I#"K<I,M$=N
M.EQ+B&FPF4%82H*[.%Q(Y   ) HC=6S4NVFWL2YS(>HH!Z70BRG7+N9CK20L
MMM-DK<4I"0I2@$]@#R/VUIK!H?;73=C%MFZBB2I]GCLB1-5>UMNPPE0*5(^F
M)C J6.R2 >0!R,"MK+V44JT18L:[MLOQHKS#;BX>4J6N8U*"E)"P< M<2,]^
M1.1[5KT[!.MSWYJ;TVN6B>JY079#4ET,.+DID+0IM4GIE!4G'H2A6./JR,DK
M*7J71$/05VUEPZ]M@SB]YEVXESS+\8]!I8=4X0K/!(&3@^YR:SK?'VY+L4F=
M:&9]HCB4IE-WYF(@+ZRE*]?U0I?+DH8P1\"!69"VR?;V^N^G)5U:=DW*3*E.
M3&(?20A3SZG2$M<SV'+'UN_O6DN^QS]YC2[>]?&4VI2[B]&;$ EY#DP+"^HY
MU,.)3U5X 2DGTY/I[D;];>A;+H%J%(NL%G2DTE++DJYGHN!1*N+;JE^W8X"5
M8 ';L*\K_M]H65<Y<V[%"'G6GICK3UT=;9"%-=%Y[I=0(3E"@DK 'OG.3FO3
M=#;NX:_M$>W0;^Y9(P:>9?;;#W%X+;X))Z3S1/'N0DDI.>Z3VPU3M>C4T?3+
M2KB8_P DJ0B00SR\['' K9/J](4IMLD]^R2,=\T&NO\ ?=M;;>I6HY]\M_G[
M>ZPU(Z=TR&70I;+96TE?$*!=6G)3GN<^W;+L>EM!+O,R%9YC)G(8Z<RW0KNX
M>2"",NLI<P3AP@*4,X([]DXT;FQTY=O8AG4$?IVZ,N-;"+>0I 5(:?R^>K]*
M<LH3Z>'NH^Y[;K1&T_\ !+4TR[/7 7 N.RG6 LR M@R'0ZZD!3ZF@GD/Z+:3
M@)R2020^M2ZNT%;;"NRSM1Q(D2(XQ;G&(EU+3S"E*#3:%*0L+3W[')]@<^QJ
M-ZKM6V&WH=A26 EY%JE3F;.FX.A"F4,AIU;;1<X)66U%/, *(YG/UC7HO8Z\
M/7F9=)&K3-EK4DL&5'>=2CC,;DI"DJD%( #8;PVEL8[X^%2C<';I_7#B2BY,
MPVW+9,MDA+D4N\D/AOU)]:<%);'8YR"1V]Z*U34;;)AN'=X][M\)LONL-RHU
M\4TAYQ:^HME2DN@.>H\N"L@9[  G.+KG3.@M"1+9,N$2X,-N2(T5CY/G2$J:
MZ;2F@[Z7!Q2ADJ"U^_$=\]J:JV)3J/4TF[INW21)+C;T):7T-+9<88:6@]%]
MHJ/^S@]SQPH@I/8UO=8;3PM<7!A=RN$UNW1[>Y!9A0GELX#F ZI2PK*N24H2
M 1VP>YY=@UCVE-L85Q%BD2K<B6VPTT;3(NRB0AJ,IM!+*G.Y#"E J(R4C))Q
MFLS2-MV^>E1Y=CNL.[2T2@6Y/RRN:Z70PM*4<U.*)PTIS",D %2L9R:UXV5>
M>L[T67?_ #4MZ1%?<F*AX4LLQ@QW'/N5 <B<_$C%>J]H9<.X6RXVJ]1XLVWL
M0V&1(@EQHAEA]DDI2XD^I,C( /I*![Y[$-1/;?LZ9B6X3XSZ;)#5<K?!MUV4
MB5TFV5^IM2' M0+96,Y(()KQN$30FF'=*:>DVAY+-^<;$1)6MQI"F(Z&V@Z2
MO..'!L>X42,]SFM+'\/5S#4&-*UBY+B0X:XK3:H[P2GE!7%)#?F.D!R<+OU.
M624\L=ZF6L]L$ZO;M0-Q,1RW1'F&7$L\B'5!LMO#U#!0MI*L?'VR*#3:/OFW
MVC;WJIJ++7:7+<N+;YL^\W%:FG"$++33;C[JNR,N)P,=P??%8]]MNT]B@W=<
MBXPH)AB3<YJ85X<:D)2\$ETJZ;H7P6.GZ/J_4P!Z:Q)'AW5U8TIC4*Q-:+2W
M'%-O-I?7TG4/+667VUY<+RE]E #V/(&ONW^':/;(UXAL7)(ARHTEF$E8DK,)
M3[80KBE4DME(QV] 5C *LC)*S)43;)R0U<)-UAV9Q;B&X;K-^\J%=)L-I4UT
MWAQ^C<2@@8)!2%#VJ2W5S1NKKI&T^]>HS]ZMZRMJ-$NRFI[*@CBHY;<#H]*O
M5D]PKO[UH1LNY(3=7)=W:<E7&#/B+6W"*4MJE)9!4D%PG">C[9[\O<8[ZFR;
M?:EMFNXB8A2S9K8Y<),>7.AMG+LG!]T22MQ/)2C@I:P  23BB+-L6D+1IE85
M;(:8I$5J&.*U'Z)LJ*$]R?8N+.?<Y[DU&+!LK8+6VZJ:EZYR5RI$H+=DO!MH
MNRO,8;;ZA2@\@WDI Y<._8D5/Q[=_>OV@ATK:32TZ7(?D6]UWK+<<4PJ:_T
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MW+90ZVWZ^?-(4DD*R!WS\*]7=OM+OOS7W-.6E;TW_C+BH394_P"H*]9XY5W
M/?X@&I!2@A]ZVDTG?7("G['!0B(ZVX&FXK00ZEMM;;;:QQ[H2'#@=L$#%;,:
M#TTF5"DC3UK$B$VEJ*Z(3?)A"<A*4'CZ0,G 'MD_;6]I0:>7HVP3X9B2;);G
MXO2;8Z+D5!1TVR2VC&/JI))2/8$]L5ZQM,V>$&Q'M4%@-+2ZCIQD)X+2C@E0
MP.Q"/2#\!V]JV=*#0IT'II,CS"=/6M+W0\KU!";ST>)3T_J_5XDC'M@D?&LB
M;I*QW(@R[/ DD.(=!=C(4>:$E*%=Q[I22 ?@"16VI0:B-H^Q0K-)M$>S0&+5
M)Y=>$W&0EEWD,*Y( P<CWR*_?X)V3RHC&SP#'!4H-&,@IRI'34<8]R@E)^T'
M'M6VI0::'HS3]OA^4C6.W,1NDXQT6XJ GIKQS1C'U5<4Y'L<#/M6,O;G2CL&
M-"7IJT.1(JBMAA<%HH:4<9*04X!.!G'O@5(J4&"W8[<S*$ENWQ420XIT/)92
M%A:DA*E9QG)  )^( %9U*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E
M*4"E*4"E*4'&7W5_^:]%_.&)_E/UV4U_%(_(*XU^ZO\ \UZ+^<,3_*?KLIK^
M*1^047C[I2E$*4I0*4I0*XP\!'\L_BD_/9[_ %,RNSZXP\!'\L_BD_/9[_4S
M*+QV?2E*(H+7;.J+AJG<&7;KD]#MUHC<EK-T? #9MZE%I$4#IY*U)5U,A0([
M9KXMN_%[:9O"I;$*+"@!R,GF&5R&'0\VRRIQ!F)4I+G+D5+2RE(*3R(.39MR
MW2@6R^/P%VZX.1H\MJWOW)M+7EVI#B$J0V05A9)YH&0@I!6 3[XT^H=R9LS;
M.!J.RV6?'<NTB&RPW)1'+R67W4(#I27>/U5]@59!(R,9HJ!1O$3?D6E4Y]JU
MREK@S7(L.$VEQUUZ.Z^DJ<"9*NDCBT%@CF@^H=0$IJ<6C<'4%QVPO%]*K*F?
M'=*8DE;[*8KS?H]2N$EQ"5>I20DO8)"<E(5VPKIO4MN$ZU;+;-GS(\YB+*G>
M7:0Q&2Y/,<!:2]R)(0ON@*'LHA.<#?2MX;+%BVSA GR'+DA?E(C3;?-U27T,
M=/NL)!*E@C) P"2105J[OU<NA+F1)]GML9<=<E-RN\9WI/.HB,+2PEL2,)6M
M2UXX+4"&R0%D\JENF-R]2W>]6YR4+6FTRKBS;3':C.!\%=O3*+G4+I'99*>/
M#V^.:\-P=R=/M6ZX(U3&N<6/%>#+T!JY,PG$I5'0XM*N,M(D#BOZJ.1[X"3[
MG?+WDLMH1,;>M5R@P8*Y41E]330:D.1NRVF@'"K)P>(4$YP?LH(;K_?NZ6#6
M=PLUF$"1T.I'")D< M/H:2YD\9/44CU?^B0#GLHX[M:;JZAM4"\6J;=+%:GH
MWR@RN[R(SC;+RFH[+C;3:.OE#J@^>_-7\42$G/:W-3WU.G[$;DM*F278[1^B
M#BAU'4( (Y)_KXSGM[]\8,-A[ZVVX,PRG3]Z1(GI9<MT5Q$<.3$N+4D%'TW%
M..!)ZA3V[C-!XS=9WZRV31R+:W'E]>QO7"4A]I;KS_0994&VR%IPI961R4%8
M^PU#K1N_J^]O6"<N;9HT%]UY*4,MMK\XOR:G4LX;EN\%!8P 5<E9'I&"#*-,
M;VN34QF9MMFR+M,==;C6J,PTATD292 "M3P0"EN,HJR0/3D*5R K)U5OI;M/
M.WBW,VAZ5>K?;WK@F$B7#42IM"%K0L)?*FR.H,E0 .%<2KMDC56O>FY:LU'9
M;789=D>;E)A&5("%OAI3D:2\Z@!+H'(%A  )]/(YSVK>;8ZZU#J:3%:O*K8K
MS]H1=&/(QG&N@2X4%"N3JN?;B<CC\?Q8R]+[T6/4VK5:;88?CW%)=2M*W(Z@
MEUL)+J"E#JEI(*B.2DA)*3A1[9T\K>.[-ZB3$1IB>MAFYS("V65QU.2$,QPZ
M'$DNA*??N%$>X [YP$*M>OM6QTNWDWRV7-^V6F<]-:5%7Q7TIO$-<4O?1N<0
M1R.< I])^,OTQN=/7K"TVF4[;V8%PD366F6N3\I3K<B2/5R>YMH*&@0H(6G(
M4,H'$5N=,[Z:8U3JF/8[=U5OR0"ATJ9 *RR'N);#G5'H5]8H"<@CEFLV7NO!
MBV^YW,VR6+7!?7$3<7Y$2.S(=2[TEH0IU]!&%!0RH)!XG&>V0KJ?<]8VJ]:V
MU+;I;9AVJXOQTM3[C(?:>!:9#;7E>R&TI4LJYH4%'N,=ZV;V[]\MUUDPIMTT
M^B0Q*EPWHBHCJ'HR&8ZW$S7!UR>BI24^G ]+J %D^\@M>_5FO!BNQ;7=5VYT
M0^I<2ECH,&4<,I5]+R/JP"4)4!D'..]?EJWXLM]EN0[9;IERNHD",B'"D0WE
M.9;4YS#B'RT$A*%9"E@@]L=QDJ/:/WLU%J"\62VS;5#A3[P]A$,-N<X265*,
MMMXDC*PWT5)("1EY/90[G=WJZVUW<RX0M4ZA?LD9AB,NT11=7+>W)Y<NJO*%
MHZR@L!)22H) 3V'/)UQW-@L:[=GS;%<7DPHDEI=RYMA$1"9B&5IZ/7(['B5.
M)&2$CMCL);==R+>SIN/?$-O^15<%1$DL)6IW@M:"I YC"24'"L^V#Q[T17:]
M^;S<]37*U695M=3UVF8KTN* 6<SVXJ^HA$I2U8"R1R#)RGZN#VSM':^NNJ-U
M;-%G7:V*4B-=D/6B"VMM^*6GV6T%\%U0)4!R&4IQR..0[U.]*[D1M3P;@^W9
M;G;WHL1J?Y24AGJO-.H4IM2>#BAE7!0PH@@COBHO?_$%9&;'>W;4U*>GQX34
MB*HLI*'UNLJ=3Q]65!M(ROVP/;-%:J7O1=8VJ)MDD773]L+<]31N3[75AQ&.
M+Q;ZBTR1EU9:XE*^D4J"NR@4D[BY:ZO<W2.WU[3-AV(7.XL-SP^P5-N-K0Y@
M))6GB%$)*<Y/J3_O]#O; B--FZP)]J=:;4[*BOQVG%N#H!U)24.J Y9P <G(
MP0GWK[G;LS+5JAR-=--7.+;$P(\EU*_++7%+DA;7-PI>(*>R3A')0P3BB(18
MMV+[H_1MFCW2="><FVV,]"DF+R4VI3JD%+RG93:%92,\RML ]L*) J5;2;AW
MG6^H4/W"X06HLVP0Y[-L:8XK2XIQY+BTJZJLIR@9P#C*1GME4KU9NC9='SGX
M5T1)0XVAET<6TJ#B%ES*D]\D-AI:E]L@#MG-8UGW8M]TOD"U2+1<[5<I@0MA
MJ:ADDM+:=<2YEMQ0"2&'!C/($#( .:"JX.O=70[I>;F;Y;+D[9XER7)CJB.
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M]*0@J( 0G[ :W%OVNTW:KY&NT2"['DQEEQAM$MX1VEEKHE26>?3!+8XYX_\
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M*@0K(("M4_<T=CEI"DVZ]J21D$7I_!_^M?OS9^Q_]FWS]-/_ /WKJ*WPF[;
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M:W9+6K&J],VR>F],,N,,O39[D@-I6,**4J. 2,C/V$U>]*40I2E I2E I2E
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7E*4"E*4"E*4"E*4"E*4"E*4"E*4'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>tm263197d5_def14aimg04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm263197d5_def14aimg04.jpg
M_]C_X  02D9)1@ ! 0   0 !  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" 1, U$# 2(  A$! Q$!_\0
M'0 !  (# 0$! 0            8'! 4( P(!"?_$ %(0  $#! $# 00$"@<'
M!  !#0$" P0 !081$@<3(3$(%")!%5%7U!<8&2,R87&4EM,6,T)35G:5"20W
M.%*SM&*!D=$E-$.A-6-RL7,F@I*3\/_$ !4! 0$                    !
M_\0 &!$! 0$! 0               !%! 2'_V@ , P$  A$#$0 _ /ZITI2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@
M4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@5B..3A=8[;<>.JVJ
M9=4_(5(4'D.A3?;0EO@0I*DETJ45I*2A "5\R49=*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*#F_VR>L&0=*?P<,V7+86$Q+[>S N-ZGPVI+
M49CM%7,I<('@CZQ^VJPZ9^U;U#RVX=+HTN9 DP+OF<^PNWF' [+-[A,LA3;[
M:5[+>U$^4G7C]M=']8NB#/5W(^GMSD7-$-G%+S]++B.0P^F:.!3VB2M/#UWO
M2OV5J^O'06Z=5KI@EUQS+&,,NF(SG)T1YRTB>VM2F^''M]UL  ;^NBJN]J?K
MUD/3KKEB6*Q^H+/3S'+C97YTFXKL(NJB\AWBA(; *@"/F/ U6UZ\=9,VQOIW
MT\Q_IW?(U_ZAY4@O1KL];TMH>C,L%YY\QU A'(< $GT*JV&0>S5U'O6<XMF[
M75V!%S"S6V3:W)YQ)*V9+;KO/89]Z 00-)]3O6_&]5E7GV0+?U+ZAQ\JZIWL
M9RN)9FK7%A,17;:TRZ%%3T@%I\DEPG]'P$CQM7K0\0WJ1[4N3R_99P;J%B:D
MVQ5WE1XM_O MYG?0:/B3)>+ _2XN)(\^/(^L5I.JWM"9#A/1[IO=K)UDMV01
MK_D9@3<TCV%E:6XI0I6C%1R^-&AL#2C]0JRL+]F+*>CN,9#8>FO4&+8+5.O2
MKI A7&Q^_-P65H*7(VU/@K25<5!?PD<='>R:BS'L+3K5AEBA6CJ$F!D]ORM>
M7O7ARQ(<CNRU(X\$14O(2V@>#KD?3_X'BUNF69S+KT-N&1-YNC/)"&);T>^"
MS_1H44)5I/NY_P"E2?4^M<T>RU[5/43J=GF 6U>8VW/6[S#DR<DM4>QB(YCR
M4 ]M9?00E?)7$:(^?IYW77V/8ADWX/[C8LMRJ/DMWF-OLF[1K4(*$H<24I'9
M#BP2G9\\O/ZJJ;"/8^&!/](9UMRP-W?!(S]OE3!;="\0W2HJ94GN_F]%1(.U
MZ/RH*M]G?KWF76;))=LG=9X]LOZYUQB1\:1B*7.*&RXEISWGP@ZT%\2?/'1]
M:D'3G*.LMUZI]4+)=.J4:;;\"+"EMIQJ,V;B'(ZG=$A6VM$ ;'*I]T-]G3.>
MB4T0HW4^'<L.5<95P>LJL92V\LO*4LI$GWA1&E$>>/R]!NICA?0YK%.H_4[*
M'[M](L9NN,7('NW;]U2TR6BGN<SSY [WQ3K]=!1L[VC\Z8]A_#.I*+BP,LN<
MV(Q)E>Z-\%)<FEI0#>N(^ :\#]=5_P!3_:UZBX[U?ZBV.R9O;?I6S7V+;K!@
MSUA$AV\(<".:0^@A2-<CY/\ \BK0MWL0WYJP6/!)_4]R=TKLUU3=(UB%F0B8
ML(=+J&%RNX=H"B3L(V?U>-2#,?8QBYA#ZII>R<QYN8WB)?($Q%OVNS2(Z0$*
M3^=_.^A\[1X)%#Q$(OM1YIC_ +6&08KD8CHP%*H=J:4EI 5;KC(BAYH+< VI
M*U(<1LG6RFK*]GC-LSZW^S1"O3^0M6K+9ZY;2+PBWMNH9+<E:$J['PI5\* -
M>/KK#N/LCQ\D_"BJ_P"2?2+V<Q;>A3S,#LJ@28K(0B0@]U6SW ' /&M:V?6I
MW[.W1U707I)9L)7>CD"[>IY2KB8WNY=+CJG#\'->M<]?I'>J#G3!.HW6298>
MLU]N?4J-.8P"3<K>U"3CD=KWQ;,<J;=*PK:-*(/'2@>.M^:QHOMQIR7&>B$"
MP9.U*S*^7>VQ,DCFUK0DMN)(?"5+;"!\>O*#^SQ5XV'V;/H3%>K]F_I%WOP@
MSYLWO^X\?</>&NWQX]P]WCZ[VC?U"L>Z^S%])]/^D6,?TE[7] +A G^]>X;]
M_P#=D%'#CW/S7+>][7KZC04ADWM1=3(72W,;Q&F-L(MW4.1CTF_-VD2Q9;6@
MC\^6$#\X4^FU;]?/J*Z5Z+9@BZ=)DW]_J!$ZEQT!Y\W^#";B!;:?/;+2"0E:
M0-$'1^L"HECWL]9?T\QO*8F%]08ELN=]R>5D#DF=84R6DM/#1C%LO#>B >X"
M-ZUQ\U(?9\Z 1NAV$WBRR+K_ $AF7NX/W.Y2O=$Q67'70 I+;"20VC0UQ!-!
M770K(>L'M V>V]23G%NQ#%)\Q3D'%HMC;E*=A(=*?STA:PL.+"5>4@ ;!U\J
MCN6>U5EEG]I'C&7&_ ]:[W&Q*Z/%E)7](O-+5W0YK82A?!!&]?\ S4XP+V;<
M[Z/J-EP7JHW;\#$M<EBR7:P(FO1$J7S6RT_WD'@23K:21OYU$U?[.3 YW3*Y
M6BZ37[AG4]3TEW,SWT+][6X7 ][J'^'PD@<2?('KOS003VBO:IS;I_UOZ@8]
M;.H%NQU%E@07['8)-A$Y=YDNM@JCA:=+222//G7+Y58%]ZA=8,RZWXO@]GR2
M#T_ERL*;R"?&D6ANX)1,[G!;1Y*2H)V=>%>./SK=W3V,T92.H2\ERP7>3F%A
MM]I<?3:^T8TB*WQ3+3^>5LE8"^/C7IR/K7U=?9<SI>9XWEMFZM-6?([9C*,;
ME3EXTB29:4KY%X)7(TA1^'P0KR#Y\ZH)![.G6K(NI6(YI#RN'"AYCA]SD6>X
M.6WE[K(<;3R2ZV%$D!0/H3\OUZ'-W0+VP.HF69-@,25F%GS=[(Q/%WL,2U)9
ME6%#(7VWU.-G12KB#I:1X/ZP:ZUZ+]!K;T7PBZ62)<YEYN=XDO3[I>KAHOS)
M3HTIQ0&@!Z:2/3ZSZU\=!^A<;HATCAX4W<&KJ^RA]#EU3"$=3W<<6L;1S4?A
MYZ\J/I\J#D[V=/:XZC9]F. Q%YE;<W>N[THY%CC-B$9VR16BH"09""$JWI/@
MCYZ^=3C'NIW6[JSTKR3K#C>76?'[+"<F/VK$7K,B0B5&C*4#WY)4'$K7P5^A
MH#Q]?B9XA[&"<+M?2?Z/RY*+Y@DN4M5S^B_%RB2%K4[%6WWO@!"]!7)6O)UY
MK&<]D#*[+8\@PS$>JKN/=-KY(?=>LR[,W(EQ6WB2\S'DEP<4*V0-H)3OYT%7
MY;[:V:'/^F%[M*F(6!7*P0+W?[:Y'0XMMMZ7[LZI+I'(!"EI/@^@J7?C+YM>
MO;2@8?:YT9/3@S)-G4T(R%+?E1X?>>4'=<@$K<0G0/RJ<WKV,,?N5Q=1&NAA
MX_\ T(5A;-L,7N*:3W M$GN\QM22 >/$;(WR%8_3?V-6NGLKIC+&6N7*;B$B
MYS)LEV!Q7=GYB>*G%'NGME/C_KWKY4/%!=*O:TZH9ID6)6IC/;/?KODMWG6F
M58&+(V9=C905I;G%2% *2G044N  C]NQ:733)NLEXZL]3+%=>J,:;;L#7'*V
MTXU&:-Q2Y'4[HD*VUHC6QRJ[/9XZ&QN@>!#'D7!J]23,DREW%,(1EK#KJG @
MCDL_#RUOEYUZ"O+%.A?]&,^ZIY-]-^\_TY]W_P!U]TX>Y=I@M?I<SW-[WZ)U
MZ>?6@B?1S->H'67V0[9DD"]1X?4&XP'W8\]41LLE]#RPA*FR.(2H("3X\;W4
M3Z&^TAFGM#9WCEHMD1>.Q,;AJ7G9D1 2;@%*;3":*A\.U(4X5)\A) WNIQ[.
MW0/..A-LM./2NI</),.MK+K3-J3C:8CVU**@HR/>%GPI1.N/G]52OI%T:_!7
MD74.Z_2_TG_2V^+O7:]U[/NG) 3V]\U<_3?+2?V4%4]9^NV88;U@SVP6N<RS
M;+3TZD9%$;7&0LHFH<4E*RHC9&@/A/BJYPWVO\[N_3C (UVD1H6=.9;:K;>0
M(R.,NW34%UEY"=:2%H(&T@:*#Z5>W4CV9OP@]0\JRG^DGN'T[ASN)^Z>X]SL
M<UE7O'/N#EK>N&A_^]43RGV((.0W?I'=H^4KMURP9J#'ENH@<D7AJ*4J;"T]
MT=L@A>CM>@LCS0;?VR\EZA]-NF=TSO"\T9L3%FCH[UI>L[,H2EK>2CEW5G:-
M!7H$G>JA6:=;\O\ 9^RKI$QGG4!B\V'(GIK]UG)L*&"AI,=M3380R%J\+4?B
M3Y/+R-"KZZ^=)_PX=)K]A/TK]"_2B&T>_>[^\=KBXE?Z'-.]\=?I#UK697T-
M_I/U%Z793]-^[?T(3)'NGNG/WWNLAK]/F.WK6_16_3QZT'-66^V9D5TQ?V@,
M@PS(&'[1C"[2+!*7;@GM!XA+Q4AQ 4KSR_2'[*OCV7<]D]0;-=YKW4Y'4A+2
MF4$HQTVCW)9224^?ZS?CS\N/ZZT/43V/3G@ZP\<N^CU=05VY8/T9W?H\Q>/_
M .V'=Y<?_1K]=6ETIQ#.,1B2F,QSB)F:2EM$0Q;&FV^[I2""#IYSGOX?JUKY
M[H.:>F7M"Y+FG7S),;N_5EBQBWY8_:X.+)Q82#-C(4-),M( ;)&T[/D:W49Q
MCVS.H#6.]86<AE16Y\1J[2<0N*8K:4J,)Q2'6%)UI:D@MK\[)!.ZO? /9TSG
MIIGV17:Q]3X;6-W_ "!V^SK(]C*7'%=Q0Y-)D&1M/P@#D$?KU48ROV$(.5]&
M+MA#V6KCW.1D,R_PK\U;M+B>\J/<8+?=^-)0I2#\:=^#H:U0\>%OZO=2^L^>
M67 \.R"!B"H&*V^^Y!D3UM1-?<>DM)4EIAE1#:0=DDG>OEZ:,KQ3.\YL7M,V
M;II?\D9R*"G$'+K*F)MS<54B2)90ESBG?#39"2D'1(W\Z^;I[+%WL^0X]E>
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ME7'?@Z]/ -:B7['6:0;++Q*RW.Q-X7$SJ%E-BC/R7TN0XB5%<B-Q#)2G2B.
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ML*V25*!_56;[2_2*\=9<3QRUV63!BR+;D<"[O*GN+0A3+#A4M*2A"B5D'P"
M/K(H(7[3/6/JUT38=O=G@83<K!)FQK=:X$M<PW.6^Z0D("4@-[Y<CZ_HCZZZ
M*@+D.08ZI:$-RE-I+J&SM*5Z^(#]6]U474'HY>^HW7K!,CN4J!_0;$VGIK%O
M#BS)?N:OA0XI'#@$(3Y!Y$[^52; <DS._P"<9RQ?;*Q:,7MTQJ+8WBTM,B:D
M-@NO*)64E'(Z3I*?0^M!/J4I1"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*
M4"E*4"E*4"E*4%5]>NNS?16-C4>-8)&3Y#DMQ3:[5:V9+<9+KI&R5O.?"A('
MST?)%:3,_:.N73W$L75?<!G-]0,EFK@6S#85P8D..N))VHR!IM+83I14?0*&
MQZZR_:AQ1C-,&BVJ7TL>ZJ0W9.UPXMQ9A/PB$GB\VXXM!!WX^%0.C\QXJ@,9
M]GWK'BV%]+<MD1?Z19AA-YG2&L8N-W0X^;7(2$)C>]J^!3K8&P2>/G6_ %%7
M_P!+_:$DY9U#G]/\OP^7@6:QX0N3,!^8U-8F12KB7&7V]!1!\%) (_\ G6EZ
MW>TEE?1S+;3:V^ELB_6Z]7!FU6JYMWV,P)4EQ.PCMJ!4C1"AR5H>/7S6LZ?8
M3G74;VCVNJ^88L<$MEGL:[-:[1(G,RI<A3B^3CSA9*D(2/("=D_.I#[2_3?(
MNH-WZ3O6"W>_M6/+XETN"N^VWV(R$K"G/C4.6MCPG9_50;/ ^NT[)NJ[G3Z]
MXB[C5]8L#=\DI5/;E):YO%L,[0-*/@*Y Z\ZU6OQ[VI+/=^BN9]1YMK=MENQ
MJ;.A.15/A:WUQU<!Q.AHN*( &O&_G4-S3V78O5;VL+IDV9XP+KA)QAB'$E&>
M6O\ ?$O$J3P:=2YX03Y(X_KW53VOV6.I[_1^S=*HUJ&+6.7FTZ[W*YKD1I:(
ML!"PN(.UWB7>:@GX?)''XM4/'1/3;VC;CU=Z/RLMQ7!I4W(X<Y=OEXI(N+49
M]AU"P%!3K@"1I)"O(&]ZKP]GGVBLCZ\NR92^F[^.8]'?D0W+L[>6)&I+*PE3
M7:2 OUW\7IXJ-]!NC?4;HSU\S%^ZW!.7XEED-NXRKZU'CP Q<FSPXF,EPGXF
M_524D$@;U4I]D3IQD72_IM>+5DUN^C)\C(KE/::[[;O)AUXJ;7MM2@-CSHG8
M^8%!J.IOM-9IT[ZEVC#V^D4B[.7V4]&LDM&0Q6DSNTCFI7$@]KX?DLBI;T_Z
M[NYEG.:8I.QIVQW7%8,*7+0N8A\*6^R7"T"D:^ @IY D'U%:GK/TWR++.N_1
M7(K5;O>K/CLV>]=)/?;1[NAR.$(/%2@I6U>/A!U\]57\[V2874/VA^K&49SB
M@N%EN$6"FPRS<"WW'$,%+OP-.A0TH)'YP ?50;"/[:DN^XUTSFXYT[E7N[9T
MY.;AVOZ6:CEDQE$*Y.K2$G8!/R]->:OFQY7<?Z"&_P"4V->+S&([LF9;/>FY
M:HZ4<B?SC?PJVE._'UZKAAWV5\]C=,^@]LN_3%[+VL6<NQO5@8OD6*L)>62S
MIXOI!]0KX%'TT:[3Z7VURR]*+= 3A;F*JC1G&V\9DSVY:F@"KBV7PM:5<O7?
M(ZY>?2@KWI9[35_ZG8G<,S'3:5:<%1;95Q@7E^\QW')89WIM4=&UM%7%7KL#
M7GY5[S/:IAP^B_3OJ$<>?4QF%PA0&X'O2>44R%*2%%?'2N/'T &ZI' ^A.<,
M=1LDN>+]-YW2;$+CCUPBW+'9%_8E1KG/=:4EDL,MN*0UI1'QGB->@&S6LC^P
MR_9.B_2-^U80&>I=LO-LE7Y7TJ%=MEMPJ?5\3Q9.M)\-[)^5#QT#UN]K.Q]$
MNI6+8E.M,FX_2O;<GW!AP);M3#CR66W71H["EJUZCTKZZO\ M)77IWU/@818
M,!E9I<I%F<OBS'NC,3ML-K*5Z#HTHC6];V=U2^6>R7U.ZUWGJ]D%[R%K##DS
MOT=#LCT"-/4] C:,4]\.GL<ECD0GR#Y/U5KKK[+6>=><@PR1U)QZ3:%1,"D6
M6;.9NS6V;FEU0960R\2XE2=+((4CXB%>:+XMB5[9R;O8NF$W#<%GY--SU,KW
M.W/SV8+C"XX_.)6I8*#Z*T=@'7ZZVV8^TSD6*W;#,5;Z92IW47)(\B6G'/IN
M,VW%99)"E*E':%$@;"4CZZHC,.@W4?+,*Z#-9'TE&1*Q!N=#O=@M]XA04N(X
M);8<0M+Z$@+XA9"3L$'8&ZFO6#I8_EG23$["Q[/%RD3(<1]-M3$R>*U+QZ1R
MTW_O)>VI*O"R0I0\ $;HCJ2'DKD7"T7[(X?]&UM0O?+A%>?2][EQ1R<27$?"
MKCH^4^#KQ53]+?:(ROJ].MESL72FY-=/K@\4,9-<+K'8<6T-COB(=K*"1X\[
M(.]5M<+Z7Y1=O9>C8%GEW5+RB987;;<+B'.\H+<0I()7_;*4J2"K^T4D[\[J
MO^D5^ZT]+.GMKP&X=(G+S,L4%4&+?[9>X284I#:"&5\'%I<25:2DI(^>_ ]
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M4GYCTU\ZYZE]",@@>U!G>877HM+SBWW*[0I=GO4;(XT,1$MMI"UJ9,A*E:4
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M 'KHO&_9IZ;8@Y8%V?&DPC89\FZ6T(F2"(\E](2\L N$'D !Q5M(^0%2F_\
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MIGC8O#F/Y!DJ2^ACW'&K:N?*VH$\NVGSQ&O*OEL?754_CAQ?L>ZP_P %O_\
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M!DMHQ*UNW.^76%9K:UKN3+A(0PRC]JUD ?\ S0;*E5I^,WT>^U?!_P"(X?\
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MRK$&;?D=PM,6XS5Q9$>*S%6E24QWG=@NLK4"2VD>#K7R!\UA?C-]'OM7P?\
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M)#DQ3R!M;?NR6R\%)'E0*/ \G0K+M/47'+V;>(=T;<,]+RHX6A;9463IU!Y
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MZ!1W"3W"-A0T% >*B&/R<_D6";*GS;XU)(CHO<%F//,A!,M'?<C%: A.FNZ
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M EMQWM$!P!U/YL_$-@$#R1[IZL8JN^_1 NA]]+CS*=QG@TXXRDJ>0AWAP6I
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M <_K -D*J3=,K:]!ZC9//N#%V:N%RMUODJ5(,DQU$-:="0HEI*@OQQ&E#Y
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M(6AU+1/(<=.M-+WH^ H:^+8K9OJ#FF/PY$Y=T7D;W<OD1BWN1&D!9A<^RO\
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MV*V5Q3:7<AAPKTVZA@<6HH8Y3$?_ .P-)!/D>\#ZJ"ZJ4I1'&7^U?_Y7HO\
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MK 6C2=E(THZW06+$SRR/V W6Y/Q+/;6PRKO7"2RAM)6VAQ()Y?"?C TK1\;
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M42 !^NJ+D=&<S#EM5&D1F+5:)+GT=9$7=:BPPXR6UA,E44G0.N*%(40E2QS
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M<"5A32_'$@I6?B!.JD][Z=/2>DL7$;86HSD=F(TV),A3B$):<;44]SCM7A!
M/$;\>!\@W$?J-89,LM)FH1'%K;O'OSBDHC^[+4I*5%9/C]$GS\J\G^J&'Q9-
MC;.16M:[\\IBWK:DH6F4M*22$J!T=<=>OKH>I JL[GT&OK.3WF5;)5M>L8,*
M1:K;+<<3Q4U,,EV.YI"@EHJ)*%#D4\M<=)&]U;>G62Q\@BY"Y'M;4MW(EW61
M;&9:RTRRN$8I*7.T.;GHX1Q2"21OQLA/&\RL3<>TF=/@6QZ>KC#C2I;(6ZO?
M'BWI1"SYU\)/K6=9[]9[TY,;M5Q@SG(SI;DIAOH<+3GS2L))XJ_4?-5;AW2_
M)L)F#M(M=P;G6MFVRI!F.-.P>#CRN3/YH]Q)#V^)*/B1\P=C/Z*=+KE@*$JO
M(0Y-C6YFUMR6;BI]#S39)!#19;[?D[T5+(*E#?S(6 _EUBBW=5J>O5N9NB6B
M^J"Y*;2^&P-E903RXZ!.]:K5]..H$'J7C[EZMI95 ,EUAE;,E#W-*%<>2N&P
MDG6^.R=$?74,=Z87]60N,!NU_1*\E1D7TL9"_?0$\3V>UV];^'M\^YKMG6OE
M4QQ#'+KB73Y%J;7$=N[#;Y945J[!<4M:T<CQWKXAOX?K]:#ZL/4JR9#?LBM,
M=UQI^Q* E.R$A#2DGD"M"M_$E*D+0H^-*016:UG6,RH$J8UD-I>A1E]J1(1-
M:4VTO_I6KEI)_4:JMOH#>[-"A&!E4BZR56R;:YS5U2PVRM$E"EJ6@LQPLJ$C
MBKXRKX5+\[/G<2^CDE]V"E";:F)';L*%,GEQ/N+SSCFAPUZ.("?U@[XZ%!.[
M?(QNYS(=Y@R;=+?<B+;C2X[R%A4<*25\"#HI"@G9'SUNO=656%%SA0E7BW)N
M$UL.18YE-]U]!\A3:=[4DZ)V-CQ5:RNF63VB\2+G9T6F6X\_=DB/*E.,(;:E
MJ:6E>TM*VI*FCR3KSR\*^O5N=(\Y>5BT%ZXP7;79Q9U)2W.<:0VJ*4&1^:2S
MMTJ*3Q4M8 !'PI.R0L574VW,],I&;O1I2;:Q#<F+CM)"WBA&]A(V 5'CX&Z\
M+KU:QVQX[C-W4I]V'D,J-%@HCM K4M\CB5)V.(&_B/R_6?%:UWIM<U]"Y>%A
M^)]*.V]V(E[FKL!:BH@D\>6O(_LU'9O0^\R+M**9T%5IB7"-*LT92E@QD*F-
M2I85\)&RIO2-?+P2-T%K-9+9%W"?!;NMO5.AH[LR,F0@NL)U^DXG>TC7S-:=
M[JAAD=RQQ1D5J6F]O+BV\,R6UHD+2DE24D$@^A'[2!ZD"JEE^SQ?KA;[];WY
MB%.+5.<MMP-R7Q5[Q(#Q0XP&/A"@ E1YK] 0#O0E-DZ97RU2K)=DQF/I)N]J
MN%P9DW9<@.(5$5&*TN".@<@"D\> !"?TMF@GK.>6%#=O1,NMOMDJ;H,0Y$YG
MN+))2D)XK(5L@ZXD^E8C4C%V^H3[BKW$=RA4<14V]R<@NL-G2RE#.]IY:"B=
M;/$?(57<7H5=6L;O4)QVV*G3,?9M++W)9"'4/ONDD\-A/YU!!'G:3X\ UK6K
M-.:ZJ62RQH\&X,0LHF7U^:VEXRF4.QW_  X"T$) +J4!0<5R 2 D:.@Z"I2E
M!QE_M7_^5Z+_ )AB?]I^NRFOZI'[!7&O^U?_ .5Z+_F&)_VGZ[*:_JD?L%%Q
M]TI2B%*4H%*4H%<8>P1_QG]J3_.SW_DS*[/KC#V"/^,_M2?YV>_\F91<=GTI
M2B*IRCJC>[3=LAD1&;=]#8_.A0)41]"S+E%\-$K;6%A*-!Y/%)0KF4J&T^*R
M^DL.YKN&>3+C.C2Y;M[>CMO,QEMEM#:$A"3R=6" #X X_/UWXF$_",>NE]CW
MJ98K=*N\?CV9[T5"WV^.RG2R-C6SKSXV=>M94@VO'H4N2\(MNB+679#J@EM"
MEJ(!4L_,GP-GU\4%%/WC)\,QVXV47*1"SF/(MKLJY7"2]<XDZ.],2R7F&U.I
M#'(E04V$HX^B=CBL2>=U:OMME2;BXQ;GK%%OHL#D)MIP37%^$EY*N92/B.PU
MP)X?%S^53J'TTQ&WVR?;8N,6B- GZ][C-0FTMOZ].:0-*U\M^GRI)P[%[5=$
MY#_1V";JR$H1-CV]+DE(T&QHI25>$G6QZ)W\J*JG,>I&01.G6)9M,]VE1IMQ
MAS&+;9VG$K;:6TZK@ZZ5J[H *2I00G7%1XGP*]KUFV3V/)[U?(TRTS84+&K?
M<)32 ZXS(!>D<A'(6 C:?1P\MZ3\/U6M;, QFRO.NP,>M<)QQ\25J8AMH)='
M+3G@?I?$KSZ_$?K-:V\)PO$;5=D2+=:V(T>"')L-F(V28Q6OCR; \H*RX0"-
M;*OGNB(5=.JE]6V[,+=O38Y=WF8^U$;2X)K2VTNI#Y<Y\3M31/;" 0E0/(ZU
M43D9[D=RP&W,QI4.+ MCN.1)*GU.>^2EOJBN*6EP+ 2-.!/$I45Z7Y%7J,$Q
MOZ==O?T!;/IAY)2Y/]T;[ZP4\3M>MG:0 ?K UZ5ANX-B5RO#2W\7MKTVVM,I
M8D/6Q&FD))+26UE.O@(\!)^#8]-T%7O==\J7;L@O$/'4/VJ(B>EA3T9UI++D
M=TMH#CQ64N=PI5X0E)0=#XO)J;0<MR.VYW;['D2X$:++9"8LF-;W>W/?#:EN
M(0YWE!DH"3\"TDK"20KU"9&.G^,)GSYPQVU^^7!)3+?]S;Y2 =<@LZ^+>AO?
MKH;]*PL>&+97=&LD@6AARY*:VBZN0.+O'DILI#I3Z_ 00#L#6_!%!&,MZM2[
M'GL*UP$M3[=[^Q;)R?<7$F.\Z@K3_O!<"2K10>"6U'1\J'BH]%ZV93%QR!<+
MC#M#LB\6AFXPFXZ'6VXJW)+#'%Y2EGFD>\(62D(\)4/J-6S)P7&YM\%ZD6"V
M/W<%*A/=AMJ?!2-)/,C>P/ .]BO9S$K&]#3$79K>N*F*8085%04".=;9"=:X
M'BG:?3P/'B@A?2R?=Y.1=16+Q-C3)42ZLLA<(+0R![DPKX6U*46S\6RGD?.S
MOS59]/\ (\WLF 0<H91+<9GPX$8(R.YKF"5,?E-MF2@!Q:FFPA9^ *3LZ^!.
MMF\L<@XQC;3D/';;"ALNRU,2$6F( @/I1\7=[:=)("0-J_\ 2-^0*VJ;#;$6
MQBW)MT1-OCE!9B!A(:;X$*1Q1K0XD C0\$ B@K!'4[)69G??^AW+:U?D8VZP
MB.ZB0MX\4&0"72$IYJY=H@GM^>Y6EM/M&33:7[[=H4"-8X,Y=LFJ86I3G=2R
MM:7T$G79=6$I;V-D+!WYU5M2,"QJ7?%WI_'[8]=UI*%3G(;:GE IX':R-GX2
M4_L\>E:[)>F5GR.-%B>ZQ84)#L8R6H\1L&2U'7W&62K7A"5@$ >@V!K=!KLM
M@97D_3VT.1A[M>.4>5<;=$FN0C(1QV[';D)^-H[(TH$;XZ)2%$B+6SJ*^+S8
M)\*[_1^$HQN=.DQ;K'<DRD+CNM-J+C_>4I2DDJ&QRWI7E7))%K9!C-HRN (5
MZMD2[0PL.!B8REU 4/10"@?/D^?UFL=_!\=DM0&G;%;7&H#*X\1M41!2PTI/
M%3:!K24E( *1X( H*>'5/,K[*CP(\F):9,:^V^.Z](M#C9DQI#:EA)95(*FS
M\)\E6R"/"?G]O==\J<MV07B'CK;UJB(GI84]&=:2RY'=+: X]S(<[A2KPA*2
MCP/B\FK48Z9XC%MKMO8QBT,P7EMN.1VX+:4+6V=MJ4 GR4GT)]/E7JGI]BZ)
M\^:,=M0ESTE,M[W-OE(!UL+.OBWH;WZZ&_2@KM74_+K)>IS5V;L\N!;KLQ:W
M_<8SK;L@O1TO!:.3J@CAS2GB>7+1.T^E:RT=;,QNF)_3(L,9MJ<BWN0)$B*\
MPP@R9"&BTHE9+I2EQ*NXGB%>1Q'SN=ZR6LK=D.6^(IQ3R92W"PDJ4ZA(2EPG
M7E24I "O4  "M!AV-8;.L3-TL5@MD>!=@U._-P4-]T[[C:U)X^H4>0^H^?6@
MA:<US"?EF.VTW&V1>QD4FU7(LV]91-;1"5(24 O;:\$#6U?$ =D?"?WKEFM]
MAVW+[39G8$!%OQAZZ2),SGW'>?=0E#2DJ3VRGMJ/,A7DI''YU9DS$[)<%)5)
MM$%]298G!3D=!(D!(2'MZ_3X@#EZZ&O2M#>H^#YW=K1$N=LM61/R(\AZ&Y)B
M-R4=MM:$N@*4" .2D;'S(_501*)U7N3^96BQV]QB5;YJW;:);EN=2(\MN*IT
M[=+P#^B@A24(2!O]/8(J-6?K'F\;&,5B-Q6LER"38A>9#C-M<_WH<PE+*0EW
M3:CYVZ=I!*?@\^+HCX'C42]F\L8_:V;L5<_?D0VP_P N/ D+UL'C\.]^GBM7
M?,$PBUV)<J?C-I-OM27IR4F VH,^.;BD)X^">.R!ZZ%! 9>=9!D>78D^I<*!
M9E99)M@@)YIE_F(TD$N*Y\5A2D$\. T.)Y&MUUASBXX1D5HF0G"MEFT726[$
M6HAIU39C<"L _+FK1^6S4SA8?B\^Z,9.S8+8JZO!+Z+D8;8D;*-!7/7('B=;
MWO7CTK-?Q&QRKC,N#]G@/3ID?W23)<C(4X\S_=+41M2/_2?%! \FZG7EC(IM
MEL[5N]X;NT"V(?E!:TMA]A3JEJ2E0)*=#2=C8/J-[J/7#K9E:7(EMMUE9N-Z
M:CS7Y*(T-UUN48\QR,&VP'!V>9;*N:RL(Y)&E>M6=C>'8O;82#:,;@6QD/\
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MT.)4'&F>+RU*5W-]Y"BI(3K2AH^#5F8AE]_G8O?9E[MAB2K>ISW=Y45<5$M
M:"PL-+6M2-**D$%1WQV/70DYQ6RJBIC&SP#&3%5!2R8R. CJUR9 UKMGB-I]
M#H>/%>,+#K/:,?E6:TV^-:(,A"TJ:A,I;2"I/$JT!K>M?_ H*A1UJRUBQVUY
MV-8I<^\VRWW*%[LEU+,?WB2TPIMT\R7-=X*"T\=\5#B-;K=(ZG9*S,[[_P!#
MN6UJ_(QMUA$=U$A;QXH,@$ND)3S5R[1!/;\]RI58^GN&].,90PFUVF%#8;CI
MD2W(K3?>6T1VW'#H J"]*!^2CL>:VTC L:EWQ=Z?Q^V/7=:2A4YR&VIY0*>!
MVLC9^$E/[/'I154V3K;.R:VLSY5OC(1$OK5L4U$?<Y.J2TXI;Z-*')I>@6PK
M84GR=^-?EBZPYYD.-"[Q<:2J)(CQIS<M-N=4(S+A)<2&B\E4I2$\3MLHY;.D
M[ "K@;Q.R,O,NMV:WH=92TEI:8J I ;"@T$G7@("U!.O3D=:V:UB.EN&MQI4
M9.*69,>4X'7VA :X.+!)!(XZ)VI7_P#D?K-$:[(L_3$PNRW*V7!B5,O'91;W
M6K:[)3+6M!7\#"7$* *4J5\2P$@>3XJOQU\O[F.HOB;; 1$AXZ[>IS)2M3KK
MB'G&>TWI>D)*D<BH\] $:5O8N.YXC8[U:F+7<+/ FVV.4%F(_&0MIHI&D\4D
M:&AX&O04AXE8[?&]WBV:WQH_NYB=IF*A".R226M :X$J4>/ILGZZ"/=.<ER/
M)(%T3>8 @OL+2(DTPG([<A*D [[*W%*^%6TGX_B !&MZ%==-,UNF*8FX+B[!
MG27K5=<@>F=MQHN.M2 D!7)U>QH^3L: 2 !KS=&/8M9L2A*AV2U0[1%4KF68
M3"6D%6@-Z2!\@!^P 5JW\/PW+H+++UDLMWAP'G6FFUQ&G6V' HAU(!!"3R!Y
M#ZQYH*RROJ3FERL&32;-*M5D:MD2W.(><AN277')"6EJU^=2E*4A1'HHG?RU
MYRH>6Y+C>:Y,\\_"FVC^D,"VO,EIWO%3T6,DK:/<*6TA:@K@0O>U?$#Y-G3[
M-C;;*K7+@6U#5W BJB.,H EA#9TV4Z^,);2?'G24_4*\,7C8W?K!$GVJV1/H
M^0MN2W_NJ4;6UI+:R-?I)[:0#ZCB->@H*IM?73+;GB$W(6L>9]S>AM2H#DB,
MZPTVM<A#267'"H]TE+G+F@) *%#1\$V1F.3S\3QFWI=F1W,@F.HBL^[VQV0B
M0]Q*E!#"70H#BE1^)P!(&RJME"Z?8O;ESEQ<=M4=4Y07*+<-M/?4%<]K\>3R
M^+S\_/K6=?<;M.40TQ+Q;8EUBI<#J69C*74!8]% *!T1L^?UF@J2V=>[A,PN
M[WEZ!#COP+"U<PVM1"5/*?D,J2?B/P[9&@"3\6MFL')[YFC^7W"(U>8*VH^6
MP(D!HQ'&TL-KAAQ0<*7=NI^,GC\.R/5(("9[E>,8);/Z/Q+AB%LG*=?]PML1
MNUM.=O84XH)!&DH 2M9]!X^9U4H7B5D<O"[LNT05W-9053%1T%TE (0>6M[2
M"0#\MT563?5+*;D%0H8LD2XP(,^;-D3&G2Q(]VEN1N+20X"V%%HJ*E*7PY)&
ME;W6,OJQ><A;>FIA1(UD:79"F.I3R92US%,*.UH6D)" L^-'GO1T 0JS+QT^
MQ?(6F&KGCMJN#3#CCK2),-MP(6XHJ<4 1X*E$E7UD[.ZV#F/VMXO%RVPUEY;
M;CO)A!YK;UVU*\>2GBGB3Z:&O2B*FO/5?*+%'OLY/T9>K2Q.CVF#+B6YYHJE
MN/AM?P]]?=0UR )3PY+!2-:)K OG4[,[C8+M;E0H-AN$6RW"XOR+C'=9$EIM
M7!LM([G)CD#R*E*7P.O"M[JT8W2[#8429%C8E8X\::CMR66;:RA#Z=\N*P$Z
M4-^='Y^:_9/3+$)MNAV^3B]GD08948\=Z"TM#7([5Q!3H<CY/U_.@B.2WG(8
M'2W"I-DNC$&;(D6AA]^9%,GN-NN-(6-<T>O+R=[UO6B=CX@]4+X]>8,EUJVF
MQ3,@?QY$-"%B8VMON)[Q7S*2"II1[? $)4#S.M58UQQRU7>S_1,ZVQ)=KXH3
M[F\RE3("2"@!!&AQ(!'U:&JQ(^"XY%OYOK-AMK5Z(T;@B(@/GX0G]/6_T0!Z
M^@ ]*#>4I2@XR_VK_P#RO1?\PQ/^T_7937]4C]@KC7_:O_\ *]%_S#$_[3]=
ME-?U2/V"BX^Z4I1"E*4"E*4"N,/8(_XS^U)_G9[_ ,F979]<8>P1_P 9_:D_
MSL]_Y,RBX[/I2E$5!DV!93/SZXHMCABX_):5=VIA? [5R$=4=#?#?+CY;>WK
M7)'UU!IG2*XWG&;E$9P15MCILC+,NW37(KOTI<$/(7WDZ<4E2PE+H[KA2I7=
M /H==,4H*$@8->HO5)^_3K?.M]MCR4384J+'BD,0TQ4I,-:@]S0@*"P6D(4D
MDA0)\D6'EWOV>=+TO6B#*CR[@B)):B22EEY">ZVX0OXM)4$@[&_U5.*4%/8E
MTRGV+*;3>A; Q.7>[L[<9@>07'(;I?+"5'EM2-]DA WQ/R'FL+JITPD7_)LN
ME6_&D2I-[QE%O:NC'8;6EY+KI4A3A4E:2I"VP"/'P^2-"KNI0<^9MTGO<2?)
MC6*RH.(_2K$I=GC-1W6WT>Z*;6H,..(0K3O!12HC9'(!1%>S'2"]2E6R!<(T
MRYV9+MI[XN+[7-QEE$GNH=0EQ0('<:24[4%#Q\0W5^TH*ZZJ8R_=Y&,K%@5D
MMB@ONF9962R.YMDI:7P=6A"PA7]DGQR"@-IJKK/TDR2-A3,*Y6.=MFVPD-06
MGHLU/O#<B4X6WD.NI0\WQ<:Y;4"=@@[3L=+4H*&1AE^E+O:KWA29=YGVMMNU
M382XZH]H5[EVUQV^;@4SIWF>38(4'!LG7C62>C5XAY/9&6+?)CVEF# 3'E6Y
MJ,ZY E(<4N2LK<>0I"G"4E3B LK'('?@'HRE!0R.F%ZM\ZZL8_8V["^YD<NX
M"Y,=AIMQIV$\AISX5<E<'5I!!3L$[ (V:T[/2F]7*&S$A8E)QR$8EOCW:,[,
M8!N4A$QE;KVVW5<]-(>Y.+(6L. :.M#I&E!7>#QS@5XF8]]%/1H5RNTE^UMQ
M$(,:-%2PTI1(!TVDN%8"0-\E>@'FM%U9LF4OW#)TV2R3+NB]6-F!&<C2F6D1
MWT.O%1<[CB2 4N)(*0=\2#KQ5PTH.:K5B5ZR#(+V_8K._;;TUDES)RIQ]KA[
MOVW6TL?I]W7<*/S?#@"GGO=>C/2F]7*&S$A8E)QR$8EOCW:,[,8!N4A$QE;K
MVVW5<]-(>Y.+(6L. :.M#HYMI#(4$(2@*45'B-;)]3^VON@@6(X<[C]CS"T^
MY.PK6_.D*ML6WN(;*(ZV&_#.E!+?YSNZ!XZ)WX!W4#Q7&\IQ)FQ/M8BZJ%;)
M,V.B)!3#BRI#+C+8;??0EX-%?-"DJ4E6SX5Q&R!?-*"A^G>#WNS3[0<LQ-Z\
MRDVN"S"G%V-(1:'4-$/(/-P%*N?Q=QL*Y @;^$"MST>Z8S, DXV4VM%N1_1S
MW:[*0ZA1=FAQHH[A"B5J">\ KR /&]:%6_2@HR9T_O,K.'G7,<=>N3F0IF?T
MG6\R6OHO0Y12"ON\2CDUVN' D\_UUK,9Z'AV%8+?/PZ/%@VN%>&'&%A@,N2'
M76BRZE"%$*Y)22E1 *>(WQ(%=#4H.=;'TTS!S-;7-OS,];[35N<9N3"8SI8#
M<9"7XZW5/!:$J<#O((0H+#F]D_HSG&NG<FP] G\=8MR6+]*LKK<EL.)*WIBV
M"DE;F]*45:'(DC0'G0JT:4'.MEZ?9#:H[,NU8C+L4:$BT*DV@2H_=GR&'RJ0
MZ@I=*%*+9 YK4E3FAOT%97]#LHE76#?7,4DNW,7V3(9@W14.3%8BNOMGN+/>
MY-/)0DJ2IKD004D*V*Z I17/<KHY>[K;KJNX6CWF>U9)S=L+LEM1:FKF2'65
MH^/2%A*FR'/''>MCR*^Y/2Z_W+J#D<NZ,7<MOR):V+E:1%2M^(Y'+:(W>6\'
M$\=^$%'$+0E6_)-= THCGNWX+D<6/B[Z,-9]]M4Y;4>,Y#@HAF*IULF0\VEX
M]F3Q2I0<9Y>1Y3\7$2'VA<9R7+H3-NLUA;NC!@RE-2FVHRY$>9I(9XJ?<2&4
MGXB7$!2@4C7'YW'2@JGIYB]WL/42ZRW;*M,*?&+LJZW%$8R?>=MCMM.MN*6M
MD@*/%Q(X%(T2#H:0=%3<LK8N%TL34MM_(KA)G+?=0OO05LN=A"P5'DWW.VH-
MZ("OB*0=FKQI0<VW3 \\F1,1AN8_W)5HC6SM7)OW1Q]"D2 9*7)#CO-"0VD:
M#23SY$%1\@3+HG;)RLAR)R2_[S:[$ZNQ6AY+O-+K/<+RE;^L!;+)_6P:N"O*
M+$8A,)9CLMQV4[TVTD)2-G9\#]=!SE@^*7.\75V=;<?D0Y;5[OGOE_7(:XS(
MZER&VXX_.=P@.%LA*DA*>V2#Y&_J9T@N%GL$*$,.=O;BL::BQ3'DL!5NNVE%
MZ2M:W$D+4HMGOHY*_-$?5OHUII#*2EM"6TDE6DC0V3LG_P!S7W0<T8]B-]NN
M4W<Q;2^<BAY(@N9:7VNVVRB*T'6@"ON:42K\V$%)*^1\@Z^<4Z+Y!(L4>+=[
M;.;?7(MJ+M&<$9J/-#3_ #??*VWU*>4I/+DI82I:5 $$^!TLVTAHK*$)05JY
M*XC6S]9_77W17.N;XC>L>N+B+2E%NE7^^O6AAAIY*2;?(C,)6\A*3X+18*@-
M @ _6*L;JAC$F9"QAJ-9G,@L-OF W"QM+;!DLAE:&]I=4E#@0LH44*/G6_)
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MMZ"0D;U5DY3CERNW3W"656IZ^18:XCMVLH6A*Y;*6%)*"'%)0OBX4+*%$!7
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M>3BVPHGRLI22#Y-94/I+*BSK,[<,9?DK;L]XM/OEO7&][AH<DA48(<6L<?S
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M+<W('FIZ"Y-1V(26UED-MQP7$-EPC:VT[.P"K@- .CJQF;C%D//LM2&G'6'
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M\ZVGD=<#M(*5<21Y,1L=XZBWZ\V^1*BWJW0LF<;=6PXPMOZ'1$.W$*\?F_>
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M,E4=S@\E&EE0XGYJ2D* )!.J\,AZ46Z[7>=->O-PA6ZY28\FX6MI;(C2WFN
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MEM,8R.:EE2CM1=  3Z'=;V%TAM43!;SBRIDQV'=G7GI+X#3;@6X05%"4-AM
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MKADN]A)9X)'D)2LDD 41647KGD(P2/=HV91+O*D6-J?<'?=&2BS/F2PWQ*$
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MEV#<>,EIT.2(CS96AU?;;<:"D N(6HA(6CDDD^#09^<9<Y;>GN0WK'UL7.9
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M?;2J.XREYD*X]QDK2D.M[T.;94GR//D4%3Y_FM\O'1RS7*Y1FK/&>%CG*O\
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MJBJ3SWJ/?973^^1+[ED"SM*QN9(AO,*C/IO*RX\V&RL I4I+:6N26.)YN[!
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M<FMN*#:0KR&B%'B2>=%9R?9[;QVP7-L26IIC@NVR1&@NN362)")"4J"Y!;<
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M.N=JZF7FY.OQI=OM]F@JC0N#S3C:GIJFUJ#B'@-GB-Z3Y 2GT!V$XN_26T7
MVN/$:CVBV0XDV(84&,EI*DR6PA13QT$$:)]#O=0/+NCN4R;3!?-ZBW.ZP$V^
MW0%1+:64-,MS6'7'GD*>5W#IE)(24#25:]?&= ZR7F$TS<\@5:H=EFHNA:,>
M.\IR+[HX4)4OXSW>8!/%*4D'0!5NL.R]7LRR#(AC;$:V0KDB4^TY,N%O=; ;
M1&9?0?=@^5)4>[Q(+GII6A^C16ZC]'\@MV0S,FA9+;T9+<.^B8X]:EKB%MQ+
M"4AMH/A22@1T>2M7+:M@;&L![V?9T6+'BV7*!8FF+6FVE^%%=;D2PE"4I,E:
M'TA>N)T4I0L!6DK2-[S\<ZEWS.FGWHB+=;(<*SP[A-8?;<>>D*D1^]Q:4EQ'
M;2D?"%D+)/+P./F.-=:ITB/8(L-"'[9/C-P))3%>"HDE4!4C0E..GNJ&D[2$
M$Z.RO8U02KIWT35@V3+O*[I&>4M<I9B1(*F&D]Y$5.DE3JSX]UWLDDE9]->=
MQEO3V=EV3VJ=(G6IJWVZ8Q,9";453TEI07P3)+VDI4H:5IORDE/SW6G.47ZP
M]&L1NEM9][68,1=PENQUS%1V.P%+>[*7$+=((3L)5RT20%:T=+$ZEWUB?E"U
M7^!<67[C$BV%F-9'7BON0VW]!"7P5 I*E;4I(&B2=:2"+"SG#'LLD6-Z/-;B
M+MTI;RTNLEP.MN,.,K0-*24JXNDA7G1'H:TF$=,;GCEULLFZ7N-<V+%;%VFV
MMQH)CJ[2BWM;RBXL+7Q9;'PA(_2.O( K>+USRL1Y>1NF&Y 59H*FK.W"42W+
M>FNQ2X7 Z24\D!12 ?&D@@@J5()'53.D(;C&UV^WRVXMRFKD7&$\T)+49+"D
M%#'=Y-\^\4GDM7$H)'(:%%2?)>E,N[M7[W*]B&N[75BY.-J97VUH;9;:+#G;
M=0I:%=O9TI/R!!&P=!']G^5"QYBTQ[_%0@VZZVV0L6TA)1,>[P+: ]\';4 -
M$JV/J/FM?,ZW9-;$PX,F#!>NMS-O<BN0HCSS<=$EI]PH6UW IU2!&4 4J0%%
M0.DZ._5GJ]FO:G2YEHMUK9M#,%R;"DLN^\/]^0XTK@>8#0XH#B>06?B"3K6Z
M#*ZC]*9DS'YMOMDF2[<[O?&);,R.R$B CLMQWRI15Z%A+OGUVL #8V;!S##$
M9%@LO'(3R+:E;"&8[A:[B&N!24;2"-@<0- CQ\Q5:(Z@YI8F+W.N,Z!*LT2_
MRHTFXHM+CGT=%0E)3R:0^%+22?*QOAHD@@[3O^IZY[F=X&IJ4PJT-.2YK\-4
M=;BGU-,%22%)=2-C9X[2K1T?/I1'K=>C/T_9Y\*X79)-PN_TM)7&C% \QPRI
MM.UDCT)"B3KTT?6LWI5TO/3J.\)#T";+4PS%$R+&>:<<:;WQ[G<><WY43I/$
M D^//B#3.M>6P+789!C6.6_DL%B=;VV4NI3##DF,T4/'F>[I,I)YI"/*"./G
M=3CJ1<<GM$#$4VV[08DR1>(L2<ZN IQMY*M\@E'=!0"1_P!2CZ>?F0KO./9^
MO;\'(+FS>D7>YO0Y\>./<UF2[[PZA:0MQQY22&P@)2E*4IT/05N+MTOR]&?6
M+(V+O;Y%Y7+4J3*%L4(;#*(CK:$EKO\ ,E2G%?$%^I'C0\Q^!U<R3IUAB)UP
M:B7:'*<NWN;24N^\-K:F*2@NN%1"T$+\A*4E(2 "JK/Q3(\GO^*WU5QAIM5R
MBJ6W$F/0'&6WT]M*DN]A3A6D!14DCGYX;!&] J+IZ!7"WV>XVNW9*PU%O=O$
M"\*D6XN+<^-Y:W&-.@-$]]P!*@L#X3YT>6XMO19%M$\)NW-,F#<X208WE ER
M.]RWS\\/T=>.7KX]*@6!Y/DF-X9;F+=$9N=P38;7<9DQME]XA#ZWRZ[[L7]N
MK''9XK"UE1/G245,K)U8DWZWW_(&[K:8V+61(0[(5!>=>E$QFW@\E(<!;02Z
MG3?%:E 'R"1H,J#T>DP[PR^;RRN"U-@W ->YGNEV/%$<CEW-!*DI2K]'8._)
MK"O_ $ :O^.LVIR]*:2TFY<741O/.5*3(2K7/T0I !&_B&_*:U&(=1+SE?4^
MU6ZZ-JBOVY^:PX$1U1 ^E46.ZA2V"ZX4D=PC143\]#>JS,XZ[3\-N-_MQM;,
MN?:$R)[C22H<[>B.E;;OZB75I;)]/A60/&J(WN*](!8;I;+F[(@(F1ER5OB!
M%=0F076VVP277G%;2&QYV=C0T-;.?@_3F5A-TCNMW-F7#39(-I=;5%*7%+C!
M82ZE7,A(4'#M)!UH?%4%N'6?*[99I:),!MF\MI<E1 JROA$Z,VTE;BNV7QV0
MA2@DN+60=@A))XB9]-LZO&>7:[ONLP8=EB)C(990A:I"UNQF7R5+Y<0E/=*=
M!))]=C6B&+<^DT^=>+@EN]L-8[<;O'O4J&J$52N\T6CP0]W D(4IALG:"1\0
M!\CC+\*QC^B&,Q+09'O@8+A[W;X<N3BE_H[/IRUZ_*J?D]=\M=B76YV_'FG;
M8B1(BQUR(SK2([C<I,=/=>YD.<_C.D)24$ ?%Y-23\(.5&\M8R%V9-[5=GH)
MN:HKHB]MN&U*V&.[RYGO!.NYKX5*_P#316N7[-R/Z$W"PMY$XU(D73WQB>(G
MQ1HO$M"*$\_(#"EM\MCRLJX_*I+=.E3SF0?2]MN;$1U%SB3VF'HA6VA+,9<<
MM^%I)VE9(/C1 \&JQZ:]3,A_H[:HT-,)ZZ3GH$94N8^])93WURRI83S'()[0
MUKCR&@3Z$;V[]:,J8LE[?C-V*/+Q^U3+C-7,;=[4Q3$J1'"6@' 6@?=BHDE>
MNXE.CZT$E=Z))>Q6+93>"D,6:;:0^F-K9?=9<#O'G_9+/Z._/+U&J^[-TGNB
M,U3D]ZO\6=.]Z$@LP[<IAH 1%1PE/)U9_M<MDGSL?L^L_+M_O73N Y,GPH=S
MEO&4BVSGHBG (3KB4E;2TJT% '6_EYJ!1>K^36>3)QNRH=R=Z-(N"H=QDQ5R
MUS(\=3*4M;;4CXNXZILO'>NWLI42:(L&S=*[AB\*UBU7B&J9;[(BS(5.MZG&
M7 '$J4M2$NI/D CCR\;WLZT=5;.@?N-DG057EE*IEJN-M*8T'ML1_>W0X>RW
MW#P;1K0;V=_]0KPG=7[^SC&4Y2(4*-;K(\J#]#NLK<F*? 0.3CJ5A*$A;@/$
M(42D;Y?%H8#O5?/$O+A*M5O@OLQ)\[WRX0'V4RFHZ&%)X,=TJ1R4\I!*EJUP
MY '?&BI=+Z1IEY.U=S=."4/,.]@1_4-Q'H^N7+QOO<MZ\<=>=[&KM_1"4WBU
MPM4R^LNO2K!&L"9#$$H"$,%W@X4ET[)#@V-CRDG?G0BM\ZB99=)6-077;5"N
M3UQM4MEUI+J6$-RFI/YIQ/<VZ4%KY% 62/"*]Y/7;*W9JK/;;&Q<;U!1,7)]
MUB.O-32Q(+(0UI8[//1)4LK""0-*]:";+Z'V1?4I>8AZ8)*HW:]W]]DE(=[G
M/N:[O'C\NWQXU%L<]G!ZT0X+$J^P%JA,0XS:K=9_=>\AB2T_R?!>7W7#V@D*
MVD)YJ.CNIWTTR:]9?#NMPNC<.+%1<),.)&CMK[J4LO+;*G%E1!*N(\!(UKU.
M_$-Q:-=XW4[(\=7+O-DB/6DOQ5/W=5S6\>\4F4V7N?8*=@=O7$\@=?":(VTS
MH]+G7)^,[>(R\6D7D7QVWJ@DR5/;"RWWNYQ[96 K^KWK:=Z\UJ[![.Z;,_CK
MSN0.3'+=*4[+4N+Q,]E);,9I7QGCVNPQ\7GEP5X'+Q+>BD^7<^D^+2ITM^=+
M<@H+LF2LK<<5_P!2E'U/ZZTW45#LW-\?@V&XW)O)52&)#S;$YT1(T!#FWEOL
M!7;5W!R;3R25%1!21P) >T7IY=L.L]G<L,N+/NMIMTBW,(F,E#+A?D,.*=5I
M>P$!H_"#M6_4?.0=0,!A]0X%KA7 ,.PHEQ8GNQY,=+[<@-[_ #:DJ.M'?J=Z
MUZ55N*7N6]+QBYS;_<.>1*NS=W9=G+#,9MGN$*;05<6"R4)1R0$[Y;5LZ-:M
MZYY.F!;V+"_<W\>R;(DQ[8FYW=]J1[FB(M:E>]+#CS:'G&B4ZVL)/P\>0XA;
M%TP.XP<A3>L3N$"S/KAMP)$.9 +\9QIM2E-%*4.-E"D\UCP2"#K7@$9V<XI<
M<OQ(6MF["W32XRX[(:;<#3W!:5+;4E#B5A"]%) <WH^I\[^.EUZ9ON&17F8\
MF+V77XCC4J:Y-6EQIY;:]/N$J<3R2=*5Y(UX'H*>EW_(+=;.H=[0JYL&/=WX
M+5Z=O#CK$1@R6FU*1$4HMH+;:EJ"N'CCL_.@EEBZ#2["+,(UZ@1G(-R=GJEP
MK8XQ(X.2"\N,A0D$!E0/ I6%@^OKHB9Y3A]QG9%!R&PW./;+Q&CN0W!-BJDQ
MY#"U)5Q4E+B%!04D%*@KQM0(._%2=6GI_3I-PM>/7R\RV9MB<EO,R;N^^\PX
MB3'0VZV^M96UW ZXGX5!/P[ !!J;=)[C<G,2RQ,YV7'D0KA)9;M\V:N9(MZ4
MM(*4*?62ISEON)))TEP#9U0?.1X-<LEZEX7+E;6FVL+>N\J/'[4264J2N.VD
M*6I6TO#N ;5H [/Q"L:#T9O]E:W:\EM[+YAR+6I<BU+=28KCRG4$ /ITZ@K6
M"=\5;'PC50SI]?L[L^+8Q<XR9#<?(6K9"0,GN"[@HR7&W%O2TA+JBE! 1ION
M)V1^BWZUN+CUTR2S8JQDDB-9Y,*Y1+D]"AMH<;=C+BMN.)[RRM04E0:(5I*>
M"E ;5ZT5([IT0=O7T#;I-TB(L-DB^Z12Q 4FXEHQBPIM4DND<%<N1 ;&])'R
MV?)CHI=)URL<V]Y%%F.V1$5B&(EM+ 4TR^VZHN NJVM9:;&QH)T2$G?C#_"G
ME;>6PL06;&J\7'W9YBZ-L.F*PTXS(=4A37=Y.+'NQ"=.)"@L*TG6BMO6B[)>
MM\N^H@V7'PY(A2;HB*Y(8?ELONM*0E:7 6$J#04DK2L'D4[Y <@S)?0V9=GY
MT*XY R]CDFZRKN(C, MR4N/-N(X=[ND%*>X3OALG7D#Q7YAO0@XU+L<J1/@/
M2[5(:6),6$\AR2VVP\TE+A<?<T=O%7P@ '?CXO$>M75&[Y7GF.VN6"TVS<X\
MEI]N&Y!]YCOPYI2%LK=6K0+((*N.]CX1KSZ]:NJ,FU9C9[8Q.N-FA6ZZVTR7
M&(K^IY=D("F@M*""VELJ*AOXE*2/[)!"4)Z.R89A"/<K?*:;BW.))CW.VE]E
M]N7(#^B@.I_1("2"3R&_2MS8^FHC].)N)7FY.76-,1(96XCFCM-.E6FF^:UJ
M"4!6D\E*(T/EH#6=3<KON,93C+\"8PFS&//DSH*H9<=DAECN!*5\QQ/C0^$^
M?)WZ5]X'G=]NF00+9>_HM_Z3LJ;U&<M:%H#"2M"2TODM7/\ K$\7!QY<5?"-
M41ZS<!R7(<3N&/W[(X$MAQA"(TR+:U,OI=0M*T..[>4A?E(VE*4A7G]$>*QK
M5TGN!SJ/E]ZO469=FW05-0H"F&"VF.ZTA*0IU9"MO+45$G?@:&MU$LK]H*Y6
M&9>7(#,2YVQ$"?)@R'XCD1ON176VUH+BG"74[6H%:4( *?!5NMA(ZH9>QG,3
M"^=@-U?E)1]*>[O>[AM45Q\ ,]WDIP%HC7<&PH*\>E%:O&>A5\OV#V>'D=X:
MAKM\%]F!'8@<78SCCJ' IY7=*7>);2.*0@$$[._28VSI-<5YPQEUZOD:5=T.
M J1!@%AGMICNLH2D*=60K;RU%1)WX&AK=1!/7;)ID02H\&T,,LPXI>[W<6%R
M7YKL,%*@H<60IL.;()*?A\$\AL;IULO&%W*Z0K_'M\UNVO+BN3K>VMI+SRXH
MD1D!M2U\%*XK;*2I6R6R".6J#Q@>SK/8CW=4K)F)4^;;/H\3%07"XXL/I>2^
M^I;ZBXK:0"E)2->FJW8Z1WRW9%,R*U9%!CWJ:7TR/>K8MV/P=0P"$H#Z5 I4
MP% E1!"B"/0UB8;U5RO(LQ%O>L*3;X\U=LG+8BN 1W4,\E/=\KXE)<^$-\>6
ME)5R/D5EY;U:EV//85K@):GV[W]BV3D^XN),=YU!6G_>"X$E6B@\$MJ.CY4/
M%![X]T28QNTFWQ[JMQD/VEY*G& 5 02T=$A7GGVO7QQY>AU6YS+ 963Y+8KK
M%N$:UKMKJ%JDMQ5F8M 6%+9#H=2GMK XJ0I"Q\_71&CZ7]1,AR>9947QFVI1
M>;)],L)M[;B#'TMM);65K5W-AU)"@$ZT1H^M1K).OEUM-QO'T;'BW6WB!/D6
M]YV$[%078KC:%(+BG"7D[605I0@ I\%6Z(GF<=,1F=^A7(W+W3W9IIOM=CN<
MN$MB3O?(:WV./I_:W\M'73>D]P8R21?[-?(\2YNS)3X]\@%]H-/LL-K1Q#J"
M5 QD*"MCU(*?G6E5U/RZR7J<U=F[/+@6Z[,6M_W&,ZV[(+T=+P6CDZH(X<TI
MXGERT3M/I6JLO6O-+U8H%P;L<5EJ[KM_N4N5$>:89]Y="%-JVO;Q0E25!:>
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MCO2TA">)/D<1KTJM+AT@R.495J0BT?1S]\%\^F%2'/>TD( [/:[6OEV^?/\
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M)]WCIY:Y.A7/9TOU\:,E<Z42G.J;&1Z@?1K4U$M+!WW$D05QMA/'7+:D_/\
M1'_M03&YIQJ^)BRYYM<Y, )N##[Y;6(X4"$O)4?T01R 4/7S49^E,!Z:0<DE
M6"'9&9T!KOW&!9@PB3I)\!:4Z(T5'7+QY/UU!Y71C+X&,2[/;/H60;C8V[0\
M[(ENM)BEM]Y:5( 95S24/:U\.BGYBOF]]&LZR>ZW"3<KE >*X=QAM.KG.%!2
M^ZVID)92PE+02EL!7E:B?.S14AZFV+I]:),*R3K'&ML_,GG;>FYP;>US"UZ6
MON+UL!:N(^>U*&_7=8UVL?3%[-V<3>M%N@-6",Y?93"H3#=O(6GL[=4=#FD*
M0KT\#CY]!4FZG=-7NH4ZS?GVF(T1F6E:R2'4..-@-.-@#6T+2%>2/0>M5W>.
M@667EAFY2;G;E9$ZV),]3#[C;;\H3&'@VE1;44MAMA* HI)!2D\3YH+4<?P%
MNSQ$K<QM-JNS"+?&"E1PQ,9&PAA']EQ(Y*T@;'Q'0\UI;+=.FKS<O'K+$L#\
M2V70(FQ&$QTM1)2$=X.J0HC:D\ >205 I/\ T*(@T[H#>9$AE]*>Y'GQ)46Z
M0%WU25 O/=Q:TO>ZGD%?VDA"-$)()UNMWD?2&_WB5>8["[>B!(N;EPCOO27"
MXH.6Q40H6D-G1"^)WR.TD^A&B1-(C_3YZX7#+HSV-KF1/S<R]M.,%;)X\=./
M _">/CXCO7CTK+A8_A>67!&2Q+?8KS,*DE-V999?7R2/A(= /D#T.]@57V5]
M.G\>MS5T2Y;&&+:Q9 B.[W$L..0W'RI+A0VHI00\CBH)5HIV4@#SF]#95Y:3
M/1)Q],.#=KC<;L9C)6AE')Y(;2A*T)4OG\:^1"-A/+7Q#0;?)<\QKI[-M400
M+9$N#DQNQ6YI4B-'^!2$NJ2D[VA  3\&@20CQHI-9URL?3C&[HM5Q@XO;+C<
MRI"C+:CM.RBXKXA\0!7S4/(\[(^9K =Z<7)S+G;H'XGNZLC:NX25JY]E,#W8
MIUQUSY^=;UKY[\4S[IE*RVZ9%,9]R"KAC+MECJD$\D.J6M6SI)TCRG9&SX]/
M H)0IW%WL@>MJEVA=[*T3W(9+1DE24A*'E(_2V $@+(\   U';4]TLL[3TBW
M/8C#:=G(0XY'<C)29:25H22#KN DJ ]022/6H5=>@UWO-^R9,B:?<+C)F384
M]NXJ2N,Z_&4S\4<,_%Q"BG?=T4Z\ C5?N1]+,NRA=D=DVZUPF85L?LK]MMUY
M6TTXRX&MK0LQ#Q'YLI*..^)'Q>-$)UD4;IG<7IL:^-XK(=MZE2I3,\1E*CEP
MIY..!7Z/(\-E7K\/KXK81)V#F=#@Q9&/F9)[<^+&96QW'>*.+;R$CRK2$@!8
M]$I\'0J S.DM]9EW*+;XL9O'W B0U"-]>2X9J%MEN6ASW<EE8""5)!6A:M;
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MV<PTV8\J,XU+<GMRHL]]F0AYP:<4'4K"]*!T4[T?JH((QUDO%TN,IYRV)@6
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M4)XH+C25A"R$Z&U))T!O>AHJO^L/4/*<;FY%!MD6(B!%QQRYM2VY"O>P\'.
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M6QTXL$""J/$MR4($B/,2A3[I'>CH;2PHGEOX0TV->AX^0=G>+T\Z>Q\+QN?
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M-Z23Q\GQY-!*@- "OVL:# :MS*FFE/+2IQ;I+[ZWE;4HJ("EDD#9\)'@#0
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M]@HN/NE*40I2E I2E KC#V"/^,_M2?YV>_\ )F5V?7&'L$?\9_:D_P [/?\
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MFTA3AV%?V4D*5]0()K-.;XZ(L22;_:Q&EQURX[WOC?!YE VMQ!Y:4A(()4/
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M:2E3A8']2%N J#?C7U"@N:/U Q>7DCN/,9):'K^ULN6IN>TJ4C7D[:"N0_\
MBO6+FV.SHK4F-?K9(C.R_<&WFIC:D+D[UV00K1<WXX>OZJX<L& W!SIO@O3^
M+TZO=NZKVG*&9UPR1VSN(8;")2G'YOTAQX.)<;V D+*CO6O%:C!ND.>X1)Z<
M&-C%Z=LE^SQJZWB,J$[SM<B-<'N,I:2G:&G8ZD;4=)_-)._BH1WOD6=XUB#\
M9B^Y#:K*])V6&[C-:CJ=UX/$+4.7J/3ZZ\+AU*Q&T7=BU3LJLD*Z2 @LP9%Q
M9;?<"_T.*"H*/+Y:'GY5S-[9/2K,.I'4BR'%[>'PQB5X;7(DVD38RW%%HIC\
ME H;=< 4$*.R"-@&H9T\QJ;9.N%BG_T=RRPV!S'<?BQVIN%/W,E;25)<9>D*
M9_W92"0%+^'6]^ *#MA&8V!RTL71-\MJK8^Z&&IHEMEEQPJX!"5[T5%7PZ!W
MOQZUJ&>L.!243%M9OCCJ(2><I2+M'(83R"=KTOX1R(&SKR0*YBQ[I7E,?V@/
MP?O6&>CIK9<AE9Q#NBHZO<W%.M M1$KUQ*D2''5\=[  -5/CW3_*'_9FR;%A
M8<E_I&M313:Y&"/Q^T/I1"R4RRT#)^$\RC9TD$^B:$?T#_")B@QUS(/Z36?Z
M!;/%=T]_:]U2?J+O+B/_ )K$E]6\&@-P7).9X]'1/;#T13MU82)+9.@MLE?Q
MI)!&QL;%<:KZ-KLN$9Q;\IA9%;LC@9NU>(EZL&)+G6^:L,?[N\B VV4*9X[0
MXD$Z7K:MD5X,1LVNW4GI_D^5XA=<74K$Q%DMV?!7;M'2Z)ZRELLAM8BJ6V L
M[.T\M4([GR/+;'AUM%POUYM]D@%01[U<I3<=KD?0<UD#9_;6+(ZA8K$@R9K^
M2V=F'&;9=?D.3VDMM(=&VE*45:2%_P!DG]+Y;JDO;&QMFZ67$[W&3>_Z1624
M_)M";=C3E\C..J9XEJ5'2DZ2L?"%GCQ))!JD<PQ?.<CQ'J/=+ST_N<.?<6,*
M?<M%KM3SS9+"UJDML-H2KF&Q^DA/+CL T([</4#%QCR[\<DM L2%!*KG[^U[
ML"3H N\N.]D#U^=9N/Y+:,LMR;A8[K"O,!2B@2K?(0^T5#U')!(V/JK@KJET
MZO>36[JKD.&]/K]C&)W1VQHCVGZ"<1)FRF9:5OS$6X)Y@);T#M *M'8]:[#Z
M#+Y=/(PW.4M+[H4NX8VJPNJ._7W12$\1K0Y:^+6Z"Q*4I1"E*4"E*4"E*4"E
M*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4"E*4'&7^U?_P"5Z+_F
M&)_VGZ[*:_JD?L%<:_[5_P#Y7HO^88G_ &GZ[*:_JD?L%%Q]TI2B%*4H%*4H
M%<8>P1_QG]J3_.SW_DS*[/KC#V"/^,_M2?YV>_\ )F47'9]*4HA2H-D?4Z5C
M]ZDV]O!<KO"&>.IMMBL+8<VD'X2IY).MZ.P/(-:W\,\[[,\X_<HOWB@LNE5I
M^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<
MHOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3
M\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]
MF><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@
MLNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[
M,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N
M47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I
M^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<
MHOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3
M\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]
MF><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@
MLNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[
M,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N
M47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I
M^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<
MHOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3
M\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]
MF><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@
MLNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[
M,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N
M47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I
M^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<
MHOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3
M\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]
MF><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@
MLNE5I^&>=]F><?N47[Q3\,\[[,\X_<HOWB@LNE5I^&>=]F><?N47[Q3\,\[[
M,\X_<HOWB@LNE5I^&>=]F><?N47[Q63;>K<RXW&+$5T\S*&E]U#1DR8D8--!
M1 YK(?)"1O9T"=#T-!85*4H.,O\ :O\ _*]%_P PQ/\ M/UV4U_5(_8*XU_V
MK_\ RO1?\PQ/^T_7937]4C]@HN/NE*40I2E I2E KC#V"/\ C/[4G^=GO_)F
M5V?7&'L$?\9_:D_SL]_Y,RBX[/I2E$4#EG7V_67VCX?3]Q>/XS976HSD:9D#
M<CN7I3A/<;B.)*6DK1H#BOD22-"J_MGM>Y5/A]3I_/%MXHF[&/9A"F^]."(H
MI;6MWEVBE6AL @^?&JNSJ'T"A=3\KMUSOF49 Y9H4N-/1C33K"8"I#!Y-N$]
MGNCSY(#@!-:&-[*5JB6K+[,C-LN..Y.9RYEE+T+W=MR6275MGW7N @J/':U
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MI]):BL;=>4EE7)6WDK0.(]!5Q)]GF!,Z5WK +[EF29/9;E'1%0]='(HD0D(
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M'E.J ]R?2X=E83M6T*UH?KKJ.T=-EP\&NN,77*;[D[-Q:>8<GW94;WIMMQ'
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M?=:[/I0O7&'Y*OIG_C?J)_JT;[K3\E7TS_QOU$_U:-]UKL^E"]<8?DJ^F?\
MC?J)_JT;[K3\E7TS_P ;]1/]6C?=:[/I0O7&'Y*OIG_C?J)_JT;[K3\E7TS_
M ,;]1/\ 5HWW6NSZ4+UQA^2KZ9_XWZB?ZM&^ZT_)5],_\;]1/]6C?=:[/I0O
M7&'Y*OIG_C?J)_JT;[K3\E7TS_QOU$_U:-]UKL^E"]<8?DJ^F?\ C?J)_JT;
M[K3\E7TS_P ;]1/]6C?=:[/I0O7&'Y*OIG_C?J)_JT;[K3\E7TS_ ,;]1/\
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:4I2@4I2@4I2@4I2@4I2@4I2@4I2@4I2@_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CYTOSORBENTS
CORPORATION<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001175151<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Summary<br/> Compensation <br/>
Table Total for<br/> PEO($)(1)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Compensation<br/> Actually Paid to<br/> PEO($)(2)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Average<br/> Summary<br/> Compensation<br/> Table Total for<br/> Non-PEO Named<br/> Executive<br/> Officers($)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Average<br/> Compensation<br/> Actually Paid to<br/> Non-PEO Named<br/> Executive<br/> Officers($)(3)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Value of Initial<br/> Fixed $100<br/> Investment Based<br/> On Total<br/> Shareholder<br/> Return($)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Net <br/>
Income/(Loss) ($)</td><td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center">2025</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">808,431</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right">723,164</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right">679,233</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right">564,719</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right">11.73</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right">(8,197,439</td><td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">899,695</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">953,144</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">895,556</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">770,636</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16.70</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(20,718,957</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,333,401</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">729,761</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">994,690</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">734,380</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20.37</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(29,246,760</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(1)</td><td style="text-align: justify">For years 2025, 2024 and 2023,&#160;Dr.&#160;Phillip P. Chan&#160;has been our Principal Executive Officer.
The averages for year 2025 for our Non-PEO Named Executive Officers consist of our President and Chief Operating Officer (Vincent J. Capponi),
our Chief Financial Officer (Peter J. Mariani), and our Chief Medical Officer (Efthymios, N. Deliargyris). The averages for 2024 for our
Non-PEO Named Executive Officers consists of Vincent J. Capponi, our Chief Financial Officer (Kathleen P. Bloch from January&#160;1, 2024
to August&#160;13, 2024 and Peter J. Mariani from August&#160;14, 2024 to December&#160;31, 2024), and Efthymios, N. Deliargyris. The
averages for 2023 for our Non-PEO Named Executive Officers consists of Vincent J. Capponi, Kathleen P. Bloch, and Efthymios, N. Deliargyris.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(2)</td><td style="text-align: justify">Adjustment to Compensation Actually Paid to PEO include deduction of &#8220;stock awards&#8221; and &#8220;options
awards&#8221; for the year, which include a) add award granted in the year that remain outstanding and unvested at fair value as of end
of the year, b) add award granted in the year that vested in the same year at fair value as of the vesting date, c) add or subtract (if
negative) any award granted before the year and remain outstanding and unvested as of year-end at fair value, d) add or subtract (if negative)
any award granted before the year but vested during the year at fair value as of the vesting date, e) subtract any award vested and forfeited
at fair value as of end of the prior year, f) add unvested award on which dividends or other earnings were paid during the year not otherwise
included in summary total compensation column.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;">
<tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(3)</td><td style="text-align: justify">Adjustment to Average Compensation Actually Paid to Non-PEO Named Executive Officers.</td></tr>
</table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Adjustment to Determine Compensation &#8220;Actually Paid&#8221; to PEO</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(105,600</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(91,680</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(307,110</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Option Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(100,862</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(169,888</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(374,514</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,428</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">144,361</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">188,015</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-2">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(32,639</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(58,377</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(341,105</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">126,406</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">229,032</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">231,073</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-4">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-5">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-6">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-7">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-8">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-9">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Total Adjustments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(85,267</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">53,448</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(603,641</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(76,867</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(122,274</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(180,313</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Option Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(72,984</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(244,350</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(242,195</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,724</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">188,731</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">130,704</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-10">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-11">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,886</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(53,424</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(106,288</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(164,467</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">69,037</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">159,261</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">175,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-12">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-13">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-14">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-15">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-16">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-17">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Total Adjustments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(114,514</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(124,920</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(260,310</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(1)</td><td style="text-align: justify">For years 2025, 2024 and 2023,&#160;Dr.&#160;Phillip P. Chan&#160;has been our Principal Executive Officer.
The averages for year 2025 for our Non-PEO Named Executive Officers consist of our President and Chief Operating Officer (Vincent J. Capponi),
our Chief Financial Officer (Peter J. Mariani), and our Chief Medical Officer (Efthymios, N. Deliargyris). The averages for 2024 for our
Non-PEO Named Executive Officers consists of Vincent J. Capponi, our Chief Financial Officer (Kathleen P. Bloch from January&#160;1, 2024
to August&#160;13, 2024 and Peter J. Mariani from August&#160;14, 2024 to December&#160;31, 2024), and Efthymios, N. Deliargyris. The
averages for 2023 for our Non-PEO Named Executive Officers consists of Vincent J. Capponi, Kathleen P. Bloch, and Efthymios, N. Deliargyris.</td></tr></table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 808,431<span></span>
</td>
<td class="nump">$ 899,695<span></span>
</td>
<td class="nump">$ 1,333,401<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 723,164<span></span>
</td>
<td class="nump">953,144<span></span>
</td>
<td class="nump">729,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(2)</td><td style="text-align: justify">Adjustment to Compensation Actually Paid to PEO include deduction of &#8220;stock awards&#8221; and &#8220;options
awards&#8221; for the year, which include a) add award granted in the year that remain outstanding and unvested at fair value as of end
of the year, b) add award granted in the year that vested in the same year at fair value as of the vesting date, c) add or subtract (if
negative) any award granted before the year and remain outstanding and unvested as of year-end at fair value, d) add or subtract (if negative)
any award granted before the year but vested during the year at fair value as of the vesting date, e) subtract any award vested and forfeited
at fair value as of end of the prior year, f) add unvested award on which dividends or other earnings were paid during the year not otherwise
included in summary total compensation column.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;">
<tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(3)</td><td style="text-align: justify">Adjustment to Average Compensation Actually Paid to Non-PEO Named Executive Officers.</td></tr>
</table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Adjustment to Determine Compensation &#8220;Actually Paid&#8221; to PEO</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(105,600</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(91,680</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(307,110</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Option Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(100,862</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(169,888</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(374,514</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,428</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">144,361</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">188,015</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-2">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(32,639</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(58,377</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(341,105</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">126,406</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">229,032</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">231,073</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-4">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-5">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-6">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-7">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-8">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-9">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Total Adjustments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(85,267</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">53,448</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(603,641</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(76,867</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(122,274</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(180,313</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Option Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(72,984</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(244,350</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(242,195</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,724</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">188,731</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">130,704</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-10">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-11">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,886</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(53,424</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(106,288</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(164,467</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">69,037</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">159,261</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">175,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-12">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-13">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-14">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-15">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-16">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-17">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Total Adjustments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(114,514</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(124,920</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(260,310</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 679,233<span></span>
</td>
<td class="nump">895,556<span></span>
</td>
<td class="nump">994,690<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 564,719<span></span>
</td>
<td class="nump">770,636<span></span>
</td>
<td class="nump">734,380<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(2)</td><td style="text-align: justify">Adjustment to Compensation Actually Paid to PEO include deduction of &#8220;stock awards&#8221; and &#8220;options
awards&#8221; for the year, which include a) add award granted in the year that remain outstanding and unvested at fair value as of end
of the year, b) add award granted in the year that vested in the same year at fair value as of the vesting date, c) add or subtract (if
negative) any award granted before the year and remain outstanding and unvested as of year-end at fair value, d) add or subtract (if negative)
any award granted before the year but vested during the year at fair value as of the vesting date, e) subtract any award vested and forfeited
at fair value as of end of the prior year, f) add unvested award on which dividends or other earnings were paid during the year not otherwise
included in summary total compensation column.</td></tr></table><table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;">
<tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 0.5in">(3)</td><td style="text-align: justify">Adjustment to Average Compensation Actually Paid to Non-PEO Named Executive Officers.</td></tr>
</table><table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Adjustment to Determine Compensation &#8220;Actually Paid&#8221; to PEO</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2025</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2024</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td> <td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(105,600</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(91,680</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">(307,110</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Option Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(100,862</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(169,888</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(374,514</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">27,428</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">144,361</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">188,015</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-1">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-2">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-3">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(32,639</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(58,377</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(341,105</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">126,406</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">229,032</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">231,073</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-4">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-5">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-6">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-7">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-8">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-9">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Total Adjustments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(85,267</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">53,448</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(603,641</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Stock Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(76,867</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(122,274</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(180,313</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction for Amounts Reported under the &#8220;Option Awards&#8221; Column in the SCT</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(72,984</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(244,350</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(242,195</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">19,724</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">188,731</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">130,704</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase for Fair Value of Awards Granted During the Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-10">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-11">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">20,886</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(53,424</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(106,288</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(164,467</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">69,037</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">159,261</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">175,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-12">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-13">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-14">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-15">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-16">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: hidden-fact-17">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left">Total Adjustments</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(114,514</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(124,920</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(260,310</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><img alt="" src="tm263197d5_def14aimg01.jpg" style="height: 461px; width: 650px"/><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><img alt="" src="tm263197d5_def14aimg02.jpg" style="height: 434px; width: 650px"/><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 11.73<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
<td class="nump">20.37<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="num">$ (8,197,439)<span></span>
</td>
<td class="num">(20,718,957)<span></span>
</td>
<td class="num">(29,246,760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Dr.&#160;Phillip P. Chan<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (85,267)<span></span>
</td>
<td class="nump">53,448<span></span>
</td>
<td class="num">(603,641)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">27,428<span></span>
</td>
<td class="nump">144,361<span></span>
</td>
<td class="nump">188,015<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(32,639)<span></span>
</td>
<td class="num">(58,377)<span></span>
</td>
<td class="num">(341,105)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">126,406<span></span>
</td>
<td class="nump">229,032<span></span>
</td>
<td class="nump">231,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Stock Awards Value In Compensation Table For The Applicable Year Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(105,600)<span></span>
</td>
<td class="num">(91,680)<span></span>
</td>
<td class="num">(307,110)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Option Awards Value In Compensation Table For The Applicable Year Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(100,862)<span></span>
</td>
<td class="num">(169,888)<span></span>
</td>
<td class="num">(374,514)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards Adjustments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(114,514)<span></span>
</td>
<td class="num">(124,920)<span></span>
</td>
<td class="num">(260,310)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">19,724<span></span>
</td>
<td class="nump">188,731<span></span>
</td>
<td class="nump">130,704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(53,424)<span></span>
</td>
<td class="num">(106,288)<span></span>
</td>
<td class="num">(164,467)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">20,886<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">69,037<span></span>
</td>
<td class="nump">159,261<span></span>
</td>
<td class="nump">175,076<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Stock Awards Value In Compensation Table For The Applicable Year Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(76,867)<span></span>
</td>
<td class="num">(122,274)<span></span>
</td>
<td class="num">(180,313)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Option Awards Value In Compensation Table For The Applicable Year Member</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(72,984)<span></span>
</td>
<td class="num">(244,350)<span></span>
</td>
<td class="num">(242,195)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-4<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-21<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 220<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476153/220-40-55-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479857/480-10-S50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479887/480-10-S45-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 480<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (24)(d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480244/480-10-S99-3A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 9<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-9<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 17<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480336/718-10-65-17<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 45: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (f)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481538/470-20-65-4<br><br>Reference 49: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsAdjsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">From time to time, the Company
grants stock options, stock appreciation rights, or similar option-like instruments to employees, including our named executive officers.
Historically, we have granted such equity in connection with annual compensation and performance reviews, as well as for new hires, promotions,
or other non-routine grants where the timing of such grants is tied to the event giving rise to the award. The Company does not have
any formal policy that requires us to grant, or avoid granting, stock options at particular times and no specific practice on the timing
of awards of such options in relation to the disclosure of material nonpublic information by the Company. However, the Company&#8217;s
practice is to consider such information, with participation of the Board and Compensation Committee, to ensure grants are unlikely to
occur close to the release of material nonpublic information. In all cases, the timing of grants of stock options occurs independent
of the release of any material nonpublic information, and we do not time the disclosure of material nonpublic information for the purpose
of affecting the value of executive compensation.&#160;</p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">we have granted such equity in connection with annual compensation and performance reviews, as well as for new hires, promotions,
or other non-routine grants where the timing of such grants is tied to the event giving rise to the award.the timing of grants of stock options occurs independent
of the release of any material nonpublic information<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text">the Company&#8217;s
practice is to consider such information, with participation of the Board and Compensation Committee, to ensure grants are unlikely to
occur close to the release of material nonpublic information.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>57</ContextCount>
  <ElementCount>25</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>11</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="tm263197d5_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tm263197d5_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="tm263197d5_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="tm263197d5_def14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>ctso-20251231.xsd</File>
    <File>ctso-20251231_def.xml</File>
    <File>ctso-20251231_lab.xml</File>
    <File>ctso-20251231_pre.xml</File>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="tm263197d5_def14a.htm">tm263197d5_def14a.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>tm263197d5_def14aimg01.jpg</File>
    <File>tm263197d5_def14aimg02.jpg</File>
    <File>tm263197d5_def14aimg03.jpg</File>
    <File>tm263197d5_def14aimg04.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2025</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="83">http://xbrl.sec.gov/ecd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm263197d5_def14a.htm": {
   "nsprefix": "ctso",
   "nsuri": "http://cytosorbents.com/20251231",
   "dts": {
    "schema": {
     "local": [
      "ctso-20251231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_def.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_lab.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025_pre.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-sub-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-2025.xsd",
      "https://xbrl.sec.gov/ecd/2025/ecd-sub-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "ctso-20251231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "ctso-20251231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ctso-20251231_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "tm263197d5_def14a.htm"
     ]
    }
   },
   "keyStandard": 25,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 8,
   "memberCustom": 3,
   "hidden": {
    "total": 20,
    "http://xbrl.sec.gov/ecd/2025": 17,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 57,
   "entityCount": 1,
   "segmentCount": 11,
   "elementCount": 271,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2025": 83,
    "http://xbrl.sec.gov/dei/2025": 4,
    "http://fasb.org/us-gaap/2025": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm263197d5_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm263197d5_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm263197d5_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm263197d5_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm263197d5_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm263197d5_def14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm263197d5_def14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm263197d5_def14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r105",
      "r121",
      "r156"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r108",
      "r124",
      "r159"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160",
      "r164",
      "r172"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r183"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r89",
      "r101"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r128"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r114",
      "r128"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101",
      "r152"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101",
      "r152"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r87"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r191"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r190"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r192"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r194"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r81"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r193"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ctso_EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cytosorbents.com/20251231",
     "localname": "EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments Change In Fair Value Of Awards Granted In Prior Years Forfeited During Current Year [Member]",
        "documentation": "This member presents the equity awards adjustments on the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are forfeited during applicable fiscal year."
       }
      }
     },
     "auth_ref": []
    },
    "ctso_EquityAwardsAdjustmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cytosorbents.com/20251231",
     "localname": "EquityAwardsAdjustmentsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Equity Awards Adjustments [Member]",
        "documentation": "This member presents the total equity awards adjustments, which may be comprised of adjustments for (i) the year-end fair value of any equity awards granted in the applicable year that are outstanding and unvested as of the end of the year; (ii) the change in fair value from the end of the prior fiscal year of any awards granted in prior years that are outstanding and unvested as of the end of the applicable year; (iii) for awards granted in prior years that vest in the applicable year, the amount equal to the change in value as of the vesting date (from the end of the prior fiscal year); (iv) adjustments for equity awards that failed to meet performance conditions; and (v) dividends or other earnings paid on equity awards not otherwise reflected in fair value."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r94",
      "r105",
      "r121",
      "r156"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r102",
      "r118",
      "r153"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r189"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r160"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r112"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r89",
      "r101"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160",
      "r164",
      "r172"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r90",
      "r176"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r117"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r74"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ctso_NetAdjustmentsForEquityAwardsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cytosorbents.com/20251231",
     "localname": "NetAdjustmentsForEquityAwardsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Net Adjustments For Equity Awards [Member]",
        "documentation": "This member presents the net compensation adjustment for equity awards, which is comprised of equity awards value from summary compensation table, net of total equity awards adjustments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r61",
      "r62",
      "r63",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r73",
      "r195"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r115",
      "r116",
      "r117"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r188"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r109",
      "r125",
      "r151",
      "r160"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ctso_OptionAwardsValueInCompensationTableForTheApplicableYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cytosorbents.com/20251231",
     "localname": "OptionAwardsValueInCompensationTableForTheApplicableYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Option Awards Value In Compensation Table For The Applicable Year Member",
        "documentation": "This member stands for option awards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96",
      "r107",
      "r123",
      "r158"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r110",
      "r126",
      "r161"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r110",
      "r126",
      "r161"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r91",
      "r102",
      "r118",
      "r153"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r103",
      "r119",
      "r154"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r104",
      "r120",
      "r155"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r100",
      "r111",
      "r127",
      "r162"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r85"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r106",
      "r122",
      "r157"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2025",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r221"
     ]
    },
    "ctso_StockAwardsValueInCompensationTableForTheApplicableYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://cytosorbents.com/20251231",
     "localname": "StockAwardsValueInCompensationTableForTheApplicableYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Awards Value In Compensation Table For The Applicable Year Member",
        "documentation": "This member stands for Stock awards."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r150"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r186"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2025",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "9",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480738/235-10-S50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(k)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481538/470-20-65-4"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479887/480-10-S45-3"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479857/480-10-S50-3"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "480",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3A",
   "Subparagraph": "(24)(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480244/480-10-S99-3A"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "17",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480336/718-10-65-17"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-14"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-21"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476153/220-40-55-4"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001104659-26-077798-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-26-077798-xbrl.zip
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MX+<Z.;\Y;7PS*KVN_F[X6)OU)'.N7NLY\+SD=;O9MY]2W[WY 5!+ P04
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M=MJ&?\4QO>+W/^!I;V[_'+C^]!-02P,$%     @ :J797,V2DY@-"0  7&0
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MZWB,XM %ZL+:;F7SBW0&=E 3N[*]:0Z(O.$_E7:#%A8Y(\RCR+\2'U_FD.E
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M)$T<J ,WDRQQ??W*,SXM$EM3WR)=IA^AH;8J%(B'AGD$N-$VP 3>#"]F)A+
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M44SUR@US/[7>AF\WD21*\E(STUY6\^!8HVR,L<4&Y1?:)^%[^:CP"J=T&VS
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MW4IR*[C!!;%(.&($(3"AWD]P ])@P9AR;801E?U49A8HA&%>R9R% *+#J-R
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M9S41KQ5@6C&\DL8_MH"MJ54=IE85R3' ?B?!$,G3ZJ<!6Q*B>V.7Z +SFT%
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MH?ZE6M%0:$^H->9*JX!+$%-UOA4)PCZ32"KZ/3@1VXEL)3=SG@GZDW7BMTT
MFCY*:I&O?%QT!7/,6\5Z?6P7XB-& #Z9:FA$VE.]R:P26_M@D9U-0S74<X.9
M#2M2[JX<#!*NRX^HD)_A7[A. W]?Q&**'',SP93+DI6CJ:KMTY5I46./!"\W
M8JI?5\):R]TY30739?WQ0>EOZXF.5?:*:L.-NNYPTYBBN7MAOQ R;HFQC\"F
MPM@5?HCEDJF*?'TWP\],\+JE'5CJ=VE%$*D9.,42]5TR86/7>@=6:N([BOF
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MFT7H!KMF!LUN"['<'[.D?PMS2"J6^98.,1RDL?!OR!=;[:B]M'\/M: >HH3
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MU\=#)S3M>X@R,_:CTV 8+<8Q0<ANGXJ5#6"[&".2L=%\KN1]PY^IY5,BAHE
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M R:]U#6=$2E"4C.*VQ1>+DC82,G-JV"AB\MZ_GL*>TAY[VR,TU!L0FS"K;3
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M+2=FER!>Z/J@I,VC;V2:1<<'(VEPBZ!%V/\YB.BB5Z@HV6>K5%[X%(G;LO
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MO0^YX?;2:4;<TC)U":).VT-8IR/!5RHM_,? 'TB*\SI/I_U\FC+NUA5B"8$
M78799_<">22Q<.=5'/[@SH^F1&H>YID;Z15RLL(*I;)"*:Y0HE:(</-B^/_;
MA+C#D+A\K83CJSB-A'A +E9DPE-UAV;Y7+-\5/:@;VGLCR;-(?49= 1'83!T
M3W1-XH4%C':FOLBF@/5-U!7V38_\T08Q#=Z#W%XP?62X0-ZA21JB;E4E 8K3
MCU0$:BO4$3Z* 7)WC(G4J.='5/W1"_+[((B-$M;:HF!J3/,1,X>!_4\R@GH3
M1MF;9G"[9)G6O8LFC&.!<?NWQ)P!6^&/2;/Q[QCN3CV/8!O!;0"W;'N -.$D
M@##$\HH3Y4-IP;SBBKEJQ<B$0CKONX!(W&_AM51_ R(?$QDM#(NYRS*D4$/2
M>=@1)#EA+#CB1R1"^FP:":F4JI]QD'*;U] 3(O%,L7$3I0HL.%S%MQZ?-+,0
M'OA2 0)/TL/#'/82!B@.6@0G<)LL/! [V.3;&?/ UZWS"-'][I"X,J*"'!AI
MV LCW#KBGH)?^U2FHRMRY.4(<@;7(.B"91=S)'6U =%R#9/^E+;M%E\?HW I
MBC>11WL1+3UC&0#$T6[(/T(CI@KQ<& ?1%MV\_O$580E&1T,7##8XGSDE,Y%
MP[U8<H;@P4<LVGW\%;+9W4XCGZ495S$LW>;&E"$2&5AL<VPSE@/].?M\657-
M\B;\/M*&A>C8$P,D7=NH)RK>:UL1GB+HR:AN"SX"@@EOFTR1:C)/'#;(D*N.
M,-!HN.IAGCKJ_PD$(1#\F%A88*C^"![L^H.[,./1RDG HBP25[#R(N2DC[,@
MHL.=!I,DS0W/C>!:\CEQY/N9.TRI.@4_00=*FV?V@LS#%N+9'\((W4%"ZX36
MCTS)/$%-;JWNKU5KFPY>66W3[J:VZ0>WICRZ:A$K.PWA86$T ]63)M-;+C?M
MPDV04[B13BE;,U&6F&LK8I.F<%?@Y52Z/^'Y^*(^CIUO,.MO1$%:?![>U99E
M,?^T!*]L+%TE=&E8OS 3!5BX48D]DA72.,G [V.#X4XX3M$+I"N7@4B5(XFO
M W5'862G<#MJ$ZKDMO5(G54:H-ET@MHUX\M2O18'SNM,%;?5E@*_CPI!P1M'
M5YEN$MLL,;<9Z.X ;1)Q@\.^J'6Z$>$#59,K7KF(S"M$R5[5]H-5 @9>3A#)
M\E(PM-!Q,=M/GDIO)J,AR:H?CA84NKY!ZN';8/*!JYS$:\=?_!6DWD&<L7VJ
ME]B1TW47!O=9I:3U[>_I4X47+2P@$@JS7X1+:_Z*-C5>XPBL"\='EY/?)G[$
M9R;WPUC55(]"#*DX_P9C!@SNHCTG-=<P I1M)I*E:FGS+K2*B-$5?A@D5!L-
M:A\&A/IT&FLJ6&D%(]O[CN72S?W/0H-=,7>GJF\,GS&>1,DL>&;*N$>)C.B-
M+YJFKR+V8;)2;#.F(/ZZ=%Y;AMDO&..8NXC\F@/$1KU[CNV&ON; 5KP!@?N;
M]GS,=\A;RZQP8^8YBNT=W*%P H=D.(W[ILF!_RK-%"B/HIWAA&32K:"HV0FR
M??T$L[3@+U8@L3L==E_'D*QKMO(&A+W5,2%)"J$'1<%HZF(UD9]2[&@^6^3I
MC!,\8BP!;0QUDT8UOI$5XAZ&&3B\_(PE4@,G\GRR?Q;/+"Q$DQS?Y*I$&9M$
ME4I!S:>H*%6FP/P%X=Y\#9U!>JOM]M&@.%Y2GYDK+KFK;B9N&XX5JVOYX3!\
M..CHAP=?P K)/47SRD&?T5Q6#F9ZF@=C?M5N<W]K\':K\U:U6SE7%%D@?7.]
M_7=\"H;JIM$M<S/,5#_66IWVE4]*67 DU,@14;/D;.VQ:T'&.@=D9F"!C%$&
M0_1&8PI$L-U'] H5WV<C. LB"HB102QO="3I0^03'($29F F>L^HBVYP1W_+
M)65$-HJF1^Z!35^.Y)(8)4HHR]/5@1N,O,-77/\NB*<41T/)F\9(<$!$]N-$
M3-RJAWO65'E^<8BLRL;'4:Z&1-VJQH)!$QWPDJB,4_=&^FLRS8M^%)'>\ZH-
M09@Y#HWQ'_POV8FVHX:Q\XE/%RE<C7?X7Q4R\X2KN#^EK9XY*D:K"8(MD2$'
M3_@@8#7A.&<ZIIC!(#$%&*BG(0L%OTP%GJI=4QVXQ+BZ%2UVL$(F(/X*>*)_
MFP8T&QG9&-Q+<'SI^@<Y26/EF&#[Y306"5;&;6*+:*8(IK.-[_2,2N@T=O!V
MJUYF2A]G($>Q'2_-)7N,T5YU#ZHT;,/MPOI-9C47HW&\1GZ*072X+R8)$I3@
M38V[<!_TLA!. K[E_K[1G^5)EJ0]D@M0"1S*5A^";Z-#Y OQE;":SQ&6J]!T
M&@R#%(-FY.$5WB;<*6'L5#U"*E%4IIFZ9$%PV5K%=9WZA:<G<31;*Y$A*_6O
MX;LK\I69G9K4/GNT5T%$M_(E]__>I#ZX"FS!__4OX;L7:\\*A@&Z68ZQI_Q!
M,L'5N$]1IF/CGW,* ^YGL#'A1Y6%X0"$)Q<IYS0P 354EQL*KK6DV&V>1*2R
MCD#\KT7\\?$.:N,YQ]T@P\QCQ'ANYV<[6\(:#NPW/XSED(+S%8['P8!3JDQ+
MJ,[U5L&HO@]8RK$HDG)A8BNF(A^FRYM*I>B:K5N=/O,2PGRLN5M3_ZG5;E*=
M+U[DB<H]^V[Q7<Y6S2#LIZH!F;H:WI:H3,KD8RX4!,:/V*(*,M$>_"U*N:#"
M&:(VX:HS,%S 'L8I8D,^76(<AZ%JT0+O6=GPQQLY2BCT4XE$T-#X1^MSM%9-
MXAR^LB1.9Y/$64$:[16&8Y-O7P>W>!^KA6V9P3SR6'Z JZ<+JA%+71*TV4M:
MSU:98R20[05BU;)]PH4IDM27)%+)%+.T\TSR_NK"LI_.Q@Y?80%E^<$Y& H^
MAV,5XZC[S3COY1<^G1[[ 79K$=@1VME=I_Y^T@R"E%4 118,S&)J8P%Q;(98
MTH2)+U6S4+?8^#53!#2D>A6LUC%WCJI5F;^[I1B*[S]-'&B&RY)3$$&L5PJJ
MQXRV, Z\:I Z,I4YVK$M6 -\W8(S6I%NF<L:\FAYV.Q$JO5$>Z)^^3/+^7',
MX&A3U!/(4+&9.:VMTC9#G@A0D"+]S O<J$-?.@+H5O]E U+U&(U#[9K3][6@
MDVSP__=_'>[M'_ZJ#;!*',K*WJ2O',F;=U]W%G\MC&W3D[81K1K1(MW\)41=
M!7Y,A#5]6"T=J$#-1J8V,K6*3-V/ H)4*U_9]^!&DV><^Y^#6#26DV"8%:L4
ML'*!L=OL8NJ-Q&TD;C6) [,QJU!=@A_H(E.V,_3ODE3E2J<9]VCQ-\G:O$>#
M&[,CQ,&=8J0+HWH49HI!B-5MG(_"=$ A9K#]P:S;".M&6)>Y<A50)==P456Y
M'PFZ9BXRR2)L^_.-[RY>SUR[)R$(G0JFLREGSZ%35Q<=EZY&4[@DUTI%99OR
ML.U QES HJ8(*DD=W?#HU6')5G^WG.\BUQECV0'K*2J<T%9_U5RY]F3-0L"]
M=RN5C+W@_!$*>'4UE+/2$JU4*U4NC*+>NT*SO9W5<:3W=XE2J64:J!=422TQ
M8Z>NALK]JAJJM3HX*XI5W6HZU?+#%1-6B3OHEN$T&B+;+?;AY=E\L7^QUGVN
MA0UUKW2@S?6".8RXW-=[;+KD5,-AP^U250_5;="G!U-\K;>LL%C3,ZV_!6X,
MJ?VF.A&I<^.<:\954Z9@)H!5#\56)/&A:#C529%=20\S/V9V8SH"AH.W@^N%
MAP<;S?@==NN7FTAM <_^5U/JA<L8A>8Z8=3P 7E)[U5[Z%$2#Z9]+F0Z@>?T
MLU]U97NA2JO^-OG5C"^C)E+J:@NRPAA-;OC!_?NU4#]6T5!K5Y/)!G&=/96P
MO=2S*0@2IJK&2+*SA"13S4UB "Q6++A92<?6E^.X\^4X?PW?557D8 '(6FTE
MV2<G1AQQF1"^9QP7*C(4@@^O* CX"[=25KM.5/H#:R8,[HAD.*@8#U\ +U3/
M4^<??IRC,6JX?U(7&\JW5M]2N4B^.9I+([AY, ;.L7&IT+C%%GV/C@IE:+"G
M-DPI7TK5Q4DZ*^M];JO%GC52AZCTAJ9@ PM(I7L</_BOZ>"VU!J&>;R0:KSH
M=^H3#+NRJKECEUR2[N>N92H>7=C*EB>.CRU[K';GKS;C;[)BU\LJ5314YB77
M$]4[AKVIW%F2B)NY][0!>+,5+S+I6K)KDQK.^Z#O3[/ @H:9@Y;0ZR-;"R)"
M$"YI,,1[%:MOPB^\&UBJ2841NF6O-$?:D%0J +$].J0+>PR;WG 6B7.UTM7Z
M3R'+^<HMO<?7@,$)1Q*MG[S0U*]_B:/&!G/<F@1'0VK%,;QAW.SI?@YF^NBP
MIH'G%P]+'WMV!F3*H 5B>F&4Q$D)\VELGRFSW^;[7W/[%)*>GBJ[I@V :V L
MSQP$6/>+0B 74]7[E76)\U8N$)\@$$0+,0(?B+_AWM%XKJMAKO$ OW0?$*X#
MRZ]ZH[[.["/,#V+\C81#TV3?.>7:.A)14(R@**6=;O'#L4([N(-Y&U@BTXT'
M?Y3I<Y(=BY%!1K3JV])"Y#FJE#P*8: ^%SV;,G2^Z)4<HU478A.5@&<L &/
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MZ\AF]RT#99J@UDL&W2M$-[&E(@L$KLHLC",\I1HW"3DGV4-@QE)#]T7T3K*
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M_, SQ9U]GL23:0_>"!_6+-O/;08LOIJ#K.]/\"B4+F2:ZLWX]BR>A,?@9-_
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M?LS#9 &7C642D=5!9RD>@S=KWNJ3+YC7P'B;Y_P/>+G$Q2A0D=T\3\/>-)>
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M@H$T:^"9V*9[0)W.P90 OUG"\U$8TVD?P/S@MCS-*4>O^DT<K [ ]7(_J/.
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MOSRWE[.)R/_P$?FJD(1]/Q@D@L(Y_?6[!X<WLO7#RQ;?0WF2EXO:DPGVAV$
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M!7+2D44MS74V280,1=@4G094E8K\:[[FQZ7F&HNJ2'?O4<N?A0>I^0JQMI!
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MS!O5LL;9NKEXN&U-(-<;C,^1P%9!']/XT=\AG8D57W@U6&6+&(,2G]6V<G$
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MH%EZPJSK@OK%NHI@DM<,.!O(9)%MTI1Y#\0O><;(I*YUXG2[N5/0 G^JWT$
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MF#WE9(MWF53]8E)>*OVNCFOIZ5DR!W@]7EVKUBM/4FF&S_3Q^5SCI+YW5*^
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MN<>_;@4PNR$P*4"/;[F,#^3US:&GMIE_SYBMOC'%9)WH];B&O!=WR"].5W
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MT Y-UX@\P$8L.T!?R^$:D@-()H)%>3 O_Q-+FJD9CF /Y.RB*FO)8T)5GC]
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ML!B@4F"5'@I??(FFFUPSI6,_B6MB/JR;S'60_C&%$RC"98(Y<TX9<EF%MI_
M3Q,9KQ9 )PG$+KLSV3U^:P<@9OSUQ/5-0%Y)@CQMT'&]1"X9F83&6AAM],7
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MQ2_OU</E+V;023\)"^L<'?Y+FX$\Z*&YA7_AQXKH]?Y?%C1=YA/_A_Z/6M;
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MU[P[DO_==KI(?/M]?V =_7]02P,$%     @ :J797'+.>N]?90  ;9P  !H
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MR2&$9I8=5E7XT4_C.-KY"TJ+=QGMB)$&)$  &C_;6R1="$"?>R<' :ALOD
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M35 X*IL%HJ'CUDG+T[:,=[HMU5J:G2\-B0DPM4<J1DQTRM'2+&59V&BHB3Y
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M9ZF!GF/%NV#BJ7M710B0-EN13]\A>L)@97"^(@K^:)ES)Q-TQS:2S#XBB7=
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MI=.?5T#^?)5 O>*/MDN-(@A+U/^&<U, NI/:-OU^?*3@0W/RB9 %Q?D\B-I
M9FI@\8\&H7[>H#W<&.9(5+6WW@@:SJH=WD'75DR[K7"($-0]X0$!H HSC/]M
M;\6.HC,N7U2V%8HWR#^>0#=EB<!_1J@?L]KO_4.PIA^"74,%,U:7M_I3NNM
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M1F[Q;(J %\=05K@MP#[]H$@,#HZ^RGTD!5$H[P.\Z#(4?#V2/QV[+04M54(
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M$%Y(MWS;CVVDY[8Z P+GBVLWA%4JMBY(1U0]_^$MRA_=_7%I]8V*XC\0_=.
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M873!(R(B(*)\IPL.WNE[!VQ$I(=/D.^+*J*\LGE R>9Y!T<L+*FP$96*7>D
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M* YFM.+6TB.T=[MU/P>)0E[SR*4,X\ 52KPQC:<8.O4W#&C;[HEB)5PVF21
MF$>':U6,:"<C^7#_ZN.E1O9K0LPA3-ZFP_Y<P)Y#V2",)M@PV)O*HZLY"24I
MCU_OT&+NZ]*'W)?/IN7*CGRNL8_I/WVLN$(G;_/@YV-(3\F:-,6S< );%XC<
M(?Y*&S$ \#XJ7C[4"[-[Y>( <EI#D^C)7N4QZG^115QYI8 \B]NU4<<SO/^6
MQT%03+ZXA &C0\.0X6N"V<+R6C\I^U@56ISD6(^VR]'.M4HVNC ]?ZR7R()-
M TQ/1W$C,IVCGPWM:<WM[>1T?9V]3_LQ^:ILP#$T5V6,<_R]B;+IL!1-[>V)
M=?'RPY27KJ[VB9B^ 0VZSEI;,>?3JZ@&&1\(6,6>^^K$+E,?:ZGSE0;'Y=;V
M'/OX+@[Q?*;GGX1L .C'(O@F>> VK=*YP,6SZB)#S9J) 7S=9L2%0]6]O=->
M3"@@!\J>!FTS9G\J_8@&IA],\*%"]&(?\^ +8,1;;ZTBC1LI.YZW",=#I<?F
M9S(>_(R1<LAIMK5K,&J_(;'5OG[Y7G35\OB@<K'>C]1] T$LH+WR4"[0./,K
MZOX@"XY',PA7S!7Y)5?^DNE;_BR93&>];L4:JMYP<C:Q[/9W'@K(M;AB@B"Y
MKQ)\33K>+^]UKN-2K1+V$_0;M#'D[@><Z J)DO8NJC_Q?Y[#TJIPPNS##R91
M0.[%):TYU-5NMT$,I&:CLW?@1<<25RT-_,)4(G.=^>Q^LP6U?UC8Q]30U>^T
MNS41[;:5IK/-MU".,'?Y?T2')["4(FL!4RF95"U$-_EG;T5($7D_#'_Q$BAB
M"Q&&$R$N49--\"\)%N_'&S>*F1/F>FH2IT.;-P1'M<$HW%3'XM<B]/8%ETYJ
M?BD>+=!V!PB79.]_L3[EP6?&B*(P:IE[\RIE,RSRFG-$F2,QGU<QS%N;FYM5
M<UK:SHY! AU4.=L'?+=I81G."5*CECZE<6N77?LJSG-LW5O<<&$GZ3K.Y>*E
MU>%CH(.BITN\=X*[J,AZ&BS(_1,QOC$^5CS$BTS38:Y='9N<Y/XPQ!WF=?4Q
M\:-@KVY1;=F(!55U\9='7J*?['F1/6B3 ^B ?[1E4D&!T$XH,"N_K3R"#07:
M5Z# 7L9I(NI&<@# P&AU<>IWVWCS32M@&B+X"@I8@QF J "Z1/A_M%4FD&OJ
MZ#M+KEH8L'4_H)[3V&K4>!#:3'N0%Q, =.MC;V*D@4W!)MJ!%E^[7;RIILEJ
M"\<J@Y45(0,C-83?=$4L<HVBU P_K3#BDNG)OXA/KGITD. WMS%3%OK&B+DB
M@>YE@HY]+F,U(^A:O:S:BS<17$N<)YJ(:6KH:^7?->:CD?Y9HOMA1Z=-"7?]
M29Z;7#!*(VBXT+:;\4F[$C4/[1%YI"MR7.KFU5-9O 1CC"+>[COCQ*&5^\]B
MA.+(HJ9>:TDR?;[W"F&5EU<X%["=.C$EC?:&I\S4%9L 4@B(756FGIY]O)$X
ME$^@IG\BH^O3@6(5?6P@6+<'OKNY-FR^AS?YIEP*+Z](#.N [81J4P-U4<-*
M0#IO=JO,6D=+]ZMC^7PG$A7#O%P)7%<;M_-CA2C:I\-]=3K\4G5/D$]7\@D5
MW-2ESN@?'3X*MG%9XN?-".P!.;\LG1C*TO]LR+M,P#F2&_E-T]W?(AFOFLN%
M'[FW[O-F0':&"9%<&&-WQH2H%540NV0%M:L['0*6E._C'?+[Y,QV-+L;=B':
M:Z_Z<U5DZ!YSY*-VD^64$=5P/1O+V2)YA@ZJP15T/N]UQ-:8%D<?E+J;8\=?
M$\#'SLTD/Y98.<C1W7W'W-+\5=38/43%JA4*! 2R6!L1DL1#E(AT4+=#NNFQ
MCK8\#KN S =+P@ZX!(J3?MY'.3K2=E  -=2/JFJ$Z<U'#BA06?8A272EG#KZ
MM11"P:8N"1_+%ZL,Z8SF5Y91X?!D-**EQ=O;+XH/(&$9);+&&8UH3UL'PZS%
M[ZG$GB^$B1 *X1G)&K>$\2-]W$+R>N E*M'8:J>P*,"_D&7</C%TSE;L/FK1
M6Q+?''N:+\(G&>^@F/7U6=T,ODD".=>3T-56'E-'QG0H8.P>1654;A6NSABT
MGC'FP;JW6I[0?B4_2<8=QVS,_8@]G(K?$9FJ;&>IT-XY!0KX6"Q1%=JVG12V
M*\&U@1EV2F;Q7PPA! MU$<.PAG-;!?,IQT5)-H'YFZ*02;PI"XBA08KE]>35
M )(\UO-"9_'G46I-N>^9>MS@"*C'R5\9Y3@'BH[F+14.!Q&-A%* _&.??Q/2
M:(/'/MKM6*L%-+4Q!#3NJ&A]J$E@+.LQL!HF4<[-32HN"YF:XPPA&&&@/%'@
M5T!!(,MST*PAS-()+\NB'IS9%V;009RJKC:F"#O-J]PKZ0[LGK (8C-#L_BB
MQ=&-R#N%!K>=$,V['_#)Q-5XPKCH&OW1E MZ^%-UAAYKNU ])&&Y(8Y;2MI0
M^6+?29W5]Z#@]ODQ#X'3#PD+KT(H28=8-556/&@[^Q<P[,DHZDIB]-$;<7N4
MGCO0&=X)09TN]'7>#6=\-R\^M$NVN;M#$32++E_J_-&ND90_H2^E]& MV/!;
MV90]-E+D&V)U<KX5A M#B#V<;U5J=/G411G?FSC2[$OV7@'^E<\^U^UK.E@O
MUBJW45 7ZA&[J8# ;WF:H0CKX=6;-X(ILV;P$'>N*9E$T6--9%L^\ES>$E+Z
MD]1AHC:\(O'(]WFJ<M(=-](W&PAD?<2@?ASG^*YE$$V+XY9"O.8+0Q(UKN!Z
MM1$.73*ISH%XM2J,V92'E#>-_0N@HJ\RQ3*>F<VO<*(/Q)3P^H8D,?&=7O4)
M$_4=S 4[&(&_;45OXCAIO6^LJ?AJ'8SS2I2'4.!8!*>.VNLMQ0+) QM\H01.
MK;*#5&^%LNJ1TNS9I]K"7W#8=E6P)C\@A/.KS>[ZY*59G;EUW#=Q0IZ89>,C
M*A8A [MG=H,722WW>#ERA<84K=.Q&.V+6#OX0Q80R@115U2['ST6]B3T9S*/
M#7>#+()<;IXDU8Z,,Z=-?5E#I[;U9JZX-^_?N3Z7]^BK,6$)O:7'9)+,6W W
M)Y4ER@*0B"G?Q*XQO:FUXIK2$'J;)#P598LLVCZ'DDE9>O, "E"J1<)0'<HQ
MYSMWM.>5(Q&*,4VHCQ\@O3'LAN<C;\J=FFHTLB"M+0&1/ FB?"Q"A]"WE]P3
M<<& .U5D!J+,7$!30U9K+Z ([2K/MZ )U*^O&>(,Y,EXDCP[J9MN8/ZX2QH1
M=^&LUYY6MICOXXALE7N!U*I_X;'%R;<I/[^28+5%X_KAW#T:Q1+^/#E!.OBR
MX-R).L]TG1[FDT-[> GDA>QJGJGZX6VUMQ*P-VW+A0)Z=N -Y(ROSX?WJ$I#
MM'DTF34X[JJ\9N-[Z=BJ&4.P]S(<]:. $KV4\J G :4'3W4%\;/"P1ME\[SY
M-R4AC!,?P;D>F>M;J6N%J>S2"^28W>C9I 4CY]V,Z2L2Q_KHRU0,F'S7ZNG,
M-8SFS.]!*^^/F@R"*]J$/F<^'-IY.0PN3BGU-R^+/.):M;9]UKYD@H \U:=V
M*!O<NE9K;.= PH;HBZ;//'N'L!/3&0714.4=7)APL0-!>?YG3OJC+RNV_&IK
M<8F;6D]#'R6\0JJN:&9C027[<I+1G+(Y=O4I)HC+NMV%[N&::J/Y:?\*'0*"
M5ACEA=_B>-@HCJA=E('GN6F\8#QC*&:;012OQ7*-3YY8P4NJV3Z;:9[<6QFQ
MH5/?X%)BNCPB5C%\<B=!4R8!P513?S[-S8.FB+Q)574_D@.[4PZXL+Q^8Z'Z
MQ9)2YY4:?(F1%E%*<N;RDYUW^EU%>PJF]T QOE\S)^8U!(9D73)T$WDBA'DP
MXC,(&A'M\_+E!CCB'JE%-<N7EX?YHB7;A;ZX4F818$_6U7<O<V<9DPF?#@HF
MZ!3Z;D%3/2U/.TIEJ51]VY5 =#?3C)^;Z3\<P1$B.K1)I9E=2"F$*@^H.>\D
MEK3D$TM9A3(5F./IP#5NJW,RHST?G257*/!:''BE.?Y1D'U3G7EWL:1<QLTD
MG,Z X*E$@^(.';P67;+'W7^T>0E?W"3<CD!*!47);][)0[; 6D#\=SB27 :#
M.QK@&?*NM,S<^N4Q\G.4HT14$QC6H?O>OKFFIY!%OSY7DF"J%ITF>:;Y>2'6
M9CA#N2%#0R\-$@EZ]TV1A4+:*_ZYKX(-S+A_8TSP;E6\["@_P\>[UVU%T\/6
MH^(;S*KQ$97!6K0QS:]ERR(C9EN^HI3>DN6U%$,O&QDRJ[/YPDN8RU! OL7]
MDK8%!:QBEL;<-)D?,Y]]H0B+#!DC5$.2N\-#M<6 ?'@W6#IWK$^]5,:GU*V@
MN]#(_)5-["F%\<@ \BCN^WC:H"U4]"CE5E.F?0O<9=R)(Q;;)[&>1P4H=?13
MQA^BE2K])3X=3,]DU^8V1TZS*O<#*X:V[".PH.5[B/Q_N^'ZY#K[EW1O,%GD
M&-54ACWUP8ZT]O$Z#&>3%J0?GZ.(ZH.SKI)=B=JV9*']Z$G^*8.6X#5; T(D
MJ3 1,)U<.*U5Z2XG(R/()O,IT/@+:Z0"RV)\<.=2[I:KWYE#%5_#^0,9B@ Z
M!0_=T,H%:]2KNT"UQ$MR'"KMZ0_FM%%7IG,SD]ETAO:$%CURK,B8;BNNPZ'^
M M/::L7#>2PLQO<?6%0J+A_UC<]&A! CS P@[^+&3_7&F-!JLKSKH#@^0N&W
MB348+Q,T"WI',VUA?^[JT)LS(!G.A*X:H[".5HY"R/3$>V  ^1378X[NF47Z
M\8ZQS$9&"%:AKYJC\?5GBF5$XP2#32T^O;3;-/2TW=2R>-07RN*/4"4!LA2O
M.Q3>^R+XF7]61X8[4&#Y"'RN?#5RB@@^O!2^SKHU@7?]KN!_@>-1?U%I#YH_
MHWKX^.RU.)95BO+P):G@,"6VQ)4@XS6*=Z5Q*?(V&2977 EVK]ATT&S06$YX
MGK2Q.;]F?=8@M,S3:SDH0N)F.A52CG%^EOZ5LW:WM:;L[(B0ZHDV%29*UTKX
M,T)^]PJ<RY)>&45ONTG.FJ@SF;O4X0^/#3'SK%5B'^\U=+;K18[!)FG_XO J
MRXSHM#<HLY@:;U ;7_QA,TD\04AN V)$@&C:O 1S;_@TNZA09O2\Z5RU*D*J
MS[.^W4DQ/H.P7@<<!13**Z$4ZRA7D-;GA;(1ZDI0"F6D/<VD"+ W>QRT8N#=
M*YML6N53M3%6KN9+,TSI8%K3RDC?-CH%U\<JO7)W"[;*4\*,7@M4BF%>ZHQ\
M4D DT^V_N7E\>PT%M@=79Z! ?Q,4F*^'U,I+ *(_7O_0;^3DW\/^/>S?P_[F
M,$X$1+@)=B>*UW$2.' ]SO%]VMG5;RR89I\&DT<*UGCQ+KE# =89C9?8Y8AD
M=WC/?(^:5:N&[G<K#+>>9%OZHBY%B@:XI]Y?_6R,@D)!=J.N+0'8Q/CZN5D_
M8C,-Y,IL8D=.0T^"YY% ^HR'>$_T.MN+]8G6>+%LYO/P:2V!X/3YH$3[GI1N
MBEWJY5#V)*JDW"DZA%#O9R.YG 2E-F^&^.=FY&F^=7P=I)907?F8&NP1[Q9?
M*AB?D&DZSG455NB2YE#U0+N5X8TPURO*HQ8$CSL"IYNZLCAP[9T9.MR^VDT@
M0F[9]"_HEV0:MO/6YR3K*"0>[@RMLR%IWP1[IS5*:P(QJMK1PQ^R<=A>!G>%
M PMP$9?JBC *SODDT^PR^W-HOE(G@,K"F/6>SG7>>SGCI?)@C8MWA]%.RFO5
M:(1E[R77OI,UM<:79K;,X'N&04%QJ0?RBEJ?%. D</ZC*4A! ?((*%"5,);Q
M0WY&Y,'W#+:*VOSA-M:U]Z5**6[YC6LS9 &B L?\?]N?_ZOM=W@6GQ@*$::%
M @["N8#\=R;\GKA7&OF-8@7$$AB;<?X7-MS?W+>9ZV_0M 1.\!^I56A>]<[N
M1GUE.L/K%.A";0DM57@9UUZ)0(KR*/IYG5LO?+="+$/-6&$_A6@#C3B)FYT(
M_D;>,^?DJS8T4*T<L9V5DQ'S# AXV5DHOD,=4<W@NF"GS%6;I3G-6RVC21O>
M:TFA$?D)A0G?P##60Y>78+\5L#]1D_R2.2N=K;?I-"<C:QG65=3D@SMZ?$,=
M>T_E?#T@TZ&[O2K&) JK0#R3)I#QX3$JC4*!Q03 [QEDBVPG0HJ+VP-N$@?C
ME(W;M5O<QMFYT20S9+M\P"E0I^7AI7-N)R09B1&J!+M.F9_36Y9-?;(\2#43
M;PU1>=*)$=G_REN$E/0/=47M77'.I D1:'[K/L&"&$ZD4DO$P$N%V?=3SW<&
MDHM+W)U>C._*]GUQC,;V]FT3IS^A.&*4#'>:>""K"QO_XM5O2^M_L*'0+S6#
M<4=++JLAO;I??>*'*3MKWDX_Z[890#^>"GX.6DQDR4).<K 5:LM],"U9F.F>
M^L50R5:4I\O#&FYA+#TK,3W%.=IF3F=*[EMF+ZH2J6HY( [/ALHC6&3VZ* T
MN>E5>65UF?_NV)21?_1Y9J)G15%$['TV5I=$]%S)<P6NJK8LY-1&<Z*'\)(H
M4<O=(9*T(4XH#2>YLV::?A/,25\6KU4'_&=Y7B:1]F&9[[0OJZX?Y 8=5=Z?
M:47T>LA<8HEH>^>PG!?Q!+"6%"',"@EC[IIQ_W;TLM?I+- QV),5 .!L*W9L
M[U"M4<67P'E;99KANZ;R\>MUA;6[VZ'U5!Q3!V-K2MHTWBX@GD_OJS%9YCL0
M5UNP@"Y'6LK?2"\WE:3SOC>1)[&6%DHO"?7-?<IZ9X_%H,+7J4([S>@8K<[I
M0>247?SG=H2A6 %^*]+2'+5S)VO!@C U>P>6QCY]&R.*E863+3H$(5W'W7>D
M7 6I:*TEL]4(Q.U=VJ1\QP$A9TO7S]VR.>KCE0ZF<:-T\(+GK)@_+ ]XP6U(
MF'+[+=M:$*E#NJZ!8CS/"H';_=?(R.[]:0S.MC/:,ZV<H[/-\D1/C2+'71D,
M\V;H$!#7>;;'.>#\G3+UI\V<B)C4BW:YHS(CRH@D0D1:HWFVKXN]IYU*K4R*
MY(K-U.QF!!M**U%)P@T<VX))X*5T\*B$GQM<F(V9/-+,8S&LB#&,R_-7I+!O
M:V)-DGPR3+!R-3K++Q<J&Z J;?1E[5,O4_$]S8D%PP6X 3@/%'@/EM\*D"I_
MR<5G;?T>!PP@GGRW)K\9?E7F'\P'(/-G1432?4ZXQW&96/;$GUKL2P0/$$06
MF9"AI3]A>J473=G(I"CV*OXIRAX#DI)@Y^[I2>XW.H0H,ISX+6(W"\DC7N9=
M\Y7BP*Z@;%8'M-HBYX<B"T[]0^E"9#65Y0XUU7Z],A)EGLM!"_<:RPMH*U67
MIW/M[150^,[XTCZ-QZ2^1@N6W&B^V_+M;4FPO$ XUN&3_H*%<Y<!8^TL@Q!G
MGZ#Q[K=;*ON8=\L&IY$^D=Q*6,&"A?4;JNC[,E:(XXJD0G.'>X.XF&=,&CZT
M/ TL+ON>2J9\&+W>&A*</4K3IH=5HJ5W'/N!<IY%6Y[MV+%;'$"9C&Z%HL:L
M!>S\)D$"^(-ZL]*@"/9?U9M52A00_[K>C,N, _?']6:9'Z;.7!_>R4MT-B[Q
MTHA]%;:,B*UFDHC%-E:'5UO;O26$6^=&WTXY^7E7J+$X[(27;"E[,^&>90GH
M0\D\@4DOHC?:61(>^[0-03.6PTWVJ%E45JKIU6A2Z8@%5<7[(]SV6:'$4Y09
M-;FX4E\__I2N?=GI(^*,65.MW(+*@O"IM0<WB@O+$U=$I;^]3#Y[_85=C@E^
M?Y8SMZ*)/P'7$#>UJ^%!\V0]W]>G%YD%71Q0 &>RV\ Y _2B\&.]FG+'#9O0
M)X:H(5?X7&.S@/FPC?F_+KN7G=^;%8F8[@IO66;8:/0D:U&)S!KX/\':'Z8>
ML=,1-_=<C^'Y%(OL>)=]LQ>@_</AXK?9&>#^V_Q;B/YARK6Z'!1(N-:_OJE?
MENO1Z:[D_N?&2'RV8UGY X9LI(4XMX0]*WJXT6&+M2R?RO;X+Y.1_]X]*@ (
M_)T J;\\.2W9@_(W[BC^1FJ62>*=NM_F_XV)#%IT\/\_GAI1547A6Y+(#C*]
MR?]0>N^?:(SLV@=G7Y:(V2VRM%)3+O13,JYS1]3B<&+J@F0?Y?3351RH^[\E
M=+2JH7$^5VM_)*/Y)%SP[HE59N-)KCO"4GR"?5N_WH=-IXUI;=<P0N%0!O?0
M=3U/#2TH\)[#ZKY8M[N)EZV0]N<&37P(TOR&+:.0%+GG30C8B XD>U-%_&%K
M(R^(4,.0E1=1:3Q<R'N9''A>O#'^^-MF@+2;>^J"6[JM4/9FK_T<\45T*LCB
MS*V)8WI [/.Z563H-?,M)M983&:^J4E7L-$[S8V^L0 X1'A,T>02[M_Y=]P?
M!#ZBTP*/7X$W*AD'MON%8(+I2#*% OJ;4"!Y)3<3C$URD;#0/7 (ZU_KO=X$
M8RY64ATA%.@4'(("N_F08-=MQH@+8RA ?2X#!<KJKSBW<_+Q\MMNY5-2;GBN
M*)(#&-D5_IE"]/^1HO4*IQ669E[58\-!O:,QC8D.YNGUXT!C._AF*L+-@?60
MR+3%8.$=O'%/)KTN5,L7'YNI?*VK5>R\;#IX"!=>>W#_2XKT^9#<HT08^_([
MV*Y]:6.'A1'?ZB=YXW*>%Q\ 4Z7.3RJ1J:&4C,M6?@R?C4;M-?JX/#0HH<"&
M]/PHJ.1@/+1$_WZ!+Z'6U#'$?;WA#10&T*W6=W5E;>JH+T#)VT></2(3>MB0
M,B1BC:NB$V%?#*-NNAMA&[_B.&'/64?PFJ.*>EA[SL7PXE$.7VGY651X<*EQ
MWVYV?/^(.X$[8]T!% BRU[\?7.4^OM^T!W*1G 2NG&[858G\-XM9<%-HC5-V
M>K?HDDNX_C<H#0*[ZOC)+FZR]F173<:JJE(+^D(A0B+AMHS3$@9+:R(^OEF=
MJY_8MQZN^*!GB S7L7<;#PVCU*;2TGK*U?&X7U*FM?4./JM[\SQL)H\]!$O
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M<W;$%";D6'3"PP.)9'YU(0R1T'Y\00[Q':W4FZ7G;90^E>H;\\I04M E%I7
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MX5.+;)7J?9 Z/T2GAF\I(B.O\>XQG0U/3HIEALG4BE>T]S4XM/&0HHQGR$H
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M^'"R?W^SVR6C.VQPZ2U*T!5KKMDHQZG4<U-8'!U 'W18_TN68?.O$JKCS5
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M@I(S)85<)5CT;9;61WVN))P++Z-,15<LVQ#L.U4U35B%% OYVI6Z.^G$I(C
M[<68)'6P8@_L>@"S7A'AZR,FOZ#\F-R6_]7BGG6RH(-N*VLLQ68(74L$>-I[
M8JK]//4B#F@>*9MT!ZLTJY4\91SO*)VA74X[3>[>\SWX6NE/(VB229*K4<0"
M;;FUPM&!>)Y(%FQZ+?/U'2$ @)SM6<DB\"X?OC"$49H:EFWO<U95;"..IC:G
MMX-'P/.)=(<D-K";\CU='=M'L6SJ/J@F3L#2T6)6"I:8I:7#YT?Y!:?#DHZ<
M>BQQ>W2S/OB;:SVXC]!<:"/79;@^V;-P76H1W3US[PJ/Q=F:]$+J<V6L!(XN
MK)R5=K9B<Z2MCVT%N*NC ML%PS?0"WB*TN*;W=1;TVOSQGII-<YK:H=!1C<[
M;Y1&X-A*$R!U8]P?]>#.T#<D?;>IL]5K4A98AVKC=SX8#-[0[D\Y(XU+K+E+
M!-69/O2_MGL3-1'#KK-U@3G9\TZ+(($BJ36FY^M-U=S+<-ARQ7OY(LEJIK<T
M2)*BR$6 VM )1#9NA?0MV+D3/R>;@X>8=7J*,X!FM,0"18[,6]+M7_%"PO_'
MKG\<2!5H+MPMAGPZ4=]^]>WBG0_'0\^@J3O]6!@%.5EK,*& JF<ORXD%S^T;
M@VS,EEXM2W$K64KS%A/>^: 3"O>[ IIZ=B&7-Z[1L XKXG[8B782ZQ604H^0
M%;]&+IKYD*;2G3>7R")[UY#S4=B)AA?N=:LD0J[["F@=MX&F7M3["F[G/H,D
M[YI'_#+6%Y& )+9Q#[$%@7?R*N?]/BSWQ WIB+#(T>QS<!Y;95X[3N;S.&>H
MD*6>^@M]"XL9G($:$9=C-_VP<($VD^?[B25I?L&<>".8;T?3%H9",SZL:@8/
M?R@[?.Y9%V^3 YM=BX&.X^FEMZR5Y#<SPC"FHVRK)AN4VFD2$D;&82N?4/G]
ME^N_TI8668SZ,1'%/PQMP;6MX6M'Y\[F\<GH9RX1Q!9<K%:33L177>O T#CN
M *57#ARLYP;$6=EK=\4HTZ#:USO;^Y47^XQ01+6YH3VQ<OO2;3MP&2A.D7Y$
MJ!G22;6()67=6FV2X$B(?Q*FZM[!K Y&A2M'=TG+@<O\PWJPB)S$ENPBAZJ1
MTKX^NA [WKHQ[+'94^,Q[?F&G(G_O)GGF'<LLDF.,<;&D4^;C"MX<*.#:ED1
M)8-?Z09D<WV/JD+MW::$[.OPH>DEE?M&51C$>(E=;@D.8Y\KQP_#R299\O.7
M_>2(2B3Y.<E/;55]^01<A&JQ7281S46X3S!;[V-HQY+3.]KJ1M,U3MF[+>TK
M(-J*)N]?)B#1%94;D50%FB^O(P;AA4(6* SEW8=U?KVAI%;2P<CT$41VCRZL
M*9XE4),T8('XX$FX5LZJ!AB?XZ87$C.E$EF6F@BPU+9IF2YG1-MPO#AUS)\,
M]P0A9$/2L0<Y7].QET7U$0=CIQP0%%G$>9;M=A,\RB?EE,@P9_0O_8*I@&;O
MA@DLHT$=,AO39PV8G54A)K(.-38:?'B)F2M4$8KTE'(:Y6WEV5_%'B9H=X/*
M90.#:!A]M9@83D/=@O%"+S0^>%$,+>*%E1)IS5O@F49-84R2Z+$+VO)MPA(I
M_#,E"<(#]:/%U6PXS!W*%1[[2E.A3"BANID=3L&B/QF[+I7"3E^6//9'04==
M1$T20Z\ULCAK&:=@X)7<I#0=H=!2$E2@,62]U-:@L9Q"?>,WY::I5:'QS<'.
M-NLI%#.7"4V$34ETNUUU*(YK4KR\HD++[G;V$\P FN>S7_H<$$*K*)A6E\\6
MFV+X4Z*''BX/SZRPA!>YO-7OXOQR>P^>Q"8Z-SRL7>=3P++,)C-@R>1"1JW?
M)QN,5[GK3UDXGWGW3>936G7O*)<X_!"FDAQ>=24% C)L-'X<F5!%[&\1.>@!
MJA64-"(6D2P4TK!V)RU[%U *UN:3%EZ-MW )\#2-U#VIU_B<9AU]>A[9C1U]
M5O<9MA2JD--Z(POTJ;!:"E#I@3"YHX(<3Q3YJNF59FH-#)*[KH2ZUCS+3XS"
M?3H/TL'H"E:1]E3&[,F;U*_[V!^P5P*V''Q\Z[-<2++BX];< N_<7>]+K<@^
M=Q\%$%M*Y\BAGAJ*!KY%KW*=*T<*Z*$!.S,9Y0\M+]KP,)YFVB<D4,;0$*\'
MK94ELF[@N-L]?+?)&^E:0MS8, >@0>X<FFAL,N=O:*A7A!E%:\8BGMEOV+<G
MJXJ2+<&66XZ@EM30I)M<Y_&OV9N9K?;  #JM#:J(>KNB6WK.6ESB>,"A8NEE
M'*F[KE;4F]X53JX72WY?E@&V-K%^P:!O)@-<$^\_-U,_09G<M%PR*J[@9?2=
M?7@J*6="IDJ_,Q-I6U"BR_.51BM1PUS=4=E_"L7HO4"2!1+W6]9(I<&AL16^
MU.AO$>(6W=84<B%]Q'9[!X>-FWXR0DZGYL,K4>"XOK/=S7 \J0A!&UAKB5A?
MGP0:IVZ,AI(!QNNNEA:$J1GY^URC8-\TBM=A;;GMGRUW]?.[&CQ:G,)1I'H"
M>Q.B5)RR08(^4V<#Z*QYHC%>S".?(FY]G7YYGV<!)J$?*KO?"#@MG:GEFQW5
M6L]SW^;?.[/8S&_FKFT0EV"<K.1@55V][6AI B:_@'93/#(3#YFU6U:+0.-W
MYC98E"BM_.*><2XC3X6Y>7NDV!HEXW$1>2]@!)L0+Y#/TS/4UV..'E>T08\1
M2(&JH: "$M)]&PE'^<FW#16S3ZP4:ZNI^KD8^T3;% N$ONVO\COV#,GL=.0_
M1#9\9"[V"$W8-@UM,=1!!Z_M?4OQTZ#P%,R<5"3152 %79-PX=)==>C0(J6T
M:B_5 B5J;[1JJKE2V/>+3N\(%SFG6J)Y3<6^J?H$:8_9(NT1S<BX\(,$N&)T
M?"E_413#<&ZONCZ%ZW?NA=I_XU[X+2# -EX/_TZ00'5M).[H]U]0G^%<G$"6
MS*^ A:PKX+7(=\H%G(O@*^!"W;5>K?7Z7Q?Z#=<G*$^/3V@"OG,R&/P;)T/R
MA?RK?2O>*V"G<%R)\PI(EVGBB;<@19$MJD G <9B?APY5X*%H^^VP+D0R_A&
MO,S'>&8,V@ALMT/N4?]/!@F3V4R%&G8F['POBI33;PD<2;4E]2ON-'-?\#KC
MO:Z(FAG<(FGM:YU2($[^:))UF 4?+Q=@8J!-!--&'>R[XCXU4Z?*8IQE[SAM
MIR$_R7=Y)21,XC%+M^P9P&;]P+4B>PUMSQ;'0U55=%CEIO$>>6H$*^V;V,F;
MEZ.=IY)%K6[HT2;ZZW&C:; :[2*3#%C^).^'Q1Z5FP_1MG"Z9GF'@XJSUZ%'
M].I5ZA4\<:_"T8)3B<*UU2I(G9!(0_E ^:YE[TC?LE)H\7)OW+_E5QMP  0[
M+FY32.!P*YUXS8!ECM8V2#1<3<)-]HE9NW+0EM&M[*N6[@&9V%4Y>B_$C<LT
MRW3'*HRH7^8P,!IZV1V_D7NU+3=XV*MR!&M:,2TSJY&N:,7GB#+M$WYV;6'=
M[=9U4<2+=)M?%16][X3CTMGZ[X9,<D*%3]+])(LJH+XS3+;%HL02Z1_G>)P=
M!>'T^8"I6*$!J4!8F:P5(0S#CBQZ*)5& %>B)^)26"5S!43FF/?5<5IE"]&%
M 0^]0Y%[I$TLND9GR.32Q6GJ^"WYR8:;6(KE)+F<2C'8SUU/J@^9+$N#):H1
M[LM U Q[EHV,WIF@%\-9=P6P/9J>A)KS+>8#YK U(D7^KU_?N9A&;VW$A.N(
M$E*BAS0L19/O@!9RM5W"U$8+P/GY-&4!FN5QVEA9?:CAG<OOV9I](8PSGO?:
MQ%&Z7MW7_,#EP,]F#GI&(B4(S[!3J!AB9H8'6+D[ADH9LU&KN#QN#&RSZP3@
M^<#SV;4>!';HP0JH$+RHAI?]C$()@*'3AGQ=',K^5OUAP'+'L@(UMO5<A\8@
M-4#JJ.Q3K*[5G2*C5YV$M9>19LM:K4L7T73RU=LOJ6^5.<.!XUZ.Q:?#6P6F
ME=%H^VD/M<<D5#_T#;%)8'22D,TM>'.85XZE[MY]:V/G\/(=0^7^70)P":.W
M&$B0S F.7I5-VD*$ 0,Y0M5J7%MZOB(]M=C  "UN!1]NZRBOQGG<G^WVSM7M
M&&I;D)BNJMME2:APAX.VE2%-H'37;@:HD^DC91US,_VY@*;H!E3VN6M@6$[N
M= 87KPO2IC9^$#?.P%+#T>I7B85\!;@8^V !^1!HKWGN&DZ4A? LJHI-?T<A
MOK=D9I_F/K>7"(YE>&KF^ZU"%%U*#G/(-)F9UW,^,IST)SD6-YTSIQM?S*A!
ME?-49&E#3P C'L[N8&RWW3%OQC7G2/V31XC-G<^B*ZQ,5*?N.V\*52J%JL<\
M'JQ+UE=&M(' 7*<M[$]C9DRK8E@JTXRBZ:WYYO#Y=_65A_/CY?1!B],OB_-T
M.22[ )3,H417DQM[$J6YR2S'J;3!P?F^')CO)5'#VKQ!+H>GSZN+XK8PNI_8
MN9)R,&7B?0)A*J+Z#)8&03.F7Q"YC479N>R\K!Q^'JM":$00[3VWE#B!7DBN
M2)B-[9\Q6:-(7M]+%B&5GO;\-,&XLQ-.,Y9H_GEB0B%2M_5^C=W'R%=]\[A1
M=*+/1"D9#[X% 2V5H^5,-QW-]XT^0BR:+6U(/R%AO<6^*5"W.B--3 ("D31\
M';;>,JNJ+?_"5E;1ER*-'Z6AH22)FD"1FL_O>;=I>8O"0KMN0*U+L U3VRX
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MV33(=K)>ZT/JC.M=(NS_=/FEK\DLJSU.GQW2YG8HR2F^N]&5#0E>G=,$@C"
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MG#&O<JB(NZM!N.MXAXJ]'(TB$IRWQ<F0L'7JQ,*L:+H%^10>O-TM^M_X6[L
MJ>&5:MTO2N=$V\.?ZJ3XKH4)N=4!3K?!Q?*TTM^3&#Q*5[[<\5J1D.M953?
MFB:'PO#"7=&-=$FTS*Y(!5+HE](<I?41K333H_>';7F'!+H[.C8C$'**2&>I
M9J,>X2Y'9XS5?Q7>0Z0:CO8E%.V_X#'=3&%K8727E%"TT+S")ISTLB"T+-@?
M$:0"%H_ZSCRNIB_QN:/%K8%)[,.*\/HV\G"TR#K=]4*?;F PIB$@!E'!6FL$
MIDDXAI:U'3P0N_*V^![=5HC=5N9.BE#RUE$?HYA"&2B1K 6S5F2]('P&1#FF
MWT_O@14'/'J/CAM_G-(3G 7\8(X?=2(:P(AQC'59%6B:)D@JEO\(UYO7J?]K
M10?J"!VWU#(N8BF>#EN?[-'7ZZJNQ^%[2YEX$1Q\X5[JX]N@UW9\W>!=U9W5
M"MM'EK?W++WV8M:I3@F*DGUS78MQ=ILK$V>^<//&Y=BOX(]A39X'N=]?K>%)
M<75ZTG4:-OYQ>')0D-X5X198<A0,EKW%4?:5\[0;RV(_*_=Y4?D1XJ^[7&_X
MM<G*WLCRB_(_9PFCE""%RAZ>  (-'@&XS".V=F]^BSX"'L#A]V,.V\&5;]A,
MSWEUEU!IF"L-:4]Z"V O51)@=8H*HD<_H#JG\0FSY4@0]H/,&W9;CWRK\MM]
M-(TQE7^B.'OIUL2^E+T3GI\D=5(LNY6!DNN_7<^D>G$5R<A2UFVF,.I \L%
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M&G3ZI?&\GJ=,]')[PN;G_+Q&\UMAP9R32+((,H.O=,D;_=9 HMIQ3,V0V.\
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MQ2:!)('U3I!<IQXT/S@D@R+X0A-LK17ADY_/1PY4BBXKAYJF(?.X51>_&12
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MQOZ&@KOXX9JX#(T!-.<J4E]Q0V<LRD6L.*.:*-+D;2QAR=,Q.?4#UC5+N"P
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MU@P[&;!(5UQ%&["]Z4$.T[F3;^5\8BXQ42ACIT^3:A#G!9#S0M0\HYMR[!$
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M#QN?^TUC\&&;O$/;\OWJ3:V8.4BEO]WB M93O7*D9K@ZY#47*VQ,6$E_&!]
M[L4-QZ6,KU_-P$J(F<[X8X_XFREHY)T GY]&_QH."<6I1R Y-P9]FYL(E%E"
MTHBH X_'D.Y'-_=#V.DQU6=D&%I%(&0.1\$$1%/3CH>*'6&!XS3JB&NG%!<B
M0=5Y0G[OUV@C)4'-H"R\;]F93)#WJGOM*/"=#*2")[<^OIYJC;GO62W[T79:
M5#<YQ0N=XMCFY-;)=QJB0^!T/HM&BGZ,?_DB(6M5?W:I@J_P^GH7@R-"W4P9
MQX9+3HY<W M:NXZA/,C0$BC[=*J=1G"Z=NR9!F2D95D;5XT=UN7U@CL.U"!L
MN%Z[\90)P<!NC6_@B*?WUI:.B<*U+JW&XWJF0MX=;KJ/_'::YH3/K!;BO.L"
M8G3;X&+[("I5VE=GSQM[ST^6JV*48J1'&F;>FH>+S<WG+1U]]5WJ'=UAQB81
M;,5+< E^4^;:Q(=" ,>;F-ZOQ^;;@G7F7P5/LB;\)#Q9=8G"LS6A$KQ6JV@R
M"'L$" O2GCRG/:KD@MZ2Z2%[Y89HP>&JQ9>R*OIG0V4Z*T'WS\F8*_PGR9<M
MU9!\ SKRR9I=M(0(O#4<1N%T;$22I=C6XO8@ROXB*W5A.$&H.$+VO8H6M"GW
M9;)<+47L3B2 W+&JQW:>Z8\U=] &,KKDO9\1N:H^G-PY0 P>PT*^X<GU7;+O
M=1I>[*[GIVK[I6M]B=Z+1P#C$ZZ\/$(Q(KS#H.$*JEQN:TLND-?[SDX@6W#4
M]\]=GU(5)D#[6Q?:XVSX-.1[&QA.H/B47RF8[S PN.6^1.W"G^ +60XO<A.^
MY)A,7?L;@P;"%S_KB8HZSFGA QE^6H2:)<YZ5/A*_4(SBIBW&I&V^.A_DA]Y
M/>[5K\0.Y%26<4A@:PR,\<F:8_S-_?N_\/9>04TXP-=H: *A5^E2$B! 4!"0
M+AT2>NA5:4H+$*I($>F]A #2:^@@8" 407IOTB%(+X(408J*^KO_[_D^W+GM
MFSG/.V=F=V=WSLS9[:'S-V5;"K3,?_5 <#Q0S?Q;?:>]VL+GK[*LG\EPX%BC
M D!)]DAUT?5K4UK!RQ709%$6]&9;F^9J+Q@&-*EHL[6BH-D#4XZ 0VG]1MI\
M+3YRF)%]-$"?FVE"LY%SME2*$V&)-G)DSRL85M)1>92%(BQ"05?SDKM#7GH)
MD@^@/KH^&R/WZ;&E_:^<WE(JEQ:$>GSUNLG1]<R:]F_8&-5]5"'/933"NZK[
M!C98P".W$W:A^ACK]FS)W/5D)&!LC&;4I8-&F$\#VMH@K!9+/O2_9E9S V?,
M\QZ5Q_SZUN4Q+9M"3IV?P3LD&F W4JRF.I#D05IS2<9<Z1.EW;FEX6*K'$%X
MK@%<0#4X-/7QD% <8[WSQ;0/Y0T+?CZO(P6FO,\>.TJ/8;0=ZT][0J]%04IO
M(_<?X)\4Y^__S^]@_)_P0)Q/O*T"RJ=CQ%MQQW!CIDT[4]'(@&0HG ]2Y0GX
M'+A1D!]90"W^T*(RZZ_$A%-E#\00E'Q+(NV5&6&X>F,60&?M2@[2<J@15<\X
M['H4(#"FX@A?P-48L(!(G3N;B+\KJ9.L16D^,3ZRDV U*&3-E=BR*4SAE\V0
M\Y3'4[J6JM>6-$5G54#@LFR\:7C^N9MUN'GN1T&%9I<N[F9*'=,X$B36U87/
MP[.&2ZV?*8N+*2HS[T]^M?_BN-C=X*N<FJ0$0>F&F$;;&TQH[TLJ>/@')UHA
M4<KQ"*49\=]WK9L:5#?%8I2,?,,N[=5.M7\"TU?1R^19$]S^OM>^BNA&\HYS
M3=C#("4B)I.9-!_=_N,?HS]$&/9K>MR^BKFX&1)%O-N[[66;Z9CF(M"FS<F/
M3[EI-B7XL>F.HKZA1RKE"=M#0"MQJ*P6@/1"A1SO?N7[ \\X4)?!U[N+5?RS
ME1W'LD MPZSVO8R"^G5W\_&TI,>,O;V_GW$#XF"X<WU>D//SBJ_H7#]7JOD:
MMVZB6G?P'EJ.V$ A)#GCK>!^ZV6>EXW$@7[@&KN.GI9@@!6WF61Z:81VC0>9
MR)EV*!=P,L3DM'!\M M>J22X,9&F+U;:X;YS3S=QE/VHJ(;D$XM?[TQKL%5]
MOH/R/NT\F2^+],'Z5\D.)L8*QC)L<OUOK@FY'9_2^9O>]PK.4TUM*L'1V&$.
M75&WP;<2P_VV4.&VF(S(D)975>WD3212G)1G*Z5'*V+6IR;B;7<-4U#9;Q_L
M7ZC[VACMF%<9FC)G T8&(MCZ&M0>K%6=L?YZR+<'=XC_BG1C2@Z<B^85$.U5
MI:3C91$EO)NFK&'FMBBKDI]D7!B=%OSZ8TJ:7PSS!G?=#IG,6 6/-,G12]8[
MX9'.58$[8/P$_I[ISP231POQS?L?HP-L'2CA& 7:4TD=(5D#5 Q7W!KMVHR[
M3*GG)PCTXU7@J^"A!E'+A_*,H]?4,2R9(VQ]-T/.:S:$B;X<D0V+?[W18[;1
MM;HP"F>LXFSK<S'0B X8E&;XIMXOBB=\O5R_#T\.EF9 YUA>CN=A_5#"WE&&
M(%^K@3$8'"9KX:/,WF2!;\$-[0?^3)UH)6R+Z3ED.SN5E3TSL36]!Q,"\VSQ
M@(C6HHA7&@1J7:87@DSX-WT*K.[)+^P%TT_HBH%8<!]B6)0B5=GAF1EO\_XV
M_0?HBPXN\B(N=O&QUHOF.Y>-7?.$8,G:UKX7@:X,06D6G\*OS[U:D U+P9<^
M4]U]_U;:K/7>&8^IN R1@5!(345V$>U0AF.>:V:\QBS]&>Q%R"UE F;51WY<
MG.$S>^6?=G6X*B*;@T]?5$3IJ<XPN;N(SSCNQ:<% U@*T+\N<^G&I2Q$)X,-
M6M'>4ZSO7 *V?7OVR%0"K7):TZPY=]:-+732TT^=6NRMI,J$)P?EZ2A7D!OX
M" B@AU45?0U@]2ERU3CQ(M:[E(_Z^/%.26Q+4@0&_=O\2'3/G!GXBT7T4RA3
MZG +4LS5)@G2O;8_$^W8](X&KOL_^TOIM0NIS&%%#*2WI 5-RY09G<Q0_\FF
M0<&F@7=##P)I\Z^ 5&YW8ATV$A +..@.\ROI5)@::@R 5FH&?ZIPZJ,_DW?T
MIX 'FDB."Z$MK07V>U]UC>F(X0HR" OI(9DI:Y6G-[4?-0..6@XGPQ^.(>5W
M/]!/QBX.0DA6L=77C*8J,XM"Q\G!-DB"+V?'QFZCWZEJHK&D;HM0YUI>,-\0
M&9EP'!R-0S_".D4\->,EGRHM%'BL:G\M$+C\+CXV"WQCW5[C52(=-T>D^\XM
MF,B2-$ANC%R(>!E%4 @-UA\*UPT\J-)V?<KAF2LF;GBO0*U#IC6BYRM,I,^<
M0JZAH>@7/B'%IV4@2U+E'0N/J87BC^E.9G0,TX1(/V(5]NQ*]CGFSAP\'KYB
M*WYQCI@X>,V:"VWGR$.71.-P#R, $%*ISZ2I(A" ,YK2OFWP-#GD#UMZD6C!
M&'RG)<<%6KF B2'.0$>4L3](L:7KF IO^;=:RK@C<_GEA3]KP_DVH@ I@<F8
M5WWFLV*A/ (!:R3O,3RS\>-4U^NJVN/TN[FK)U7LYT!):K.FWU4#?1Z2@,-L
MR7['ZOPTKQV?7K-^Y\AY:1^H%[24 !33=2C[&BIW-3I"']W^6S9 DAP4X?J$
MOL'&JZE+@ ;Z3U_<*243,LG;AJUQMYJ6S(4KC?Y[1+0.4(;^CO,R\=)CW<B^
M R_: L&/I9>96[&0@\8R>-JC2V+5D\;G(*;$P>;)SX%U6N4=-GQVG YE4ZV^
MYKG>'W?LW2(BL[]<DT98D[0]*D@+_\4JJKPQ^,%0C2?]9P(#;CR7;\QAA%,-
MC6EH%=Y7@49'9X_UZ5#>GFEIY?><+A5V-$R$+K.W0\KFD][5Z*)HDH42?W=
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MQ%0+(VO&%QCBK4%8JL<-E*"RD>D2N[: (_PLV\C"@YN_&@E$8LB-P'H1!@9
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M(;+B%19B9SM-I'#_R//5!:HK^=X%?KROY>C[NHY6X2_=40,$\:F^A'*,Y9M
MOU9*]GKL9OOFAI=>'/ACG! 9N3V*C%:^Q/B+NRH$D>9+2^>>\?3C$?Y+!7]8
MMJV-9T#/?(M:OD]Y%1]U' 75[^CW*\2E-T[=+N^#MA7*/U>7$PX$>;/7 UK!
M1+0H(](&6;#(5;43^2;O5I2FNG<XG90,-EQ].3BHJVZ.RCUX[ /C9:$P# Y,
M3/<;$C%BOR%]>VXO]E."\/-;&%(N".G+S'R9 0&TJX)87BNDPV[O]'5?>!=0
MT'Y8;O["X08S>B8Y(B4W%A'[,XY"\>,X;?#S4-0FS]@&P7'G5X;+QU^HR9HA
MR3E9,$WI"#.B2JTI?<>/ #H$S&J4OU*:G=T1%&4\]QPVI&?W<D2\'2GFZ6,[
M7?1[\"/I7_/,)!VY/.,R4$\6\="8'^ZFISS .!>MN-9D&E,A (3M%$2M;(5E
M2<\3^JC,;$\S&MKRHS(./K8-XJ/^E[7;9;#^=8*1$5OO-5T\]X<+GXTN1<ZL
M84;H+7MC'Z(S*6G6&LB88XK%VAD]*HJ*B(HAEAB18A#>H+\RE4%,!B\O<1@
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M4KI FRA5KPJ<TB7F:K_,NF/)<[%@)@?#WZ#\8/D^UB>CN4$G_GXL*,F)9-G
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MO7UX3B#U^HCCH+3.#(C&Y.A6R+$U;2=CLD-E/KW<1P%J20#',OT/^]FA2H,
MQ6N-BTN%O'WOR"PG.$:YNMQ(N^<*>I4F-^8+:QJAV7)2  61Q!!E$?%VN)OL
M:>@O^!=<K]=D>OS4N. 8\S[MMM2 F%O,>A&EDHN*[YU+YQ*/C.CSTYRER4.W
ME"1Y0V3C! ;7JJAA!GNI**3$#YK=8HWH1E,>YR?[2'+C<-_ H\A@_9[&_JCQ
M!P$>K,N2 ^#(,E%05F/W3SXDN8 MP(W,)GYQOCW+BHMU8KR07GKS7<-47+P"
MO)/7]R#: 4#TG5>*[>GE9[\EMM+Z<V7N)+11A7<.YHC!B%K?$ ;G<I>98X]W
MT1'R^-[PJTMTD+*[K*GC>ST,.E58]&N"FJ;=P$$612;TO=O.I@9QIG]6O')U
M3M.^IV&^?YM0P;Q-:SF_W;B5"$8"F3J:IRU)0>JB^D+JVQIVAPPD)N(KJ[3V
M]'I!)>%9A[IY&"-O5$.$"S,2T6IOSY)E<VY6WE"ESO\2]LUG.K8@)GB9=J"K
M[I614G^+8#Z=[D>S?E$+?Y2(G<UT* F.WVWFXA<,T#0V9PK"VW W R"E\IRZ
MR^3X0?/M7$:AD-$T=?JUH*&:7>'%7B2YK'=4<(-<WG3_::'?$,./B/:[6K5F
MZ<-$E,2I(R(3RG&G"H//)>?'QQIU@]9.?8)8Z=GE^O_8H(56/I2U!1[2+ JH
MI?]:/]JK*X>S__X=.<WL\H [%P9<G'Y(;LYE.*,<GTM;"D^OM>AQ4Z0Y2ADF
MW#M/R<NY:(B8/ 83Z$0?]&Q0GQ?G1.MA=&$7Q!8I_U_NYOTO_HO_XK_X+_Z+
M__\B!K3\%7,0?R'S^U%$W/);8.Y6O:X]CR2/=,XT8=0>OMZCOWFL"]-01>KX
MX7[7-1\WE;0L'<E#@JFSCII=[>\#D>2!8%I_( V-"#CJ/G\JCS7O6+B?W$$T
MQI:EZMXF-:N;/'MI&UH<XN5]>[AO#@N&I[>* XB,R181CDOR^84.B@WZTY=;
M1K&G=&/8OXB:0_,81800V3L*HK3F/2+@1G#])@4V,LI1W/RQ\-_*Q/%N!#L2
M!:X4DS>H-M0/KGKZ'LDZ\/$2! HN/F,IL/2_? ?-H7=TGFGNWRN,-!Q-W3>C
M56]E 5G7;[$.NS6-W#XB*'DK?W9.#YA]R(+?H]_;2WYY?=M=-(A/0,&0-/<=
MKOUR**3DY3C9!8+B_?%1^;@:*9^UWW!SA5Z>YP ]AYWWKI:QJ$,1K:(Y;P8B
M:J>EM7MKL>U-[W .9EO?@M=<:")O;Q#,8^'"(*X*+\_2U#7E82$2%!!'VH##
M!\=HH /)UC=%81MB(&8!?6_]++?VA!7ZN'9+!93W]9Y),$$6BR>D#A;C'@6X
M?@[M-GC-9IQ7Z 85'VT&Q5IV5R1MF9*O4VU5?+R.;F;9M]0D=$B=DX\P'UH3
MXD_XZ7(;S$E%4X?,J6$JK],$0"H<"*:XFI=EQ;OL];Y19[\*9>HJK84-D]E;
M;\W->!%CK=>@&!IX8\9&2LQ@(#S#$DPU;&M9,_O-_HTJ<N&]<<L2)'0^/ZW0
MQY F&Q^*Q\1M*<\<(QE^_7CUS;Z.X[ ?CU4(A&(@]8E.WB;#UH)(J;['$!J&
MH!!V)LR<6NI]?G?/N[&AH(3[(:7*WDV&6(*_?(1\J^B7L*])7FJ5_!Z^YK"/
M<O!JT1%Q7CS1B +:YW+>I,VUTV%N8(#D2Q_?<X$TE2$A%8RA@:GD@2$:1>;)
M.4A-QD7+@>!R6K./4SYL#2U^XYF0W,P+Y8\7,+ZE:;Z*:R>"$0Z$/T3B(=@*
M4X?E#NG)G-RC2RK,KCVL%,&N#V99G-D_3C/L?42""#M:$H;76*V&0C'&MGY!
M_ [4H"\>P9,YKZE@:\W35/NAU"J,@;&4?ID0;NLNS I#T=>[ZC\CN7:U=UY*
M+8+CF;I_I_&8NI2\(<M"4#?Z%QF;/W4E;_@<#$=(Y3.,]E/Y*+%MHF.[3>+O
M6(A?)]OX1;?=U%R"&=ZV.^3)=2+[@"BJH#TU5B@JC]IL2_$$)FY.U3<,%1<
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M\^YP^$/B=]]XYU %;MD%GBU/OIW\N_\_W"??CL *Q ?^BPBB:]5_=JP$GGC
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MU-;SR5-)%;)^I4;(%]+%!+1FG/7_C(43R%Z$'6Z4/CO0%QS2[?YBAQ'S(2M
M8^\H[JM_.#*+!HUVX7"![ABF4-XQV#LJ&PJUZ&C:#IMW[AT1XA]9E\ODN 60
MK #K!R,/H1U',T:I^%S^<L<Z?QA+0!, R3"<>*7YV1*!WM:%)(<"1)+Y.C4+
M\UW_39%(&-7KIJ^*Q&9['<[?FD:C2&PU\\K01KUN%3*-;5Z+,1I3!QHCAQ^^
MI=H^KI[;JD[3<TZCZ0H5)H*Q(9R1E;U#%(EPKB)*KS4N [ZE ZOY::FP3?1<
M)5_#DCWRJ346% %,FO8DSS7F4F5O+V+T'ZM\7O[*8/3?XY'_;:"W/3>Z!62<
M6'Y_G+LF:P&;/%+]%8R9_"_4.G5"PQ].WK^HH3M_)S9X:G?^7JS$]/S--OB7
MOHE**,WV#5R#=Q/+@XIB6\GS<4*"KX#:I)S,8U8V5W)Z<HOW<^MH\-A%2JG"
MYD0<+'0]D 6T#SO?/.(6F="_=%('N4*")<O1I!YON7C4AFSIO7.&@0;A!PLH
MF9:?)14-5NY-8Q-OZD>"(XLJNH>#%W1Z=^GZF\U5#64^RSSQ$GV0BI6AQFAB
MJ"7]!-=??,+-UVC!4<$7 L->)9+H^\M\_2[WDJ(R .V,/]-;8CO+$+")U4EC
M>\J@J 9.C$D.Y3J4B8R=\;-^3-!"*!SJ)#/AE3IQSW>!<=0;B<5;CS5Y"2F@
MMW(2\P$B?8/D^T&J9Q),PR8BI7<G9T\5K^P=Y^1F>Z#@B+S+H\<@3W88PCPT
ML!!0E?;$UGI6WW5GO9!.\J96N3!)<DEL?K8X3V36:[G'="RD#>_9V,EJ7DJ%
MY:/8:_PN4*GS]>%-QAL]=\<?*6Y!0,?!*%K]" PR\<=V_KM8Y:?'@7%;L;%N
MST^91LR2976V.1;5:VKOT!=*OTB<'?D9<UR#R\TC#V&FK\>_#[2TRLL%ESWP
MPU S,-2CJ>9@6%/]-M>!#,.9@%C$F!AV]BB1',5&EF5EDVNE^X"G4M0+/7:C
MH'2C%"X=Y?[21BF&OJ)T643%&.)O.)E%,*;O1ZXE!*"@/N7FR1/E;=:NF[CN
M;$G+] E#:#V%TKD4(9@[[VB15R?F"?EQ>8N"W^TY8WZR;&Y5B>VN\^_8JFHN
M3?UHV'ZZ*KY_WT8@A@E>D*.ZD14R$Y)OIP]Z)O;;,\AGW)7_>T<4D=<*8_N.
M!E]:R)X0'&DT2I)&G,7,?0]7VI_-JVSFOY:Y$A6>:ZT*@L[FZYP@MR7.?N4$
MYV@$"68#7P '>'"J4YC;94KP+(.5#]&U9?$2QD8)5.X\?R4[9TD'OP6D-%I?
MME>="'UV?W\+Z'K4NDY]"[ 9]K'#GLCHO:I["=G12W0BP\+:4Z$I%'S,:FR,
MBXOQXU]*E7L"64V?W(1%W(#LG>5*-:^]^%)EU+@[,RV.=URB![1;,BU0?81V
M_&Y+*6S6G,&- =R9!M[PP-2YP%N RLP?/_8A/RHV4;\*G:+X^TKW @+ S#6_
MKA7+4>.6-D7EL??'@PS6C__X(*3WADSKKPY#ACLMYBXB,ZF5?:IL-Z"K*J*%
M(^"3G_:W@&,=(_3@*6J^XF@#>[)>EGD7A%O>^Z;[2#%2IAWJ.DMFMO<$<[;W
MUAV#+>RHQY9\A93DQGF$8@8(7<J9Y7AFR6=^M_1/.%(?<^;? C8C%]:BCT=O
M 0.5M;> ?$C@ND9>]=;_W/T:_ZP,S-^\EY@?CZ$[))(#3O4,MMV&R#MFNFIJ
M8+4S:?W\I$/=)[1G\+OA=X-&Q>JRO!BS44J>X_ NS#>.$3B09QVJJHTQ*O6/
MP!R8;8-#VJ8$<U([2UB1JZEWH*/]<CR.//3!!OO"05E^BX9T5Z\'@?2,R#8?
MZ8D-:E9FQ8SOAI4K<RKULD_B'+?D&9H@I\$_[3)Q##%)>MS"23%'A>@T,]#P
M,I'\RM32I. M %V%W& 9+.0U#1@^K5EX%T*.N[5\?;];X>&97N=/50 /$$"?
MX#3> +\KXF C[LRWSO*T8P#R -B-)0(GQAZJ,?EQ<N(N)2?XCGW)$_EFXLY6
M6U(!4<W,%5IF1E/<Z%/XG)W:?-3R[[U;=Y(W/'M"E=[<]Y/Z@8Q]UBU J&;W
MDR:FH("<B*VDGIGP%K"F/<6SO5/@F/:)A2W&G<B&M]Q#ATYG==O"&._51U01
M)>G6!W>S?AV'?5_?<5_U]B7'"&GI]D)QMNH(":0J-\0\J%\- ,N9"WMEX7$W
MK967?Z-XCYJ2X%X3O,UN]!L<R'W*=@Y4>)3[A>D#OO.6?'E8R2NS?;VW0D/4
MZR*C_-[]BI P/&;@F2I]RI0_:G<\=8'ADZ;H76&(_"T@.O]^$8=L4>%FM\QS
MJ!Z6(8HR$_0 S[]UY(@_=O;3J%>X$R\<:&_M0JL^&%H2K6#X*/&.WWW&#I3S
MUG\=*"5L:1A^-TF$Y'W)+P9,1>3X\@Z\>H5).9F8QI,>C62"=P6J[!Z81IQ]
M_\V<1NON@;)3& 'GKU4PM#V6O;E3<I(WMB4C0:>RY:<939<@0X6E+(V38 I>
M3@P-#2Y(O.LBM8AS408!Z7#?>S]S7KR-#<]'.]"=9:7(A+/VO9F=I:8U=LC%
MC2++UI%5+5\,VILIT<^K8IQ12Z,Y*]F_NM9[68@M1LE@W#+0Z)$YQS7I&)WA
M)IMK?.(_^ [_@^24#QQ=_K$(EA4@>0W'MWLUW9B:5M.&-'LF;-A5IV#+J_(V
MW\Y2$QG++IV"EQQTQ)8Q_^YWHZ3A;\^F_C$C?Q4W3'6G-V,#![>XV ^7/';!
MJ7=^#>50HC.$___DY<[_Q*  #\/ET>O>V(X1$]M+$)=5"15YB3ZYO@+.?@%Y
M"CWI1\XE$\K'X[2>1C+:A?L:'78;?+5SKM-L;'RI1B2*;_'.VTRQ>*2=KD&)
M=#O^W7PS=&Y++5&"64,$9A*@:E5Q61B9B:@Z1"MCG%;96EFIX/B;H;6Z!N:8
M'Z)JKU<&HV@OS&L!3ZG;VIPYUWP\)3/2O,L;4R2>S-(98':_/U6?M7HE"C0/
MI#'"2TYYY2U^1KF>N8?RQO^J<=&?%18^22/ ADFAH R%;3#!@O-(O[[)HZLK
M%*"-_UU<B7[?MF7X I3:/A"ES.9/!FE9]7)A?\<YA4^_G)\D]M/R:[9W_5=0
MQ;E#-WN?CU#BPR?Z$G+,QD8(/LP*(4/D";LBTYO@"\UVH<I[P4_D/X5#CS\-
ME3*_^%CN'PI7_-U=PQTKY>^?+&DPC\75-7TC[!PY]F:?>F0EQI]<O\XGB=G*
M;M$_]7U6&6ZSW8&IGV>E9/B'3T<E<FCI(_W(;]]-.R(U0CJ%TQ?/Y8FE[[M^
MU N9TO%X].SQ"(=:Y.BF^:<V]G6HO^8Q7@GK4N*#5S.B_N&W $D-'HO].;=T
MNHN+(W;T3IQW#P+(5M+J= N@_6CG3U":4;V-T2M6?53IA7ZM4@\"*S;+#42N
MYJ71,Q4A6-E!G#1]Y^45]&>E=>;YR HI-[1Q_LR'FCWS1:H7L(JBO!XP];>2
M"/T<F_LX4XQCCV*Z/]=L;9&QSCD_Y*L:,'J\IP$+AQWU/I;3Q5=A\_,OW*N
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M)OS21U/7P\8BGS>=PO87_+ZT-6]&I4:>VQ7< P^V"_<IAJ$P$NS$G(\A%K<
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M&<A:VL!OR$CCXS0-U'1"TZ/OH'?54EK.JZEF5OF;$G>7)7X/<\7RO9FS#ON
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M4&3G>[Q-?T1#7&(R+WQAB+^I5$QJ,WAFRE6\E?>SQ&GW7'3\,O2XN!>1\VW
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MS*.W*-9DVAY7GQJ!1^X:6"OEVPE-+P>SLJLL_30:R)216'H],Y-E( 5S]4?
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MZA;\^,OA&<94-<V^HNE3RZ% \-9A(KMTE"+@MNC/OHT _4\;:QO6#C:Y:?\
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MIS#=!!!2*\W8];NCK=C=QP'CU0056W^4Q((@F 4:Q+,(F8TAI$L9O1A^Z/:
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M5?E0FRV6+C);8O.'F!642V.J;2"UN@W* %8AM_X0!F&B(=K8AQMN#O8>:'U
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M!?\#\"GH4!T37YW^_F!ZQN80>:A?;=SBW5(%":P*+E0'"C^!%6#&O.K:2_E
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MS"?"QWP:5 <RHJ^F3<ET+LUV7P V P<>NJ)LU>VUH(FA<4JMYX1N24?Y9$,
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M>KH_&\:LR*-2C%3JA]+W_P",+PG12O<22:8\O.O6JS.B&'GSO2=<',73W)_
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M:C:C.^]J3GN^'^N2'R40F"WW1&W&:A9?TV-(;AA?Q"LJ8'J$(M@B&.JJK.A
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M8M+U0]-\6B%Y@?G7%05=LBYT%5X(2B5U<4@;24(</+%6GTP)^32[Z"R5/R1
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M;8?:8M%(XCOHT][HB"\.SV1XFM_*,&A"HN\K&:B%O;;E?T!.H9BL7=]^>J"
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M\@19VC[@&DO,!K,%=W1=57[FE\CI^BRWRPW]?7]AIP (MENG[40$Y^?3(?%
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M*JM]P-.3,XK[=94ZK2<ZZ?HMN]<ODBV!]%36."B@-I'%PL'FF=*3UA#5^P!
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M'@B"P\ATE=)>((Y1XS$ CQ.^X[ F/;"V/^6HU]-4-[9'ZVE8LH*+;,1O47^
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MK%^I/!G]:I1OT?>'8.17LV?Z\=3;@PC3,]):B7Z%S9\"_UDYQ!G:X+A#Y/S
M?5385.+T#X&B$R?NG%!\]B3U=S@UVF-$,@+_E.3>C1^^ )@;!5;]IH4MEI)P
MULZIO@\KW0^=NB/.,\?2)R- A;(;<KTSHEVJ[5J\3F#X1P->8:#B3]8=N8_<
M$3?<+XFI?S;4W%42CA@MGJ8O4:)_\B&DX@%D>]-2I:169V$33VPV$Z]&0Z6^
MPRIP)S[)%2)FIOUU5/J@_/CIY/R?K9<A0D\$Y)SC,/9VY'U B8)/(23+AS:7
M@0LN70_N^)6][\-U)VN(^E'>0O]@^M:X ^5XX(KKSH"%]3R%2O*'?[_.G_A
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MY@ -:^ P1O6?^)+ZWP%4%Y/_!E!+ P04    " !JI=E<\DVK+MP2 @!_30(
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M$SZ"DM$+8IY_[O]\1! 7 HQ, 9=T."<AJSM\4M@&G-O@(+ .,-/B U$9^\)
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M@.?,:]E+XT[-V*8TW4W$?NB=)R! ^RRAZ*'_TB*@%F:N/Z^R2)Y:FE9<_WV
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MQCE&!\'XX$SV"9;($(8 9("UE,U^,:(FU3Q;#>9S2@C/5VK73/K=V%HC5+E
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MYL/=J&Q#6<#%2X+&EGO[("I50D8+$J!>WIO$W403+0?"Z)6[ZH,==D#3<,M
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M..D<Y!7^]J 8-R#V/TU*(1;D[<IXY:<XXSCU+:DNNN_'^YK6651'-!%QH0Q
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MKJXK+48Z!8:F09\37U&8?H[3YW0AF,XJ^9H\;@(Y&:^Y]3K'D8YD(P3!L93
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MJ/0!:!G<)X$.^D&[#H\>@C] BU/=<Q3%!M+@A@+Z1 .>B^X=?;%HV'"X$B:
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M$8\R8!O(I:3K\['V729QC6H8W&*#S:$O#C2+-$&>)U,]AOQ$= (A$M"X]6O
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M>5%'I@X,*B''-V8O="QOZ],)A&_Z!"7]WO,S"L.R,PEHU3ZYE.5'0CD)E38
M;UM'Z*ZBL2JEOVS8L6>6Y+D(($LP&/5H"#)+;*/"YV0"^IXLN=;KY<Y8B(DN
M0:-R$^B2:-3#H0R RMF8S)U1< XMQ;6_M2XEK6YG6K7! ;C,<%.K[Y0!CER
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M$QR<-4ERL>#^%$O!G)U?C@CN\&6JH[I'9TNF+NPKXFQ_Q7V,CQ,^VSF>*S)
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M.[)'E$<4Z/#[S)(;S<E)SQ)![T]'Q7,D7)0*P?.%[1M--4AH[GCV'Q68[O#
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MF-T&W?J7:[QK K1VZ9"@,GGQWAF @>P6#K24 B"#(M/CB"NAE2X\3/][>Z8
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MBFGA=EZ=NG.2-PHXH^V@OW11LQF@\.7<E'2(,\E&*6#+WFG?'E!@;?WN%PS
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M>A.?+&L](4:G+%D+L;6R7TX("?3YS-\H;_GYF(&7KTJ">4BDY.VNF(K3[@7
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MSC@*O7#558&<%ZIP?!9U[X!H?V")3,UL5]ZEP7&C28KSC%Z)0D/A&N_BG<Y
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MY5N@PZWU-3Y#SET8C36B\SZ>0>?4<LIO6]IRF++"!_<-3_;TNERIZ8(ZE0!
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M"% 7H9MXS_E+@7A,WJY:_.$))V746<IFM3A'DSE&)$^E8[9ZV4L^7!TY[*>
MY;&BXV62L]E"X@M)3I:W3Q3OQ5'QI!I8_2[Z<<,6E,@G<EKQJ)H,DR8LRGV)
M'WH[[X1QMB&V!JBRD91H<#D=64FMO+QXW_VCMZ&TT3*%IW,ZV9+!^?6W)58G
ME"Y1RH)_?!R%VPDG+?]6J\N_M'[BF9 W=WIN#R;PJ>HD[)^_-0DAE@LIS(<+
MC,KIOM--3,R-BUGC&'O^S#IP&.TW_4Q&\*[J0NZW4%Q+A#>5(5GZ%B!5LO;^
MVBI+7AT8V2UXX!C^S/1".*#NX^J^1>S]26;*A*0U/E9(P+I\SDO*!O[/K$L]
M>7*5[F^#$+:6VBUF:+?/;6NG'DF#-ZH>A%-V)D;E=;SH*K)0(%0%O$[3LAN^
M@D>&J%^D]32A,[[U.)J):;V+89RP+(+5S+?N9"0C\4#I+0;O$0'CLY0\P6GY
MB^S/32$V7X\,*QYJUVVX$^)],JC]$2A]LK;6),18 #\VL8A[-7P:CPPXJ@UI
M+_HYV4R?$NTP+1<Y6")Y69YD[AL;21W-=E"B!\P!*_J1%0W5!'I,#_@CO2@N
MYI^(8VL ]"6BV2U:47/<_ADF3+2,[)"E[NBO*HYC'^6/YJS9OU2[UL4R6B2"
MTAU>QZ9'"S$>!;C,C'U!:/5#]+!)1EULJ?FM)IW6+N]NO? F8XR758^MV5?C
MC@11W_-/>8#7HE"-7?:.HZ\ WJ-0,B)MAY<=L@?6=NU0UQ3_V/??ZXKR00Y1
MHPH(C4*B^L86&-+/1,2*/N]/RNZ*S^E^S1S\NL;7E32[,""W5Q<B2$=X]:VV
MWTHD6$00"C8=_9E]1<^X",%F'3C$UVXTQH?$ ]N&&BQ%&#-^E"=E839:R4-_
MCF5#U[:>'MD'1VHUQ4ZA'+4_#>AJ^-5:63+)&.15N<6R4V4NOSQC%1 D$GQQ
MKVOO?$1O!VD>\NF1#*:L_<F,6%;KT(XLNH[Q>=IZ[&MH', :/2'<&8J@OQ>N
MX<%T ([[6NW(1/4:58X?E"&P-REGL8.QM[^!NL,!C*IQC1@.S4[R?^7"B/Z>
MLZ#.N&BSW<BQQ0>MM(291CWW^T^$Q BWOTNW'7Y9??(O:][[6:.'<A;V4]QK
M;.T9'Y29_<EQW-'RORW&Z2FU\#0?3G4U@=M[NA]'$X8WG'[I[.H;S5RU6"%M
M90/0.%P7]A0Z5'9<MO(A6,##Y1:>T[]Z/Q#$,@D[R?ED+NJ>+I=M+^KN%^2M
MP^VNG/* N<1\BC8JWMF K1^71"8<<)Z7C?CXX7?^_KZ2?;Q?3[508,B2_$]M
MU29U- V^X4TT.X0"HXSF7QF5^[E;>^58-\2<\<#)LIWKDYPG0<Z?P'/NOD^%
M\QO]]DRV Q=9S#_,H;Q]K6]9^_&F4,$A=DI+U7UJP8.[QGS1IO'1,ZL"PH#7
MO"F0,<["ZE> W'1Q,3:DXE.=Q>?+NZ%V45MGT@,ZS7^).NY6A+2Q+UG4#7_?
M^AKUEZA.Q1]1:L%;05C*>U9?%CB9: ]J5I\^&*M\J(X6!=S(;H9^]RQUM+.^
MESWU4;,VNTT*^3(/WG%*:@776IGX;-_SZ%5K#5"PM6WZ84Y]9>J_&/Q8WC8F
MG3W-TG'TNLZ+MGH@):WY.8J"ZAYO<_7WK1]%IX(G%#^?ETMDS4TS] /7JC W
MC%I).JVJ4MPLR\14%M#6\T=++]V)<*?P%F#QM@>2R1="-\E1,7.M0SG3_-[P
MD(FJ+)EFWKFV6XQ/)TA#0SB/5IX(!@PE*RGN]CB0>N,S3EF]GHG^\#N19^_Q
M%_=Y,1:%XP(9!NE5P"J6%8Y (NE]'CL)[QK)3?R#8/(F>&960CR><.-Y&83P
M0&S.Y?.I/_\TL>+1M$)%242W!5,4O'5\$!8Q4^D?@_UNSS/IZ"<G=3<RR]EO
MD;YMCLVIH;:X' PV?\$3>N?7B-7CRB@K=RWAIK&Q-5T@F HVHZ^H<J=M^W\[
M<4:LKRNY'B+0#F>[ZR)>VC2?&S>2V39FB2!'P[D MXPZ]V\](4!0<!J_QB 9
M:[2"^ Z]F]G\8[>:H@H)4,,)<A5]:FPFW*>:AF,HRD3@V+[K_DI>G[#]O?]M
M0JCZU'>79+9A7?[WWL'' YJ1\:.*N7E:1&U^-.<!&3T^VAC^-9"$Z$YI&5BE
M]]+:OJR^V!NTZ/634=+!JD; _R:;,"L+=8[1?F)(_"&7.M_%YU7KSNWSR9X1
MQ92%0(<QZVV)7_..G7&_&HZS(]LO8W2%-:I_".AM/2_5FA9.;E-/,2X7D+E-
M>\'77C=>D;>6*:)Y1[WTM:1;P_I,:X]"]S+[A@*[2"1(B4F"1D6.!3HJ8;<:
M\FB73VORM9[8+D6/<''GP8FM:FPB+!"6<;,-9POHDAT/J3W6B^IYR-_?8G0,
MIS'J54@3:TZLZ3ECIIEYMFB8_I!+N"^3.R-14]R$M[:(ML\<J9^74LC.OIUK
M_G8CFZ'=P6I@.B&[NWX&4]K93274'8M)@5 IY=)XM*RIC'^B4"(+]]W9K#37
M]R:HC)15[!UPNPRA1?>E\6U"M<V>+2@11.OU.;U$SV)AUP$>&_#2K5R=2,)T
MT?D"W=?T)N4<L(;.=G9X'3?@4J^A79\-3UIW=MBB"A,N)L%E\ZMC0Y0Y7 M+
M5'JJ%.*KG<R\T^F>U[:[UZ\G?3!]7]ZCFC\W*CSK4?U24M.SX1!+]K60WX6A
ML5,AJFRT227)] B?\M;RO84MU?Q](-R%UXL357RW=H?"H\<C0_5^[ZMJ_Z;=
MMP:NZ8<A%+LO#8%K6Y+^C(2Z>+,MM?K?U!"U[A7AJP_2 4MN[ZMG8,LDIW**
M39,O?-1FX9>CJ8N\G2G.@:1[=(FN.4;<6U8NFV/TX80T0M^E+^G]'N=5S8B
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M\GG*/UO^JV+\R)15:$S:+YI/&#5'4?FJ<)7 *:"S/['*G&73K;=2KU))"\%
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MM(F"W5ZG.[A0*_A4.$ 521F=^!@9.'\;HK,CE1O0+O^S=^YUQF'3<1P7A">
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M=M$/&:/5)#H8-9M"O0[&-54(I[=1B]%71H(ZD@H4 4Z\K7($JS(SMA2L=LN
MQ7/"C1NRJ&U=0NZPY&%C%V_LW)C?ZB_@U1P\X?@Z.M12O TO1R'&X/%)N\>(
MQB<7(Y).G%P][\Y (KG9LH^WO\=US[RF,GVF8?^^B+F#<%)>CNBJ'/A;[F]J
M$'PZT?)YL7Q")6%CI,[=)G/JO-59#3"V0MR]*>R\4?[2'DBK&'3Z$<+[9BWS
MCHQP2;+.L6#N\[98@ZDB+7+[3!K1O.EM7E<M!T$B!N^I7B[C@F6'ONS&N4,
M>EI#Y^&7D%D:3>]<3S,KU8GWE?J[X;"? F%[)N5[0@13?N5(X9Y),8R)K;QI
M1:]Y.%P5AYA#(I*0V27FT'7)X G7N[L'10*9(DLGJ8R;G;.CB%Z;L?EPN8\J
MJRN:I _C5., \%#%MP400?0I*/WY"[$/#KH.=(9V=+P@0,@W4K?J$IL?9&X
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MBIEB9MO9(J'P]R0--35]E"!Y([R7=<6D\?E1Z51&6/O[M))>G;X8  @<;<!
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M]>]ZP64IG<=$M*I&(=O A5="Z?ZIR815MD#4ZTN;AO6HI%\F#^Y&IE]%C2Y
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M";K(MTO,Q4HA<DS,23[K#H\(@8/Y8'L=1C8:29A?^^DPBB:K#+5=#5[^>ZE
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MGEG<K1VD+$$]HQ_HY!3(^HLA-M[T\*1S%?)^C56Q_6UNV<M"T@,TS%7)-5Q
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MJBYMABDO44+AYW*\#M.J:DTIM53_0"M**3>":KI^:J:@,#W&NE3XXM,JP[N
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MEVVH7V;QQA037=F0SR#'ONU0;>LSX<_+;9'IHVVB 9#/C\P76LW5#*M_IVA
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M[K)3O''#*L60J9]^_#O?G#3M@16"=@>QQK(A_I\=I?8F14UJOFDWJ,<ZM[>
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MIYIR3VC]VXS$K@)0M'4[7AW/?:I'TU^F_?(MG9JR/FXK6_*"@O60_'J+PE[
M"/F\R%(2C3F<T/!06PCM\JNO*6O'4R'8& HEV7#:,105F-\4-DDHKF7C5&*\
M^Z;TRES(?0!GZUUK(H6B'*@?U9HS=*..M=+;;,8QH*.JDW'S8@63NKE 3HP!
MU'RBF4? 7!)1)&GP^;ZUT:L)GP'EJ?;J<:H =^F< *>,B7=QF;XO6;(?ZX4*
M86/OQ.98!#$$J)!+TC?(\[$^%A>[F7D0;_S!7$TNRBUB&3>?*=NK[Y84-XDY
M8U?]@":7*2ELJA38EO0EX^"Q)G6FK'11H<L4.M6'3NK/85]_!KPY41ZCV#/6
M%^[&B8JV&G\::OP:']06L@^^=H&/R+G"I_80*;US3-]A2O+J6"6\PPI?9U^^
MP+.8D<BX/P)]I8L;$AQS:QIMX.8*#:\^'O. B 1#]:%-XKB:J-+[SRR#0;ZM
MYB4\"S["B+?UR")DR7C:$K#A%-C6@L/@5%TU753@4[6\W?IGIHNI,)'=UE8Z
MDDR=]5W<*%*R0EO=#Q++JT'9$6/AUP0$]0W-IY54AH:=#?GZ\7^4I88)IQVE
M6#)3+K;$>!B7UOMFG3G "[%]_INYT9P\%E;;X=<:KQD)31_W[/99$ZI^BQEY
MQJ9I9W.4#D9\<LO*"X4(2Z-_&&>".N_BTL=(!-@-J5*?3\757F?$/;K$?,]^
MLWMCTNC<!ADTPMOK:*@L^!%U6_#V6D R^HZ[N3F,G-:>G[()/WA[P>:-RAZ6
M!-?OM,U$W0<J5&I!L'-UG^.R(O?@+24DKL[WVH0Q#%12DU?'6@VX<ZQ:B(_8
MXU$:/G&6&![Y,E9-$.V27Y_7$7<5M:S5;.'WN0R6/74C:AK,.^/1\ ]J=RU1
MMBMF[D>LH<(JD?&O+&=Q>4K5J^Q3!9FAO<$.& 8=Q:G8TDVL9L[O#*9]-:'X
MO0G4-#V'*U;]"5P24PJ'$Y=0V5!F%!7X4IW[=V,VARK]=E.5/2N5ZKD+J@!%
M1$L,);MAI&>=M)T<X1EP$O#_8U1B_P N_P"WM<__ 9[T_0,T_?$WL)[EO2#?
ML+ZH_0<8^65]]D#W1G?>7N(/0O%%T<81II2F%*STG]4\N2#]!TCZ.Y._X_CY
MU,'$<?[_-?K+CSNX1F#4RXXS%P^T% [V(Q^4QK+9]T5[FQNO$S5YZ<P.(UE9
M%ZL3I\Q3)KWFZ9:(X</Z\V&2NO\ C!KV.+718SUACU;R ]XWT$-J["\INR>9
MDEE/"5>2!L-@!3(Y,D4CC^O/-O1BM[($T[:.+ -9A>_"\!SX7,]A+,WD1E%A
M=97KINY(Q/#STU4<S0Y9TDW)^%I[AS&QY9%K+/W95GUMK=][G6B?53F[D1/2
MP"A283L=-?\U!^^ #N8\2EE.LE>R<I14B[]SH&1$O-UG!BG)T-:0Z%.2'BE8
M8L*IBH@4K>CG-YMH./IK/H3A&@SYZ^&X/H\I>7S!WM:?>7\,?>[>0?KC^TDX
MN.7&Y3JS.Y?K_AQV=NQMN6:#L:C6/5]\]+C0I3[5[&-(C7B:9>*=#:\^^8*B
M'6%E[EJGC3]IZ "KJ<=V6IU]M4^-+E>/("OODV::G[Q5%B$=$.5N_/92BD0R
MB#_S#.@SX8L*E).5HWN;M'%8I+K^O Q3P%"7ZSUQM6_[!MLZ87F=Z-J\N-@&
M;>4%=HT&]\@#U (;V/F]6O5?6S8]B7T-/";\#(TT%C$Q[X+@M5R-!G;<8G 9
M](_='GX;/JP =2V:F_\>5J0A 0J.Q'$GAS4Z&PYHIZ\4W\@I>KD_V^!JY=%N
M[A=1N.W.#X&33Y0/^EE,-Z35C\(!"=-+/)O9'SJS4 T-401*./J7N*<W4EBV
M9, >IEHC5]YN^3=4Y5M_*1#%R2]R;2+PGQY'+Z;B.9/EGMH,\GY1AVZ6E9(4
MO=P>@&<\E,[U!ANF#RA^&8R_8P\\J,WPH=)N)#E(KA(=/J.GLL LOSKA;1AT
MQ"%52K*^Q.AR?I_"E?"G]]'L7EU*9S6)M7K3<HC(QQUF4[5*-_:#N:K0@*J/
M!?:$H&>;H]Z'8I<*"!'_&!:O@C,MGH(9>T6>LM"[?WUP10V2R;3UFX:U10%)
MJ<#XH-P0KZ,#DK(AO$XNSTZQM^:ITC_ 10J=U#FWGKEOC77]\ _#'/;RA7<!
MZJ9-V%3/=$ZO%Q9R^&U"KI(];<2=>(2Y/!Q.^AN748<=&>>S]X\Q$;Y!J;"$
M5:18%(_Q3)%=]LEGI9D)("*F6Z!D,)7TPLU8J,FWI]%W#[QY7WB,?XRIMSI*
M\[J1&#!OZ-]TLRC^!'+>/?N (@7UX5A<XYVP# 9_E.24R.7.*[:&[,5V1/BB
MJ8':?_"H/XDF'5(0(H'+IH]BAL._Z;'A_%3 ._T*I;S*T[.);JU]';WN=BRD
MF8QC/_T:FSZI11;?*'/=F"B:?_A<!FD>S1P%AM#Z?V\$X1ZL/+N0H>VZ6^FJ
MA$8*WVJD]C*69 PZTSWPNND2.=AP4#ED=F9FO"MV1D5&N]60#:0IMWC UY8'
MEL>PL<V=%VZ2S)LVUGA!\HZ/O6FY5CFU_%MS?;RLB]*OQY-]QF+6WF\RE=,J
M6.FSX(SQO02F)-Q'OTT8Y[;1UTNFD!!"-ID 5PFC=8<WQ;A^JDR0(Y_W=1):
M\(<-;<D?]F5 -X^:UT&Y)I_+WSJ1%[<*_+(*7? I=!J41$.)?M_PV+3(_FBU
M9NIDI^:[2EWL2U$R=U V,'O$V#>52IIE$Q$Y.@PC0'6*)6\8!RR^2AYZ98?F
MDTLJG22Q22GAXBQ I3RKNYHIW)U_6HB@%/QK' E4":4^B8M4SJ&#!<@B/OY$
M[^34PL2H?*^T2?K.(S%#1#.OIJE&X*DN3U]&@X#ZMF+ZDC=;% YQ*I5.P=VB
M&C%ZNBG?6U!91G>-R:3CT)E9-TC<1"!T!I+_BU"=NY?PZY.C!EK>E57#@$".
MGUZRFQG7 _T^VC$Z(8^6WDF9S5^@+5.28A@<A._!I;@#F#F>$_$3R:/5$/X1
M#/(IZOV[R>,2N8G1'^$U52-M5NYBAV.KO!WO1/I5TJ_ZF>E'4S!A#-L)6*EF
M]PA\J?Y5\^5CGT]/S+#(8UK31,]DCD%6^MR7%O98S12&DI &&G2-?"KH5/<B
MU#B<QL=54L+&NM,>H9#6./#ZMKE&=8K5-)/]V9(N>KHSLT-:DCA.IWLS=\)7
M2.Z#9F0#/IF'NI5V]<N>\B)J'&Q"?\XI /L'6#8V,LP%Q3Z&1%90#;C\BK&S
M7 M>WEHI3P?-_9F-*H0=A1%B@6D,U14GI[ *G[1&"I*N7CRZH55R&(MW2[Q9
M][;&+(U&00]=79TUG,E5E1A*Z "\OAP,QFD%9(!\)=WJ5R:*IH<^#@[2R4O!
M8B;5M"+B&TMK696%DRQ:Y4UVO+]PV7<*(.L-:7EJ$5+-/WY9=*R)L5QHU%J^
M-<8]%J29.S5#9(-F1A&(A=N-2EMS*#GO.EA7^"FSO:V%NV@U#7#\[36O6M)2
M;M .%3H*Z%:17T%D2,\U76'\Z<UDX]$\_WS+6K.DJCAYM9-Y#@((0=!Q3-N(
MO9'^;*5=[JC2=.4:9#0PZ!_)P:+V]=T_0.E":]^K=YIA-A?6M)%**</ N&5-
M:]9X$\BM.=4'E2D"75-:284;[1ECJF=K7_-3? ;PD9R[+)[4(%99!Z+,#_UC
MKT9TXYHO(M[H4+_/8#;4I1&J'<2\8Z;5A\V\>+/RU:]?V5/C&D<9?3=69Z0E
M7H!36\RO3.+J-NOPM<.- U)8+1;,=&G#K6%0"V%7A3[K_H$QOA//34UVHCSU
M0T\%CE%!W!M6B*@OMGRD]4Y8D([-7TTE[08F!\GD0P?<**^HBL^_].,KEA%M
M%-:ZX$."FA_V"3=LC,*-T^AK!.3,_39Z8^>HWU]R#K@_6'V\AH(/+;IIUS4S
MMF2#R?Q2O[: ='B^">^1V#SOKF'WET[3)OD',&T\\H(XV7MO/I*U"J+%"W-X
M>SDF(!3-@$2&.^H<H]OV#6M#C[7M-XO@?-V8K^-+'XY31MX;Q#W@ 2MQWS,,
M BGEIK=-;1JWKUSRXA;AWA1)CB)U9:^>+#D^X6UZ#*R,PGX_+(^0*G][#EW"
MY3+>5YUJ;9=M=6"J"GZ5Q2"4/+BAZ&-9LYVY;.5[,9,?X'JF8"6P&5AY[LES
M/_1V_^CGJEM_E47)LS>0L2%.EV"*#/V%J*PY,\H6=F::1<_DZJ:# ^*:.TJR
MLO7O</UI9P?-/.4<-MW3%? >?C.H'HR+MR^RMF)6)EHF'2^>Y/>I:A2K>:RG
MA__V\&R]\6YIJ2"NJ1ILO_J&5+[;2U A=E(A*+=LW?MKL7:;1*@W'C6Z8&%+
MBT!C-(S:X_4T^0@:0>9\:L2E=PJ,E ,1'Q7J54?M5KG>L ?_R%09W(8E?)5B
MBN'XP+3@))(:70'$(9:PU%\Y#(D^5<^Q_9X.0*YJ>>&C9V=:62D"E"&D6B#^
M4DTO8GCZ"IE)SS6?K8T<0-8]<PQ2/V-/F&\O3K6#XYZW]+BS43%/%(ULRG)Y
M8L.;ARX]%WD3LC*# <5(TE0[[%S]U>I-\-!#J?MT_>^P-5_3II:=2&I4IC)%
MFE03-OC6$0RA*7(\$[.G_Z=2?1Z+C;\)37ZHV[I6I/G:4-)#E,7=FUWE:\FE
M,3Z%6Q)OTT70?7%"0%3_W@PP.,%G!)&$WT0NBJ/P[MF!>N4%8^@-"+C!MMH9
M!IKL#"LGCHA0 D[X<KRFHR/C4PI^__$GDX?)^%MK5&B-__XG^]UZ]ZG<[''X
M#0R,#A<\JRY/G[_3%)'I!0P29>/8J&C9'^M2JVCYY"OT;F %2?4$^S=63;6%
MII8KYS+LJ=2U18>>Y9,S.<8!6]%'*T5#:2=$94N>_+6H2_7F_2;BVD7DO?]$
MX[=,LDI2"URE2IX]'\%-)!3&51L_?_#Q3MF%1>8!GK5U%3*O<&48 ()G<_3E
MO7D.)A?4YZ06[SN^T;!JSI@AG7=ZI3FRA4<.F[<K,BT(?6JIYUVV"A+TE.9
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M__Q=T+*ND^J=PI5PX\TB@%!-Y@<#2S 5;J_4:&^>A\P_&VG9;M'TF].<\G8
M]C3H9)!4'"E,>+LX0 ]0X'G/BZD%RD\V,+TEW80/YUT[WLENV)Z67ASNL?2Q
MS-SYV#U13;L"AKY;0D+\Q-U2-D[= A[[J=;MP8"O(/QCN2 =M57'7T\#A/2_
MT+V/*D_B-EDE)4+O= 00H_\!RM(+B,Y^'6QC/NF+M86)GBN_0JRH!EB'7.MJ
M>U(0R4_E@7KIPE@$?FH4%.S"^R-]XGTN4_W2XCF/3HO;NX\CX^>!^7.2@OGF
MB;F?B4SD(]2A^#A)?T=Q#X-A?AMM[J\&VHW7FH(3B#3R-)F?!-ARL-O7K-FX
M59M%5!#2'9KOGX]J59@=@IIG=&LHHTJBI8VIINQHT'3PB%3(?>.I"C-]<0S+
M_)#P&GMGSD(J*]N^KQJM$9E"U=]8JA,^G'H/Z^;]A!E+=^;HC;?SDZGVI2U9
MZFJ'/5*&"LMY/=\!*)"3AD_6%X!47=AK.DD.7BMZ/HT6,0[,C=>2H*:->P60
M$:P,9E,4@]XY?U\M5OG.06K:S>6$T<>;8J6QH7)R?<!+$ ="965B?1E($5/K
M=XFEN>Z,J;Z0F'&R]W_G+8+0CM%2U^[AM_X'B(^G9_%R);^SH:D52U,D#^0_
MGHJX\C^D?#=96*/IG,F7;U]4&S_.NE.[6/\9;R9@KI=;J<R[SV<T'KBC,\\K
M$ O@>QS3AYR]VOOO-NH%MM65D5LCL'0%B-JQ"A+:G3<T8@?;TXK 79*XE:5V
M.5]4NU9K=;_!(7P[UM1@"^JH*0 0PH37J7<OL%*8DXR#)D7>HFFYGYQNM.D%
M]/3E@OG.(\V,5!9/EE.&'Z.6AG_-=XU]MI3S*JU>?UCW4@'+4);],\Q*E0]7
M.)3IFI7R*6#"R$[W"P[:-O[AIX73NMX12IM*0@1^] F#X>OMHM&;FT#G)I,$
M41C[C8.:]:,J25\,!VK8">WCUN]&I<XI*=X:&_ET:*HM=PTFB7I:F8I%K1;+
MO!:^V8>^"+M4Z.%^B@^15UF8[T4$N45:M3Q?*VB804Y?!4/J"<OX%CD7K1:@
M#)C>4NOUZ7L2U]MNI^+V)A$7@:U]Y=?JN9PN^5H!^" M:3-?'J6L.0"([X<L
M]_YYPF5-<+CGZ"AV_<,;:/'B/.CXM5%NJW+W/T!;/P0H\.0(E.*@BZ')>T'\
M6H-X0AQ9E12YYI&=PQ!5YL()B_3)P+9WJQO 2$EU<LC8["U[F1IT@>BT/;B1
MZ3LIN6]JK>%^_3M_4^;XM-)+%*N/54SNT^5/R1MC:E]+&*'%DB(.O7'8+V9^
M-=?]70OMSTNIM-.^Z%;.J^:>5RK2F"/0KW;4N(^5E79E(YH#/A1-IXJ#\,D]
M<?$I0Z\FFD-A;I_B3&@W#ZWNQ69\#ZH);-'Z(?M]=:M5^.?L,)%3:X_+TT'V
M]>,XDJ'./G\5]&! V MT74DN6-4/]_5 9RO] 9NL=V7@CL/JF?)E#:3-FAEX
M2680)0OU<%3;!9!. ")J$U%3H%698+;=M 5]E03JW8K@DE0]C:]<CSX[+!.0
MN7'+[TAMACW\'\+'$U.\$+C4JA-XZM^!UAW1-[+:7[]<)LZPR63[J 4E%WG/
MX L'^A"U 2I937=]P!2W2T,\2%G&8W+(M?NKQ%?B?X#O7B>BNS:;2:>>5]-$
M.4Z-QB^%\-\%?P;+7X&5K?5XBYSA>E[9_Y=%>A/6?X#_R](],Y=O*7_T_WZQ
M\XJMT[AUO"CY!Y![]@^0(=:N\/^9T7D^Z#B%*>(QJ:DR/PBHU+.,]GPMQ+R0
MK+#]!2I:V';)N<0.LG$,G8"I&-(QD<?5?K#])+E<]K/O'FI>.@Y="8T70T(U
MQ8PXQJE!K&9ZA-<N<)4P(/W'GT/!^N[MECO:P6>>T>ZML-3'ZZ[.;G%3JZYA
M;A65#4W'D2^B(#P6&G,!C4V^A$7[UR/[U*/FU<):7F&$*96DS$R941C;))_Y
M_/[*73G0OL047O:2Y8.W*[AIK?JB[F@Q<$SU3Y&JLV8./"Y@$ (@!:9R.VCO
M-Y?=B?-7%;=-RV;Q7]BG!/V":F4M$,HU>TIN=8BV+*!Z\H.%:UI[4>#YJWD^
M87IT?$:1138MJ&XAG9V;1^GG5A&;$F]61^"D1,P_@$;UP+IW+NN.9[Q (#H;
MJA60WG])LQ'_?0,.NXN]%Z= ]J>)[4..3&J\[<11QN'9R%97G_'W)U$RO!T_
M(O12*=:[U(B#O#C;Y]^GO.8X<,H\^H8\JM^L6RXOQVY _@%^^WB-J(X$*??F
M4CGQAIOIZ6VTV:T(>(WG;Y@VIX16))OS*7O1,Q#D=E'9Q GA_/P"$W\XY5^;
MSR><)T]^>L!@L8H;R_'RWF(R1$;%ITBF!M(Q1!!2[P*!84MT>;( :I70"5>^
M<T>&5,^7Q^EF[L8R_A=Z9]["2;Q_5L5OT>^X[B22P1"!=*^?9@(*TCZFFU_7
M.K4ILCY)51"ZW)8@>U)21W-JN/DFD!P1L,[3B7[]'.CZLFE*EM*U@_$-U",@
M-)W"N:)&2D:+AVK0K1)J;U.6/BP_PZ3[$1-UL.O2X764)^'RXVM(2>6G($^A
MN!95<5#AL'B<_A;(":Z! 5Y<N3J^;SE=@!X%273] X3D)">RXS?T9M8^=RRQ
M7CJ-.\DN&1L3#$N=>,Q5C*K+@U><'YUOCTF&^,^A3#1J*3YPOV+_UBY+,#87
M/D5,G+CQ11CKS-?W14@5^)MT8=3;ET6^286T(0NMWT$L#D\TGY7/+AT&$&.6
MLJ(]R>XGA,G3;\P'2N>K"?WN_/%LL1USU;!@;IA&L&T:(O0ND%$V3='=9\R_
M\Q_:*(=35XJV1;[?P,8<G+XI/B/ 6\4?A_I>;+T]%EWT*V*"$L$%B&P$%,GN
M&+7_B-7C>_&QZ2:YPR+SB:: '0U3B+Y%D#P<@[GB9UO\M39>[[;"G&J#4\VD
M?]S%([GKT8VMT[*7(LDVCN;G9M)]).<,U_S0=*_C>B9#L)=[ZQB_\O8@)I/B
M,_X!F)MSG\(>N:1;9 %TM?+;WU-FQ^Y\,P\V>M&YZ>5.SV<QS9&I;I/5OA^L
M3*9"K-<%H"L@VOGN5!'9-M#H)_O%OEFU>>&D_>-F\[&RO[1;XUK"0U/JRMYR
M%>J!^BU!?3.KZ=$Q39#-$P?3*FQF.[=&\S/&;89,OO>9["7%Z1M%U+2=1-?-
MYF2Y'''NNA;5V?CFE.VSAJQ-7'0T&)I6 A[XC9O*Z .3@64W2<^YTU2=Y2J-
MRX3\!3&/MZP4<K]#TFUXGNU9Y @''H'!4%(X!CZ3)K%YK%+L[UXG]P?2B12^
MB#]Y).Z33/3N.;;=R_B70U9,GIYG)G^U"YL20GVZ09+2P]&W;7DKDAV+=QAK
MD$EE^,,F^2BMQ7S:OHB!'?Y?0^>/)N';J2\BJIV<N@FIR#@V*-<,UAX!S5Y^
M@$1L'(!*RGOU /!VL  @=#SNI& 2OE]:.03IB+MDLZ6GX<0N@_K@BWD+?DU@
M;9!P-/4^G9)/.(]%F-Z]QKS]YY4YR&QEM]::F59B('C)!K+,*<QP5XQAUZ1"
M?YN@EPS\E-4Q1QQ\Q]DB,!UD=4R/FKM(9%I(J4Y["\FFZ>('.X&M9TL!.$,5
M_V<PB3V^0CV0&:.]T>DNZL$(/61B;MF1WL-7VEC.7@O== O7999)$>#]P5W=
MVY;M@?M.,5PHO^FT%ZAAZA?V8]%3@<6< 5-%K(+-+54+[=$['^OS^6V6^1$U
M!82Y(8NK^QZK]I<&X!A),(44B"EEV&]CS*=SDXU.Q6A!BH<S\2+"4D"P;L.T
M$.2Y<"P1 >^L=)HF#PS\\]IU@W7O[.'L]HV_]KC=:/)WR>RUH >\<1YIRF2H
M$F"%CR)=1#P1=RZ /YG=O44IGWCP,:=B\(?V)4OO%4ZI-EP+'@5&?-CD^AY>
M&@R!&?>PKH9?:5B?:&PA\3;>5JD04?A65"&D7XR:2>^'84&76AHIW&C0-ILF
MP-RQC?8QIZU[N_FIY@<IPU^M!C6490(<PM+3VB6@@D&G"#:06K'=[A$6.QZU
M@9LE//@MMIH0\SZ598[+17P88[Z@DK#BK D?_Z7IHG,;S/64Q>W<_E/M)!WD
MHCVMQ<*NL@)A:9/'_(3%[X5XRU19SZ$;I"],O0N^^0CG:+'LRHJU\$X-4KO!
MJ)<VNM&^59DIST.PJ;J#",G.BGCN,'),X2[H@C-]H)Y-[M&57S:J8>@RT>[^
M#3LO%3XYY@I4T P$3=T'T4F7#Y]U^HTNWG"V(B'UC,+!S*AX3B&-;_:]:_;]
M$ HPTIY<?[- !8U0_L79Q'I;O$1UQ]1^:?U%R[([,RFVU2!7U0U;#V@J9\/_
M WQ@C_5K3I8TAJK$+9P91XI;2AIO73"#-MCE%AWC#!(VNL";2G>O*=,4+94\
MGE&$!V#;::7VJQM7JT>;=?V7EXVU<#\0LZ5 T?Z[S,REW, ]C9#SRCQQUU9S
MPJC#QC/QB)*J?C(W;E$N94C+=RHUH@;=,8U-$A(C^XNH;+#Q3?(@2ZM:\]!@
M1E#:%Z+L;-IGLR#W2IMN<F(E'O#2M_S8'F)GMQ\USX+&^C-C+,7E&GA$G\$\
ML/O55+IB$0P6K-_]#=/02%D^HT2WW=R/:W;9KI;C6^#80XKZ:.FRB/<)AD7$
M@5@%X!DW__&$AU].TJ\B?(*]^/$3>WE:R&7I0W>-) 2^)D^'H7WIV E=W%<5
M/G3;!' ^JZFG>%XK</WX07;)QE'=3#RYIJ;'^[DY/&6L7 E&YOM/,KZ)7.-5
M#:.B_L$:*8VJ;$EF=\Q+K:A30M,^^6'I6";XYR()A3*[,6SS7DN=O+=["K+A
M('ZT<V3/TVOJ6WO3-"QEP9EC8'EC&.)CNCGERU1*U.PZ?#=T\P]+\^:\A 6C
M9RZ5>5FK7 [,ICNS1MQKAB[;W)3K#HS'?)/,."6EXDG&(5%*UY=37K56>-QB
M MX;@7="799(XJL:(EKHFQFD&6!3"*+-PHV0!QI56:&$7XGV9>SS^9J@1;CY
M6VA\.;M;Z8OV83M(:3F*I#SX=Y-R=; L46IS? Z%]\Y%QB-@F5V;F=] ;LH7
M-VP!PZ)*N*IJ&@(JG[FW@7PL"Z-DEO>WO31+_7./D)<T8JMF0](/<D;$.T=5
M$#/Y8RJ >W+WQ[_,G<WB26*""[7$D.B<3Y+1W!*=TAO.7E1<BK-[MBY77)D:
MQQPVU-\.S2PW,=^B66#IS,I0;]OZ97.3;X2[3=6AO.:KWR"4V[J3>$Z3-ZTK
M6YT2K>*'+LVX+':X7IC.EUT2/EUJ #\:<*<_2'32E<&N1].;+YSV[8/BL[C?
M41I,&RXF/5MP@X3-UV\@>BZE?@I[]TM^.\ KMBUN/EUL;XHRYL%]NDI*82A@
M&-G6]XS",]DSJXP_A5[MMNYDHNY"HXFK1KUT$Q/^JS$8NN;V%ND*RH@[]O:J
M(\J N=,WFMQ:/56X+U*"24P0BJ0#6/W<6@?(C08)K"3A&U$?Y&"=^+1X/>Z>
MO-*5F=?>B_E1II/6IS$K_AY=/$;UI(0OE89.#[,;>*8,&6J+=.K_ '>GDL:[
MM@RU\FP6.R'=HC+# K;,3;E#!_Y^3)6;PP?TE;EEQQ97[]AH9"&='WP6)45D
M/F24)C6>:#K5(]U$$\?/709M$SF.VYK3^OGMCN'+6L!%7^(]<!I?EJQZEIBH
MZ=*+0IT29JE2\1E!JJ/MR]FN6I?NU68,99V+=!_(M^M47_5*$F;HC!$,U?O=
M@*=9PI]-\?4;/W*<,AV]+1ZB-]65;;3QZ=PGCOG,"L"*8\NZ(OHM&+3JMZ6E
MU.TQ>S,>=<;:9&$D31&5A6#->L@**F(R!%C_<=;EV9+C=!V?G)"S?+_N\G9V
MU>=;3T(?(XMH8?N:?431B-%P! +!8##,#N/L4N)59-][AAU+0[I[><S+Z*/4
M37!(IHW'3]VO4SVI(-&?-&SD,8'[AJS'7T0;-Z^TV*IKOI]WK?@ZW#$@/(F8
M=O&7$T0U']K $1\\2QA*2KRA^FR5[G+Y2Z>]WYMBRWZ&<ZXW 0&(4\.RR0:E
M;15_Y3FL9.@<^@W49F3(G=D@H%V&U>U"N$%H>?'2T>Y)S!<-^RYG-N<&)=.[
M)1X#/>>[?P%5%%QYL?@'7ULMN/+VB59W4S(_G6E%.[GQU$7]/OG^(X+#Y2(L
M7_AYC5V'\0[GW42MQ>,O+YZ<58-B)R+V3'WYPF F7[KLKH&W6P?GY1P9&%%[
M>]WVU5>T]#(\'.$\J/MZD^PW.?S<IZ0$,D %%^.5T^XA=N;+04[F@*9FM/#R
MDB6$ZFL0U7T&S(F;6TEJU"='C?']4?;=PVR.$8MVO..S+NUL@O17$V6_!Z4%
M->M.;1$(#!U=G:0D8''!WO*ZW;71SJ!:%WGDZKYZZW3FKMV0ZI_4RAXB'V^J
M?[>2&U-J$=#L%%0=ZMZ*/!)F.OQ]?DW8,\S#NST9,J@>M$9=&HS-W))9H:5*
M^?/#!,<[N/9XYP_60*T6PF>L#1;V*F]VASXY-?.M3"0'R$@:YR=SJC#( (BJ
M(SLYX[YX&CEWK51E/"HR>&2'Z%WVJJ0.^(!2'L#DDNR61$5(_ @]D ?ZC7*^
M$GA)CYZ'['NUJ>LE&#(R-UA<YC+RH2*D::#RO_+9[C4W!*_'"J^S['W]S./_
MJ\V\-4:_&ZKU<K^:A\B^NV;!.D_>GSR(3L*L<O>>[+"SEF;KH%^%M?K3'US*
M"!Y_3?4G2Z3\P$NJ'GVKS,\ DS*YR40=J: <L4F_S(<X&%)%7LIP>L2)&\>.
M).F&$EG <0?73C\B!05^:%X<I:V<\3]Y-3GT,UM8SH1$\M00L&080E4I .-\
MS7A\8?P>G[]I!AK!V]:O5/DX/F/<._6@,K>3XL"BF[!9TP^'MDLS^0^?3P!T
M"U<\;'QC9NE).@@C[T07 ARM@C6_/\6'N],8ZF$DV906?I&> W/1L 7[A^)!
MC$O_'8)?S!E9.>]CU.>&4D@F)O-IDVQTH:HS/#8Y0IZV@=0P2*KI^=$0[H3]
M^M&:3TIB),(TF/?40,S"\;WS@SJ]IJPOG1,J&.:^"F*J>,D:9.Y8_UK?._5G
M M_;ES=[?9^<@2]5S)!1>:ZZ$$^%?.[7P?<MN0I_GWDQ?3D:SUF-E'Q0#I1%
MMUK](K ';:6E7_66$)/[IN_2%TBTM:]7K=J8%@J<B+9B-1:SOC9E8:YG,)!.
M'$-$QIB J2STU%_B(ZD5VWQ<@^B](QD@&+M#3[*W^JN,CN4_?JVI>5 B],G&
M73*-@7XT#;QPAL S&PJU5+T^#_!L=W,8,1:&:/(C-KS<I&$0L+,>/\*0W/"5
MWP_2:M^C>%-AZ>408&Q9*V6BS\4,'4'FI]]<KN ?2A_XHK)N<O !ZR(^V(M8
MF,U[8%N^'2.8Z"X.<DGILX=0:! __8(JG]ZI_OM9^Z[RJU?8D78D7=CA1S9X
M$+Z(KY3<"T?@K<5^AU2_N+.D(#7DQ5W"NHB\/G%HZW@K"@DP8QYD2AM[UU1G
M)QW-724WVKX$ERY%;C>E:= 1Q]W?EE)VRU=K\<!I9WNG1'6L]?69;CEYRRX@
M3!;LV;M(*@ZNUG+W^U_W[(8B[0+)8],L7JY CAC[6P<3R<H1$2GD*&<MSUBZ
MPJ(@8&Z8,@.7D-^K'6^*Y*Y7[ZWD^]BJ0@(S1!I^OVE]**^>$Y@U=/]7*D_!
M,Q@W^_XY6OZQ/;1IM5@"DK6);QU0-NHO[<##D#R"P%!=B9^M/>:FLG/[CGS_
MB[;O"FJ" ;JE*@1!B(#2B1 @0$ 0Z2)5DM #TH(H DH+&" @5:07Z80B4D0Z
MA)Y"5>D00'H+1:DB37I1O^]^_\Q]NG/OXYW9]YV=W3E[SL.>+4X17WI2(+_U
M,B-K7?_=CO.ICJ?&Q/W\%T81!R(HF+"'!ZUM?_M5HLB/XZ$.>QF/>:IS@CO2
M\C/[/'HCGPENH%GK')UFT5"",7[#D*9MY/Z3E>BGYM^&<#/ZD*NZY/FM>ZVL
MF<>H&(K:K7"UZD06(HN81$XM;MS==IK>V4IPJ;-'G\T!A<'7*,^5,'+%';S7
MBR%[5W_#F<W6<)Q',*X'REQXJJ>1U^OVVV+:VS7#Z)XW?QTE7.%:-.S*A2$O
MG"[*_W@F:1M&4EJ6]V8J\)6\-C@Y0Y 1B>?;$3J,"H<#K/GC&!&7??&L20;O
MA_J\WS_O74Q[]$7)]]-"?@P/0B1SC.(&MQ;?5M<ZV&I<*5+.:KHF7M=J\2>:
MX5R)V?(4W,1)<3$\46XB7+Q94/VS,OY I:OSS5^A>T_7K"-L6.<IF+.Y.\7S
MBQ@7N4XF+(L^([&NJ>H+[Z'"PS;>^,5+EN0EZ<P$]X87)=SEK)]CS\0RBAE4
M)\I?1BDB2Z+DDQG589*,XKY\SP-KG?WIF]>CFF$1'OMB3B\CR;\-7+9<QCF+
MRY.SN-BU&&ZT?!%P#G?ZRR^M]#&%1R!R]K='T&",B]K"^N(NPTOA';)ZONKZ
M"C'I^!_:S\\=[XJI.FB,C_\IG7^F>FP\0$L<G\>>'!P+^F_;;B<;HG-8SRX?
MN7<8DQ;MD8+/5[U0;,4BA'D(#.6.2"G^D1>Q+AQ^3ZLF:Y<Y63]Q'XJJO?N,
MQ-'<D)_,):JKO8025L9)2U0KSX\CPXKNM;L/ASQ6_>Y.D&_V<5R %MULCYN>
M*0+/,9M#B=]IC5K,+V4^Z"3+V!&^1=AP_Q._.K9[]ZF<8A!^X.V0"MM92DF%
M$0QSV/#*_=U[K+/]O<W/1H'+EU*._>L+Q7#<2^U-\N^DZ/>:-"T4Z:JDT1!@
M)]/2'US@.8W<^LG(F)=4HN04-C' X&_RAT6.">%_7-2&)-KG5S]'-+3O',S(
M<AWV-;&)RWB(K:J(&<)O*Y^=CN9/&&N$$5%(1$04 I%^*6'*Z,H0[KXL_0.7
M*_6IYK39>V71H!\K"R8*:BO,N)01MPW@B/0B/^99!HXGIBUR'D3GA[_9? Z6
M,=";\QR@"AEEJD,3&9 MZ7& \..#&(\K7,V+UKY[>IB4];C!W?>F8^_E_0L.
MPQ[Y;R&@HN(J(^7Z[DO.\BA6=LWR+!,?]=?\%N[HEG'2WIGK?8(2<^F<&;1N
M<&J@+U_@<]@O87J*;N1'N%BII7&69J.MMPNB0/%9 Q?4QTDYT]8*K, +AK@V
M"0L* U^EF:2W3)O\P%9B\RA6XR0Q_+ZA[F8.G6K\@C8O F;[3E)+(".EF+,<
MB!<RNM(A^V2%0+OIF7TRR/!%P_?ATY)9"F:ZB&RZ2MUG"--@1QH/F#(#3HK_
M(?>U&-<I)77GR%!5#WB76CNSX?$UJR$]B@4)V5; @MB/2:=YAP<V2L81*!GS
M]E^/-Q5^^S@;/JV(K2U)!6MY$8';D@"X-8!1LT*45<"#OW[L%>O2,XK;"?;9
MM: TF2V"@K6A,P*A[*/J7@!4SV!DV-FAU<)E8#7$P&DR\[_OREPG9R?67[EF
MD<6Y_?.5R%'\2W']!OV4E#R/*OV^?*/)K[Y;7&=RQ+Z=^W3290Q![^[-!^"@
M+#IO)*?3FB0$)<=F(FKO-;0>+\T%#,[V"X7:/F\H'S1 XT$-UK*<'ISIFQWM
M%Q?BMD>?FMO522:=-;.MR0CNWVDE%9O IC/S?3;\U(&ZKT(9YY4OOZZ<;6M=
MJ<-^AU9@]O"EI[@!##DKX9KG@HHA<5 @8'^D11LY:QL>BWGZ2]VO-IHX<K(Q
M#.1(5?P:%$[B>68(VW^HY><NJQZ-0L$-8I[PQ3)*K10?\L$6$8?7Q*CI1E&W
M7V._<*MG?T@I9%_U*@1]KN4[-DGD^.G6/A!X[9AR%]K;7T-B2;ARS3JM5+GS
M)D $^2[ H2$Z#'D\;@*. IJFA :Q_MI^W#['$M83?29YV9D/K!Y6&$CG@5Z9
M)%1GZ3BK8HN4\7IV?>PPX>?6JLUN%+"1YP ;>D0=EDBQ*Z5(P-D4!- @-N4L
MQ>)REPP&KZ?E[-AJ*[U5[8R_W]]6'M%=GKT:;A?MV=.( <XB+7#R* 22QRL.
MH<4?8CS5AOK:V![^EXU3W].*4S/"ZU+U!BO3I7-11CB HN=)_QD8PUD,-!X/
M=I$_2*JY]^YYYG8(@3$[+Z[_7=<ZB1]]:O@LA7M\.ESYTZ<H_<E =CU/^\&:
M':R]H.H:#-XP2'APKX(9XY92AL)DI)@79I09_W431QUL66>_UM_-QEY89=;<
MV/AJ6X <2AKD T_6X5Q9B6$I#,^/KY9.M>]W9SZ4XS:VNBILGLR<>OL^<Q,C
MVYQ.%1HAZAY$A<\4Y/P*U>+Z=(*YU>O@U[0@[9/N]<8K44Z)VV*\:T_]<%Y'
MPD.V  P%B3A.YOUPR1O.+;]34R?K]8D-6VF4%?HO#9VCJVR#FL/GUXHE)0XP
MX? HH>P3!DON)^-DE<3%B_V%LB[4 4]\DRXTC)/2LR$ 1W)JCWX7#5@)X62J
M7GC!_%!19J_R0'75OZ5:36Q=5%YPWI1/GQ/41*33Y.4W28,O_1#QOCQSBG F
MV3TAV0%SQA;>3S!Y2R6</>Q$%*-E,SC_N-*"])QV& 0L0SY53QOD'2WP)*KK
MG7VA>6PY?H/#)%/M.ZU><!OI8X?J''W0@:U)S\A@7.>WA.JU1<[?^VH0C -4
MYJI.\,2<A?=X<%,46@*PWI\6(+"_GR?4^*2^:CUU[N['>K]W.=NA=V-UJE53
M9AD_=L%Y734*+ZNV?]WB7NIPM'+/ZQ#UVSC=4.ZZC1R=1[G.?#9G0B(N=ETE
MA$M$V5S7D,95 3BLX'*,_:[?[XP )L^5(\Q\-JZ1R@:U,TT+_^:[:\N'X+P*
M:E#?UC^_UXM96+3JK4F<7S1']P<N_;S-/9F),G#X7,8G0Z1#AB&X4W\EZ[3_
MM;]4>3YX2'#Z9&"$]FIG0U 3]G[JQ+\M)#81%$HB/>B0N,B"QW3&72%Q6,"5
MQV_;4^X*ZO)I \LXQ)#O0+WCS,C/Z)Z,-Q^;JL&:B9SQ$67XO9&!=\YWGL_A
MC3_'0'%VH!+W8%AF-,I66^ 7#FP['HM4(HB/\B2I32AS@YW< YVJJK(.[U\@
M32D.3X4_'MN@F>?@AT6 Y,0\FBOQ0MKH79CK5@[CW@_K9*"H[P FC.>YVE9(
M<1*K^(LT&B2N0?]KH+"<U:Y0DA+SC9N>K4I<1BI2Y%6/PEA\5?@:1B;J)6"-
MA@9OQXG$T;9<?CJQY4J;R%R;OH;\'LS.:^MDEVWA9YVVRL=85R: ^$I7PJ;%
MJ,%)*][C]&G4'?08US_AW!LZQV.:]G,V0;AMP*>YQV':,D6;5"(J>J%!2#^7
M>".VG(H26=Z3J%N*S-_%IPL8W5GM/N,>3W!^>K16 ]8#Z9[/A DF8>,7!3'/
M]$I_=OLY-5ZQ6Z$BGHF6:2-NV1A$XM"]7Y!T*8#/DESK#MN/6D7]/B](09?S
M#@C]D4(<<U)):6%EQZ0WD/.^3EK[-^K8HN U7S^.D)E2)_]'U/S,GEY?KNP?
MSRQ*PY5;&G@!QA1T>8DD @X[*-(:S!O[[;L3Q%\ON?E2K[+?L:)4VUH2:U@A
MB4:\;++$!0L#Y_3#]4<B[LK\]+VF'31VT[/9;B'A^A9SZ=(X-ZAW3F!&!2JZ
M'W^<P2C]RS)]I;[ZL3W!R6H#/R:\\-:_]#YM[KMYS?B=:*IYI;:)QNM"G(14
MS V\5ZC4S)VMX&#BNIB[?VX>;J N-#$_-^ %<G57%_2X=QJI?R^LF#-/^N)X
M!E]6>FJ'MISL#3@U _XX&;QK@%'=(U,2N?^ET7<&L4F\V?[FD2<0V?G_U65<
M).^RKOGG\.$KYD&P BE:?4?*_2].84 )B&NA!M,E S-V#D7<SDF_WAS@3@P@
M?:5_&;S>9,XU&\?*CD^QR2^8>^AC,S/+D#P,9S,=$ #2]MS7S^T;&7OW)M&I
MLA%.OK*7J#S!ENR'A3D;;S=E"3!+>.4(BZ?%B'SSF)F:J+B%[QA-B-RN8D5-
MY[!<5XW"3  FRB9^,PC\\Y7SD?^,JUOZA*'<]F$U5/GO-%WI7\FZUA?R\X/A
M ZKFP>V*P>?E8DJ309GWHYGB!QU7#:F[WJ54KB\DQR4AX#+,324 ;)!$Q\ND
MXR1=,NEJG]OA>.+(D[909BYCRQ/;'VHP0G4B4IDA %HW\Z=@/4E$.#, I+FM
M:]F[E3VW.YB=-?TGZRFTJ6,(9H+ $J#JJ;\4HZ0&_?RN)N>72VQ_?5Q+#S$W
M%9.1_&TN,D PLGOFV.]&M[P1G9;T"X:A\<8&FHK#QZX0;/YQ"% >^HW^?<]
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M6%X61C&(XCC66$T?61I7VJ\/DW1:-NKPKQ9F!,T#Y$6I2Z_PK K%O<CQ" &
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MZ;OJX.Q-.?0[K\* /BV-[3GECHLBX=GK@6#.),8C)6_,3.AZ%FCZT G/41X
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MV)X2&Z5O.4FRD4&IBEKE<_LF>/2_#"'@'"^@G43_H[GH@<Z"!09B!-&&7$X
M647-NW=37:?C@JE;6E_,#/,N4"SIS3*J.C[39\I3@4GR"8*AVPTT)]DD_H9]
M\"E8*FNTR?9"VZAXK!)RQ0TC2D^L[;G>W9J8^/!5J18?A-N$V. ;8U[VRT>%
MS_(7729=YBZD^+6F]T@'XID;0;U@EU"#8,I5 3!WL,J'CA1[6_<3%R]2(I]N
M>(I#YM'IW$>WT(50IR97*?AG3N@-2B\7Z:-?)>9,NS_EF[&7DLO:())AR.C@
MV&?'Z[]6WD2(FT'H(=!4[\D+XH5 FWB8$8]X_P*B-NFR8 PZVUU)*?.6".GF
M55T/.U4%)X42:1TH956#2%YR3^*[;*>/V$-QEO9UNY'M;H9N)_C%9R'/% 4>
M(H"[$8]W7W\)SCK1G,RC^/XSQZ"7WRII8]LF?]O7RO7G-QW1HL&IW7A'8-U!
MU9N$R3H$@"PNN2W>;\?HC656G,]V<55Y&K%>!M/AJ1O1ZKZ&:'=Z8)^DD113
M@"UU\2\%_S*N9D[!V1@[GWLG=K'?7<SMTL VD"MUU"@;_N);#!D+A(T'>",U
M?I%W-R@8).9Y[5 UT"\T')>Y-/&C9CJ\&^RME-< _%!/:4!-58['GRM#.I(O
M*1E<NI6_S\ORTFW0K@^Z[ON#;H78BF'*"2(=HC%51RE"\$B_O.[M^MF,0>QT
M0:<C;Y-:U@:)=#TJ,E]D0!6$8PLF6BF*9[7$40A_.RRV=UFXXX;Y3<RAWK?$
MC%[*1E8UZC!$T4,5[)#,#@(/;.Q>%;85[9,<F/:K>H1UJ3T2DBA?WLGG5"9(
MT.: !7@3@EC$0L7$[WC!,S$1FV(M@L0^0_9FY>/5MQE,*D1V0S$+Q*CA,.J<
M]>13D**+WWEY3 5_-G#D]9),&FKSA?#H)-/DU+6AA0ERT3#];5H X0/+'"*H
M3D@VMP6?]T0PROP9O4#%B2[H1DN]67KFB-?[J8@9,;#&6,4%F?BEOBQ4/]^W
MAI+@\.W"XQ2QQV].,]4&;/;HR;'_SF3[4 @9]3OP.O7;<A(\UHJZ4V&UIWQ[
MX0TBC397>V+A/ -Q4_!:_KP!KYB4C35B8R]70! 4 REWWS.0+_WR;-@'C=U8
MV;),\J6D?2.U1+J7(KHP_BI[U7!12OX10I*2\+=4$W2WMY9"X51IB%^57V"R
MW@>:H:MDRR(UL>J]\7.Y6'RN9T22/,FJ'VU,?_VZR!*S8&9+>Q4,$JAC991!
M(TSBN^W18L/ '9OW"IS&1Z0!605BQ24)=_V]\X97D//V5Y7^Q5NS>==\$=R4
MDSW%Y#DP0[3T?6"4=OIZ*N(@]/.6=.?LSR6XZQ.,C=B^2]M?@,KIE*  1KW
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M>8-I;-)#H;%F63ARO'.0\^H.*,>WIGE)-^^<WH0MG"?!ZY/Z BVVJ1LEFW@
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M*1WY)%8.U%OJKQ"KT29]YT)$L)1;4;9$Q\*7:F]C#NQ@D:*06I/[(7!M_*[
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M')W</WBZ.0X-&7_8X<SP&+]\I*00=3991+OWM+TAI9ZG.*0 *3M_DK1* @
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M@%KZN^TE;+R^KU]6 NZ8$*?5>P0HCMU?;&V[WQ2ZF6C+-7"+D \U25I2*;U
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M$A)BQ72;*L2D2RKU"#YNYCF!3^<I 2A5=SO^.N)V54/Z#@]R3+9HR#*J<SH
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M86EM9S R+FIP9U!+ 0(4 Q0    ( &JEV5SCA,RX+NH! "@: @ :
M      "  2\7 @!T;3(V,S$Y-V0U7V1E9C$T86EM9S S+FIP9U!+ 0(4 Q0
M   ( &JEV5SR3:LNW!(" ']- @ :              "  94!! !T;3(V,S$Y
I-V0U7V1E9C$T86EM9S T+FIP9U!+!08     "0 ) &L"  "I% 8    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>tm263197d5_def14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ctso="http://cytosorbents.com/20251231"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ctso-20251231.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:StockAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:OptionAwardsValueInCompensationTableForTheApplicableYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ctso:EquityAwardsAdjustmentsChangeInFairValueOfAwardsGrantedInPriorYearsForfeitedDuringCurrentYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001175151</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-107">CYTOSORBENTS CORPORATION</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c0" id="ixv-6885">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="c0" id="ixv-3243">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;From time to time, the Company
grants stock options, stock appreciation rights, or similar option-like instruments to employees, including our named executive officers.
Historically, we have granted such equity in connection with annual compensation and performance reviews, as well as for new hires, promotions,
or other non-routine grants where the timing of such grants is tied to the event giving rise to the award. The Company does not have
any formal policy that requires us to grant, or avoid granting, stock options at particular times and no specific practice on the timing
of awards of such options in relation to the disclosure of material nonpublic information by the Company. However, the Company&#x2019;s
practice is to consider such information, with participation of the Board and Compensation Committee, to ensure grants are unlikely to
occur close to the release of material nonpublic information. In all cases, the timing of grants of stock options occurs independent
of the release of any material nonpublic information, and we do not time the disclosure of material nonpublic information for the purpose
of affecting the value of executive compensation.&#160;&lt;/p&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="c0" id="ixv-6886">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgMethodTextBlock contextRef="c0" id="ixv-6887">we have granted such equity in connection with annual compensation and performance reviews, as well as for new hires, promotions,
or other non-routine grants where the timing of such grants is tied to the event giving rise to the award.the timing of grants of stock options occurs independent
of the release of any material nonpublic information</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="c0" id="ixv-6888">the Company&#x2019;s
practice is to consider such information, with participation of the Board and Compensation Committee, to ensure grants are unlikely to
occur close to the release of material nonpublic information.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c0" id="ixv-6889">true</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="c0" id="ixv-6891">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:PvpTableTextBlock contextRef="c0" id="ixv-4570">&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;Summary&lt;br/&gt; Compensation &lt;br/&gt;
Table Total for&lt;br/&gt; PEO($)(1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;Compensation&lt;br/&gt; Actually Paid to&lt;br/&gt; PEO($)(2)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;Average&lt;br/&gt; Summary&lt;br/&gt; Compensation&lt;br/&gt; Table Total for&lt;br/&gt; Non-PEO Named&lt;br/&gt; Executive&lt;br/&gt; Officers($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;Average&lt;br/&gt; Compensation&lt;br/&gt; Actually Paid to&lt;br/&gt; Non-PEO Named&lt;br/&gt; Executive&lt;br/&gt; Officers($)(3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;Value of Initial&lt;br/&gt; Fixed $100&lt;br/&gt; Investment Based&lt;br/&gt; On Total&lt;br/&gt; Shareholder&lt;br/&gt; Return($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"&gt;Net &lt;br/&gt;
Income/(Loss) ($)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;808,431&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;723,164&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;679,233&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;564,719&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;11.73&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 11%; font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(8,197,439&lt;/td&gt;&lt;td style="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;899,695&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;953,144&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;895,556&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;770,636&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;16.70&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(20,718,957&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;1,333,401&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;729,761&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;994,690&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;734,380&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;20.37&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;$&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(29,246,760&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;For years 2025, 2024 and 2023,&#160;Dr.&#160;Phillip P. Chan&#160;has been our Principal Executive Officer.
The averages for year 2025 for our Non-PEO Named Executive Officers consist of our President and Chief Operating Officer (Vincent J. Capponi),
our Chief Financial Officer (Peter J. Mariani), and our Chief Medical Officer (Efthymios, N. Deliargyris). The averages for 2024 for our
Non-PEO Named Executive Officers consists of Vincent J. Capponi, our Chief Financial Officer (Kathleen P. Bloch from January&#160;1, 2024
to August&#160;13, 2024 and Peter J. Mariani from August&#160;14, 2024 to December&#160;31, 2024), and Efthymios, N. Deliargyris. The
averages for 2023 for our Non-PEO Named Executive Officers consists of Vincent J. Capponi, Kathleen P. Bloch, and Efthymios, N. Deliargyris.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Adjustment to Compensation Actually Paid to PEO include deduction of &#x201c;stock awards&#x201d; and &#x201c;options
awards&#x201d; for the year, which include a) add award granted in the year that remain outstanding and unvested at fair value as of end
of the year, b) add award granted in the year that vested in the same year at fair value as of the vesting date, c) add or subtract (if
negative) any award granted before the year and remain outstanding and unvested as of year-end at fair value, d) add or subtract (if negative)
any award granted before the year but vested during the year at fair value as of the vesting date, e) subtract any award vested and forfeited
at fair value as of end of the prior year, f) add unvested award on which dividends or other earnings were paid during the year not otherwise
included in summary total compensation column.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(3)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Adjustment to Average Compensation Actually Paid to Non-PEO Named Executive Officers.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Adjustment to Determine Compensation &#x201c;Actually Paid&#x201d; to PEO&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Stock Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(105,600&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(91,680&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(307,110&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Option Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(100,862&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(169,888&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(374,514&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;27,428&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;144,361&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;188,015&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-1"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(32,639&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(58,377&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(341,105&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;126,406&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;229,032&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;231,073&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-4"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-5"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-6"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-7"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-8"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-9"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total Adjustments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(85,267&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;53,448&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(603,641&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Stock Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(76,867&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(122,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(180,313&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Option Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(72,984&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(244,350&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(242,195&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;19,724&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;188,731&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;130,704&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-10"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-11"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;20,886&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(53,424&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(106,288&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(164,467&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;69,037&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;159,261&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;175,076&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-12"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-13"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-14"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-15"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-16"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-17"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total Adjustments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(114,514&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(124,920&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(260,310&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c0" decimals="0" id="ixv-6892" unitRef="usd">808431</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c0" decimals="0" id="ixv-6893" unitRef="usd">723164</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c0" decimals="0" id="ixv-6894" unitRef="usd">679233</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c0" decimals="0" id="ixv-6895" unitRef="usd">564719</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c0" decimals="2" id="ixv-6896" unitRef="usd">11.73</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" id="ixv-6897" unitRef="usd">-8197439</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c1" decimals="0" id="ixv-6898" unitRef="usd">899695</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c1" decimals="0" id="ixv-6899" unitRef="usd">953144</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c1" decimals="0" id="ixv-6900" unitRef="usd">895556</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c1" decimals="0" id="ixv-6901" unitRef="usd">770636</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c1" decimals="2" id="ixv-6902" unitRef="usd">16.7</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c1" decimals="0" id="ixv-6903" unitRef="usd">-20718957</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt contextRef="c2" decimals="0" id="ixv-6904" unitRef="usd">1333401</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c2" decimals="0" id="ixv-6905" unitRef="usd">729761</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c2" decimals="0" id="ixv-6906" unitRef="usd">994690</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c2" decimals="0" id="ixv-6907" unitRef="usd">734380</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c2" decimals="2" id="ixv-6908" unitRef="usd">20.37</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c2" decimals="0" id="ixv-6909" unitRef="usd">-29246760</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c0" id="ixv-4697">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(1)&lt;/td&gt;&lt;td style="text-align: justify"&gt;For years 2025, 2024 and 2023,&#160;Dr.&#160;Phillip P. Chan&#160;has been our Principal Executive Officer.
The averages for year 2025 for our Non-PEO Named Executive Officers consist of our President and Chief Operating Officer (Vincent J. Capponi),
our Chief Financial Officer (Peter J. Mariani), and our Chief Medical Officer (Efthymios, N. Deliargyris). The averages for 2024 for our
Non-PEO Named Executive Officers consists of Vincent J. Capponi, our Chief Financial Officer (Kathleen P. Bloch from January&#160;1, 2024
to August&#160;13, 2024 and Peter J. Mariani from August&#160;14, 2024 to December&#160;31, 2024), and Efthymios, N. Deliargyris. The
averages for 2023 for our Non-PEO Named Executive Officers consists of Vincent J. Capponi, Kathleen P. Bloch, and Efthymios, N. Deliargyris.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c0" id="ixv-6910">Dr.&#160;Phillip P. Chan</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c0" id="ixv-4704">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Adjustment to Compensation Actually Paid to PEO include deduction of &#x201c;stock awards&#x201d; and &#x201c;options
awards&#x201d; for the year, which include a) add award granted in the year that remain outstanding and unvested at fair value as of end
of the year, b) add award granted in the year that vested in the same year at fair value as of the vesting date, c) add or subtract (if
negative) any award granted before the year and remain outstanding and unvested as of year-end at fair value, d) add or subtract (if negative)
any award granted before the year but vested during the year at fair value as of the vesting date, e) subtract any award vested and forfeited
at fair value as of end of the prior year, f) add unvested award on which dividends or other earnings were paid during the year not otherwise
included in summary total compensation column.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(3)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Adjustment to Average Compensation Actually Paid to Non-PEO Named Executive Officers.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Adjustment to Determine Compensation &#x201c;Actually Paid&#x201d; to PEO&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Stock Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(105,600&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(91,680&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(307,110&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Option Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(100,862&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(169,888&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(374,514&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;27,428&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;144,361&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;188,015&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-1"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(32,639&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(58,377&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(341,105&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;126,406&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;229,032&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;231,073&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-4"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-5"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-6"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-7"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-8"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-9"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total Adjustments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(85,267&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;53,448&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(603,641&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Stock Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(76,867&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(122,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(180,313&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Option Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(72,984&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(244,350&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(242,195&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;19,724&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;188,731&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;130,704&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-10"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-11"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;20,886&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(53,424&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(106,288&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(164,467&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;69,037&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;159,261&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;175,076&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-12"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-13"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-14"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-15"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-16"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-17"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total Adjustments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(114,514&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(124,920&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(260,310&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c0" id="ixv-4705">&lt;table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;" width="100%"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(2)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Adjustment to Compensation Actually Paid to PEO include deduction of &#x201c;stock awards&#x201d; and &#x201c;options
awards&#x201d; for the year, which include a) add award granted in the year that remain outstanding and unvested at fair value as of end
of the year, b) add award granted in the year that vested in the same year at fair value as of the vesting date, c) add or subtract (if
negative) any award granted before the year and remain outstanding and unvested as of year-end at fair value, d) add or subtract (if negative)
any award granted before the year but vested during the year at fair value as of the vesting date, e) subtract any award vested and forfeited
at fair value as of end of the prior year, f) add unvested award on which dividends or other earnings were paid during the year not otherwise
included in summary total compensation column.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table cellpadding="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"&gt;&lt;/td&gt;&lt;td style="width: 0.5in"&gt;(3)&lt;/td&gt;&lt;td style="text-align: justify"&gt;Adjustment to Average Compensation Actually Paid to Non-PEO Named Executive Officers.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="10" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;Adjustment to Determine Compensation &#x201c;Actually Paid&#x201d; to PEO&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font-size: 10pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2024&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 61%; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Stock Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(105,600&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(91,680&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"&gt;(307,110&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Option Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(100,862&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(169,888&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(374,514&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;27,428&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;144,361&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;188,015&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-1"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-3"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(32,639&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(58,377&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(341,105&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;126,406&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;229,032&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;231,073&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-4"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-5"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-6"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-7"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-8"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-9"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total Adjustments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(85,267&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;53,448&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(603,641&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Stock Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(76,867&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(122,274&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(180,313&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction for Amounts Reported under the &#x201c;Option Awards&#x201d; Column in the SCT&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(72,984&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(244,350&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(242,195&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Fair Value of Awards Granted During the Year that Remain Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;19,724&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;188,731&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;130,704&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase for Fair Value of Awards Granted During the Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-10"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-11"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;20,886&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Current Year-end of Awards Granted Prior to Year that were Outstanding and Unvested as of Year-end&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(53,424&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(106,288&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(164,467&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase/(Decrease) for Change in Fair Value from Prior Year-end to Vesting Date of Awards Granted Prior to Year that Vested During the Year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;69,037&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;159,261&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;175,076&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Deduction of Fair Value of Awards Granted Prior to year that were Forfeited during year&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-12"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-13"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-14"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Increase based on Dividends or Other Earnings Paid during year Prior to Vesting Date of Award&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-15"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-16"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;&lt;span style="-sec-ix-hidden: hidden-fact-17"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt; &lt;tr style="vertical-align: bottom; "&gt; &lt;td style="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;Total Adjustments&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(114,514&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(124,920&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: right"&gt;(260,310&lt;/td&gt;&lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt; &lt;/table&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:AdjToCompAmt contextRef="c3" decimals="0" id="ixv-6911" unitRef="usd">-105600</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c4" decimals="0" id="ixv-6912" unitRef="usd">-91680</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c5" decimals="0" id="ixv-6913" unitRef="usd">-307110</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c6" decimals="0" id="ixv-6914" unitRef="usd">-100862</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c7" decimals="0" id="ixv-6915" unitRef="usd">-169888</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c8" decimals="0" id="ixv-6916" unitRef="usd">-374514</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c9" decimals="0" id="ixv-6917" unitRef="usd">27428</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c10" decimals="0" id="ixv-6918" unitRef="usd">144361</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c11" decimals="0" id="ixv-6919" unitRef="usd">188015</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c15" decimals="0" id="ixv-6920" unitRef="usd">-32639</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c16" decimals="0" id="ixv-6921" unitRef="usd">-58377</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c17" decimals="0" id="ixv-6922" unitRef="usd">-341105</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c18" decimals="0" id="ixv-6923" unitRef="usd">126406</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c19" decimals="0" id="ixv-6924" unitRef="usd">229032</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c20" decimals="0" id="ixv-6925" unitRef="usd">231073</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c27" decimals="0" id="ixv-6926" unitRef="usd">-85267</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c28" decimals="0" id="ixv-6927" unitRef="usd">53448</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c29" decimals="0" id="ixv-6928" unitRef="usd">-603641</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c30" decimals="0" id="ixv-6929" unitRef="usd">-76867</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c31" decimals="0" id="ixv-6930" unitRef="usd">-122274</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c32" decimals="0" id="ixv-6931" unitRef="usd">-180313</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c33" decimals="0" id="ixv-6932" unitRef="usd">-72984</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c34" decimals="0" id="ixv-6933" unitRef="usd">-244350</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c35" decimals="0" id="ixv-6934" unitRef="usd">-242195</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c36" decimals="0" id="ixv-6935" unitRef="usd">19724</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c37" decimals="0" id="ixv-6936" unitRef="usd">188731</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c38" decimals="0" id="ixv-6937" unitRef="usd">130704</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c41" decimals="0" id="ixv-6938" unitRef="usd">20886</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c42" decimals="0" id="ixv-6939" unitRef="usd">-53424</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c43" decimals="0" id="ixv-6940" unitRef="usd">-106288</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c44" decimals="0" id="ixv-6941" unitRef="usd">-164467</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c45" decimals="0" id="ixv-6942" unitRef="usd">69037</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c46" decimals="0" id="ixv-6943" unitRef="usd">159261</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c47" decimals="0" id="ixv-6944" unitRef="usd">175076</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c54" decimals="0" id="ixv-6945" unitRef="usd">-114514</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c55" decimals="0" id="ixv-6946" unitRef="usd">-124920</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c56" decimals="0" id="ixv-6947" unitRef="usd">-260310</ecd:AdjToCompAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c0" id="ixv-5038">&lt;img alt="" src="tm263197d5_def14aimg01.jpg" style="height: 461px; width: 650px"/&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c0" id="ixv-5058">&lt;img alt="" src="tm263197d5_def14aimg02.jpg" style="height: 434px; width: 650px"/&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <dei:DocumentType contextRef="c0" id="hidden-fact-0">DEF 14A</dei:DocumentType>
    <ecd:AdjToCompAmt
      contextRef="c12"
      id="hidden-fact-1"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c13"
      id="hidden-fact-2"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c14"
      id="hidden-fact-3"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c21"
      id="hidden-fact-4"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c22"
      id="hidden-fact-5"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c23"
      id="hidden-fact-6"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c24"
      id="hidden-fact-7"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c25"
      id="hidden-fact-8"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c26"
      id="hidden-fact-9"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c39"
      id="hidden-fact-10"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c40"
      id="hidden-fact-11"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c48"
      id="hidden-fact-12"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c49"
      id="hidden-fact-13"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c50"
      id="hidden-fact-14"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c51"
      id="hidden-fact-15"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c52"
      id="hidden-fact-16"
      unitRef="usd"
      xsi:nil="true"/>
    <ecd:AdjToCompAmt
      contextRef="c53"
      id="hidden-fact-17"
      unitRef="usd"
      xsi:nil="true"/>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-6968">0001175151</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-6969">false</dei:AmendmentFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
